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Carbohydrates provide energy in living organisms and are a structural component of the 
cell wall. Over the past decade, certain carbohydrates have also been associated with the 
growth of beneficial bacteria in the human gut. Prominent examples of such ‘prebiotics’ 
include inulin1, trans- galactooligosaccharides2, resistant starches3 and mannan 
oligosaccharides4, 5. Carbohydrates also play a pivotal role in recognition processes 
when attached to proteins or lipids6. Moreover, glycosylation, the attachment of a 
carbohydrate moiety, can drastically change both the physicochemical and biological 
properties compared to the aglycon.  
 
Indeed, glycosylation is known to improve the stability of labile compounds such as 
vitamin C7, modulate the activity spectrum of antibiotics8, and enhance the solubility of 
flavonoids and stilbenoids9. Vancomycin, for example, exhibits its antibacterial activity 
by binding essential bacterial cell wall mucopeptide precursors terminating in the 
sequence L-Lys–D-Ala–D-Ala, which blocks their further processing into peptidoglycans. 
Although this binding is ensured by five hydrogen bonds between amide protons of the 
aglycon and the cellwall precursors, the carbohydrate moieties were found to be crucial 
in the required dimerization and anchoring of the antibiotic to the cell membrane8. The 
increased hydrophilicity, on the other hand, significantly influences the pharmacokinetic 
and dynamic properties of drugs, while glycosylation also allows targeting to specific 
organs, thus enabling the use of smaller doses10. In addition, glycosylation often leads to 
a modified perception of flavors and fragrances. A prime example is glycyrrhizin, found 
in sweetwood (Glycirhyza glabra). The latter terpenoid glycoside loses most of its 
sweetness upon hydrolysis11. The α-glucoside of L-menthol, in turn, is only slowly 
hydrolyzed in the mouth, resulting in a prolonged sensation of freshness12. 
Consequently, the development of a cheap and efficient glycosylation technology is 
highly desirable. 
 
Chemical glycosylation is typically performed based on the Fischer or Koenings-Knorr 
reaction13. The former is performed by reacting an aldose or ketose with an alcohol in 
the presence of an acid catalyst, while the latter uses glycosyl halides, activated with 
silver salts, as glycosyl donors. Unfortunately, the substrates of the Fisher glycosylation 
are limited to simple alcohols, and product isolation is hampered by the formation of 
different isomers and anomers14. In contrast, the regioselectivity of Koenings-Knorr 
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glycosylations can be controlled by applying appropriate protection strategies, while the 
anomeric configuration is strongly dependent on the neighboring group participation of 
the C2 substituent and the type of solvents and catalysts used15.  
 
Despite the continuous development of new procedures, including the use of glycosyl 
trichloroacetimidates16 and the more stable n-pentenyl glycosides17, chemical synthesis 
of glycosides still suffers from a number of drawbacks. Indeed, labor-intensive activation 
and protection procedures require the use of toxic catalysts and solvents, resulting in 
the generation of large amounts of (toxic) waste. Moreover, the commonly used 
multistep synthetic routes often result in low yields, while limiting the overall 
productivity13, 15. Biocatalytic approaches are, therefore, an attractive alternative that 
enables one-step reactions with high regio- and stereoselectivity18. Enzymatic 
glycosylation reactions typically generate 5-fold less waste and have a 15-fold higher 
space-time yield, a tremendous improvement in the eco-efficiency19. 
 
In general, four types of carbohydrate-active enzymes (CAZymes) can be used to 
transfer glycosyl moieties (Figure I.1). Glycoside hydrolases (GH) are in vivo hydrolytic 
enzymes, transferring the cleaved glycosyl moieties to water20. However, GHs can also 
be used for synthetic purposes when applied under either kinetic (transglycosylation) or 
thermodynamic (reverse hydrolysis) control21. Although many specificities have been 
reported, the yields are typically low. Indeed, the presence of water is essential to retain 
enzymatic activity, but inevitably also leads to hydrolysis of the substrates or products. 
As a result, the water activity of the reaction mixtures should be carefully balanced, 
compromising high yields, and generally resulting in poor productivities. 
 
Glycosyl transferases (GT), on the other hand, can be considered nature’s catalysts for 
glycosylation reactions. These enzymes have evolved over millions of years to optimally 
catalyze glycosyl transfer reactions, and thus combine high yields and productivities 
with excellent regio- and stereocontrol22. Unfortunately, their application is hampered 
by the high price of the required nucleotide-activated donor substrates (e.g., uridine 
diphosphate glucose (UDP-Glc)). Furthermore GTs are often membrane-associated 
enzymes originating from plants, complicating expression and purification procedures23. 
As a result, the overall productivity, also taking the production of active enzyme into 
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consideration, is rather limited. Although many GTs have nowadays been identified in 
microorganisms24, and the in situ formation of UDP-Glc from sucrose and UDP has been 
described25, the use of GTs is limited to the field of therapeutic compounds like complex 
oligosaccharides26. 
 
 
Figure I.1 Glycosylation reactions catalyzed by glycosyl transferases (GT), transglycosidases (TG), 
glycoside phosphorylases (GP) and glycoside hydrolases (GH). The four classes of CAZymes are listed with 
their respective benefits and drawbacks; adapted from27.  
 
Two types of glycosyl transferring enzymes have properties that lay between GHs and 
GTs. These enzymes are capable of achieving moderate yields, without the need for 
expensive nucleotide-activated donor substrates. Transglycosidases (TG), on the one 
hand, employ non-activated carbohydrates (e.g., sucrose) for the transfer of a glycosyl 
group28. Glycoside phosphorylases (GP), on the other hand, require glycosyl phosphates 
(e.g., α-D-glucose 1-phosphate (αG1P)) as donor29. TGs have been successfully applied 
for the synthesis of prebiotic oligosaccharides30 and various glycoconjugates31-33. 
Nevertheless, their application is hampered by the limited availability of specificities, 
typically only allowing the transfer of α-glucosyl or β-fructosyl moieties to a narrow 
range of acceptors27. Indeed, their low affinity towards non-carbohydrate acceptors, 
combined with the loss of activity due to the use of solvents, generally limits the 
productivity of these enzymes for the glycosylation of small organic compounds. 
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In vivo, glycoside phosphorylases degrade di- and oligosaccharides using inorganic 
phosphate; thereby producing a glycosyl phosphate and a saccharide of reduced chain 
length. The phosphate moiety can be conveniently transferred from C1 to C6 by a 
phosphomutase, allowing its use in the glycolysis without further activation by a 
kinase34. Moreover, the high-energy content of the produced glycosyl phosphates allows 
the reactions to be reversed, enabling the application of GPs for synthetic purposes in 
vitro. This property has already been vastly exploited, resulting in the synthesis of 
several unnatural tri- and disaccharides using cellobiose phosphorylase (CP)35, 36. 
Besides CP, also cellodextrin phosphorylase (CDP) and sucrose phosphorylase (SP) have 
been used to glycosylate a variety of compounds. Indeed, the former has been applied 
for the glycosylation of oligosaccharides37, alkyl glucosides38 and phenolic glucosides39, 
while the latter has been described for the synthesis of 2-O-α-D-glucopyranosyl L-
ascorbic acid7 and 2-O-(α-D-glucopyranosyl) sn-glycerol40. Despite many endeavors in 
the field of enzyme engineering39, 41-43, the industrial applicability of these enzymes is 
still hampered by the limited number of specificities and the availability of αG1P. 
 
Therefore, an efficient strategy for the production of αG1P was first developed 
(CHAPTER 1). The use of the recently reported Bifidobacterium adolescentis SP 
Sepabeads44, combined with a yeast treatment and crystallization step allowed the 
isolation of large quantities of pure αG1P. Besides enzyme engineering, process 
engineering (i.e. optimizing the reaction temperature, pH, substrate concentrations and 
the use of solvents) and molecular imprinting are valuable tools to expand the 
applicability of enzymes. In view of the recently reported SP cross-linked enzyme 
aggregates (CLEA)45, a new technology combining covalent immobilization and 
molecular imprinting was established in CHAPTER 2. The latter technique was developed 
to combine an enhanced selectivity towards alternative substrates with an improved 
thermostability. Next, the glycosylation potential of SP was scrutinized using various 
cosolvents (CHAPTER 3) and biphasic reaction systems (CHAPTER 4). A broad range of 
solvents and operational conditions were evaluated, identifying the IL AMMOENG 101 
and ethyl acetate as potent solvents for glycosylation reactions. Moreover, the use of the 
optimized reaction conditions allowed the synthesis of a broad range of challenging α-
glucosides. 
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The optimized reaction conditions obtained in CHAPTER 3 and 4 were then combined 
with the αG1P produced in CHAPTER 1, allowing the synthesis of various β-glucosides 
with cellobiose phosphorylase. In addition, the concept of imprinted cross-linked 
enzyme aggregates (iCLEAs) was revisited using CP (CHAPTER 5). Next, the use of 
cosolvents and biphasic catalysis with the α-L-rhamnosidase from Aspergillus terreus 
was evaluated (CHAPTER 6), thereby expanding the diversity of glycosides to α-L-
rhamnosides. The previously obtained glucosides were then further glycosylated using 
cellodextrin phosphorylase and αG1P as donor. Careful optimization of the reaction 
conditions allowed the synthesis of numerous cellobiosides and cellotriosides, while the 
performance of the CDP originating from Clostridium stercorarium was further improved 
by enzyme engineering (CHAPTER 7). Next, the previously studied GPs were combined for 
the synthesis and isolation of a wide range of glycosylated antioxidants. The solubility, 
thermal stability and radical scavenging properties of the established antioxidant library 
was then scrutinized, thereby revealing the application potential of glycosylated 
antioxidants (CHAPTER 8). Finally, a recently developed SP mutant43 was evaluated for 
the production of kojibiose. The use of an integrated approach during the design of the 
process, allowed the synthesis and isolation of crystalline kojibiose with high yields 
(CHAPTER 9).  
  
 
 
 
 
 
 
 
 
 
CHAPTER 1 
Operational stability of immobilized sucrose 
phosphorylase: continuous production of α-glucose 
1-phosphate at elevated temperatures 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter has been published as: 
K. De Winter, A. Cerdobbel, W. Soetaert and T. Desmet, 2011, Operational stability of 
immobilized sucrose phosphorylase: Continuous production of α-glucose 1-phosphate at 
elevated temperatures, Process Biochemistry, 46, 2074-2078. 
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1 ABSTRACT 
Sucrose phosphorylase (SP) is a useful biocatalyst for the selective transfer of α-glucosyl 
residues to a variety of acceptor molecules. At the industrial scale, however, conversions 
of sucrose would preferably be performed at 60 °C or higher. Previous research has  
shown that the stability of the SP from Bifidobacterium adolescentis can be significantly 
improved by immobilization on Sepabeads EC-HFA. Therefore, this biocatalyst has now 
been applied for the continuous production of α-D-glucose 1-phosphate from sucrose. To 
lower the costs, the enzyme has only been partially purified prior to immobilization. 
Interestingly, the presence of the substrate sucrose was found to dramatically enhance 
the stability of the biocatalyst, allowing its use in a packed-bed reactor for more than 
2 weeks at 60 °C without loss of activity. The overall process generated a space-time 
yield of 179 g/L/h, and the product could be recovered in crystalline form with a yield of 
86 %.  
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2 INTRODUCTION 
Glycosyl phosphates, such as α-D-glucose 1-phosphate (αG1P), are key intermediates in 
the synthesis of nucleotide sugars, the activated donors of glycosyl transferases46. They 
are, however, also efficient glycosyl donors in their own right, for both chemical and 
enzymatic glycosylation reactions47. Moreover, αG1P can also be used for a number of 
other applications. Among these are the stimulation of active calcium transport in 
intestines as nutritional supplement, and its use in medicine as a substitute of inorganic 
phosphate in parenteral nutrition48, 49. 
 
Glycosyl phosphates can be produced by chemical synthesis, but these procedures suffer 
from low yields and lack of anomeric selectivity50. Biocatalytic synthesis typically relies 
on kinases, which require adenosinetriphoshpate (ATP) as phosphate donor. Although 
several strategies have been developed to recycle this cofactor, the high costs involved 
with the latter strategy hamper large-scale applications51. In that respect, glycoside 
phosphorylases are a very attractive alternative, as they only require cheap inorganic 
phosphate for the production of glucose 1-phosphate from a di- or oligosaccharide52. 
The β-form has, for example, been produced at 60 °C using the thermostable trehalose 
phosphorylase from Thermoanaerobacter brockii53. Interestingly, α-D-galactose 1-
phosphate has recently also become available as product thanks to the creation of 
variants of cellobiose phosphorylase with activity towards lactose41, 54.   
 
Similarly, sucrose phosphorylase can be used for the production of αG1P by the 
phosphorolysis of sucrose into αG1P and fructose52. Moreover, a variety of glycosylated 
compounds can be produced with this enzyme, thanks to its broad acceptor specificity55. 
For example, an exceptionally efficient process for the production of 2-O-(α-D-
glucopyranosyl) sn-glycerol has recently been developed with SP40, 56. The product is 
commercially available under the tradename Glycoin® and is used as a moisturizing 
agent in cosmetics. 
 
At the industrial scale, however, all these conversions of sucrose would preferably be 
performed at 60 °C or higher, mainly to avoid microbial contamination and to lower the 
viscosity of the reaction solution57-59. We have recently shown that immobilization of the 
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SP from Bifidobacterium adolescentis significantly enhances its stability. Indeed, covalent 
binding to Sepabeads EC-HFA resulted in a biocatalyst with a half-life of more than 10 h 
at 60 °C44, while a cross-linked enzyme aggregate (CLEA) of SP did not lose any activity 
even after 10 days incubation at 60 °C45. 
 
In this chapter, a continuous production process for αG1P was developed with 
immobilized SP operating at 60 °C. For that purpose, Sepabeads were preferred over 
CLEAs because the latter are not well suited for use in a packed-bed reactor60. The 
immobilization of heat purified enzyme has been evaluated, thereby avoiding the 
expensive and labor-intensive His-tag purification. The operational stability of the 
obtained biocatalyst was examined, and an efficient downstream-processing procedure 
for αG1P was established.  
3 RESULTS & DISCUSSION 
3.1 Immobilization of heat purified SP 
Immobilization of the His-tag purified SP from B. adolescentis on Sepabeads EC-HFA 
results in a highly stable biocatalyst with an increased temperature optimum44. For 
industrial applications, however, the purification of an enzyme by chromatographic 
techniques prior to immobilization is rather expensive. We have recently shown that the 
contaminating phosphatase activity present in the E. coli host can also be efficiently 
removed by heat treatment of crude cell extracts45. We have, therefore, now evaluated 
the immobilization efficiency of heat purified SP. 
 
Under optimal conditions, immobilization of 0.25 mg heat purified protein on 1 g 
Sepabeads EC-HFA was found to result in an immobilization yield of 60 %, which is 
lower than the 72 % obtained with the His-tag purified enzyme at the same 
protein/resin ratio44. However, in previous work we found that His-tag purification is 
hampered by a yield of only 45 %, compared to nearly 100 % for heat purification44, 45. 
Therefore, the overall yield of purification and immobilization is higher for the latter 
process (60 %), than for the former (33 %). Characterization of the new immobilized SP 
preparation revealed that its thermal behavior is similar to that of the His-tag purified 
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immobilizate, i.e. an optimal temperature for phosphorolytic activity of 65 °C 
(Figure S1.1) and a residual activity of 75 % after 16 h incubation at 60 °C. 
 
SP is known to catalyze a minor hydrolytic reaction27, which could have a negative 
impact on the product yield. The specificity of the immobilized enzyme has therefore 
also been determined (Figure 1.1).  
 
Figure 1.1 Phosphorolysis and hydrolysis of sucrose by immobilized SP. Experiments were performed 
with 2.5 U/mL enzyme and 400 mM substrate at pH 7.0 and 60 °C. Both the release of αG1P (▼) and 
glucose (■) were followed in time. 
 
Using 400 mM sucrose as substrate at 60 °C and pH 7, the hydrolytic activity was found 
to be only 0.4 % of the phosphorolytic activity, resulting in the release of small amounts 
of glucose. Once the equilibrium of the phosphorolytic reaction is reached, slow 
hydrolysis of the formed αG1P is also observed. Consequently, the conversion must be 
stopped at the appropriate time, although the product loss would only become 
substantial after several hours. Similar results were obtained with the free enzyme 
(Figure S1.2), which indicates that the latter immobilization does not influence the 
specificity of SP.  
 
Finally, the operational stability of both the His-tag purified and heat purified 
immobilized biocatalysts was evaluated by recycling the beads for consecutive batch 
reactions at 60 °C (Figure 1.2).  
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Figure 1.2 Repeated batch conversion of sucrose by immobilized SP at 60 °C. The initial velocity of the 
His-tag purified (○) and heat purified (●) immobilized biocatalysts was measured after each conversion. 
Both enzyme preparations were immobilized on Sepabeads EC-HFA by offering 4 U to the resin under 
optimal conditions. The initial velocity was determined in 25 mL substrate at 60 °C. 
 
Both resins were found to retain 90 % of their initial activity after 20 reaction cycles. In 
spite of this promising characteristic, a continuous production process in a packed-bed 
reactor was believed to be more appropriate for industrial applications, as this would 
results in a much higher space-time yield.  
3.2 Continuous production of αG1P 
Different amounts of the new SP preparation, obtained by immobilizing 111 U/mL resin, 
were packed in a plug-flow reactor to identify the optimal conditions for the continuous 
production of αG1P (Figure 1.3). A substrate solution consisting of 400 mM sucrose in 
400 mM phosphate buffer at pH 7.0 and 60 °C was then pumped through the columns at 
a flow rate of 0.75 mL/min. The maximal substrate conversion (69 %) of this 
equilibrium reaction could nearly be reached when 18 mL of resin was used (average 
residence time of 24 min). Increasing the resin volume, therefore, would lower the 
productivity of the reactor. Indeed, the space-time yield dropped from 179 to 92 g/L/h 
when 36 mL of resin was used, as the additional 18 mL resin could not further increase 
the αG1P concentration. In contrast, lowering the resin volume allows for a more 
economical use of the immobilized enzyme, albeit at the expense of the degree of 
conversion. With 9 mL of resin, for example, the space-time yield increased to 254 g/L/h 
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but only 49 % of the substrate was converted to αG1P. The choice of the optimal reactor 
configuration will thus depend on the price of the biocatalyst and the substrate.  
 
Figure 1.3 Continuous production of αG1P by immobilized SP at 60 °C. The αG1P yield for packed bed 
reactors with 36 (●), 18 (○) and 9 (▼) ml Sepabeads EC-HFA respectively was determined. Substrate 
containing 400 mM sucrose in 400 mM phosphate buffer at pH 7.0 was pumped through each packed bed 
at a constant flow rate of 0.75 mL/min.  
 
Interestingly, we found that the conversion rate remained constant up to extended 
reaction times of 240 h. Nevertheless, the immobilized enzyme is known to lose 25 % of 
its activity after only 16 h incubation at 60 °C. The latter indicates that the presence of 
the substrate sucrose has a dramatic effect on the stability of the biocatalyst, 
emphasizing the excellent performance of immobilized SP under the operational 
conditions. It is well known that enzymes can be stabilized through interactions with 
their substrate61 or with sugars in general62. We have previously shown that sucrose can 
also increase the yield of the immobilization process44. Clearly, the interactions between 
sucrose and SP are crucial to maintain the structural integrity of the enzyme as much as 
possible. 
3.3 Purification and crystallization of αG1P 
After the continuous production of αG1P, the product was purified from the reaction 
mixture that also contained sucrose, phosphate, fructose and traces of glucose, released 
by the minor hydrolytic activity of SP. Conveniently, these contaminating carbohydrates 
could be efficiently removed by treatment with yeast (Figure 1.4).  
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Figure 1.4 General scheme for the production and purification of αG1P. Sucrose is converted to fructose 
and αG1P by immobilized SP at 60 °C. Contaminating carbohydrates can then be removed by treatment 
with yeast at 30 °C.  
 
Initially, sucrose was rapidly hydrolyzed to glucose and fructose by the yeast’s invertase 
activity. Glucose and fructose were then completely metabolized within 2 and 6 hours 
respectively, resulting in the formation of ethanol, CO2 and minor amounts of glycerol. In 
contrast to the undesired carbohydrates, αG1P was not consumed by the yeast as the 
latter charged compound cannot pass through the yeast’s membrane (Figure 1.5). 
Afterwards, the yeast was removed by filtration, resulting in a near quantitative 
recovery of αG1P.  
 
Figure 1.5 Removal of contaminating carbohydrates from αG1P by treatment with yeast. Time courses of 
the concentration of αG1P (●), fructose (∆), glucose (▼) and sucrose (○). Baker’s yeast was added to a 
concentration of 20 g/L and gently stirred during 8 h at 30 °C. 
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The product, however, still contained the remaining inorganic phosphate present in the 
reaction mixture. This contamination can be removed by chemical precipitation of 
phosphate followed by filtration63. Although 94 % recovery was achieved, crystals of 
αG1P could not be generated. The latter is most likely caused by interference of some 
compounds present in the precipitation liquid, e.g. acetic acid or Mg2+ ions53.  
 
To circumvent this problem, the production process was adapted to minimize the 
amount of phosphate, eliminating the need for its removal. To that extent, the 
phosphorolysis of sucrose (500 mM) was performed with varying concentrations of 
phosphate, allowing the reactions to proceed until apparent equilibrium. Lower 
phosphate concentrations at the start of the reaction evidently resulted in lower 
phosphate concentrations at equilibrium, but also decreased the degree of sucrose 
conversion (Table 1.1). 
 
Table 1.1 Concentration of αG1P and phosphate at apparent equilibrium after the phosphorolysis of 
500 mM sucrose at 60 °C and pH 7.0 (HPLC analysis). The concentration of phosphate at the start of the 
reaction was varied. 
[Pi]a 
(mM) 
[αG1P]b 
(mM) 
[Pi]b 
(mM) 
conversionc 
(%) 
100 97.6  ± 2.2 2.4 ± 0.3 19.5 
200 175.1 ± 4.1 25.0 ± 0.9 35.0 
300 245.5 ± 4.9 54.6 ± 1.2 49.1 
400 321.1 ± 5.8 78.9 ± 2.6 64.2 
500 354.5 ± 7.3 145.6 ±3.3 70.9 
a at the start of the reaction; b at apparent equilibrium.; c of sucrose 
 
The optimal sucrose/phosphate ratio thus depends on the required specifications for 
the process, i.e. either high yields or a high purity. At a ratio of 5, crystals of αG1P could 
be generated with a yield of 86 %, exhibiting a contamination with phosphate of less 
than 1 %. However, if phosphate contamination of the product is no constraint, a ratio of 
1 will result in a higher αG1P yield towards sucrose. 
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4 CONCLUSION 
In this chapter, a continuous production process for αG1P was developed with 
immobilized sucrose phosphorylase. The use of heat purified SP was found to be a 
practical alternative to the His-tag purified enzyme, yielding a biocatalyst preparation 
that is cheaper but still free from contaminating phosphatase activity. In that way, a 
packed-bed reactor was constructed, allowing a space-time yield of 179 g/L/h at 60 °C. 
Interestingly, the substrate sucrose was found to have a significant effect on the stability 
of the enzyme, which does not lose activity even after 2 weeks of continuous operation 
at 60 °C. The produced αG1P could be conveniently purified by yeast treatment and, 
recovered in crystalline form with a yield of 86 %.    
 
This is the first time that a continuous production process with SP is described at 
elevated temperatures. Enzymatic synthesis of αG1P with the immobilized SP from 
Leuconostoc mesenteroides has been reported previously, but all these processes were 
carried out at 30 or 37 °C in contrast with the 60 °C reported here52, 64-66. This process 
can thus serve as proof of principle for the development of other glycosyl transfer 
reactions catalyzed by immobilized SP at the industrial scale. Indeed, the procedures 
reported here can be easily scaled-up, as is nicely illustrated by the established use of 
immobilized glucose isomerase in a similar packed-bed reactor67. 
5 MATERIALS & METHODS 
5.1 Materials 
Amino-epoxy (EC-HFA) Sepabeads were kindly provided by Resindion S.R.L (Mitsubishi 
Chemical Corporation). Instant baker’s yeast was purchased from Algist Bruggeman. All 
other chemicals were analytical grade and purchased from Sigma-Aldrich. 
5.2 Enzyme production and purification 
E. coli XL10-Gold cells were used for transformation with the constitutive expression 
plasmid pCXshP34_BaSP68. The resulting strain was cultivated in 1 L shake flasks 
incubated at 37 °C using LB medium (10 g/L tryptone, 5 g/L yeast extract, 5 g/L NaCl, 
pH 7.0) supplemented with 100 mg/L ampicillin. After 8 h of growth and expression, the 
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cells were harvested by centrifugation (10 000 g, 4 °C, 20 min), and frozen until further 
use. Cell extracts were prepared by treatment of frozen pellets with the EasyLyse 
Bacterial Protein Extraction Solution (Epicentre). Subsequently, cell debris was removed 
by centrifugation (18 000 g, 4 °C, 30 min). The crude enzyme preparation was heat 
purified by incubation at 60 °C for 1 h, followed by centrifugation (18 000 g, 4 °C, 
30 min). Alternatively, the N-terminal His6-tagged protein was purified by nickel-
nitrilotriacetic acid (Ni-NTA) metal affinity chromatography, as described by the 
supplier (Qiagen). 
5.3 Enzyme immobilization 
Unless stated otherwise, immobilization was performed by adding 0.1 g Sepabeads EC-
HFA to 5 mL of a SP solution (0.8 U/mL) containing 500 mM sucrose in 40 mM 
phosphate buffer at pH 7.2. The mixture was incubated during 22 h at 25 °C and gently 
stirred at 150 rpm. After immobilization, the resin was washed intensively with 100 mM 
phosphate buffer at pH 7.0. The immobilization yield is defined as the ratio of the 
activity detected on the Sepabeads and the activity present in the original enzyme 
solution. Recycling of the beads was evaluated by performing consecutive batch 
reactions of 1 hour at 60 °C. To that purpose, 4 U of either His-tag purified or heat 
purified SP were offered to Sepabeads EC-HFA at the same protein:resin ratio. The 
obtained biocatalysts were allowed to react with 25 mL substrate consisting of 400 mM 
sucrose in 400 mM phosphate buffer at pH 7.0 in a Thermoshaker (Eppendorf) at 750 
rpm and 60 °C. The biocatalysts were recovered by sedimentation and washed five times 
with 100 mM phosphate buffer at pH 7.0 in between reaction cycles. 
5.4 Activity assays 
The activity of the free enzyme was determined discontinuously by measuring the 
release of the reducing sugar fructose from the non-reducing substrate sucrose with the 
bicinchoninic acid (BCA) method69. One unit (U) of activity was defined as the amount of 
enzyme that releases 1 μmol of fructose per minute from a 100 mM phosphate buffer 
containing 100 mM sucrose at pH 7.0 and 37 °C. The activity of immobilized SP was 
determined by adding the total amount of washed immobilized enzyme (0.1 g) into 40 
mL substrate solution. The mixture was incubated in a thermoshaker (Eppendorf) with 
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constant shaking (750 rpm) at 37 °C and samples were analyzed with the BCA method. 
The ratio of hydrolysis over phosphorolysis was determined by measuring the release of 
glucose and αG1P in parallel. The former was determined with the glucose 
oxidase/peroxidase assay70, and the latter with a coupled enzymatic assay based on the 
action of phosphoglucomutase (PGM) and glucose-6-phosphate dehydrogenase (G6P-
DH)71, 72. The assay solution consisted of 2 mM EDTA, 10 mM MgSO4, 2 mM β-NAD, 10 
μM glucose-1,6-bisphosphate, 1.2 U PGM, 1.2 U G6P-DH and 100 mM sucrose in 100 mM 
phosphate buffer at pH 7.0 and 37 °C. All reported errors correspond to the standard 
errors. 
5.5 Thermal stability assay 
The immobilized enzyme was placed in 100 mM phosphate buffer at pH 7.0 and 
incubated at 60 °C in a thermoshaker (Eppendorf) with constant shaking (750 rpm). 
After 16 h, the remaining activity was determined using the BCA method.  
5.6 Continuous production of αG1P 
About 4000, 2000 and 1000 U of heat purified SP were immobilized on 36, 18 and 9 mL 
Sepabeads EC-HFA, respectively. The obtained immobilized biocatalysts were packed in 
three identical columns (diameter of 1.4 cm, volume of 50 mL), equipped with a water 
jacket at 60 °C. The packing height of the columns was 23.4, 11.7 and 5.8 cm 
respectively. The columns were equilibrated with 400 mM phosphate buffer, pH 7.0. The 
substrate solution contained 400 mM sucrose in 400 mM phosphate buffer at pH 7.0, 
and was brought to reaction temperature (60 °C) through incubation in a water bath. 
The temperature of the effluent was monitored. The solution was pumped through each 
packed bed at a constant flow rate of 0.75 mL/min delivered by a MasterFlex pump 
(type 77521). At regular intervals, 1 mL samples were analyzed on a Varian ProStar 
HPLC using an aminex HPX-87H column (Bio-Rad) at 30 °C. The eluent consisted of 
5 mM H2SO4 in milliQ at a flow rate of 0.6 mL/min. Adequate detection was achieved 
with a refractive index detector.   
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5.7 Purification and crystallization of αG1P 
The product was purified by removal of sucrose, fructose and glucose by treatment with 
baker’s yeast (20 g/L) for 8 h at 30 °C. At certain times, 1 mL samples were analyzed by 
HPLC, as described above. If required, phosphate was precipitated by the addition of 
magnesium acetate and ammonia63. Biomass and precipitated phosphate were removed 
by filtration through a Seitz EKS filter. The filtrate was brought to a pH of 7.0 and was 
subsequently concentrated in a rotary evaporator (Büchi, Rotavapor R-134) at 60 °C to a 
brix of 45 (measured with an Atago hand refractometer). The solution was then slowly 
cooled to 0 °C over a period of 4 h, and incubated overnight on ice to promote crystal 
growth. Finally, the crystals were filtered through Whatman paper, washed with ethanol 
and dried overnight at 70 °C in an oven.  
6 SUPPLEMENTARY INFORMATION 
 
Figure S1.1 Thermoactivity of His-tag (●) and heat purified (○) SP. Experiments were performed with 
100 mM sucrose in a 100 mM phosphate buffer at pH 7.0. 
CHAPTER 1 OPERATIONAL STABILITY OF IMMOBILIZED SUCROSE PHOSPHORYLASE 
 
22 
 
 
Figure S1.2 Phosphorolysis and hydrolysis catalyzed by free SP originating from B. adolescentis. 
Experiments were performed with 2.5 U/mL enzyme and 400 mM substrate at pH 7.0 and 60 °C. Both the 
release of αG1P (▼) and glucose (■) were followed in time. 
  
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 2 
An imprinted cross-linked enzyme aggregate (iCLEA) 
of sucrose phosphorylase: combining improved 
stability with altered specificity 
 
 
 
 
 
 
 
 
 
 
 
This chapter has been published as: 
K. De Winter, W. Soetaert and T. Desmet, 2012, An imprinted cross-linked enzyme 
aggregate (iCLEA) of sucrose phosphorylase: Combining improved stability with altered 
specificity, International Journal of Molecular Sciences, 13, 11333-11342.
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1 ABSTRACT 
The industrial use of sucrose phosphorylase (SP), an interesting biocatalyst for the 
selective transfer of α-glucosyl residues to various acceptor molecules, has been 
hampered by a lack of long-term stability and low activity towards alternative 
substrates. Recent research indicated that the stability of the SP from Bifidobacterium 
adolescentis can be significantly improved by immobilization on Sepabeads or the 
formation of a cross-linked enzyme aggregate (CLEA). In this chapter, it is shown that 
the transglucosylation activity of such a CLEA can also be improved by molecular 
imprinting with a suitable substrate. To obtain proof of concept, SP was imprinted with 
α-glucosyl glycerol and subsequently cross-linked with glutaraldehyde. As a 
consequence, the enzyme’s specific activity towards glycerol as acceptor substrate was 
increased two-fold while simultaneously providing an exceptional stability at 60 °C. This 
procedure can be performed in an aqueous environment and gives rise to a new enzyme 
formulation called iCLEA. 
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2 INTRODUCTION 
Sucrose phosphorylase catalyzes the reversible phosphorolysis of sucrose into α-D-
glucose 1-phosphate (αG1P) and D-fructose (CHAPTER 1). Although it is formally 
classified as a glycosyl transferase (EC 2.4.1.7), the enzyme belongs to the glycoside 
hydrolase family 1373 and follows the typical double displacement mechanism of 
retaining glycosidases74. The crystal structure of the enzyme from Bifidobacterium 
adolescentis has been determined and consists of a (β/α)8 barrel containing Asp192 
(nucleophile) and Glu232 (acid/base) as catalytic residues75. Besides the synthesis of 
αG1P (CHAPTER 1), SP can be employed for the transfer of glucose to a wide variety of 
carbohydrates as well as non-carbohydrate molecules55. For example, an exceptionally 
efficient process for the production of α-glucosyl glycerol (αGG) has been developed 
with SP40, 56. The product is a moisturizing agent for cosmetics and is commercially 
available under the tradename Glycoin. 
 
Unfortunately, the use of SP as industrial biocatalyst has been limited by a lack of long-
term stability and low activity on alternative substrates76, 77. Very recently, however, 
significant improvements in the thermostability of the SP from B. adolescentis have been 
realized by immobilization on Sepabeads (CHAPTER 1)44, formation of a cross-linked 
enzyme aggregate (CLEA)45, 78 and introduction of specific mutations79. In contrast, an 
enzyme with a modified specificity has not yet been reported, although studies aiming to 
alter the acceptor specificity of SP by protein engineering have revealed insight into the 
glycosylation mechanism80 and succeeded to suppress the hydrolytic activity without 
affecting the ability of phenolic compounds to act as acceptor81. 
 
Molecular imprinting is an attractive alternative to mutagenesis for the manipulation of 
enzymatic properties82. Indeed, the three-dimensional structure of a protein can be 
modified by noncovalent interactions with an imprinting molecule in mild denaturing 
conditions83. Unfortunately, imprinted enzymes are only able to maintain their new 
conformation when transferred to a non-aqueous environment or when immobilized by 
cross-linking84, 85. For the latter strategy, a radical polymerization procedure has been 
reported that requires transfer to organic solvents and derivatization of the enzyme86-88.  
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In this chapter, the molecular imprinting of the SP from B. adolescentis using cross-
linking by glutaraldehyde78 instead of radical polymerization in pure organic solvents, is 
described. Indeed, the use of an aqueous environment yields a considerably simpler 
imprinting procedure resulting in an imprinted cross-linked enzyme aggregate (iCLEA) 
exhibiting altered acceptor specificity as well as excellent stability at 60 °C. 
3 RESULTS & DISCUSSION 
3.1 Production of iCLEAs 
For the preparation of the imprinted cross-linked enzyme aggregate (iCLEA), the 
stabilized LNFI variant of the SP from B. adolescentis was used79. The enzyme was 
recombinantly expressed in E. coli and partially purified by means of heat treatment, 
which has shown to remove the contaminating phosphatase activity45. The next steps in 
the preparation of the iCLEA then consist of imprinting, followed by precipitation 
(Figure 2.1).  
 
 
Figure 2.1 General scheme for the production of imprinted cross-linked enzyme aggregates (iCLEAs). 
 
To that end, the precipitation of SP in the presence of a number of possible imprinting 
molecules was first evaluated (Table 2.1). Previous research has identified tert-butyl 
alcohol as the precipitant of choice45. However, the presence of phosphate or αG1P (100-
500 mM) resulted in the appearance of a second phase upon addition of tert-butyl 
alcohol, excluding these molecules from use as imprinters. Also, addition of sucrose in a 
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concentration higher than 200 mM was found to inhibit the precipitation of SP, whereas 
glycerol and αGG did not affect precipitation. Clearly, these results indicate the 
importance of evaluating precipitation thoroughly, prior to the production of an iCLEA. 
 
Table 2.1 Precipitation of SP in the presence of different imprinting molecules. Precipitation was achieved 
by adding 6 mL tert-butyl alcohol to 4 mL enzyme solution under agitation at 4 °C. 
Imprinting molecule [C]a (M) Precipitation (%) SPresidualb (%) 
None / 97.8 1.2 
Sucrose 0.2 96.4 1.6 
Sucrose 0.5 52.1 38.5 
Sucrose 1 40.6 56.8 
Glycerol 0.5 98.2 1.1 
Glycerol 1 96.6 1.3 
Glycerol 2 97.6 1.4 
Sucrose + glycerol 0.5 + 2 68.9 25.6 
Sucrose + glycerol 0.2 + 2 96.6 1.5 
αGG 0.2 97.3 1.4 
a of the imprinting molecules; b after precipitation. 
 
Finally, the aggregated enzyme molecules were chemically cross-linked with 
glutaraldehyde to obtain the corresponding immobilizates. A typical immobilization 
yield of 30 % has been reported for SP45, and this value was also obtained in the 
presence of glycerol or αGG. However, the addition of sucrose during precipitation was 
found to increase the immobilization yield by roughly 10 %. This result is in accordance 
with work published by Wang and collaborators, who reported a sugar-assisted 
precipitation strategy to increase the activity of a Penicillin G Acylase CLEA89. 
  
The specificity of the obtained formulations was then examined and compared with that 
of a non-imprinted CLEA. More specifically, their activity towards phosphate 
(phosphorolysis) and glycerol (transglucosylation) as acceptor was determined 
(Figure 2.1). 
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Figure 2.2 Transglucosylation/phosphorolysis ratio for different CLEA formulations. a Cross-linking was 
initiated upon addition of the imprinting molecules.  b Cross-linking was initiated after 30 min incubation. c 
200 mM αGG was used. d 1 M αGG was used. 
 
Imprinting with sucrose, glycerol or a combination of both was found to have no 
influence on the specificity of the enzyme preparation. However, initiating aggregation 
and cross-linking after 30 min incubation with sucrose and glycerol did significantly 
increase the transglucosylation activity. This must mean that the presence of 
glycosylated product is required to modify the enzyme’s acceptor specificity. Indeed, 
imprinting with 200 mM αGG (enzyme/αGG ratio ≅ 1:11 000) almost doubled the 
specific activity on glycerol, from 2.22 U/mg for the non-imprinted CLEA to 4.12 U/mg 
for the iCLEA. Increasing the αGG concentration to 1 M (enzyme/αGG ratio ≅ 1:55 000) 
during imprinting, however, did not significantly improve the acceptor specificity much 
further. 
3.2 Characterization of the iCLEAs 
When SP is used for transglucosylation reactions, both primary and secondary 
hydrolysis can decrease the atom economy27, 55. Although αGG itself is a very poor 
substrate, hydrolysis of sucrose can be quite significant and even lead to the formation 
of inhibiting products40, 90. Therefore, the hydrolytic activity of the CLEA and iCLEA were 
examined in the presence of sucrose and glycerol as substrates. Hydrolysis was found to 
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be identical for both biocatalysts, meaning that the ratio with transglucosylation is only 
half as high for the iCLEA than for the CLEA. To further asses its applicability in 
carbohydrate conversions, the thermostability of the iCLEA preparation was evaluated 
by incubation at 60 °C and measuring the residual activity at several points in time 
(Figure 2.3).  
 
Figure 2.3 Stability of different SP formulations at 60°C. The residual activity of soluble SP (●), CLEAs (○) 
and iCLEAs (▼) was measured every 24 h. 
 
The iCLEA was found to exhibit a comparable thermostability to the non-imprinted 
CLEA, and thus to be drastically more stable than the soluble enzyme. Indeed, an 
impressive 75 % of the initial activity was still present after three weeks incubation at 
60 °C. Next, the efficiency of the newly formed iCLEA was demonstrated by comparing 
its performance with that of the reference CLEA in a batch production of αGG at 60 °C 
(Figure 2.4). This clearly showed that the maximal transfer yield of 84 %40 could be 
reached twice as fast with the iCLEA compared to its non-imprinted counterpart. 
Furthermore, the newly formed iCLEA also proved its excellent operational stability by 
losing no activity during five consecutive batch conversions. 
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Figure 2.4 Synthesis of αGG with immobilized SP at 60 °C. The conversions were performed with 5 
mg/mL CLEAs (○) or iCLEAs (●) in a 50 mM MOPS buffer pH 7.0 containing 800 mM sucrose and 2 M 
glycerol. 
4 CONCLUSION 
Although molecular imprinting of a cross-linked enzyme aggregate (iCLEA) has been 
described for improving the activity of the hydroxynitrile lyase from Linum 
usitatissimum91, this is the first time it is used to alter the transglycosylation specificity 
of a biocatalyst. As proof of concept, sucrose phosphorylase was imprinted with α-
glucosyl glycerol and subsequently cross-linked with glutaraldehyde. As a result, the 
enzyme’s specificity towards glycerol as acceptor was increased two-fold. Furthermore, 
the obtained biocatalyst was extremely stable, and could be used for an industrially 
relevant production process at 60 °C. This convenient procedure thus allows to 
simultaneously improve stability and specificity, and could find widespread application 
in the field of enzyme engineering. 
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5 MATERIALS & METHODS 
5.1 Materials 
Glucosyl glycerol was produced as previously described40. Tert-butyl alcohol, 
glutaraldehyde, and sodium borohydride were purchased from Aldrich-Chemie, Fisher 
and Acros, respectively. All other reagents were analytical grade and purchased from 
Sigma-Aldrich. 
5.2 Enzyme production and purification 
E. coli BL21 (DE3) (Novagen) cells were used for transformation with the constitutive 
expression plasmid pCXshP34_BaSP_LNFI68, 79. The resulting strain was routinely grown 
in 50 mL LB medium (CHAPTER 1). After overnight growth, the culture was inoculated 
into 1 L of double LB medium (20 g tryptone/L, 10 g yeast extract/L, 5 g NaCl/L; pH7.0) 
supplemented with 30 g/L glucose and 100 mg/L ampicillin in a 2 L Biostat M reactor 
(B. Braun Biotech Inc). Fermentation was done at 37 °C and 550 rpm with aeration at 1.2 
vvm. When necessary, antifoam was added manually to prevent foaming. After 
approximately 8 h of growth (OD600 ~ 25), the cells were harvested by centrifugation 
(10 000 g, 4 °C, 20 min). The obtained pellets were frozen at -20 °C until further use.  
 
Cell extracts were prepared by treatment of frozen pellets with 50 mM MOPS pH 7.0 
supplemented with 1 mg/mL lysozyme for 30 min at room temperature, followed by 2 x 
2 min sonification (Branson 250 Sonifier, level 3, 50 % duty cycle). Subsequently, cell 
debris was removed by centrifugation (18 000 g, 4 °C, 30 min). Finally, the crude enzyme 
preparation was heat purified by incubation at 60 °C for 60 min as described in 
CHAPTER 1. 
5.3 Preparation of the iCLEA 
The heat purified SP enzyme was diluted to a final protein concentration of 2 mg/mL 
and allowed to react with the imprinting molecules for 30 min at 37 °C. Next, 6 mL of 
tert-butanol was added to 4 mL of the imprinted SP solution under agitation. After 30 
min, 1.36 mg glutaraldehyde was gently added to cross-link the enzyme aggregate, and 
the mixture was kept under stirring for 60 min. Reduction of the formed imine bonds 
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was achieved by adding 10 mL of a solution containing 1 mg/mL sodium borohydride in 
0.1 M sodium bicarbonate buffer at pH 10.0. After 15 min, another 10 mL was added and 
allowed to react for 15 min. Finally, the iCLEA was harvested by centrifugation 
(10 000 g, 4 °C, 30 min) and washed five times with 50 mM MOPS buffer at pH 7.0. All 
steps were performed in a thermoshaker (Eppendorf) at 750 rpm and 4 °C. The 
immobilization yield is defined as the ratio of the activity detected in the iCLEA 
preparation to that present in the original enzyme solution. 
5.4 Activity assays 
Phosphorolysis of sucrose was measured discontinuously with an enzymatic assay, in 
which the production of αG1P is coupled to the reduction of NAD+ in the presence of 
phosphoglucomutase and glucose-6-phosphate dehydrogenase72. The reactions were 
analyzed by inactivation of samples (5 min at 95 °C) at regular intervals, followed by 
measurement of the absorbance at 340 nm in a microplate reader 680XR (Bio-Rad). One 
unit of phosphorolysis activity corresponds to the release of 1 μmol fructose per minute 
from 100 mM sucrose in 100 mM phosphate buffer at pH 7.0 and 37 °C. 
 
The transglucosylation activity of SP towards glycerol was determined indirectly by 
measuring the increase in reducing sugars. More specifically, the release of fructose (and 
glucose) from sucrose as donor substrate was determined discontinuously with the BCA 
method (CHAPTER 1). In parallel, the release of glucose through hydrolysis was 
determined discontinuously with the glucose oxidase/peroxidase assay (CHAPTER 1). 
When glucose was detected, its concentration was subtracted twice from the 
concentration of reducing sugars measured with the BCA method, to calculate the net 
transglucosylation activity. One unit of transglucosylation activity corresponds to the 
production of 1 μmol αGG per minute from 800 mM sucrose and 2 M glycerol in 50 mM 
MOPS buffer at pH 7.0 and 60 °C.  
 
Alternatively, the concentration of αGG was determined directly by HPLC analysis using 
an aminex HPX-87C column (Bio-Rad) with milliQ water as the mobile phase at a 
constant flow rate of 0.6 mL/min and 85 °C. The hydrolytic activity was quantified using 
50 mM donor and 65 mM acceptor, which is identical to the conditions used to assess 
the transglucosylation potential of SP77. Protein concentrations were measured 
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according to the Lowry method92, using bovine serum albumin as standard. All reported 
errors correspond to the standard errors. 
5.5 Stability assays 
The thermostability of the iCLEAs was determined by incubation in 50 mM MOPS buffer 
pH 7.0 in a water bath at 60 °C. Every 24 h, samples were taken and the residual activity 
was analyzed using the BCA method. In addition, the operational stability was evaluated 
by using the iCLEAs for consecutive batch conversions of 800 mM sucrose and 2 M 
glycerol at 60 °C. After each reaction, the iCLEAs were recuperated by centrifugation 
(10 000 g, 4 °C, 30 min) and washed three times with 50 mM MOPS buffer at pH 7.0. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 3 
Ionic liquids as cosolvents for glycosylation by 
sucrose phosphorylase: balancing acceptor solubility 
and enzyme stability. 
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1 ABSTRACT 
Over the past decade, disaccharide phosphorylases have received increasing attention as 
promising biocatalysts for glycoside synthesis. Unfortunately, these enzymes typically 
have a very low affinity for non-carbohydrate acceptors, which urges the addition of 
cosolvents to increase the dissolved concentration of these acceptors. However, 
commonly applied solvents such as methanol and dimethyl sulfoxide (DMSO) are not 
compatible with many intended applications of carbohydrate-derived products. In this 
chapter, the solubility of a wide range of relevant acceptors was assessed in the 
presence of ionic liquids (ILs) as alternative and ‘green’ solvents. The IL AMMOENG 101 
was found to be the most effective cosolvent for compounds as diverse as medium- and 
long-chain alcohols, flavonoids, alkaloids, phenolics and terpenes.  Moreover, this IL was 
shown to be less deleterious to the stability and activity of sucrose phosphorylase than 
the commonly used dimethyl sulfoxide. To demonstrate the usefulness of this solvent 
system, a process for the resveratrol glycosylation was established in a buffer containing 
20 % AMMOENG 101, 1 M sucrose and saturated amounts of acceptor. A single 
regioisomer 3-O-α-D-glucopyranosyl (E)-resveratrol was obtained as proven by NMR 
spectroscopy. 
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2 INTRODUCTION 
Glycosylation of small molecules can substantially improve their physicochemical and 
biological properties, thereby extending their application potential in various 
industries10, 19, 23, 93. Prominent examples include the increased solubility of therapeutic 
flavonoids94, the prolonged stability of ascorbic acid in cosmetic formulations95, and the 
modified perception of flavors and fragrances12. Despite the continuous development of 
new procedures, chemical synthesis of glycosides still suffers from low yields because of 
the need for (de)protection and activation steps13, 15. Biocatalytic approaches are, 
therefore, an attractive alternative that enables one-step reactions with high regio- and 
stereoselectivity18. Enzymatic glycosylation reactions typically generate 5-fold less 
waste and have a 15-fold higher space-time yield, which is a tremendous improvement 
in the eco-efficiency19. 
 
Currently, few enzymes are available to perform glycosylation reactions cost-efficiently 
at the industrial scale96. On the one hand, glycosyl transferases (GT) require nucleotide-
activated sugars that are relatively expensive97 and glycoside hydrolases (GH) suffer 
from low yields when used in the synthetic direction27. Consequently, disaccharide 
phosphorylases have received increasing attention in recent years as promising 
biocatalysts for glycoside synthesis29, 98, 99. These enzymes catalyze the reversible 
phosphorolysis of glycosidic bonds, and thus only require a glycosyl phosphate as donor 
substrate for synthetic reactions.  
 
Unfortunately, disaccharide phosphorylases typically have a very low affinity (Km > 1 M) 
for non-carbohydrate acceptors77, 100. The catalytic efficiency of sucrose phosphorylase 
(SP) towards such compounds is usually not significantly higher than the contaminating 
hydrolytic activity77. Nevertheless, an efficient process for the production of 2-O-(α-D-
glucopyranosyl) sn-glycerol has been developed with this enzyme by careful 
optimization of the substrate concentrations40, 101. Moreover, it was shown in CHAPTER 2 
that the efficiency of the SP biocatalyst could be further increased by molecular 
imprinting. For hydrophobic acceptors like flavonoids and other polyphenols, however, 
concentrations compensating for the high Km values are not readily achieved in aqueous 
solutions. Enzymatic glycosylation of these compounds is, therefore, commonly 
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performed in the presence of organic cosolvents, such as DMSO or methanol. However, 
these solvents are not compatible with numerous applications of carbohydrate-derived 
products102, and their presence can lead to the partial inactivation of the biocatalyst33, 77, 
79.  
 
Ionic liquids (ILs) have emerged recently as a completely new class of solvents for 
biocatalytic applications103, 104. These green solvents consist of salts with a low melting 
point (<100 °C) that possess no vapor pressure and are inflammable105. Due to their 
ability to dissolve both polar and hydrophobic substrates, ILs have been successfully 
applied for the synthesis of glycosidic compounds106-109. For example, the yield for the 
galactosylation of N-acetylglucosamine with β-galactosidase from Bacillus circulans 
could be doubled upon addition of 25 % [MMIM][MeSO4]105. However, no attention has 
yet been paid to the use of ILs as cosolvents for disaccharide phosphorylases.  
 
In this chapter, the stability and activity of the SP from Bifidobacterium adolescentis was 
evaluated in the presence of various ILs, and the solubility of relevant acceptors in these 
systems was determined. 
3 RESULTS & DISCUSSION 
3.1 Solubility of acceptors in IL cosolvent systems 
The enzymatic glycosylation of hydrophobic compounds is complicated by their low 
solubility in aqueous systems9, 33. Therefore, the effect of various ILs (Figure S3.2) on 
solubility was evaluated, and compared with that of conventional cosolvents at a 
concentration of 20 % (Table 3.1). Optimal values (pH 6.5 and 60 °C) for the sucrose 
phosphorylase from B. adolescentis44 were used. Furthermore, the influence of sucrose 
(1 M) was also assessed, since this substrate serves as glycosyl donor for SP and will 
thus be present during the actual reactions. The initial screening was performed with 
resveratrol and quercetin as target compounds with powerful anti-oxidant and anti-
inflammatory properties, but a very low solubility in water110-112. 
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Table 3.1 Solubility at pH 6.5 and 60 °C, in the presence of 20 % cosolvent and 1 M sucrose. 
 Solubility resveratrol (mM) Solubility quercetin (mM) 
Solvent - sucrose + sucrose - sucrose + sucrose 
Water 0.2 ± 0.1 2.4 ± 0.3 < 0.1 < 0.1 
MeOH 2.2 ± 0.2 5.8 ± 0.6 0.2 ± 0.1 0.4 ± 0.1 
DMSO 37.5 ± 2.9 46.3 ± 3.8 9.4 ± 0.9 12.1 ± 1.1 
Tween 20 44.5 ± 3.3 56.1 ± 4.2 10.5 ± 1.1 11.8 ± 2.0 
Triton X-100 11.5 ± 1.3 18.6 ± 0.9 1.6 ± 0.2 2.2 ± 0.4 
[MMIM] [MeSO4] 13.8 ± 1.3 15.4 ± 0.8 0.5 ± 0.1 0.5 ± 0.2 
[BMIM][BF4] 10.1 ± 1.2 12.6 ± 1.1 0.4 ± 0.1 0.5 ± 0.2 
[BMIM][dca] 11.8 ± 1.6 16.4 ± 1.8 0.5 ± 0.1 0.6 ± 0.1 
[BMIM][I] 39.5 ± 3.2 47.3 ± 3.9 0.8 ± 0.2 1.2 ± 0.3 
[EMIM][EtSO4] 14.6 ± 1.2 18.1 ± 1.4 0.6 ± 0.1 0.9 ± 0.1 
[EMIM][dca] 130.4 ± 9.8 145.1 ± 11.6 1.5 ± 0.2 1.8 ± 0.4 
AMMOENG 101 246.6 ± 15.2 286.5 ± 12.9 21.2 ± 1.1 24.9 ± 2.0 
 
As expected, only traces of resveratrol or quercetin could be dissolved in the cosolvent-
free system. The addition of 20 % ILs resulted in a remarkable increase in solubility, 
without affecting the ability to dissolve 1 M sucrose. All ILs easily outranked methanol as 
cosolvent. Furthermore, both [EMIM][dca] and AMMOENG 101 proved to better dissolve 
resveratrol compared to DMSO, which was recently used for the enzymatic synthesis of 
resveratrol glucosides9. The nature of the anion as well as the cation appears to be 
important for the imidazolium-based ILs, which is in agreement with previous 
observations102, 113. Interestingly, the presence of 1 M sucrose was found to further 
increase the solubility, although the effect was rather limited in most cases. The highest 
solubility was obtained when using AMMOENG 101 (Figure 3.1), an ethoxylated 
quaternary ammnonium salt manufactured by Solvent Innovation. This IL, also 
commercialized by Evonik Industries as TEGO K5, has already been used to capture 
carbon dioxide from fuel gas streams114, and to solubilize water-insoluble ketones115. 
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Figure 3.1 Chemical structure of the ethoxylated quaternary ammnonium salt AMMOENG 101. 
 
The solubilizing properties of AMMOENG 101 were then examined in more detail, by 
varying the amount of cosolvent added (Figure 3.2). As could be expected, increasing the 
concentration of IL resulted in an increased solubility of the acceptors. However, a 
maximum was observed at 60 % AMMOENG 101, after which the solubility decreased. 
Resveratrol could be dissolved up to an impressive 2 M, whereas the highest solubility of 
quercetin was found to be 0.2 M.  
 
 
Figure 3.2 Solubility at pH 6.5 and 60 °C in the presence of various concentrations of AMMOENG 101. 
 
Finally, the solubility of other glycosylation acceptors was determined in both DMSO and 
AMMOENG 101 cosolvent systems (Table 3.2). Based on their structure, these acceptors 
can be divided into five classes, i.e. flavonoids, medium- and long-chain alcohols, 
terpenes, alkaloids and phenolics. The addition of a cosolvent enhanced the solubility of 
all of them but the IL was remarkably more efficient than DMSO. For example, the 
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solubility of sparingly soluble substances such as curcumin and dodecanol could be 
increased to 46 mM and 510 mM, respectively, by the addition of 40 % AMMOENG 101. 
The same condition resulted in a tenfold increased solubility of 3-hydroxy-2-
nitropyridine and cinnamyl alcohol. Solubility of hexanol and geraniol was increased by 
two orders of magnitude, resulting in a concentration of 3.1 M for the former. In 
conclusion, the IL was found to boost the solubility of various chemicals, from rather 
hydrophilic to very hydrophobic, regardless of their type. 
 
Table 3.2 Solubility of various compounds at 60 °C in a 50 mM MES buffer at pH 6.5 containing 20 and 
40 % DMSO and AMMOENG 101 respectively.  
 Solubility (mM) 
Compound Buffer         DMSO       AMMOENG 101 
  20 % 40 % 20 % 40 % 
Resveratrol 0.2 ± 0.1 37.5 ± 2.9 97.5 ± 6.9 246 ± 15 1166 ± 95 
Quercetin < 0.1 9.4 ± 0.9 22.1 ± 1.3 21.2 ± 1.1 76.5 ± 5.2 
Curcumin < 0.1 8.2 ± 0.5 19.1 ± 1.1 13.5 ± 0.8 45.9 ± 1.8 
Dodecanol 1.3 ± 0.2 3.6 ± 0.2 18.1 ± 1.7 268 ± 18 508 ± 39 
Hexanol 6.3 ± 0.8 12.3 ± 0.9 31.1 ± 2.2 1664 ± 106 3108 ± 159 
Geraniol 4.3 ± 0.3 9.3 ± 0.3 19.1 ± 1.4 403 ± 26 1861 ± 94 
Linalool 5.2 ± 0.6 7.3 ± 0.4 16.1 ± 1.2 294 ± 18 1130 ± 82 
3-Hydroxypyridine 255 ± 20 457 ± 26 923 ± 68 654 ± 51 1395 ± 109 
3-Hydroxy-2-nitropyridine 261 ± 18 602 ± 54 1356 ± 96 968 ± 63 2652 ± 153 
Saligenin 352 ± 16 409 ± 11 920 ± 48 721 ± 52 2560 ± 192 
Salicylic acid 7.3 ± 0.7 61.8 ± 3.6 162 ± 12 271 ± 21 854 ± 66 
Vanillyl alcohol 70.4 ± 5.9 452 ± 11 796 ± 66 817.3 ± 75.6 1018 ± 72 
Cinnamyl alcohol 17.4 ± 1.3 40.6 ± 2.9 137 ± 9 937 ± 46 2751 ± 196 
4-Nitrophenol 167 ± 12 187 ± 16 442 ± 31 642 ± 52 1219 ± 86 
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3.2 Stability and activity in IL cosolvent systems 
Although the addition of ILs allows dissolving a wide variety of compounds, their 
presence could negatively affect the stability of the biocatalyst33, 106. Therefore, the half-
life (t50) of the SP from B. adolescentis was determined in the presence of different 
cosolvents (Table 3.3). In agreement with previous studies on other enzymes, 
[MMIM][MeSO4], AMMOENG 101 and DMSO were found to be less deleterious for the 
stability of SP than for example [BMIM][I], [BMIM][BF4] and methanol106, 107, 115, 116. 
Moreover, in accordance to the results in CHAPTER 1 and CHAPTER 2, the presence of 
sucrose appears to be a critical parameter for the enzyme’s stability. Indeed, the 
addition of 1 M sucrose resulted in a 25-fold increased half-life when 20 % DMSO or 
AMMOENG 101 is present. Similar patterns were obtained with the well-known 
protectant trehalose,117 which is not a substrate of SP. The results indicate that 
stabilization does not originate from the binding of substrate in the active site but rather 
from non-specific interactions at the protein surface118, 119.  
 
Table 3.3 Stability of SP at pH 6.5 and 60 °C, in the presence of 20 % cosolvent and 1 M sucrose. 
 t50 (min) 
Solvent - sucrose + sucrose 
Water 3210 ± 126 4261 ± 192 
[EMIM][EtSO4]                        16.0 ± 2.1 54.7 ± 3.2 
[EMIM][dca]                        5.1 ± 0.3 32.5 ± 2.6 
[BMIM][dca]                       4.8 ± 0.2 29.5 ± 1.9 
[BMIM][I]                       <1 2.1 ± 0.1 
[BMIM][BF4]                      3.2 ± 0.1 33.8 ± 2.7 
[MMIM] ][MeSO4]                                         32.6 ± 3.2 85.3 ± 6.6 
AMMOENG 101 128 ± 6 3162 ± 198 
DMSO 106 ± 9 2622 ±144 
MeOH 3.2 ± 0.5 26.8 ± 2.4 
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Next, the stability of SP was determined at varying concentrations of both AMMOENG 
101 and DMSO (Figure 3.3), the former being superior allowing a 24 h half-life at the 
concentration of 60 %, whereas such a t50 was already reached at a DMSO concentration 
of only 30 %. Activity of SP in both cosolvents was assessed as well. The enzyme 
displayed a relative activity of 98 and 87 % in 20 and 40 % IL, respectively, compared to 
86 and 34 % in identical concentrations of DMSO. According to these results, the IL 
AMMOENG 101 is a much better cosolvent than the commonly used DMSO. 
 
Figure 3.3 Half-life of SP at pH 6.5 and 60 °C, in the presence of 1 M sucrose and varying cosolvent 
concentrations. 
 
Although the SP from B. adolescentis already is quite stable, a stabilized variant (‘LNFI’) 
containing 6 mutations has recently been created79. Furthermore, immobilized 
preparations of the enzyme have also been prepared, either by the covalent coupling to 
Sepabeads44 or by the production of a cross-linked enzyme aggregate (CLEA)45, 78. All of 
these are known to be more thermostable than the native enzyme and they are shown 
here to be also more resistant to the presence of 20 % AMMOENG 101 (Figure 3.4). 
Indeed, the enzyme’s t50 could be increased by about 15 and 40 h when using the LNFI 
variant or Sepabeads immobilizate, respectively. The CLEA was the most stable, and 
exhibited an impressive half-life of 100 h. These results support previous findings that 
thermal and solvent stability are closely related106, 120, 121. 
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Figure 3.4 Stability of various SP formulations at 60 °C and pH 6.5, in the presence of 20 % AMMOENG 
101 and 1 M sucrose. Wild-type enzyme (●), LNFI variant (○), Sepabeads immobilizate (▼) and CLEA 
immobilizate (∆).  
3.3 Production of glycosides in ILs 
The applicability of AMMOENG 101 as cosolvent for the production of glycosides with SP 
was assessed using the glycosylation of resveratrol as case study (Figure 3.5). After 24 h 
reaction of sucrose with resveratrol saturated in 20 % AMMOENG 101, a single new 
peak could be observed at 8.5 min, next to the signal of resveratrol at 10.9 min 
(Figure 3.6).  
 
 
Figure 3.5 Enzymatic glucosylation of resveratrol catalyzed by thermostable SP in an ionic liquid 
cosolvent system. 
 
The product was purified by silica gel chromatography, and identified as 3-O-α-D-
glucopyranosyl (E)-resveratrol by NMR spectroscopy. Glycosylation of resveratrol has 
already been achieved with Bacillus cereus and Streptococcus mutans as whole-cell 
biocatalysts122, 123. More recently, the synthesis of a mixture of α-glucosyl derivatives 
using cyclodextrin glucanotransferase was described9. However, this is the first report 
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on the use of a purified enzyme for the glucosylation of resveratrol yielding a single 
product. 
 
 
Figure 3.6 Production of α-glycosyl resveratrol (8.5 min) with SP at pH 6.5 and 60 °C, using 1 M sucrose 
and resveratrol (10.9 min) saturated in 20 % AMMOENG 101 (above) or DMSO (beneath) after 24 h 
incubation. 
 
In contrast, about 10 times less product was formed when DMSO was used as cosolvent 
under optimal reaction conditions. The difference was even more pronounced with 
quercetin as acceptor substrate. Indeed, numerous attempts using 20 and 40 % of 
DMSO, DMF, methanol, ethanol and acetone as organic cosolvents failed to yield product. 
Only minor amounts of quercetin could be dissolved in 20 % of these solvents, whereas 
the addition of 40 % resulted in rapid inactivation of the enzyme. However, glycosylated 
products could clearly be detected when quercetin was saturated in 20 % AMMOENG 
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101 (Figure S3.1). In addition, the glycosylation of all compounds from Table 3.2 was 
evaluated using similar reaction conditions. Glucosides of hexanol, geraniol, 3-
hydroxypyridine, saligenin, vanillyl alcohol and cinnamyl alcohol were observed by 
means of TLC analysis. These results identified the IL AMMOENG 101 as a powerful tool 
for glycosylation reactions with disaccharide phosphorylases, efficiently balancing 
acceptor solubility and enzyme stability. 
4 CONCLUSION 
Following the work on glycoside synthesis with SP in conventional solvents55, this is the 
first report on the use of ionic liquids with disaccharide phosphorylases. The stability 
and activity of SP, as well as the solubility of a wide range of interesting acceptors was 
assessed. The results show that the solubility of flavonoids, medium- and long-chain 
alcohols, terpenes, alkaloids and phenolics can be improved significantly by addition of 
AMMOENG 101. Moreover, this IL was found to be less deleterious to the stability and 
activity of SP compared to organic solvents like DMSO or methanol. The presence of 1 M 
sucrose as a substrate significantly improves the enzyme stability in the presence of 
cosolvents. As proof of concept, the production of 3-O-α-D-glucopyranosyl (E)-
resveratrol was demonstrated to be much more efficient in AMMOENG 101 compared to 
DMSO as cosolvent. Consequently, the use of ILs could find widespread application for 
glycoside synthesis with disaccharide phosphorylases. 
5 MATERIALS & METHODS 
5.1 Materials 
AMMOENG 101 and amino-epoxy (EC-HFA) Sepabeads were kindly provided by Evonik 
Industries AG and Resindion S.R.L (Mitsubishi Chemical Corporation), respectively. The 
other ILs were purchased from IoLiTec Ionic Liquids Technologies GmbH, and had a 
purity of at least 99 %. All other chemicals were analytical grade and purchased from 
Sigma-Aldrich.  Recombinant SP was produced and partially purified by heat treatment 
as described in CHAPTER 2. The immobilized SP variants were produced according to the 
protocols described in CHAPTER 1 and 2. 
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5.2 HPLC analysis 
HPLC analysis was performed on a reversed phase column (Alltech Prevail C-18, 250 
mm × 4.6 mm), with milliQ water (solvent A) and methanol (solvent B), both containing 
0.05 % formic acid, as the mobile phase. The flow rate and temperature were set at 
1.0 mL/min and 30 °C, respectively. The gradient elution was as follows: 100 % of 
solvent A (0 - 2 min), 0 to 90 % solvent B (2 - 20 min), 90 % solvent B (20 – 25 min), 90 
to 0 % solvent B (25 – 30 min) and 100 % solvent A (30 – 38 min). Adequate detection 
was obtained with an Alltech 2000ES evaporative light scattering detector (ELSD) for 
dodecanol, hexanol, geraniol, linalool, 3-hydroxypyridine, 3-hydroxy-2-nitropyridine, 
saligenin and salicylic acid. The tube temperature, gas flow and gain were set at 25 °C, 
1.5 L/min and 4, respectively. The other compounds were quantified using a Varian 
Prostar 320 UV/Vis detector at 306, 373, 335, 254, 317 and 246 nm for resveratrol, 
quercetin, curcumin, cinnamyl alcohol, 4-nitrophenol and vanillyl alcohol, respectively. 
The obtained peaks were calibrated using standard curves of the specific compounds, 
prepared in DMSO or methanol. All HPLC analyses were performed in triplicate. 
5.3 Solubility measurements 
The dissolution of all compounds in the different cosolvent systems was performed in a 
water bath at 60 °C with ± 0.1 °C accuracy. Varying amounts of cosolvent and sucrose 
were added to 50 mM MES buffer at pH 6.5, and transferred to a 10 mL falcon. Next, the 
desired compounds were added until clear precipitation was observed. The samples 
were vortexed multiple times and allowed to equilibrate for 48 h. Undissolved solids 
were removed by filtration through a 0.45 µm microporous membrane at the same 
temperature. Finally, the obtained solutions were diluted in DMSO or methanol, and 
subjected to HPLC analysis. 
5.4 Stability assays 
The thermostability of SP was determined by incubating 25 U/mL in 50 mM MES buffer 
at pH 6.5 in a water bath at 60 °C. If required, sucrose and cosolvents were added. At 
regular intervals, samples were taken and diluted 100 times in 50 mM MOPS buffer at 
pH 7.0. The samples were stored at 4 °C, and the activity at 37 °C was determined using 
the continuous αG1P assay (CHAPTER 1). The t50-values were calculated from the 
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equations obtained by fitting the linear part of the stability curves. The stability of the 
immobilized biocatalysts was evaluated by incubating 1 and 15 mg of CLEAs and 
Sepabeads, respectively, in 300 µL 50 mM MES buffer at pH 6.5 containing 20 % IL 
AMMOENG 101 and 1 M sucrose. At regular intervals, samples were taken and diluted 
100 times in 50 mM MOPS buffer at pH 7.0. The samples were stored at 4 °C, and the 
activity at 37 °C was determined using the discontinuous αG1P assay (CHAPTER 1). All 
reported errors correspond to the standard errors. 
5.5 Production and purification of glycosides 
The glycosylation of flavonoids was carried out at 10 mL scale in a 50 mM MES buffer at 
pH 6.5 containing 1 M sucrose and 20 % cosolvent. The substrate solutions were 
saturated with resveratrol or quercetin, and 50 U/mL of the SP variant ‘LNFI’ was added. 
After 24 h, the reactions were stopped by inactivation (10 min at 95 °C) and centrifuged 
(12 000 g, 4 °C, 15 min) to remove all particulates. Next, the supernatant was diluted, 
and subjected to HPLC analysis. Alternatively, the aqueous buffer was evaporated in 
vacuo and the residue was purified by column chromatography on silica gel 
(EtOAC/MeOH/H2O = 30:5:4). TLC analysis (EtOAC/MeOH/H2O = 30:5:4) was conducted 
on Merck Silica gel 60 F254 precoated plates. Detection was achieved by spraying with 10 
% (v/v) H2SO4 and heating. 
5.6 Structure elucidation of glucosides 
The chemical structure of the purified resveratrol glycoside was inferred from the 
combination of 1D NMR (1H NMR and 13C NMR) and 2D NMR (gCOSY, gHSQC and 
gHMBC) spectroscopic analysis; J values are given in Hz. According to the COSY 
experiment, the proton spectrum displays a –CH=CH- group, AA’BB’ and AMX spin 
systems of para-disubstituted and 1,3,5-trisubstituted aromatic rings, and one 
saccharide unit. The set of extracted vicinal constants (d, J = 3.5 Hz) identified α-glucose, 
while the magnitude of J7-H, 8-H (16.3 Hz) proved the E-conformation of resveratrol. The 
position of the glycosylation was confirmed by the HMBC contact of the C-3 with 1”-H. 
Spectral analysis and interpretation was kindly performed by the group of Prof. Vladimír 
Křen at the Institute of Microbiology (Czech Republic).  
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3-O-α-D-Glucopyranosyl (E)-resveratrol 
1H NMR (400 MHz; CD3OD): 7.39 (2 H, d, J = 8.6, 
2’-H and 6’-H), 7.04 (1 H, d, J = 16.3, 8-H), 6.87 (1 
H, d, J = 16.3, 7-H), 6.86 (1 H,s, 2-H),6.80 (2 H, d, J 
= 8.6, 3’-H and 5’-H), 6.62 (1 H, s, 6-H), 6.54 (1 H, 
s, 4-H), 5.50 (1 H, d, J = 3.5, 1”-H), 3.87 (1 H, dd, J 
= 9.7 and 8.9, 3”-H), 3.76 (2 H, m, 6”-Ha, 6”-Hb), 
3.72 (1 H, ddd, J = 9.7, 4.2 and 2.5, 5”-H), 3.60 (1 
H, dd, J = 9.7 and 3.6, 2”-H) and 3.48 (1 H, dd, J = 
9.7 and 8.9, 4”-H). 
13C NMR (100 MHz; CD3OD): 160.23 (C-3), 159.87 (C-5), 158.73 (C-4'), 141.75 (C-1), 130.63 (C-
1’), 130.25 (C-8), 129.18 (C-2’ and C-6’), 127.01 (C-7), 116.83 (C-3’ and C-5’), 108.70 (C-6), 
107.85 (C-2), 104.88 (C-4), 99.61 (C-1”), 75.28 (C-3”), 74.63 (C-5”), 73.64 (C-2”), 71.81 (C-4”), 
62.63 (C-6”). 
6 SUPPLEMENTARY INFORMATION 
 
 
Figure S3.1 Production of quercetin glucosides (7 - 12 min) with SP at pH 6.5 and 60 °C, using 1 M sucrose 
and quercetin (14.1 min) saturated in 20 % DMSO (above) or AMMOENG 101 (beneath) after 24 h 
incubation. 
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Figure S3.2 Structure of the various ionic liquids used during this research: [MMIM] [MeSO4] (A), 
[BMIM][BF4] (B), [BMIM][dca] (C), [BMIM][I] (D), [EMIM][EtSO4](E) and [EMIM][dca] (F). 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 4 
Biphasic catalysis with sucrose phosphorylase: 
chemoenzymatic synthesis of α-D-glucosides.  
 
 
 
 
 
 
 
 
 
 
 
This chapter has been published as: 
K. De Winter, T. Desmet, T. Devlamynck, L. Van Renterghem, T. Verhaeghe, H. Pelantova, 
V. Kren and W. Soetaert, 2014, Biphasic catalysis with disaccharide phosphorylases: 
Chemoenzymatic synthesis of α-D-glucosides using sucrose phosphorylase, Organic 
Process Research & Development, 18, 781-787. 
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1 ABSTRACT 
Thanks to its broad acceptor specificity, sucrose phosphorylase (SP) has been exploited 
for the transfer of glucose to a wide variety of acceptor molecules. Unfortunately, the 
low affinity (Km > 1 M) of SP towards these acceptors typically urges the addition of 
cosolvents, which often either fail to dissolve sufficient substrate or progressively give 
rise to enzyme inhibition and denaturation. In this work, a buffer/ethyl acetate ratio of 
5:3 was identified to be the optimal solvent system, allowing the use of SP in biphasic 
systems. Careful optimization of the reaction conditions enabled the synthesis of a range 
of α-D-glucosides, such as cinnamyl α-D-glucopyranoside, geranyl α-D-glucopyranoside, 
2-O-α-D-glucopyranosyl pyrogallol and series of alkyl gallyl 4-O-α-D-glucopyranosides. 
The usefulness of biphasic catalysis was further illustrated by comparing the 
glucosylation of pyrogallol in a cosolvent and biphasic reaction system. The acceptor 
yield for the former reached only 17.4 %, whereas roughly 60 % of the initial pyrogallol 
was converted when using biphasic catalysis. 
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2 INTRODUCTION 
Numerous biologically active molecules exist as glycosides in nature. Glycosylation can 
expand structural diversity8, induce targeting of drugs to specific organs and tissues124, 
and improve the solubility of hydrophobic compounds94. Furthermore, glycosylation is 
known to drastically extend the stability of labile molecules95 and mediate the controlled 
release of flavors and fragrances12. Unfortunately, large-scale chemical synthesis of 
these molecules is limited by low yields, the use of toxic catalysts and the generation of 
waste13, 15. Biocatalytic approaches, allowing one-step reactions with high regio- and 
stereoselectivity, have therefore attracted much attention over the past decade18. 
 
Enzymatic glycosylation is typically performed with glycosyltransferases (GTs) or 
glycoside hydrolases (GH). However, the former requires relatively expensive 
nucleotide-activated sugars97 while the latter suffers from low yields when used in the 
synthetic direction27. Less research has been done with disaccharide phosphorylases, 
although they show potential as biocatalysts for glycoside synthesis29, 98, 99. Indeed, these 
enzymes use a glycosyl phosphate donor, which is much cheaper than the activated 
sugar nucleotides required by GTs and can be synthesized by phosphorolysis of their 
natural substrates29. 
 
Sucrose phosphorylase (SP) catalyzes the reversible phosphorolysis of sucrose into α-D-
glucose 1-phosphate (αG1P) and D-fructose. Its broad acceptor specificity has been 
exploited for the transfer of glucose to a wide variety of acceptor molecules, such as 
polyols40, phenolics125, 126, hydroxyfuranones127 and stilbenoids128. Unfortunately, the 
low affinity (Km > 1 M) of SP towards these acceptors typically urges the addition of 
cosolvents like DMSO or methanol. However, low concentrations of these cosolvents 
often fail to dissolve sufficient substrate, whereas high concentrations progressively give 
rise to enzyme inhibition and denaturation33, 79. 
 
Besides the use of ionic liquids (CHAPTER 3), the application of liquid-liquid biphasic 
systems containing water and a water-immiscible organic solvent, however, provides an 
interesting alternative. The aqueous phase contains the enzymes and water soluble 
substrates, while hydrophobic substrates are dissolved in the organic phase. Stirring or 
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shaking will transfer these substrates from the organic to the aqueous phase, where they 
can be converted by the enzymes. Improved enzyme stability and ease of product 
recovery, while avoiding substrate and product inhibition, are among the major 
advantages of biphasic systems129, 130. The usefulness of this type of catalysis has been 
widely illustrated for numerous applications, including the synthesis of 
oligosaccharides131 and glycosides132, 133 with glycosidases.  
 
Although SP has recently been successfully applied for glycosylation reactions in ILs 
(CHAPTER 3) and supercritical carbon dioxide100, no reports on its use in biphasic reaction 
systems are available to date. In this chapter, the glycosylation of various acceptors with 
the SP from Bifidobacterium adolescentis in biphasic systems is described. 
3 RESULTS & DISCUSSION 
3.1 Exploring biphasic catalysis with SP 
The β-D-glucoside of cinnamyl alcohol has recently gained attention from the 
pharmaceutical industry due to its claimed anti-fatigue, anti-aging, antioxidant, and 
immune enhancing properties134-136. The enzymatic glucosylation of cinnamyl alcohol 
has already been reported in an IL based cosolvent system using the SP from B. 
adolescentis (BaSP) (CHAPTER 3). Unfortunately, the latter synthesis suffered from low 
yields and labor intensive product recovery. Consequently, the use of a cosolvent was 
avoided by reacting 250 µL of the alcohol with 250 µL MES buffer at pH 6.5 
supplemented with 2 M sucrose and 50 U/mL BaSP. TLC analysis of the reaction mixture 
after 48 h incubation at 60 °C revealed a clear new spot having an Rf higher than sucrose 
and lower than cinnamyl alcohol (Figure S4.1). The product was purified by silica gel 
chromatography and identified to be cinnamyl α-D-glucopyranoside by NMR 
spectroscopy.  
 
Encouraged by these results, conditions enabling the efficient enzymatic glucosylation 
with BaSP were further optimized. Indeed, a number of factors are known to influence 
the glycosylation efficiency, including the pH, the type and concentration of both donor 
and acceptor, as well as the reaction temperature21. A full factorial design experiment 
was performed to determine their relative importance on the glucosylation of cinnamyl 
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alcohol. The cheap and readily available donor sucrose was used, and the temperature 
was fixed at 37 °C (Table 4.1).  
 
Table 4.1 Optimization of SP catalyzed synthesis of cinnamyl α-D-glucopyranoside in a biphasic system: 
23 factorial design. The reaction mixtures were incubated during 48 h at 37 °C. 
Run pH 
[Sucrose] 
(M) 
Buffer/acceptor 
ratio 
Product spot 
intensity 
1 6 0.5 5:1 ++ 
2 6 0.5 1:1 + 
3 6 2 5:1 +++ 
4 6 2 1:1 ++++ 
5 7.5 0.5 5:1 ++ 
6 7.5 0.5 1:1 + 
7 7.5 2 5:1 +++++ 
8 7.5 2 1:1 ++++ 
 
The glucosylation yield was found to be strongly influenced by the buffer/acceptor 
(solvent) ratio, while high sucrose concentrations were generally required to obtain 
proper glucosylation. Indeed, a product concentration of 4.8 g/L was achieved when 
using 2 M sucrose at pH 7.5 with a 5:1 solvent ratio. The pH was found to only influence 
the product spot intensity when reacting 2 M sucrose with a 5:1 solvent ratio. However, 
the limited differences can be explained by the low product concentrations obtained for 
the other conditions, and the narrow pH range (6 to 7.5) applied. Next, the pH (5 to 9) 
and solvent ratio (10:1 to 1:5) were varied to identify optima at pH 7.5 and a ratio of 5:3. 
Although higher sucrose concentrations were not feasible due to viscosity limitations, 
the glycosylation efficiency could be further improved by increasing the reaction 
temperature to 50 °C. Finally, the optimal reaction conditions were found to be a solvent 
ratio of 5:3, 2 M sucrose, pH 7.5 and 50 °C, resulting in the production of 6.4 g/L 
cinnamyl α-D-glucopyranoside. Interestingly, using αG1P as donor resulted in 
significantly less product formation (4.1 g/L compared to 6.4 g/L), confirming sucrose to 
be the preferred donor substrate55. 
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3.2 Selection of a suitable water-immiscible solvent 
Although these results confirmed the SP mediated transfer of a glucose moiety using 
biphasic catalysis, a suitable water immiscible solvent is required to allow glycosylation 
of solid acceptors. The latter solvent should be able to dissolve high amounts of 
acceptor, without impairing the glucosylation reaction catalyzed by the enzyme. Various 
solvents were supplemented with 50 mg/mL cinnamyl alcohol and reacted under the 
optimal conditions (Figure 4.1).  
 
Figure 4.1 Biphasic glycosylation of cinnamyl alcohol with BaSP. The acceptor was dissolved to 50 mg/mL 
in butyl acetate (1), ethyl acetate (2), methyl-tert-butylether (3), octane (4) and diethyl ether (5). The 
organic and aqueous (‘) phase was spotted for each reaction. 
 
TLC analysis revealed the highest conversion when using ethyl acetate (EtOAc). 
However, SP mediated glucosylation of cinnamyl alcohol was also observed when butyl 
acetate (BuOAc), methyl-tert-butylether (MTBE), octane, diethyl ether, cyclohexene and 
pentane were used.  
 
Next, the solubility of different acceptors was evaluated in the most promising solvents 
(Table S4.1). Although the solubility of all compounds was found to be very low in 
octane, the majority of the evaluated acceptors could be dissolved in BuOAc, MTBE and 
EtOAc. The latter was found to be less deleterious for the glycosylation activity of SP, and 
was therefore used in all further experiments (Figure 4.1). Finally, the concentration of 
cinnamyl alcohol in the organic phase was varied to reveal optimal glucoside formation 
at 100 mg/mL.   
Cinnamyl alcohol 
Glucosides 
Carbohydrates
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3.3 Evaluation of the glycosylation potential of SP 
The glycosylation potential of SP was then evaluated by incubating various acceptors 
under optimal glucosylation conditions. Semi-quantative data for a large number of 
acceptors was obtained through TLC analysis (Table 4.2), while HPLC experiments 
allowed detailed analysis of a limited amount of reactions (Table 4.3). 
 
Table 4.2 Glycosylation potential of the SP from B. adolescentis in a biphasic reaction system. TLC analysis 
was performed after 48 h incubation at 50 °C. 
Acceptor Product spot 
intensity 
Acceptor Product spot 
intensity 
Pentanola +++ Cinnamyl alcohola +++ 
Hexanola ++ Mentholb - 
Heptanola + Saligeninb ++++ 
Octanola + p-Nitrophenolb + 
Nonanola - Phenolb  - 
Decanola - Hydroquinoneb + 
Dodecanola - Catecholb +++ 
Cyclohexanola ++++ Resorcinolb +++ 
2-Hexanola +++ Pyrogallol b +++++ 
Linaloola - Methyl gallateb ++++ 
Eugenola ++ Ethyl gallateb ++++ 
Nerolidola - Propyl gallateb +++ 
β-Citronellola  + Lauryl gallateb - 
Geraniola ++ Salicylic acid methyl estera + 
2-Phenylethanola + Curcuminb - 
1R-Phenylethanola +++++ Resveratrolb + 
1S-Phenylethanola +++++ Quercetinb  + 
Benzyl alcohola ++ Vanillinb ++ 
Anisyl alcohola + Vanillyl alcoholb +++ 
a Glycosylation was performed using the acceptor as organic phase. b Glycosylation was performed using 
EtOAc supplemented with 100 mg/mL acceptor as organic phase. 
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These results illustrate the versatile applicability of biphasic catalysis for the production 
of glycosides with SP. The structure of numerous glucosides was confirmed by NMR 
spectroscopy. Aliphatic alcohols could be glycosylated up to octanol, but the obtained 
product concentrations decreased with increasing chain lengths. 
 
Table 4.3 Glycosylation of various acceptors with the SP from B. adolescentis. HPLC analysis was 
performed after 48 h incubation at 50 °C. 
Acceptor 
[Glucoside] 
(mM) 
[Glucoside] 
(g/L) 
Glucosided 
(g) 
YieldAcceptor 
(%) 
YieldDonor 
(%) 
Geraniola 20.4 6.5 0.65 0.9 1.6 
1R-Phenylethanola 133.2 37.9 3.79 4.3 10.7 
1S-Phenylethanola 126.7 36.0 3.60 4.1 10.1 
Cinnamyl alcohola 21.5 6.4 0.64 0.8 1.7 
Cinnamyl alcoholb 16.2 4.8 0.48 5.8 1.3 
Hydroquinoneb 2.6 0.7 0.07 0.7 0.2 
Resorcinolb 27.1 7.4 0.74 7.9 2.2 
Pyrogallol b 175.8 50.6 5.06 59.1 14.1 
Pyrogallol c 112.6 32.4 3.24 75.7 9.0 
Methyl gallateb 87.4 30.2 3.02 42.9 7.0 
Ethyl gallateb 50.9 18.3 1.83 26.9 4.0 
Propyl gallateb 24.7 9.2 0.92 14.0 1.9 
a Glycosylation was performed using the acceptor as organic phase. b Glycosylation was performed using 
EtOAc supplemented with 100 mg/mL acceptor as organic phase. c Glycosylation was performed using 
EtOAc supplemented with 50 mg/mL acceptor as organic phase. d Glucoside produced in a 100 mL 
reaction. 
 
Surprisingly, secondary alcohols were found to be more easily glycosylated compared to 
primary alcohols. Indeed, 48 h incubation under optimal reaction conditions resulted in 
glucoside concentrations of 37.9 and 36.0 g/L for 1R- and 1S-phenylethanol, 
respectively, while only traces of product were detected when reacting 2-phenylethanol. 
The structure of R- and S-1-phenylethyl α-D-glucopyranoside was confirmed by NMR 
spectroscopy. Also, BaSP was found to glycosylate a range of structurally diverse 
compounds with olfactory properties. Examples include the monoterpenoids geraniol 
and β-citronellol, aromatic alcohols such as benzyl alcohol, anisyl alcohol, cinnamyl 
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alcohol and vanillyl alcohol, as well as the phenylpropanoid eugenol and the phenolic 
aldehyde vanillin. Although these glycosides were generally produced in significantly 
lower concentrations compared to secondary alcohols (Table 4.3), we were able to 
confirm the formation of geranyl α-D-glucopyranoside and cinnamyl α-D-
glucopyranoside by NMR spectroscopy.   
 
In contrast to earlier work with the SP from L. mesenteroides125, we failed to obtain any 
glycosides of phenol. However, we were able to couple a glucose moiety to 
hydroquinone, catechol, resorcinol and pyrogallol, indicating the necessity of additional 
phenolic hydroxyl groups to ensure correct positioning in the active site. Indeed, the 
formation of 1-O-α-D-glucopyranosyl hydroquinone (0.7 g/L), 1-O-α-D-glucopyranosyl 
resorcinol (7.4 g/L) and 2-O-α-D-glucopyranosyl pyrogallol (50.6 g/L) was confirmed by 
NMR spectroscopy. In addition, glucosylation of a series of gallic acid esters was 
observed, as confirmed by NMR spectroscopy. These potent antioxidants, including ethyl 
gallate (E313) and propyl gallate (E310), are commonly applied in foods, cosmetics and 
hair products137, 138. The methyl ester glucoside could be produced up to 30 g/L, while 
longer alkyl chains were found to result in lower glucoside concentrations (Table 4.3).  
 
In conclusion, a wide variety of glucosides could be synthesized using the SP from B. 
adolescentis. Industrially relevant glucoside concentrations of several g/L were obtained 
for a number of acceptors96, 139. Not surprisingly, the acceptor yields were much lower 
when using the pure acceptor as organic phase (Table 4.3). The latter, however, could be 
increased from 0.8 to 5.8 % for cinnamyl alcohol, by dissolving 100 mg/mL of the 
acceptor in EtOAc, rather than using the alcohol in its undiluted form. Moreover, the 
acceptor yield for pyrogallol could be improved from 59.1 to 75.7 % by decreasing the 
acceptor concentration from 100 to 50 mg/mL. However, these increased yields were 
achieved at the expense of lower product concentrations (Table 4.3). 
  
The donor yields, on the contrary, were less than 20 % for all acceptors (Table 4.3). 
Indeed, higher concentrations of sucrose were added to stabilize the enzyme 
(CHAPTER 3), and push the conversion in the synthesis direction. Therefore, considerable 
amounts of sucrose remained present at the end of the reaction (Figure 4.2). Moreover, 
SP is known to exhibit an undesirable hydrolytic side reaction, yielding D-glucose and D-
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fructose as products. The liberated glucose can then be glucosylated by SP, resulting in 
the formation of ‘glucobiose’ products55, 90.  Unfortunately, this competition between D-
glucose and the acceptor compound was found to further decrease the donor yield. 
 
Figure 4.2 HPLC chromatogram showing the glucosylation of propyl gallate and formation of glucobiose 
products with SP. The sample was analyzed after 24 h incubation under optimal biphasic reaction 
conditions at 50 °C: gallic acid propyl ester (4.9 min), propyl gallyl 4-O-α-D-glucopyranoside (8.2 min), D-
fructose (21.7 min), D-glucose (23.2 min), sucrose (28.3 min) and glucobiose products (30.2 – 31.9 min).   
3.4 Cosolvent or biphasic catalysis? 
Finally, the performance of biphasic catalysis was compared with a recently reported 
cosolvent system (CHAPTER 3), using the glycosylation of pyrogallol as a case study. 
Therefore, the water immiscible EtOAc was replaced by the IL AMMOENG 101, which 
has been successfully applied for the SP mediated synthesis of 3-O-α-D-glucopyranosyl 
(E)-resveratrol128. All other parameters were identical for both reactions (Figure 4.3).  
 
Interestingly, the acceptor yield for the cosolvent system reached only 17.4 %, while 
roughly 60 % of the initial pyrogallol was converted when using a biphasic system. This 
significant difference can be explained by the transfer ratio of the enzyme under the 
operational conditions. Indeed, a ratio of 5.7 for the biphasic system, compared to 1.1 for 
the cosolvent system, indicates that less hydrolysis (and synthesis of glucobioses) occurs 
upon application of biphasic catalysis. In addition, the course of product formation 
reveals the absence of secondary hydrolysis (i.e. the degradation of 2-O-α-D-
glucopyranosyl pyrogallol), as previously reported by the Nidetzky group for α-glucosyl 
glycerol40 (Figure 4.3). 
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Figure 4.3 Synthesis of 2-O-α-D-glucopyranosyl pyrogallol in a cosolvent (○) and biphasic (●) reaction 
system. The reaction mixture consisted of 62.5 % aqueous MOPS buffer at pH 7.5 containing 2 M sucrose 
and 50 U/mL SP, and 37.5 % EtOAc supplemented with 100 mg/mL pyrogallol. For the cosolvent system, 
EtOAc was replaced by the IL AMMOENG 101. 
4 CONCLUSION 
Following the work on SP mediated glycoside synthesis in conventional solvents55, ILs 
(CHAPTER 3) and  supercritical carbon dioxide100, this is the first report on the use of 
disaccharide phosphorylases in biphasic reaction systems. Careful optimization allowed 
the glucosylation of aliphatic alcohols, monoterpenoids, aromatic alcohols and 
phenolics. In addition a series of alkyl gallyl 4-O-α-D-glucopyranosides were successfully 
synthesized up to 30 g/L. These glucosylations were achieved by reacting 62.5 % 
aqueous MOPS buffer at pH 7.5 containing 2 M sucrose and 50 U/mL SP, and 37.5 % 
EtOAc supplemented with 100 mg/mL acceptor. Also, the production of 2-O-α-D-
glucopyranosyl pyrogallol was compared in cosolvent and biphasic systems. The 
transfer ratio was found to be 5 times higher when using the latter system, resulting in 
less hydrolysis and formation of glucobiose side product. Consequently, the use of 
biphasic catalysis was identified to be a valuable alternative for glycoside synthesis with 
disaccharide phosphorylases. 
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5 MATERIALS & METHODS 
5.1 Materials 
The IL AMMOENG 101 was kindly provided by Evonik Industries AG, and ethyl acetate 
was bought from Fiers. All other chemicals were analytical grade and purchased from 
Sigma-Aldrich. The recombinant SP from B. adolescentis was produced and partially 
purified by heat treatment as described in CHAPTER 2. The activity of the enzyme was 
determined as shown in CHAPTER 2, and one unit of SP was defined as the activity that 
corresponds to the release of 1 μmol fructose per minute from 100 mM sucrose in 100 
mM phosphate buffer at pH 7.0 and 37 °C. NMR spectra were measured on a Bruker 
AVANCE III 600 MHz spectrometer (600.23 MHz for 1H, and 150.94 MHz for 13C) in 
CD3OD at 25 °C. HPLC measurements were performed on a Varian Prostar. 
5.2 Glycosylation reactions with SP 
Small scale biphasic glycosylation reactions were performed in a Thermoshaker 
(Eppendorf) at 1400 rpm. Varying amounts of different water immiscible acceptors 
were added to 500 µL aqueous buffer in a 1.5 mL eppendorf. Alternatively, water 
immiscible organic solvents containing 100 mg/mL acceptor were used. The acidity of 
the aqueous phase was varied by using a citrate-phosphate buffer (pH 5.0-5.4), MES 
buffer (pH 5.5-6.5), MOPS buffer (pH 6.6-7.5) or tricine buffer (pH 7.6-9). Unless stated 
otherwise, the reactions were incubated at 50 °C in the presence of 2 M sucrose and 
50 U/mL SP. The acceptor (YieldAcceptor) and donor yield (YieldDonor) are defined as the 
ratio of the amount of product formed to the amount of acceptor and donor added to the 
reaction, respectively (mol/mol).  
5.3 Solubility measurements 
The dissolution of various acceptor molecules in different water immiscible solvents 
was performed in a water bath at 50 °C with ± 0.1 °C accuracy. Varying amounts of 
acceptor were added to a 2 mL eppendorf, and solvent was added to 1 mL. Next, the 
samples were vortexed multiple times and allowed to equilibrate for 48 h, after which 
the samples were checked for remaining particles. The latter technique allows to map 
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the solubilizing properties of various solvents, whilst avoiding the time consuming HPLC 
analyses required by the method described in CHAPTER 3.  
5.4 TLC analysis 
TLC analysis was performed on Merck Silica gel 60 F254 precoated plates. The eluens was 
a mixture of EtOAC/MeOH/H2O = 30:5:4, and spots were visualized by UV detection at 
254 nm, or charring with 10 % (v/v) H2SO4. All TLC plates of a single experiment were 
visually compared, thereby rating the intensity of product spots between +++++ and + 
for the highest intensity and a barely visible spot respectively. Both the aqueous and the 
solvent phase were spotted on TLC. The intensity of both product spots was combined to 
yield a single rating. 
5.5 HPLC analysis 
HPLC analysis was performed on an X-bridge amide column (250 mm × 4.6 mm, 3.5 µm, 
Waters, USA) with milliQ water (solvent A) and acetonitrile (solvent B), both containing 
0.2 % triethylamine, as the mobile phase. The flow rate and temperature were set at 
1.0 mL/min and 30 °C, respectively. The gradient elution was as follows: 95 % of solvent 
A (0 - 12 min), 5 to 25 % solvent B (12 - 15 min), 25 % solvent B (15 - 40 min), 25 to 5 % 
solvent B (40 - 41 min) and 95 % solvent A (41 - 50 min). Adequate detection was 
obtained with an Alltech 2000ES evaporative light scattering detector (ELSD). The tube 
temperature, gas flow and gain were set at 30 °C, 1.5 L/min and 1, respectively. 
Homogeneous samples containing both phases were obtained after intensive mixing. 
These samples were then diluted in DMSO, and subjected to HPLC analysis. The resulting 
concentrations thus refer to the amount of product present in the total reaction volume. 
The obtained peaks were calibrated using authentic standard curves prepared in milliQ 
water or methanol. All HPLC analyses were performed in triplicate. 
5.6 Comparison of biphasic and cosolvent glycosylation reactions 
The glycosylation of pyrogallol was carried out at 10 mL scale. The reaction mixture 
consisted of 62.5 % aqueous MOPS buffer at pH 7.5 containing 2 M sucrose and 50 U/mL 
SP, and 37.5 % EtOAc supplemented with 100 mg/mL pyrogallol. Alternatively, EtOAc 
was replaced by the IL AMMOENG 101. Reaction mixtures were incubated in a 
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thermoshaker (Eppendorf) at 750 rpm and 50 °C. The concentration of 2-O-α-D-
glucopyranosyl pyrogallol and fructose was determined by means of HPLC analysis. The 
transfer ratio is defined as the ratio of the amount of glucose transferred to the acceptor 
over the sum of the free glucose and the glucose incorporated in glucobioses. The former 
was calculated based on the glucoside concentration, while the latter was obtained by 
subtracting the amount of glucoside from the obtained fructose concentration. 
5.7 Production and purification of glucosides 
The glycosylation of hydroquinone, resorcinol, pyrogallol, methyl gallate, ethyl gallate 
and propyl gallate was carried out at 100 mL scale in magnetically stirred flasks. 
Biphasic reaction mixtures were created by adding 62.5 mL aqueous buffer to 37.5 mL 
organic solvent. The aqueous buffer consisted of 50 mM MOPS at pH 7.5 containing 2 M 
sucrose and 50 U/mL SP. EtOAc supplemented with 100 mg/mL hydroquinone, 
resorcinol, pyrogallol, methyl gallate, ethyl gallate or propyl gallate was used as organic 
phase. Alternatively, glycosylation of 1-phenylethanol, geraniol and cinnamyl alcohol 
was performed by substituting the EtOAc by the pure acceptor. Reactions were 
terminated after 48 h incubation at 50 °C, after which the reaction mixtures were heated 
(10 min at 95 °C) and centrifuged (12 000 g, 4 °C, 15 min) to remove debris. The samples 
were then evaporated in vacuo and the residue was purified by column chromatography 
(silicagel, EtOAC/MeOH/H2O = 30:5:4).  
5.8 Structure elucidation of glucosides 
The structures of the newly formed glucosides were determined by a combination of 1D 
NMR (1H NMR and 13C NMR) and 2D NMR (gCOSY, gHSQC and gHMBC) spectroscopy. 
Residual signals of solvent were used as internal standard (H 3.330 ppm, C 49.30 ppm), 
and digital resolution enabled us to report H to three and C to two decimal places. The 
proton spin systems were assigned by COSY, and then the assignment was transferred to 
carbons by HSQC. HMBC experiments enabled us to assign quaternary carbons and to 
join individual spin systems together. Chemical shifts are given in -scale [ppm], and 
coupling constants in Hz. Spectral analysis and interpretation was kindly performed by 
the group of Prof. Vladimír Křen at the Institute of Microbiology (Czech Republic). 
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1-O-α-D-Glucopyranosyl hydroquinone 
1H NMR (600.23 MHz, CD3OD, 25 oC): 3.427 (1H, dd, J = 9.7, 8.9 Hz, H-
4), 3.543 (1H, dd, J = 9.8, 3.7 Hz, H-2), 3.722 (1H, dd, J = 11.3, 4.9 Hz, H-
6u), 3.752 (1H, ddd, J = 9.7, 4.9, 2.0 Hz, H-5), 3.791 (1H, dd, J = 11.3, 2.0 
Hz, H-6d), 3. 863 (1H, dd, J = 9.8, 8.9 Hz, H-3), 5.310 (1H, d, J = 3.7 Hz, 
H-1), 6.720 (2H, m, ΣJ = 8.9 Hz, H-meta), 7.026 (2H, m, ΣJ = 8.9 Hz, H-
ortho) 
13C NMR (150.94 MHz, CD3OD, 25 oC): 62.73 (C-6), 71.92 (C-4), 73.73 (C-2), 74.50 (C-5), 75.28 (C-
3), 100.85 (C-1), 116.99 (C-meta), 120.17 (C-ortho), 152.22 (C-ipso), 154.14 (C-para) 
 
 
1-O-α-D-Glucopyranosyl resorcinol 
1H NMR (600.23 MHz, CD3OD, 25 oC): 3.462 (1H, dd, J = 9.9, 8.9 Hz, H-
4), 3.569 (1H, dd, J = 9.8, 3.7 Hz, H-2), 3.671 (1H, ddd, J = 9.9, 4.4, 2.7 
Hz, H-5), 3.728 (1H, dd, J = 12.0, 4.4 Hz, H-6u), 3.762 (1H, dd, J = 12.0, 
2.7 Hz, H-6d), 5.457 (1H, d, J = 3.7 Hz, H-1), 6.548 (1H, ddd, J = 8.1, 2.3, 
0.8 Hz, H-6’), 6.636 (1H, dd, J = 2.3, 2.3 Hz, H-2’), 6.662 (1H, ddd, J = 
8.2, 2.3, 0.8 Hz, H-4’), 7.087 (1H, dd, J = 8.2, 8.1 Hz, H-5’) 
13C NMR (150.94 MHz, CD3OD, 25oC): 62.58 (C-6), 71.75 (C-4), 73.63 (C-2), 74.58 (C-5), 75.26 (C-
3), 99.52 (C-1), 105.85 (C-2’), 109.57 (C-4’), 110.83 (C-6’), 131.14 (C-5’), 159.90 (C-3’), 160.09 
(C-1’) 
 
 
2-O-α-D-Glucopyranosyl pyrogallol 
1H NMR (600.23 MHz, CD3OD, 25 oC): 3.441 (1H, dd, J = 10.1, 8.9 Hz, H-4), 
3.604 (1H, dd, J = 9.6, 3.9 Hz, H-2), 3.771 (1H, dd, J = 11.8, 5.5 Hz, H-6u), 
3.881 (1H, dd, J = 9.6, 8.9 Hz, H-3), 3.902 (1H, dd, J = 11.8, 2.4 Hz, H-6d), 
4.234 (1H, ddd, J = 10.1, 5.5, 2.4 Hz, H-5), 5.024 (1H, d, J = 3.9 Hz, H-1) 
6.385 (2H, d, J = 8.2 Hz, H-meta), 6.813 (1Ht, J = 8.2 Hz, H-para) 
 13C NMR (150.94 MHz, CD3OD, 25 oC): 62.60 (C-6), 71.41 (C-4), 73.66 (C-2), 75.30 (C-3), 75.56 
(C-5), 106.01 (C-1), 108.95 (C-meta), 126.47 (C-para), 136.12 (C-ipso), 152.27 (C-ortho) 
 
 
Methyl gallyl 4-O-α-D-glucopyranoside 
1H NMR (600.23 MHz, CD3OD, 25 oC): 3.482 (1H, dd, J =  10.1, 9.2 Hz, 
H-4), 3.619 (1H, dd, J = 9.6, 3.8 Hz, H-2), 3.796 (1H, dd, J = 11.9, 4.9 
Hz, H-6u), 3.860 (3H, s, H-1’),  3.868 (1H, dd, J = 11.9, 2.5 Hz, H-6d), 
3.902 (1H, dd, J = 9.6, 9.2 Hz, H-3), 4.243 (1H, ddd, J = 10.1, 4.9, 2.5 
Hz, H-5), 5.149 (1H, d, J = 3.8 Hz, H-1), 7.063 (2H, s, H-meta) 
 13C NMR (150.94 MHz, CD3OD, 25oC): 52.88 (C-1’), 62.41 (C-6), 
71.18 (C-4), 73.66 (C-2), 75.22 (C-3), 75.46 (C-5), 105.45 (C-1), 110.34 (C-meta), 128.10 (C-
para), 139.75 (C-ipso), 152.31 (C-ortho), 168.60 (CO) 
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Ethyl gallyl 4-O-α-D-glucopyranoside 
1H NMR (600.23 MHz, CD3OD, 25 oC): 1.372 (3H, t, J = 7.1 Hz, H-2’), 
3.479 (1H, dd, J =  10.1, 9.2 Hz, H-4), 3.619 (1H, dd, J = 9.6, 3.8 Hz, H-2), 
3.793 (1H, dd, J = 11.8, 5.0 Hz, H-6u), 3.872 (1H, dd, J = 11.8, 2.5 Hz, H-
6d), 3.901 (1H, dd, J = 9.6, 9.2 Hz, H-3), 4.242 (1H, ddd, J = 10.1, 5.0, 2.5 
Hz, H-5), 4.317 (1H, q, J = 7.1 Hz, H-1’), 5.146 (1H, d, J = 3.8 Hz, H-1), 
7.068 (2H, s, H-meta) 
13C NMR (150.94 MHz, CD3OD, 25oC): 14.85 (C-2’),  62.36 (C-1’), 62.45 
(C-6), 71.22 (C-4), 73.67 (C-2), 75.24 (C-3), 75.50 (C-5), 105.51 (C-1), 110.31 (C-meta), 128.47 
(C-para), 139.72 (C-ipso), 152.29 (C-ortho), 168.13 (CO) 
 
 
Propyl gallyl 4-O-α-D-glucopyranoside 
1H NMR (600.23 MHz, CD3OD, 25 oC): 1.038 (3H, t, J = 7.4 Hz, H-3’), 
1.778 (2H, tq, J = 7.4, 6.6 Hz, H-2’), 3.485 (1H, dd, J =  10.0, 9.2 Hz, 
H-4), 3.622 (1H, dd, J = 9.6, 3.8 Hz, H-2), 3.798 (1H, dd, J = 11.9, 4.9 
Hz, H-6u), 3.872 (1H, dd, J = 11.9, 2.5 Hz, H-6d), 3.906 (1H, dd, J = 
9.6, 9.2 Hz, H-3),4.223 (2H, t, J = 6.6 Hz, H-1’),  4.246 (1H, ddd, J = 
10.0, 4.9, 2.5 Hz, H-5), 5.153 (1H, d, J = 3.8 Hz, H-1), 7.070 (2H, s, H-
meta) 
13C NMR (150.94 MHz, CD3OD, 25oC): 11.07 (C-3’), 23.40 (C-2’), 62.41 (C-6), 67.92 (C-1’), 71.17 
(C-4), 73.64 (C-2), 75.21 (C-3), 75.45 (C-5), 105.44 (C-1), 110.28 (C-meta), 128.39 (C-para), 
139.69 (C-ipso), 152.28 (C-ortho), 168.16 (CO) 
 
 
1R-Phenylethyl α-D-glucopyranoside 
1H NMR (600.23 MHz, CD3OD, 25 oC): 1.493 (3H, d, J = 6.6 Hz, H-2’), 3.304 
(1H, dd, J =  9.8, 8.9 Hz, H-4), 3.333 (1H, dd, J = 9.8, 3.8 Hz, H-2), 3.709 (1H, 
m, H-6u), 3.735 (1H, m, H-5), 3.775 (1H, dd, J = 9.7, 8.9 Hz, H-3), 3.886 (1H, 
m, H-6d), 4.626 (1H, d, J = 3.8 Hz, H-1), 4.909 (1H, q, J = 6.6 Hz, H-1’),7.272 
(1H, m, H-para), 7.345 (2H, m, H-meta), 7.455 (2H, m, H-ortho) 
13C NMR (150.94 MHz, CD3OD, 25oC): 24.92 (C-2’), 63.13 (C-6), 72.34 (C-4), 
73.78 (C-2), 74.19 (C-5), 74.59 (C-1’), 75.40 (C-3), 97.14 (C-1), 128.19 (C-ortho), 128.90 (C-para), 
129.71 (C-meta), 144.30 (C-ipso) 
 
 
1S-Phenylethyl α-D-glucopyranoside 
1H NMR (600.23 MHz, CD3OD, 25 oC): 1.499 (3H, d, J = 6.5 Hz, H-2’), 3.323 
(1H, dd, J =  10.0, 8.5 Hz, H-4), 3.362 (1H, ddd, J = 10.0, 4.3, 2.3 Hz, H-5), 
3.429 (1H, dd, J = 9.7, 3.8 Hz, H-2), 3.435 (1H, dd, J = 11.8, 2.3 Hz, H-6u), 
3.543 (1H, dd, J = 11.9, 4.3 Hz, H-6d),  3.664 (1H, dd, J = 9.7, 8.5 Hz, H-3), 
4.808 (1H, q, J = 6.5 Hz, H-1’), 5.058 (1H, d, J = 3.8 Hz, H-1), 7.254 (1H, m, H-
para),  7.326 (2H, m, H-meta), 7.427 (2H, m, H-ortho) 
 13C NMR (150.94 MHz, CD3OD, 25oC): 22.44 (C-2’), 62.33 (C-6), 71.81 (C-4), 73.88 (C-2), 75.38 
(C-3), 77.17 (C-1’), 78.42 (C-5), 99.34 (C-1), 127.73 (C-ortho), 128.65 (C-para), 129.54 (C-meta), 
145.60 (C-ipso) 
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Cinnamyl α-D-glucopyranoside 
1H NMR (600.23 MHz, CD3OD, 25 oC): 3.325 (1H, dd, J = 10.0, 8.9 Hz, H-4), 
3.446 (1H, dd, J = 9.7, 3.7 Hz, H-2), 3.661 (1H, ddd, J = 10.0, 5.7, 2.3 Hz, H-
5), 3.707 (1H, dd, J = 11.7, 5.7 Hz, H-6u), 3.714 (1H, dd, J = 9.7, 8.9 Hz, H-
3), 3.851 (1H, dd, J = 11.7, 2.3 Hz, H-6d), 4.240 (1H, ddd, J = 12.8, 6.6, 1.4 
Hz, H-1’u), 4.407 (1H, ddd, J = 12.8, 5.8, 1.6 Hz, H-1’d), 4.922 (1H, d, J = 3.7 
Hz, H-1), 6.410 (1H, ddd, J = 16.0, 6.6, 5.8 Hz, H-2’), 6.714 (1H, ddd, J = 
16.0, 1.6, 1.4 Hz, H-3’), 7.242 (1H, m, H-para),  7.321 (2H, m, H-meta), 
7.439 (2H, m, H-ortho) 
 13C NMR (150.94 MHz, CD3OD, 25 oC): 63.03 (C-6), 69.44 (C-1’), 72.18 (C-4), 73.87 (C-2), 74.15 
(C-5), 75.44 (C-3), 99.61 (C-1), 126.89 (C-2’), 127.82 (C-ortho), 129.01 (C-para), 129.89 (C-
meta), 134.21 (C-3’), 138.52 (C-ipso) 
 
Geranyl α-D-glucopyranoside 
1H NMR (600.23 MHz, CD3OD, 25 oC): 1.630 (3H, s, H-9’), 1.695 
(3H, q, J = 1.0 Hz, H-8’), 1.715 (3H, s, 3’-Me), 2.067 (2H, m, H-
4’), 2.141 (2H, m, H-5’),  3.316(1H, dd, J =  9.9, 8.8 Hz, H-4), 
3.403 (1H, dd, J = 9.7, 3.8 Hz, H-2), 3.608 (1H, ddd, J = 9.9, 5.5, 
2.4 Hz, H-5), 3.658 (1H, dd, J = 9.7, 8.8 Hz, H-3), 3.704 (1H, ddd, 
J = 11.8, 5.5 Hz, H-6u), 3.824 (1H, dd, J = 11.8, 2.4 Hz, H-6d), 
4.121 (1H, dd, J = 12.1, 7.5 Hz, H-1’u), 4.242 (1H, dd, J = 12.1, 6.4 Hz, H-1’d), 4.838 (1H, d, J = 3.8 
Hz, H-1), 5.128 (1H, m, H-6’), 5.409 (1H, m, H-2’) 
13C NMR (150.94 MHz, CD3OD, 25 oC): 16.79 (3’-Me), 18.04 (C-9’), 26.17 (C-8’), 27.74 (C-5’), 
41.01 (C-4’), 62.96 (C-6), 65.11 (C-1’), 72.12 (C-4), 73.85 (C-2), 73.97 (C-5), 75.49 (C-3), 99.17 
(C-1), 121.95 (C-2’), 125.36 (C-6’), 132.82 (C-7’), 141.86 (C-3’) 
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6 SUPPLEMENTARY INFORMATION 
Table S4.1 Solubility of various acceptors in ethyl acetate, octane, butyl acetate and methyl-tert-
butylether at 50 °C.   
Acceptor 
Solubility (mg/mL) 
EtOAc BuOAc MTBE octane  
Gallic acid ethyl ester 200 – 210 50 – 60 90 – 100 < 10 
Hydroquinone 170 – 180 50 – 60 60 – 70 < 10 
Pyrogallol 490 – 500 210 – 220 240 – 250 < 10 
Saligenin 450 – 460 230 – 240 250 – 260 < 10 
Curcumin 10 – 20 10 – 20 < 10 < 10 
Resveratrol 10 – 20 < 10 < 10 < 10 
p-Nitrophenol 740 – 750 480 – 490 540 – 550 < 10 
Vanillyl alcohol 20 – 30 < 10 < 10 < 10 
 
 
 
Figure S4.1 Glycosylation of cinnamyl alcohol with sucrose phosphorylase from B. adolescentis. Standards 
of sucrose (1), fructose (2) and cinnamyl alcohol (3) were spotted along the aqueous phase (4) and the 
cinnamyl alcohol phase (5) after 48 h incubation at 60 °C.  
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CHAPTER 5 
Chemoenzymatic synthesis of β-D-glucosides using 
cellobiose phosphorylase from                       
Clostridium thermocellum. 
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1 ABSTRACT 
As illustrated in the previous chapters, disaccharide phosphorylases have been 
successfully applied for the synthesis of numerous α-glucosides. In contrast, much less 
research has been done with respect to the production of β-glucosides. Although 
cellobiose phosphorylase (CP) was already successfully used for the synthesis of various 
disaccharides and branched trisaccharides, its glycosylation potential towards small 
organic compounds hasn’t been explored to date. Unfortunately, disaccharide 
phosphorylases typically have a very low affinity for non-carbohydrate acceptors, which 
urges the addition of solvents. The IL AMMOENG 101 and EtOAc were identified as the 
most promising solvents, allowing the synthesis of various β-glucosides. Next to hexyl, 
heptyl, octyl, nonyl, decyl and undecyl β-D-glucopyranoside, also the formation of 
vanillyl 4-O-β-D-glucopyranoside, 2-phenylethyl β-D-glucopyranoside, β-citronellyl β-D-
glucopyranoside and 1-O-β-D-glucopyranosyl hydroquinone was confirmed by NMR 
spectroscopy. Moreover, the stability of CP could be drastically improved by creating 
cross-linked enzyme aggregates, while the efficiency of the biocatalyst for the synthesis 
of octyl β-D-glucopyranoside was doubled by imprinting with octanol. The usefulness of 
the latter system was illustrated by performing three consecutive batch conversions 
with octanol iCLEAs, yielding roughly 2 g of octyl β-D-glucopyranoside. 
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2 INTRODUCTION 
Despite the continuous development of new procedures, the synthesis of glycosides still 
remains a challenge to date15. Numerous chemical routes have been described for the 
production of these molecules, but their application is limited by poor yields, the use of 
toxic catalysts and the generation of waste13. Consequently, biocatalytic approaches 
have received increasing attention in recent years as promising alternative for glycoside 
synthesis18. Indeed, enzymatic glycosylation reactions enable one-step conversions with 
high regio- and stereoselectivity; thereby generating 5-fold less waste19. 
 
Over the past decade, disaccharide phosphorylases have been identified as potent 
enzymes for the synthesis of glycosides. While glycosyltransferases require expensive 
nucleotide-activated sugars97 and glycoside hydrolases suffer from unfavorable 
equilibrium constants18, these enzymes use cheap glycosyl phosphate donors and can be 
efficiently used in the synthesis direction29. Examples include the α-glucosylation of 
alcohols with maltose phosphorylase140 and the synthesis of 2-O-α-D-glucopyranosyl 
glycerol40 (CHAPTER 2), 1-O-α-D-glucopyranosyl hydroquinone125 (CHAPTER 4), 2-O-α-D-
glucopyranosyl L-ascorbic acid,7 and geranyl α-D-glucopyranoside141 (CHAPTER 4) using 
sucrose phosphorylase (SP). In CHAPTER 3, it is shown that the efficiency of these 
glucosylation reactions can be vastly improved by the addition of ionic liquids (ILs), 
while CHAPTER 4 illustrated the usefulness of biphasic catalysis. Moreover, various 
immobilization techniques have been successfully applied resulting in biocatalysts with 
enhanced activity and stability, while allowing their recycling in repetitive batch 
conversions (CHAPTER 1 and 2). In contrast to the extended work on α-glucosides, only a 
single report describing the synthesis of β-glucosides with disaccharide phosphorylases 
is known to date142. Nevertheless, numerous biologically active molecules exist as β-
glucosides in nature. For example arbutin, the β-glucoside of hydroquinone, can be 
found in wheat, pear skins and Bergenia crassifolia143. This skin whitening compound is 
used in cosmetics to reduce irritation caused by hydroquinone144 and treat urogenital 
tract infections145. Alkyl β-glucosides, on the other hand, are potent non-ionic 
surfactants with good emulsifying and antimicrobial properties146. These compounds 
are widely used in pharmaceuticals, detergents, and food ingredients147. 
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Cellobiose phosphorylase (CP) catalyzes the reversible phosphorolysis of cellobiose and 
inorganic phosphate to α-D-glucose 1-phosphate (αG1P) and D-glucose148. Unlike SP, CP 
is an inverting phosphorylase following a single displacement reaction, thereby forming 
glycosides with opposite anomeric configuration compared to the donor substrate149. 
Thanks to its relatively broad acceptor specificity with respect to carbohydrates, CP has 
been successfully used for the synthesis of various disaccharides150 and branched 
trisaccharides36. More recently, mutant CPs with enhanced activity towards alkyl42 and 
aryl β-glucosides151 have been reported. Nevertheless, all of these acceptors contain a 
glucose moiety as point of attachment whereas the direct glycosylation of non-
carbohydrate acceptors such as long-chain alcohols, flavonoids, alkaloids, phenolics and 
terpenes has not been achieved yet. 
 
In this chapter, the glycosylation of various small organic compounds with the CP from 
Clostridium thermocellum is described in IL cosolvent and biphasic systems. Moreover, 
the enzyme was immobilized and imprinted to increase both the stability and activity of 
the biocatalyst.  
3 RESULTS & DISCUSSION 
3.1 Development of a suitable glycosylation system 
Although much work has been done with the CP from C. thermocellum (CtCP), limited 
information on the kinetic thermostability of the enzyme is known to date. Nevertheless, 
carbohydrate conversions are preferably performed at elevated temperatures58. 
Therefore, the stability of the CtCP was evaluated at various temperatures (Figure 5.1).  
 
In contrast to the rapid inactivation at 60 °C, CP was found to be remarkably stable at 
37 °C. However, applying enzymes much below their optimal temperature typically 
comes at the expense of a lower turnover. A balance between stability and activity was 
found for CP at 50 °C, retaining over 58 % of its initial activity after 24 h, while operating 
at roughly 80 % of its maximal velocity152.  
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Figure 5.1 Kinetic thermostability of the CP from C. thermocellum. The enzyme was dissolved in MES 
buffer (50 mM, pH 6.5) an incubated at 37 (■), 45 (∆), 50 (▼), 55 (○) and 60 °C (●). 
 
In addition, the typically very low affinity of disaccharide phosphorylases for non-
carbohydrate acceptors urges the addition of solvents77. Therefore, the half-life (t50) of 
CtCP was also determined in the presence of some commonly used organic cosolvents, 
as well as in some ILs (Table 5.1).  
 
Table 5.1 Stability of the CP from C. thermocellum at pH 6.5 and 50 °C, in the presence of various organic 
solvents and ILs.  
 t50a [min] 
Solvent 20 % 37.5 % 
MeOH                      229 ± 12 11.2 ± 0.9 
EtOH                        42.1 ± 3.3 3.5 ± 0.3 
DMSO 736 ± 49 256 ± 19 
[BMIM][dca]                       24.2 ± 2.2 3.5 ± 0.2 
[BMIM][I]                       <1 <1 
[BMIM][BF4]                      3.2 ± 0.1 <1 
[MMIM] [MeSO4]                                         82.6 ± 6.2 10.3 ± 0.6 
AMMOENG 101 1092 ± 96 654 ± 48 
EtOAc 966 ± 78 902 ± 64 
a The time required to reduce the initial enzymatic activity by 50 % at 50 °C. 
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Both methanol and ethanol were found to destabilize CP, reducing the t50 at 50 °C from 
over 32 h to less than 4 and 1 h, respectively. Moreover, these short chain alcohols can 
be glycosylated by CP142, impairing their application as cosolvent. In parallel to SP, also 
the ILs [BMIM][dca], [BMIM][I] and [BMIM][BF4] were found to destabilize CP, while 
DMSO and the quaternary ammonium salt  AMMOENG 101 were less deleterious for the 
stability of CP. Interestingly, the enzyme was also found to be compatible with EtOAc, 
allowing the use of biphasic catalysis. In contrast to the application of cosolvents, 
increasing the EtOAc concentration from 20 to 37.5 % did not significantly influence the 
stability of CP (Table 5.1). Next, the activity of the enzyme was assessed in the most 
promising solvent systems. CP displayed a relative activity of 94 and 92 % in 20 % IL 
and 37.5 % EtOAc respectively, thus allowing its use in the latter solvent systems.  
3.2 Exploring the glycosylation potential of CP 
Having established adequate cosolvent and biphasic catalysis conditions, the 
glycosylation potential of CP towards various small organic compounds was evaluated. 
Table 5.2 illustrates the broad acceptor promiscuity of the CP from C. thermocellum. The 
synthesis of alkyl β-glucosides was found to show similar characteristics to 
glycosidases153. Indeed, increasing the chain length resulted in decreased glucoside 
concentrations, and primary alcohols were found to be more easily glycosylated 
compared to secondary alcohols. For example, after 48 h incubation under optimal 
reaction conditions, 70.6 and 68.4 mM hexyl and octyl β-D-glucopyranoside were 
obtained. In contrast barely any glucosides could be detected when using 2-hexanol or 
2-octanol as acceptor. 
 
Interestingly, the glycosylation potential of CP is not limited to linear aliphatic alcohols. 
Next to cyclohexanol, some substituted alcohols with olfactory properties were 
successfully glucosylated. Despite being produced in lower concentrations, we were able 
to confirm the formation of vanillyl 4-O-β-D-glucopyranoside, β-citronellyl β-D-
glucopyranoside and 2-phenylethyl β-D-glucopyranoside. Glycosylation of both R and S-
1-phenylethanol failed, confirming the difficult glycosylation of secondary alcohols. 
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Table 5.2 Glycosylation potential of the CP from C. thermocellum. TLC or HPLC analysis was performed 
after 48 h incubation at 50 °C. 
Acceptor Product (mM) Acceptor Product (mM) 
Pentanol + a, d 1R-phenylethanol - a 
Hexanol 70.6 a 1S-phenylethanol  - a 
Heptanol  72.2 a 2-Phenylethanol  58.7 a 
Octanol  68.4 a Cinnamyl alcohol + a 
Nonanol  54.6 a Menthol - b, - c 
Decanol  48.3 a Vannillyl alcohol 24.5b, 26.3c 
Dodecanol  29.6 a Phenol - b, - c 
Cyclohexanol  + a p-Nitrophenol - b, - c 
2-Hexanol  + a Hydroquinone 1.9 b, 1.8c 
2-Octanol  + a Catechol - b, - c 
Linalool  - a, e Resorcinol - b, - c 
Eugenol  - a Pyrogallol + b, + c 
β-Citronellol  19.8 a Curcumin - b, - c 
Geraniol  + a Quercetin - b, - c 
Nerolidol  - a Resveratrol - b, - c 
Anisyl alcohol + a Vanillin + b, + c 
a Glycosylation was performed using 37.5 % acceptor as organic phase. b Glycosylation was performed 
using 37.5 % EtOAc as organic phase. c Glycosylation was performed in a cosolvent system containing 
20 % IL. d +, Product was detected by TLC analysis. e -, No product was detected by TLC analysis. 
 
CtCP was also able to couple a glucose moiety to the phenolic hydroxyl groups of 
hydroquinone, pyrogallol and vanillin. Although these reactions were rather inefficient 
compared to SP, 1-O-β-D-glucopyranosyl hydroquinone could be isolated, and its 
structure was confirmed by NMR spectroscopy. Remarkably, no significant differences 
were observed between the IL based cosolvent and biphasic system. 
3.3 Cross-linked enzyme aggregates of CP 
Over the past decade, immobilization has proven to be a valuable technique to enhance 
the operational stability of enzymes154. Unlike other immobilization techniques, the 
formation of cross-linked enzyme aggregates (CLEAs) does not require expensive 
carriers, and avoids dilution of the enzyme’s activity155. First, the precipitation of CP was 
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evaluated in the presence of tert-butanol (Figure 5.2). While 80 % of the enzyme 
remained soluble after the addition of 20 % tert-butanol, all CP was precipitated after 
30 min incubation at a solvent concentration of 50 %. Lower concentrations or shorter 
incubation failed to yield complete precipitation (Figure 5.2).  
 
Figure 5.2 Precipitation of the CP from C. thermocellum. Various ratios of CtCP and tert-butanol were 
incubated during 30 min at 4 °C (●). The incubation time was varied at a volumetric ratio of 1 (bars).  
 
Next, the glutaraldehyde (GA) based cross-linking step was optimized by varying the 
amount of cross-linker and the incubation time (Figure 5.3).  
 
Figure 5.3 Optimization of CP CLEA formation. The gluateraldehyde:protein ratio was varied using a 
reaction time of 1h (bars), while the reaction time was varied at a ratio of 0.6 (●). 
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A maximal yield of 67 % was reached when incubating the enzyme at a GA:protein ratio 
of 0.6 for 90 min. Lower ratios or shorter incubation resulted in less CLEA, while further 
increasing the amount of GA or the incubation time strongly reduced the activity of the 
immobilized biocatalyst (Figure 5.3). 
 
In parallel with previous studies on SP, the optimal temperature of the obtained CP 
CLEAs shifted from 70 °C for the soluble enzyme, to an impressive 90 °C (Figure 5.4)45. 
The observed difference can be explained by the increased mobility of the reactants at 
this elevated temperature (enhanced substrate diffusion), while maintaining the enzyme 
in a stable conformation through immobilization. The increased optimal temperature 
can thus been considered an indirect effect caused by the increased stability of the 
immobilized biocatalyst. Moreover, the pH range was found to have broadened (Figure 
S5.1), indicating enhanced operational stability.  
 
Figure 5.4 The effect of temperature on the activity of soluble (○) and immobilized (●) CP from C. 
thermocellum. The activity was measured in a MES buffer (50 mM, pH 6.5) containing 50 mM αG1P and 
50 mM glucose. 
 
The latter was further investigated by determining the stability of the CP CLEAs at 50 °C 
(Figure 5.5). Immobilization boosted the half-life at 50 °C from 34 h to almost 11 days. A 
similar pattern was observed upon addition of the IL AMMOENG 101 or EtOAc, revealing 
close correlation between thermal and solvent stability.  
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Figure 5.5 Half-life of CP and CP CLEAs at 50 °C. The biocatalysts were incubated in MES buffer (50 mM, 
pH 6.5) containing 20 % AMMOENG 101 or 37.5 % EtOAc. 
3.4 Imprinted cross-linked enzyme aggregates of CP 
In CHAPTER 2, it has been shown that the activity of CLEAs can be improved by molecular 
imprinting. The applicability of the latter technique was evaluated using the 
glycosylation of octanol as case study. To that end, CP was incubated with 250 mM 
octanol or octyl β-D-glucopyranoside (OG) prior to the formation of CLEAs. The 
effectiveness of the obtained immobilizates for the synthesis of OG was then evaluated 
(Figure 5.6). 
 
Figure 5.6 Synthesis of octyl β-D-glucopyranoside at 50 °C. Biphasic catalysis was performed with CP 
CLEAs (●), octyl β-D-glucopyranoside iCLEAs (▼) or octanol iCLEAs (○). 
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Imprinting with OG did not significantly increase the transglycosylation activity of the 
enzyme, but the addition of octanol roughly doubled the initial rate of OG synthesis 
(Figure 5.6). Interestingly, the activity of both iCLEAs towards glucose was decreased by 
80 and 45 %, respectively, further illustrating their altered specificity. In contrast to SP 
(CHAPTER 2) imprinting with the acceptor molecule rather than the glucoside was found 
to enhance the desired glycosylation activity.  
 
Finally, the applicability and reusability of the octanol iCLEAs was assessed at 50 mL 
scale. After 24 h incubation at 50 °C, the iCLEAs were recuperated by centrifugation and 
the reaction mixture was subjected to hydrophobic membrane filtration. Next, the 
octanol phase was evaporated in vacuo, yielding 674 mg octyl β-D-glucopyranoside. This 
procedure was repeated three times without loss of productivity, revealing excellent 
mechanical stability and recyclability of the biocatalyst. 
4 CONCLUSION 
In this chapter, the stability of CP was assessed at elevated temperatures in the presence 
of various solvents. CtCP was found to be compatible with the IL AMMOENG 101 and 
EtOAc, allowing the glycosylation of aliphatic alcohols, monoterpenoids, aromatic 
alcohols and phenolics. The stability of the biocatalyst could be improved by cross-
linking the enzyme, resulting in an impressive half-life at 50 °C of 11 days. Moreover, the 
efficiency of the CLEAs for the synthesis of octyl β-D-glucopyranoside could be roughly 
doubled by molecular imprinting with octanol. As proof of concept, three consecutive 
batch productions of octyl β-D-glucopyranoside were performed, revealing the excellent 
operational stability and recyclability of the CP octanol iCLEAs. Consequently, CP was 
identified to be a valuable alternative for the synthesis of β-glucosides. 
5 MATERIALS & METHODS 
5.1 Materials 
The IL AMMOENG 101 was kindly provided by Evonik Industries AG, and EtOAc was 
bought from Fiers. The other ILs were purchased from IoLiTec Ionic Liquids 
Technologies GmbH, and had a purity of at least 99 %. All other chemicals were 
analytical grade and purchased from Sigma-Aldrich. 
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5.2 Production and purification of cellobiose phosphorylase 
Overexpression of CP was carried out using E. coli JW0987 cells transformed with the 
expression vector pTrc99a harboring the codon optimized CP gene from Clostridium 
thermocellum YM4. The strain was routinely grown at 37 °C on 500 mL LB medium 
(10 g/L tryptone, 5 g/L yeast extract, 5 g/L NaCl) supplemented with ampicillin 
(100 mg/L). After overnight growth, the culture was inoculated into 15 L of double LB 
medium (20 g/L tryptone, 10 g/L yeast extract, 5 g/L NaCl) supplemented with glucose 
(30 g/L) and ampicillin (100 mg/L) in a 30 L Biostat C reactor (B. Braun Biotech Inc., 
Pennsylvania). The temperature, pH and stirrer speed were set at 37 °C, 7 and 800 rpm 
respectively. Adequate aeration was achieved by passing 1.1 vvm air through the 
reactor, and foaming was prevented by manually adding anti-foam (10 % (v/v) antifoam 
silicone Snapsil RE 20, VWR BDH Prolabo) when required. Induction was performed by 
adding IPTG to a final concentration of 0.1 mM as soon as the OD600 reached 0.6. After 8 
h of growth (OD600 ~ 34), the cells were harvested by centrifugation (10 000 g, 4 °C, 20 
min), and frozen at -20 °C.  
 
Next, the obtained pellets were lysed as described in CHAPTER 2 and the N-terminal His6-
tagged protein was purified by nickel-nitrilotriacetic acid metal affinity chromatography. 
The protocol as described by the supplier (Qiagen) was used, except for the imidazole 
concentration of the elution buffer, which was reduced to 175 mM. The obtained enzyme 
solution was washed with MES buffer (50 mM, pH 6.5) and concentrated using 
Centricons (Amicon Ultra 30K, Millipore). 
5.3 Preparation of CLEAs and iCLEAs  
Cross-linked enzyme aggregates of CP were prepared by adding 100 µL tert-butanol to 
100 µL His6-tagged purified protein (2.4 mg/mL) under agitation in a thermoshaker 
(Eppendorf) at 1000 rpm. After 30 min incubation at 4 °C, varying amounts of 
glutaraldehyde (25 % (v/v)) were added and the mixture was kept under stirring for 15, 
30, 60, 75, 90, 120, 150 or 180 min. Reduction of the formed imine bonds was achieved 
by adding 500 µL sodium bicarbonate buffer (100 mM, pH 10.0) supplemented with 
sodium borohydride (1 mg/mL). After 15 min incubation at 4 °C, another 500 µL was 
added and allowed to react during 15 min. Next, the resulting CLEAs were harvested by 
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centrifugation (17 000 g, 4 °C, 15 min), and subsequently washed 5 times with 1 mL MES 
buffer (50 mM, pH 6.5). iCLEAs were prepared by incubating CP with 250 mM octanol 
(3.25 mg) or octyl β-D-glucopyranoside (7.31 mg) during 30 min at 37 °C prior to the 
addition of tert-butanol.  
 
Large-scale production of CLEAs and iCLEAs was performed by adding 4 mL tert-butanol 
to 4 mL His6-tagged purified protein (2.4 mg/mL) in 50 mL falcons. The 
glutaraldehyde:protein ratio was set at 0.6 (5.76 mg), and the reaction mixture was 
incubated during 90 min at 4 °C. Next, two times 10 mL sodium bicarbonate buffer 
(100 mM, pH 10.0) supplemented with sodium borohydride (1 mg/mL) was added. The 
CLEAs were then harvested by centrifugation (10 000 g, 4 °C, 20 min), washed 5 times 
with 20 mL MES buffer (50 mM, pH 6.5) and freeze-dried (Alpha 1-4, Christ).  
5.4 Activity assays 
The activity of CP and CP CLEAs was determined in the synthesis direction by measuring 
the release of phosphate from αG1P with the method of Gawronski and Benson156. One 
unit of CP activity corresponds to the release of 1 μmol phosphate per minute from 50 
mM αG1P and 50 mM glucose in a 50 mM MES buffer at pH 6.5 and 37 °C. The activity of 
the CLEAs was determined by adding 1 mL substrate buffer (50 mM αG1P and 50 mM 
glucose in 50 mM MES buffer pH 6.5) to the obtained biocatalyst. The reactions were 
performed in a thermoshaker (Eppendorf) at 1000 rpm. Alternatively, a citrate-
phosphate buffer (pH 4.0-5.4), MES buffer (pH 5.5-6.5), MOPS buffer (pH 6.6-7.5) and 
tricine buffer (pH 7.6-9.0) were used. Unless stated otherwise, the temperature was set 
at 37 °C. The immobilization yield is defined as the ratio of the activity detected in the 
CLEA preparation to that present in the original enzyme solution. Protein concentrations 
were measured according to the Lowry method, using bovine serum albumin as 
standard92. All assays were performed in triplicate and had a CV of less than 10 %. All 
reported errors correspond to the standard errors. 
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5.5 Stability assays 
The kinetic thermostability was determined by diluting 20 U/mL CP in a 50 mM MES at 
pH 6.5. If required, solvents were added and the mixtures were incubated in a water 
bath at various temperatures. At regular intervals, samples were taken and diluted 200 
times in 50 mM MES buffer at pH 6.5. The diluted samples were stored at 4 °C, and their 
activity was determined at 37 °C using the Gawronski method. The stability of the CLEAs 
was evaluated by incubating 6 mg CP CLEA in 1.5 mL MES buffer (50 mM, pH 6.5) in a 
thermoshaker (Eppendorf) at 1000 rpm. Alternatively, the MES buffer contained 20 % 
AMMOENG 101 or 37.5 % EtOAc. At regular intervals, homogeneous samples (100 µL) 
were taken after intensive mixing, centrifuged (17 000 g, 4 °C, 15 min) and washed three 
times with 1 mL MES buffer (50 mM, pH 6.5). The samples were stored at 4 °C, and the 
activity was determined at 37 °C using the Gawronski assay. The t50-values, which is the 
time required to reduce the initial enzymatic activity by 50 % at a certain temperature, 
were calculated from the equations obtained by fitting the linear part of the stability 
curves. 
5.6 Analytical methods 
The formation of glucosides was assessed by TLC or HPLC. Separation and detection 
were achieved on Merck Silica gel 60 F254 precoated plates as described in CHAPTER 4. 
The concentration of glucosides was determined by HPLC analysis. Adequate separation 
and detection was achieved using an X-bridge amide column (250 mm × 4.6 mm, 3.5 µm, 
Waters, USA) coupled with an Alltech 2000ES ELSD, as described in CHAPTER 4. When 
using biphasic catalysis, homogeneous samples, obtained after intensive mixing, were 
diluted in DMSO. The resulting concentrations thus refer to the amount of product 
present in the total reaction volume. All calibration curves were prepared with authentic 
samples.  
5.7 Glycosylation reactions with CP 
Biphasic catalysis was performed by adding water immiscible acceptors (300 µL) to 
500 µL 50 mM MES buffer at pH 6.5 containing 200 mM αG1P. Alternatively, 300 µL 
EtOAc supplemented with various acceptors (30 mg) was used as organic phase. 
Cosolvent catalysis was achieved by adding 200 µL AMMOENG 101  and various 
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acceptors (37.5 mg) to 800 µL 50 mM MES buffer at pH 6.5 containing 200 mM αG1P. All 
reactions were performed in a thermoshaker (eppendorf) at 1000 rpm and 50 °C in the 
presence of 5 U/mL CP. After 24 h, samples were inactivated (10 min at 95 °C) and 
subjected to TLC or HPLC analysis. 
5.8 Production and purification of glucosides 
The glycosylation of hexanol, heptanol, octanol, nonanol, decanol, dodecanol, β-
citronellol and 2-phenylethanol was carried out by adding the acceptors (18.75 mL) to 
31.25 mL 50 mM MES buffer at pH 6.5 containing 200 mM αG1P. Glycosylation of 
vannillyl alcohol and hydroquinone was achieved by using EtOAc (18.75 mL) containing 
the acceptors (1.875 g) as organic phase. All reactions were performed in magnetically 
stirred flasks at 50 °C in the presence of 5 U/mL CP. After 48 h, the reaction mixtures 
were heated (10 min, 95 °C) and centrifuged (10 000 g, 4 °C, 20 min) to remove debris. 
The samples were then evaporated in vacuo and the residue was purified by column 
chromatography (silicagel, EtOAC/MeOH/H2O = 30:5:4).  
 
Synthesis of octyl β-D-glucopyranoside was carried out at 50 mL scale in a biphasic 
system consisting of octanol (18.75 mL) and 31.25 mL 50 mM MES buffer at pH 6.5 
containing 200 mM αG1P. The reactions were performed in magnetically stirred flasks at 
50 °C in the presence of 40 mg CP CLEA, octanol iCLEA or octyl β-D-glucopyranoside 
iCLEA respectively. At regular intervals, samples were inactivated (10 min at 95 °C) and 
subjected to HPLC analysis. Alternatively, the reaction was stopped after 24 h incubation 
at 50 °C. The octanol iCLEAs were recuperated by centrifugation (10 000 g, 4 °C, 20 min), 
and the reaction mixture was passed through a pretreated hydrophobic membrane 
(Accurel PP1E, Membrane, Germany). Prior to its application, the membrane was 
consecutively treated with 50 mL of the following solutions: hexadecane, 
hexadecane/water (50:50), octanol and finally an octanol/water (50:50). The resulting 
octanol phase was then evaporated in vacuo and the residue was weighed. The iCLEAs 
were recycled for the next batch conversion.  
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5.9 Structure elucidation of glucosides  
NMR spectra were measured on a Bruker AVANCE III 700 MHz spectrometer 
(700.13 MHz for 1H and 176.05 MHz for 13C) in CD3OD at 25 °C. Residual signals of 
solvent were used as an internal standard (H 3.330 ppm, C 49.3 ppm). 1H NMR, 13C 
NMR, COSY, HSQC, and HMBC spectra were measured using standard manufacturers’ 
software (Topspin 3.2, Bruker BioSpin GmbH, Rheinstetten). Chemical shifts are given in 
-scale [ppm], and coupling constants in Hz. Digital resolution enabled us to report 
chemical shifts of protons to three and coupling constants to one and carbon chemical 
shifts to two decimal places. Some hydrogen chemical shifts were read out from HSQC 
and are reported to two decimal places. The proton spin systems were assigned by 
COSY, and then the assignment was transferred to carbons by HSQC. HMBC experiment 
enabled us to assign quaternary carbons and join individual spin systems together. 
Spectral analysis and interpretation was kindly performed by the group of Prof. Vladimír 
Křen at the Institute of Microbiology (Czech Republic). 
 
Hexyl β-D-glucopyranoside 
1H NMR (CD3OD):  0.926 (3H, t, J = 7.1 Hz, H-6’), 1.33 
(2H, m, H-4’), 1.35 (2H, m, H-5’), 1.404 (2H, m, H-3’), 
1.638 (2H, m, H-2’), 3.200 (1H, dd, J = 9.2, 7.8 Hz, H-2), 
3.281 (1H, ddd, J = 9.6, 5.6, 2.3 Hz, H-5), 3.320 (1H, dd, J 
= 9.6, 8.7 Hz, H-4), 3.381 (1H, dd, J = 9.2, 8.7 Hz, H-3), 3.554 (1H, dt, J = 9.6, 6.8 Hz, H-1’u), 3.696 
(1H, dd, J = 11.9, 5.6 Hz, H-6u), 3.880 (1H, dd, J = 11.9, 2.3 Hz, H-6d), 3.916 (1H, dt, J = 9.6, 6.9 Hz, 
H-1’d), 4.273 (1H, d, J = 7.8 Hz, H-1) 
13C NMR (CD3OD):  14.68 (C-6’), 23.91 (C-5’), 27.01 (C-3’), 30.98 (C-2’), 33.10 (C-4’), 62.97 (C-6), 
71.14 (C-1’), 71.83 (C-4), 75.28 (C-2), 78.05 (C-5), 78.29 (C-3), 104.54 (C-1) 
 
Heptyl β-D-glucopyranoside 
1H NMR (CD3OD):  0.921 (3H, t, J = 7.1 Hz, H-7’), 1.33 
(2H, m, H-5’), 1.34 (2H, m, H-6’), 1.36 (2H, m, H-4’), 
1.398 (2H, m, H-3’), 1.640 (2H, m, H-2’), 3.197 (1H, dd, J 
= 9.2, 7.8 Hz, H-2), 3.279 (1H, ddd, J = 9.6, 5.6, 2.3 Hz, 
H-5), 3.317 (1H, dd, J = 9.6, 8.7 Hz, H-4), 3.379 (1H, dd, J 
= 9.2, 8.7 Hz, H-3), 3.553 (1H, dt, J = 9.6, 6.8 Hz, H-1’u), 3.695 (1H, dd, J = 11.9, 5.6 Hz, H-6u), 
3.880 (1H, dd, J = 11.9, 2.3 Hz, H-6d), 3.915 (1H, dt, J = 9.6, 6.9 Hz, H-1’d), 4.271 (1H, d, J = 7.8 Hz, 
H-1) 
13C NMR (CD3OD):  14.72 (C-7’), 23.92 (C-6’), 27.31 (C-3’), 30.54 (C-4’), 31.04 (C-2’), 33.25 (C-
5’), 62.99 (C-6), 71.14 (C-1’), 71.86 (C-4), 75.31 (C-2), 78.08 (C-5), 78.31 (C-3), 104.56 (C-1) 
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Octyl β-D-glucopyranoside 
1H NMR (CD3OD):  0.921 (3H, t, J = 7.1 Hz, H-8’), 
1.31 (2H, m, H-6’), 1.33 (4H, m, H-4’, H-7’), 1.34 
(2H, m, H-5’), 1.402 (2H, m, H-3’), 1.640 (2H, m, H-
2’), 3.191 (1H, dd, J = 9.2, 7.8 Hz, H-2), 3.274 (1H, 
ddd, J = 9.6, 5.5, 2.2 Hz, H-5), 3.309 (1H, dd, J = 9.6, 
8.6 Hz, H-4), 3.370 (1H, dd, J = 9.2, 8.6 Hz, H-3), 3.553 (1H, dt, J = 9.6, 6.8 Hz, H-1’u), 3.690 (1H, 
dd, J = 11.9, 5.5 Hz, H-6u), 3.881 (1H, dd, J = 11.9, 2.2 Hz, H-6d), 3.917 (1H, dt, J = 9.6, 6.9 Hz, H-
1’d), 4.267 (1H, d, J = 7.8 Hz, H-1) 
13C NMR (CD3OD):  14.72 (C-8’), 24.00 (C-7’), 27.39 (C-3’), 30.70a (C-4’), 30.87a (C-5’), 31.08 (C-
2’), 33.29 (C-6’), 63.04 (C-6), 71.18 (C-1’), 71.92 (C-4), 75.38 (C-2), 78.16 (C-5), 78.38 (C-3), 
104.62 (C-1); a might be interchanged 
 
Nonyl β-D-glucopyranoside 
1H NMR (CD3OD):  0.921 (3H, t, J = 7.1 Hz, H-9’), 
1.31 (2H, m, H-7’), 1.32 (2H, m, H-8’), 1.33 (6H, 
m, H-4’, H-5’, H-6’), 1.403 (2H, m, H-3’), 1.640 
(2H, m, H-2’), 3.187 (1H, dd, J = 9.2, 7.8 Hz, H-2), 
3.271 (1H, ddd, J = 9.6, 5.5, 2.2 Hz, H-5), 3.303 
(1H, dd, J = 9.6, 8.5 Hz, H-4), 3.363 (1H, dd, J = 9.2, 8.5 Hz, H-3), 3.553 (1H, dt, J = 9.6, 6.8 Hz, H-
1’u), 3.686 (1H, dd, J = 11.9, 5.5 Hz, H-6u), 3.881 (1H, dd, J = 11.9, 2.2 Hz, H-6d), 3.918 (1H, dt, J = 
9.6, 6.9 Hz, H-1’d), 4.265 (1H, d, J = 7.8 Hz, H-1) 
13C NMR (CD3OD):  14.73 (C-9’), 24.03 (C-8’), 27.42 (C-3’), 30.73a (C-6’), 30.94a (C-5’), 31.02a (C-
4’), 31.11 (C-2’), 33.36 (C-7’), 63.08 (C-6), 71.20 (C-1’), 71.97 (C-4), 75.43 (C-2), 78.21 (C-5), 
78.44 (C-3), 104.67 (C-1); a might be interchanged 
 
Decyl β-D-glucopyranoside 
1H NMR (CD3OD):  0.920 (3H, t, J = 7.1 
Hz, H-10’), 1.30 (2H, m, H-8’), 1.32 (2H, 
m, H-7’), 1.33 (8H, m, H-4’, H-5’, H-6’, H-
9’), 1.403 (2H, m, H-3’), 1.640 (2H, m, H-
2’), 3.189 (1H, dd, J = 9.2, 7.8 Hz, H-2), 
3.273 (1H, ddd, J = 9.6, 5.5, 2.2 Hz, H-5), 3.305 (1H, dd, J = 9.6, 8.5 Hz, H-4), 3.365 (1H, dd, J = 9.2, 
8.5 Hz, H-3), 3.553 (1H, dt, J = 9.6, 6.8 Hz, H-1’u), 3.688 (1H, dd, J = 11.9, 5.5 Hz, H-6u), 3.882 (1H, 
dd, J = 11.9, 2.2 Hz, H-6d), 3.918 (1H, dt, J = 9.6, 6.9 Hz, H-1’d), 4.266 (1H, d, J = 7.8 Hz, H-1) 
13C NMR (CD3OD):  14.74 (C-10’), 24.03 (C-9’), 27.41 (C-3’), 30.77a (C-7’), 30.93a (C-6’), 31.01a 
(C-5’), 31.05a (C-4’), 31.10 (C-2’), 33.36 (C-8’), 63.07 (C-6), 71.20 (C-1’), 71.95 (C-4), 75.41 (C-2), 
78.20 (C-5), 78.42 (C-3), 104.66 (C-1); a might be interchanged 
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Dodecyl β-D-glucopyranoside 
1H NMR (CD3OD):  0.920 (3H, t, J = 7.1 
Hz, H-11’), 1.31 (4H, m, H-8’, H-9’), 1.32 
(6H, m, H-4’, H-5’, H-6’), 1.33 (4H, m, H-
7’, H-10’), 1.402 (2H, m, H-3’), 1.640 
(2H, m, H-2’), 3.189 (1H, dd, J = 9.2, 7.8 
Hz, H-2), 3.272 (1H, ddd, J = 9.6, 5.5, 2.2 Hz, H-5), 3.305 (1H, dd, J = 9.6, 8.5 Hz, H-4), 3.365 (1H, 
dd, J = 9.2, 8.5 Hz, H-3), 3.553 (1H, dt, J = 9.6, 6.8 Hz, H-1’u), 3.688 (1H, dd, J = 11.9, 5.5 Hz, H-6u), 
3.881 (1H, dd, J = 11.9, 2.2 Hz, H-6d), 3.918 (1H, dt, J = 9.6, 6.9 Hz, H-1’d), 4.266 (1H, d, J = 7.8 Hz, 
H-1) 
13C NMR (CD3OD):  14.74 (C-11’), 24.03 (C-10’), 27.41 (C-3’), 30.77a (C-8’), 30.93a (C-7’), 31.05a 
(C-5’, C-6’), 31.10a (C-4’, C-2’), 33.37 (C-9’), 63.07 (C-6), 71.20 (C-1’), 71.95 (C-4), 75.41 (C-2), 
78.20 (C-5), 78.42 (C-3), 104.66 (C-1); a might be interchanged 
 
2-Phenylethyl β-D-glucopyranoside 
1H NMR (CD3OD):  2.941 (1H, m, ΣJ = 25.0 Hz, H-2’u), 2.973 
(1H, m, ΣJ = 25.0 Hz, H-2’d), 3.205 (1H, dd, J = 9.2, 7.8 Hz, H-2), 
3.286 (1H, m, H-5), 3.305 (1H, m, H-4), 3.369 (1H, dd, J = 9.2, 
8.6 Hz, H-3), 3.684 (1H, dd, J = 11.9, 5.5 Hz, H-6u), 3.779 (1H, 
ddd, J = 9.7, 8.2, 6.7 Hz, H-1’u), 3.882 (1H, dd, J = 11.9, 2.1 Hz, H-
6d), 4.111 (1H, ddd, J = 9.7, 8.2, 6.8 Hz, H-1’d), 4.322 (1H, d, J = 7.8 Hz, H-1), 7.197 (1H, m, H-
para), 7.267 (4H, m, H-ortho, H-meta) 
13C NMR (CD3OD):   37.53 (C-2’), 63.05 (C-6), 71.94 (C-4), 72.01 (C-1’), 75.40 (C-2), 78.26 (C-5), 
78.40 (C-3), 104.68 (C-1), 127.50 (C-para), 129.64 (C-meta), 130.32 (C-ortho), 140.36 (C-ipso) 
 
β-Citronellyl β-D-glucopyranoside 
1H NMR (CD3OD):  0.935 (3H, d, J = 6.6 Hz, 3’-Me), 
1.18 (1H, m, H-4’u), 1.37 (1H, m, H-4’d), 1.44 (1H, m, H-
2’u), 1.610 (1H, m, H-3’), 1.627 (3H, d, J = 1.3 Hz, 7’-
Me), 1.68 (1H, m, H-2’d), 1.692 (3H, d, J = 1.3 Hz, H-8’), 
1.999 (1H, m, H-5’u), 2.040 (1H, m, H-5’d), 3.184 (1H, 
dd, J = 9.2, 7.8 Hz, H-2), 3.275 (1H, ddd, J = 9.6, 5.4, 2.2 Hz, H-5), 3.305 (1H, dd, J = 9.6, 8.5 Hz, H-
4), 3.365 (1H, dd, J = 9.2, 8.5Hz, H-3), 3.606 (1H, ddd, J = 9.6, 8.0, 5.8 Hz, H-1’), 3.691 (1H, dd, J = 
11.9, 5.4 Hz, H-6u), 3.885 (1H, dd, J = 11.9, 2.2 Hz, H-6d), 3.956 (1H, ddd, J = 9.6, 7.8, 6.8 Hz, H-
1’d), 4.267 (1H, d, J = 7.8 Hz, H-1), 5.127 (1H, m, H-6’) 
13C NMR (CD3OD):   18.02 (7’-Me), 20.21 (3’-Me), 26.19 (C-8’), 26.77 (C-5’), 30.88 (C-3’), 38.04 
(C-2’), 38.73 (C-4’), 63.07 (C-6), 69.43 (C-1’), 71.97 (C-4), 75.41 (C-2), 78.21 (C-5), 78.45 (C-3), 
104.64 (C-1), 126.19 (C-6’), 132.25 (C-7’) 
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Vanillyl 4-O-β-D-glucopyranoside 
1H NMR (CD3OD):  3.253 (1H, dd, J = 9.1, 7.8 Hz, H-2), 
3.272 (1H, ddd, J = 9.5, 5.8, 2.3 Hz, H-5), 3.311 (1H, dd, J = 
9.5, 8.7 Hz, H-4), 3.354 (1H, dd, J = 9.1, 8.7 Hz, H-3), 3.710 
(1H, dd, J = 11.9, 5.8 Hz, H-6u), 3.878 (3H, s, 3’-OMe), 
3.918 (1H, dd, J = 11.9, 2.3 Hz, H-6d), 4.336 (1H, d, J = 7.8 
Hz, H-1), 4.609 (1H, d, J = 11.4 Hz, CH2 u), 4.838 (1H, d, J = 11.4 Hz, CH2 d),  6.769 (1H, d, J = 8.0 
Hz, H-5’), 6.845 (1H, dd, J = 8.0, 2.0 Hz, H-6’), 7.071 (1H, d, J = 2.0 Hz, H-2’) 
13C NMR (CD3OD):   56.67 (3’-OMe), 63.14 (C-6), 72.04a (CH2), 72.05a (C-4), 75.42 (C-2), 78.32 
(C-5), 78.40 (C-3), 103.04 (C-1), 113.62 (C-2’), 116.09 (C-5’), 122.76 (C-6’), 130.60 (C-1’), 147.65 
(C-4’), 149.23 (C-3’) ); a might be interchanged 
 
1-O-β-D-Glucopyranosyl hydroquinone 
1H NMR (CD3OD):  3.395 (2H, m, H-4, H-5), 3.428 (1H, dd, 
J = 9.2, 7.5 Hz, H-2), 3.460 (1H, m, H-3), 3.718 (1H, m, H-
6u), 3.902 (1H, m, H-6d), 4.755 (1H, d, J = 7.5 Hz, H-1), 
6.718 (2H, m, ΣJ = 9.1 Hz, H-meta), 6.985 (2H, m, ΣJ = 9.1 
Hz, H-ortho) 
13C NMR (CD3OD):  62.84 (C-6), 71.72 (C-4), 75.27 (C-2), 78.27 (C-3), 78.32 (C-5), 103.92 (C-1), 
116.90 (C-meta), 119.67 (C-ortho), 152.72 (C-ipso), 154.08 (C-para) 
6 SUPPLEMENTARY INFORMATION 
 
Figure S5.1 The effect of pH on the activity of soluble (○) and immobilized (●) CP from C. thermocellum. 
The activity was measured in a 50 mM buffer containing 50 mM αG1P and 50 mM glucose at 37 °C. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 6 
Chemoenzymatic synthesis of α-L-rhamnosides using                                                                         
recombinant α-L-rhamnosidase from             
Aspergillus terreus 
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1 ABSTRACT 
This chapter describes an efficient, large scale fermentation of the recombinant α-L-
rhamnosidase originating from Aspergillus terreus. High-cell-density Pichia pastoris 
fermentation resulted in yields up to 627 U/L/h. The recombinant enzyme was used for 
the reverse rhamnosylation of various small organic compounds. A full factorial 
experimental design setup was applied to identify the importance of temperature, 
substrate concentrations, solvent type and concentration as well as the acidity of the 
reaction mixture. Careful optimization of these parameters allowed the synthesis of a 
range of α-L-rhamnosides among which cyclohexyl α-L-rhamnopyranoside, anisyl α-L-
rhamnopyranoside and 2-phenylethyl α-L-rhamnopyranoside. In addition, α-L-
rhamnosylation of phenolic hydroxyls in phenols such as hydroquinone, resorcinol, 
catechol and phenol was observed, which is a rather unique reaction catalyzed by 
glycosidases. 
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2 INTRODUCTION 
L-Rhamnose is widely distributed in plants and bacteria as a component of the cell 
walls157 and of various natural products. Rhamnose is typically produced by the 
biocatalytic cleavage of rutin158. Some rhamnosides are important bioactive compounds, 
e.g., cytotoxic saponins159, antifungal plant glycoalkaloids160, and bacterial virulence 
factors161. Clear correlations between the presence of specific sugar residues and the 
biological activity of these molecules have been demonstrated in a plethora of 
examples10. In plants, L-rhamnose is also bound to some volatile compounds, e.g., aroma 
terpenol glycosides of wine162. Finally, Citrus spp. accumulate large amounts of L-
rhamnose-containing flavonoid glycosides (e.g., naringin and hesperidin), having 
different flavors and important antioxidant and anti-inflammatory activity163. 
 
Quite recently -L-rhamnose and/or -L-rhamnosides were found to interact with the 
specific receptors on keratinocytes, which play an important role in cell and tissue 
aging164. This finding triggered a vigorous research in the cosmetic application of 
rhamnosides. Indeed, the use of rhamnose and rhamnosides has been patented165 and 
the respective preparations have already reached the market. Later, it was found that 
rhamnose itself does not penetrate the skin but when conjugated, e.g. in the form of 
pentyl rhamnoside, its concentration in stratum corneum and epidermis is doubled166. 
Another rhamnoside, e.g. undecyl rhamnoside has anti-inflamatory activity in the skin, 
which is mediated by release inhibition of prostaglandin 2 and by the inhibition of NF-
kB transcription factor. This demonstrates clearly the importance of the preparation of 
rhamnosides especially by enzymatic methods, which do not involve any harmful and 
irritant chemicals, making the products applicable in the cosmetics and food industry. 
 
α-L-Rhamnosidase (EC 3.2.1.40) is known to be an inverting enzyme, not being able to 
catalyze transglycosylation reactions. Recently, the alkali- and thermo-stable α-L-
rhamnosidase from Aspergillus terreus was described167. This extracellular -L-
rhamnosidase was purified, characterized, sequenced and expressed in Pichia pastoris. 
This chapter describes large scale fermentation of the α-L-rhamnosidase and reverse 
rhamnosylation of series aliphatic and aromatic alcohols using this recombinant 
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enzyme. To our best knowledge the glycosylation of phenolic OH groups catalyzed by 
glycosidases has not been described yet. 
3 RESULTS & DISCUSSION 
3.1 Production of recombinant α-L-rhamnosidase 
The production of α-L-rhamnosidase by Aspergillus terreus has already been optimized 
yielding an expression level of 5.5 U/mL after 8 days of cultivation158. The encoding gene 
has also been expressed in Pichia pastoris KM71H, resulting in yields up to 8 U/mL after 
a 6 day batch fermentation167. Here, a high-cell-density P. pastoris fermentation was 
established to circumvent the high material costs related to the use of BMGY and BMMY 
media, as well as the poor space time productivity reported to date. A 2 L fermenter was 
inoculated with 100 mL preculture, routinely grown on BMGY medium. A sharp increase 
in the dissolved oxygen (DO) indicated the end of the glycerol batch phase after 
approximately 12 h (Figure 6.1). At this moment, the OD600 reached 30.2. Next, a 
6.6 g/L/h glycerol feed was started resulting in exponential growth to an OD600 of 
roughly 150 after 26 h. Higher feed rates were found to result in anoxic conditions, while 
lower rates decreased the space time yield of the fermentation. 
 
Figure 6.1 Production of α-L-rhamnosidase in a 2 L high-cell-density P. pastoris fermentation. The optical 
density (●), α-L-rhamnosidase activity (○) and dissolved oxygen (∆) were monitored during 7 days.  
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The glycerol feed was stopped after 26 h, and the addition of methanol was commenced. 
The methanol feed was linearly increased from 0.8 g/L/h to 2.1 g/L/h over the next 10 h 
of fermentation. This feed rate was maintained during 5 days, resulting in an OD600 of 
302 and the secretion of 95.3 U/mL α-L-rhamnosidase. Prolonged fermentation resulted 
in a decrease of α-L-rhamnosidase activity (Figure 6.1). Thus the space time yield was 
increased to an impressive 627 U/L/h, compared to previously reported values of 28.6 
and 55.6 U/L/h158, 167. This efficient fermentation should allow the production of α-L-
rhamnosidase at a lower cost, enabling the development of new applications at the 
industrial scale.  
3.2 Reverse hydrolysis with α-L-rhamnosidase 
The hydrolysis of rutin to quercetin-3-β-D-glucopyranoside (isoquercitrin) by α-L-
rhamnosidase has recently been achieved at the kilogram scale158. Isoquercitrin and 
rhamnose were added to 150 mg/mL and 1.5 M respectively in a 50 mM MOPS buffer at 
pH 7.0 and 37 °C in the presence of 20 U/mL α-L-rhamnosidase. However, no rutin could 
be detected after three days. Nevertheless, when DMSO was added to 50 %, a new strong 
spot was observed on TLC after 24 h. The product was identified to be the expected rutin 
by TLC co-chromatography with an authentic sample (Figure 6.2).  
 
 
Figure 6.2 Synthesis of rutin from isoquercitrin and rhamnose (1.5 M) in the presence of 20 U/mL α-L-
rhamnosidase at 37 °C. Isoquercitrin was saturated in a 50 mM MOPS buffer at pH 7.0 (blanc (1), reaction 
(2)). Alternatively 50 % DMSO was added (blanc (3), reaction (4)). Co-chromatography of sample 4 with 
50 mg/mL rutin was also performed (5). 
Isoquercitrin
  
Rutin
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Encouraged by the successful synthesis of rutin from isoquercitrin and rhamnose, the 
rhamnosylation of three simple phenolic compounds was evaluated. To that end, 750 
mg/mL phenol, catechol or pyrogallol was added to a 50 mM MOPS buffer at pH 7.0. 
Alternatively, they were dissolved to 50 mg/mL. The glycosylation of these compounds 
was tested in the presence of 50 % DMSO. A single new spot having Rf higher than 
rhamnose and lower than the acceptor appeared after 24 h in case of catechol (50 
mg/mL), while the other two phenols failed to yield any glycosides (Figure S6.1). The 
product was purified by silica gel chromatography and identified to be 1-O-α-L-
rhamnopyranosyl catechol by NMR spectroscopy. Therefore, conditions enabling the 
efficient enzymatic rhamnosylation (reverse glycosylation or more correctly 
“condensation”) with A. terreus α-L-rhamnosidase were further optimized. 
3.3 Influence of solvents on the glycosylation activity of α-L-rhamnosidase 
Reverse hydrolysis is based on the reaction equilibrium shift towards synthesis of the 
glycosidic linkage. According to thermodynamics, this can be achieved either by 
increasing substrate concentrations, decreasing the water activity, or by the 
combination of both. Enzymatic glycosylation via reverse hydrolysis is, therefore, 
commonly performed in the presence of organic cosolvents, such as DMSO or acetone. 
However, these solvents often tend to inactivate biocatalysts168, urging a balance 
between cosolvent addition and enzyme stability.  
 
Hence, the activity of A. terreus α-L-rhamnosidase towards catechol was evaluated at 
various DMSO concentrations (Table S6.1). The addition of cosolvent was found to be 
crucial for effective rhamnosylation. Product formation was observed between 20 and 60 % 
DMSO with the maximum yield at 40 %. Higher concentrations of DMSO resulted in a 
lower yield due to the enzyme inactivation compared to the gain caused by the 
improved equilibrium conditions. Therefore, the rhamnosylation activity of A. terreus α-
L-rhamnosidase was assessed in the presence of various cosolvents. Short chain 
alcohols, such as methanol and ethanol have been identified as good acceptors, impeding 
thus their use as cosolvent169. Due to the ability to dissolve both polar and hydrophobic 
substrates, ionic liquids (ILs) have recently been successfully employed for the synthesis 
of glycosidic compounds (CHAPTER 3). Therefore, a range of organic solvents as well as 
some ILs were evaluated for the rhamnosylation of catechol (Table 6.1). 
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Table 6.1 Influence of various cosolvents on the catechol glycosylation activity of α-L-rhamnosidase. 
Catechol and L-rhamnose were dissolved to 50 mg/mL and 1.5 M respectively in a 50 mM MES buffer at 
pH 7.0 containing 40 % cosolvent. Samples were analyzed after 24 h incubation at 37 °C. 
Solvent Product spot 
intensity 
Solvent Product spot 
intensity 
Acetone +++++ [MMIM][MeSO4]                                         -
tert-Butyl alcohol +++ [BMIM][BF4]                      - 
Acetonitrile +++ [BMIM][dca]                       - 
DMSO +++++ [BMIM][I]                        - 
DMF ++ [EMIM][EtSO4]                        - 
PEG Mn 300 +++++ [EMIM][dca]                       - 
PEG Mn 4000 +++++ AMMOENG 101 + 
 
The enzyme was found to maintain the highest glycosylation activity in commonly used 
solvents such as DMSO, polyethylene glycol and acetone. However, rhamnosylation of 
catechol was also achieved when using 40 % dimethylformamide, acetonitrile, tert-butyl 
alcohol, or the IL AMMOENG 101, which was recently used for the glycosylation of 
resveratrol (CHAPTER 3). The addition of other ILs failed to yield any glycosides. Acetone 
is readily available, easy to remove by evaporation and exhibits excellent solubilizing 
properties and it was, therefore, used in all further experiments. Additional tests (Table 
6.2) confirmed 40 % acetone to be the optimal cosolvent concentration. 
 
Table 6.2 Influence of acetone on the glycosylation activity of α-L-rhamnosidase. Catechol and rhamnose 
were dissolved to 50 mg/mL and 1.5 M respectively in a 50 mM MOPS buffer at pH 7.0. Samples were 
analyzed after 24 h at 37 °C. 
 
  
[acetone] 
(%) 
Product spot 
intensity 
[acetone] 
(%) 
Product spot 
intensity 
10 - 60 + 
20 ++ 70 + 
30 +++ 80 - 
40 +++++ 90 - 
50 +++ 100 - 
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3.4 Optimization of reverse hydrolysis conditions  
Besides the cosolvent, a number of other factors can influence the glycosylation 
efficiency, including the pH, concentration of both substrates, as well as the 
temperature170. A full factorial design experiment was performed to determine their 
relative importance on the glycosylation yield of catechol (Table 6.3). Thermodynamic 
considerations predict more product formation when higher concentrations of substrate 
are used. Indeed, despite the inhibition of α-L-rhamnosidase by rhamnose167, similar 
conditions using 1.5 M rhamnose compared to 0.5 M were found to yield more product. 
However, no glycosides could be detected when 500 mg/mL catechol was added, 
revealing strong destabilizing or inhibitory effects of the acceptor at high 
concentrations.  
 
Table 6.3 Optimization of α-L-rhamnosidase catalyzed synthesis of catechol-rhamnoside: 23 factorial 
design. The temperature was fixed at 37 °C. 
Run pH 
[Rhamnose] 
(M) 
[Catechol] 
(mg/mL) 
Product spot 
intensity 
1 5.5 0.5 50 +++ 
2 5.5 0.5 500 - 
3 5.5 1.5 50 +++++ 
4 5.5 1.5 500 - 
5 7.5 0.5 50 ++ 
6 7.5 0.5 500 - 
7 7.5 1.5 50 ++++ 
8 7.5 1.5 500 - 
 
Next, the pH (4 to 10) and catechol concentration (10 to 500 mg/mL) were varied to 
indentify 40 % acetone, 1.5 M rhamnose, 200 mg/mL catechol, pH 6.0 and 37 °C to be 
optimal conditions for the reverse hydrolysis glycosylation of catechol with α-L-
rhamnosidase (Table S6.2). Higher rhamnose concentrations were not feasible in a 40 % 
acetone buffer, whereas higher temperatures were found to result in a lower product 
formation, most likely caused by the combined destabilizing effect of elevated 
temperatures and high catechol concentrations. 
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3.5 Reverse hydrolysis in biphasic systems 
The glycosylation of alcohols through the reverse hydrolysis action of glycosidases has 
been reported frequently. Indeed, various alkyl glucosides have been synthesized using 
both α and β-glucosidases170, β-galactosidases171 and -N-acetylhexosaminidases172. In 
contrast, the synthesis of alkyl α-L-rhamnosides has only been reported for methanol, 
ethanol and 2-propanol169. Here, the effect of the pH and the concentration of both 
substrates on the α-L-rhamnosidase catalyzed synthesis of hexyl α-L-rhamnopyranoside 
in a biphasic system was investigated. A full factorial design experiment was performed 
to determine the relative importance of these factors on the glycosylation yield 
(Table 6.4). 
 
Table 6.4 Optimization of α-L-rhamnosidase catalyzed synthesis of hexyl rhamnoside in a biphasic 
system: 23 factorial design. The temperature was fixed at 37 °C. 
Run pH 
[Rhamnose] 
(M) 
Buffer/hexanol 
ratio 
Product spot 
intensity 
1 5.5 0.5 5 +++++ 
2 5.5 0.5 0.5 + 
3 5.5 2 5 ++++ 
4 5.5 2 0.5 + 
5 7.5 0.5 5 +++ 
6 7.5 0.5 0.5 + 
7 7.5 2 5 +++ 
8 7.5 2 0.5 + 
 
Both the pH and hexanol amount were found to strongly influence the glycosylation 
yield. Interestingly, the rhamnose concentration did not significantly influence the 
rhamnosylation of hexanol. Further experiments were conducted to obtain optimal 
conditions at pH 5.5, 50 °C, 0.5 M rhamnose, and a buffer/hexanol ratio of 2.5 (Table 
S6.3). 
3.6 Synthesis of α-L-rhamnosides 
The glycosylation potential of the α-L-rhamnosidase from A. terreus was then evaluated 
by incubating various acceptors under optimal rhamnosylation conditions (Figure 6.3).  
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Figure 6.3 Glycosylation of various small organic compounds with α-L-rhamnosidase under optimal 
reaction conditions for cosolvent (catechol) and biphasic (hexanol, heptanol, anisyl alcohol and 2-
phenylethanol) systems. 
 
The synthesis of alkyl α-L-rhamnosides by reverse hydrolysis was found to show similar 
characteristics to other glycosidases153. The longer the alkyl chain, the lower the 
reaction yield (Table 6.5). Indeed 48 h incubation under optimal reaction conditions, 
resulted in rhamnoside concentrations of 13.4 and 9.1 g/L for hexanol and heptanol 
respectively (Figure 6.3). Also, primary alcohols were found to be more easily 
glycosylated compared to secondary alcohols.  
 
NMR confirmation of hexyl α-L-rhamnopyranoside, heptyl α-L-rhamnopyranoside and 
cyclohexyl α-L-rhamnopyranoside was obtained. However, no alkyl rhamnosides could 
be isolated when reacting 2-hexanol or 2-octanol (Table 6.5). Interestingly, the 
rhamnosylation potential of the enzyme is not limited to aliphatic alcohols. Various 
flavors and fragrances, such as for example the monoterpenoids geraniol and β-
citronellol were rhamnosylated as well162. Moreover, aromatic compounds with 
olfactory properties such as anisyl alcohol, cinnamyl alcohol and 2-phenylethanol were 
successfully glycosylated. Although anisyl α-L-rhamnopyranoside (2.3 g/L) and 2-
phenylethyl α-L-rhamnopyranoside (5.6 g/L) were produced in substantially lower 
concentrations compared to aliphatic alkyl α-L-rhamnosides (Figure 6.3), confirmation 
of these glycosides was achieved by NMR spectroscopy. 
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Table 6.5 Glycosylation potential of the α-L-rhamnosidase from A. terreus. TLC analysis was performed 
after 48 h. 
Acceptor Product spot 
intensity 
Acceptor Product spot 
intensity 
Hexanola +++++c S-1-Phenylethanola - 
Heptanola ++++d Benzyl alcohola + 
Octanola +++e Anisyl alcohola +++ 
Nonanola ++f Cinnamyl alcohola ++++ 
Decanola +g Saligeninb +++ 
Dodecanola - 4-Phenoxyphenolb  + 
Cyclohexanola +++++ Phenolb  + 
2-Octanola - Pinacolb  - 
2-Hexanola - Gallic acidb  - 
Linaloola - Vanillinb  + 
Eugenola - Ethyl gallateb  - 
Penta-erythritola  - Vanillyl alcoholb  +++ 
Nerolidola - Pyrogallolb  - 
β-Citronellola  + p-Nitrophenolb  - 
Geraniola +++ Resveratrolb + 
Salicylic acid methyl estera + Hydroquinoneb +++ 
2-Phenylethanola ++++ Catecholb +++ 
R-1-Phenylethanola - Resorcinolb +++ 
a Glycosylation was performed in a biphasic system. The acceptor was used as second phase. 
b Glycosylation was performed in a cosolvent system. c Corresponds to a product concentration ≥ 10 g/L. 
d Corresponds to a product concentration  between 5 and 10 g/L. e Corresponds to a product concentration  
between 2 and 5 g/L. f Corresponds to a product concentration  between 1 and 2 g/L. g Corresponds to a 
product concentration  ≤ 1 g/L. 
 
Glycosylation of both R and S-1-phenylethanol failed illustrating thus the difficult 
glycosylation of secondary alcohols. Surprisingly, hydroquinone, resorcinol and catechol 
could be easily rhamnosylated. Indeed, the formation of 1-O-α-L-rhamnopyranosyl 
hydroquinone, 1-O-α-L-rhamnopyranosyl resorcinol and 1-O-α-L-rhamnopyranosyl 
catechol was confirmed by NMR spectroscopy. In contrast to the formation of 1.8 g/L 1-
O-α-L-rhamnopyranosyl catechol after 2 days, glycosylation of phenol was found to be 
much less efficient, while no pyrogallol rhamnosides could be obtained. These results 
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emphasize the importance of optimizing reaction conditions. Indeed, the initial reaction 
conditions only allowed the glycosylation of catechol, while no glycosides of phenol 
could be detected. Following the work on short alkyl α-L-rhamnoside production169, this 
is probably the first report on the use of glycosidases for the synthesis of phenolic 
glycosides. 
4 CONCLUSION 
In this chapter, the glycosylation potential of α-L-rhamnosidase originating from 
Aspergillus terreus was evaluated. The recombinant expression in P. pastoris was 
substantially improved to 627 U/L/h, allowing thus the cost-effective production of α-L-
rhamnosidase at the industrial scale. The obtained enzyme was used to explore 
rhamnosylation of various alcohols. Careful optimization of the reaction conditions 
allowed the synthesis of numerous alkyl α-L-rhamnosides. In addition, rhamnosylation 
of small phenolics such as hydroquinone, resorcinol, catechol and phenol was observed. 
Consequently, the use of α-L-rhamnosidase could find widespread application for 
glycoside synthesis in the cosmetics and food industry. 
5 MATERIALS & METHODS 
5.1 Materials 
NMR spectra were measured on a Bruker AVANCE III 400 MHz spectrometer 
(400.00 MHz for 1H, and 100.59 MHz for 13C) and 600 MHz spectrometer (600.23 MHz 
for 1H, and 150.93 MHz for 13C) in CD3OD at 25 and 30 °C. HPLC measurements were 
performed on a Varian Prostar, and absorbance at 405 nm was measured in a Bio-Rad 
microplate reader 680XR. 
5.2 α-L-Rhamnosidase production 
Pichia pastoris KM71H (Invitrogen, USA) containing the gene encoding for α-L-
rhamnosidase from Aspergillus terreus was grown on YPD (yeast extract peptone 
dextrose: 1 % (w/v) yeast extract, 2 % (w/v) peptone, 2 % (w/v) glucose) medium and 
stored on YPD plates (YPD medium with 2 % (w/v) agar). Alternatively, the culture was 
cryopreserved at -80 °C in 15 % (v/v) glycerol. A single colony was inoculated in 100 mL 
BMGY (buffered glycerol-complex: 1 % (w/v) yeast extract, 2 % (w/v) peptone, 100 mM 
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potassium phosphate pH 6.0, 1.34 % (w/v) YNB (yeast nitrogen base, BD Difco, USA), 4 × 
10-5 % (w/v) biotin and 1 % (v/v) glycerol) medium on a rotary shaker at 30 °C and 
200 rpm. After 24 h growth, the culture was inoculated into 1 L of BSM (basal salts 
medium: 26.7 mL/L H3PO4 (85 % (w/v)), 0.93 g/L CaSO4 . 2 H2O, 18.2 g/L K2SO4, 
14.9 g/L MgSO4 . 7 H2O and 4.13 g/L KOH) medium with 4.35 mL PTM1 salts (6.0 g/L 
CuSO4 . 5 H2O, 0.08 g/L NaI, 30 g/L MnSO4 . H2O, 0.2 g/L Na2MoO4 . 2 H2O, 0.02 g/L 
H3BO3, 0.5 g/L CoCl2, 20.0 g/L ZnCl2, 65.0 g/L FeSO4 . 7 H2O, 0.2 g/L biotin and 5 mL/L 
H2SO4 conc.) and 10 g/L glycerol in a 2 L Biostat M reactor. Fermentation was performed 
at 30 °C and 1000 rpm with aeration at 1.5 vvm (set point DO 100 %). A pulsed feed of 
anti-foam (10 % (v/v) antifoam silicone Snapsil RE 20, VWR Prolabo) was controlled to 
administer 1 drop every 30 min to prevent foaming. The pH was set and maintained at 5 
by addition of aqueous ammonium hydroxide (28 % (w/v) NH3) or 5 M sulfuric acid. The 
initial batch phase was continued until the glycerol had been consumed, and was 
followed by a glycerol fed-batch phase. To that end, the fermenter was supplemented 
with a continuous feed of 6.6 g/L/h of 50 % (v/v) glycerol containing 12 mL/L PTM1 
salts during 14 h. To induce AOX transcription, methanol supplemented with 12 mL/L 
PTM1 salts was added at a rate of 0.8 g/L/h. The feeding rate of methanol was gradually 
increased to 2.1 g/L/h over 10 h and maintained for the remainder of the fermentation. 
5.3 Enzyme purification and concentration 
The culture supernatant was harvested 5 days after induction by centrifugation (10 min, 
10 000 g, 4 °C), and subjected to dialysis against 10 mM MES buffer at pH 6. Finally the 
obtained enzyme solution was washed with 50 mM MES buffer and concentrated using 
centricons (Amicon Ultra 30K, Millipore). 
5.4 Activity assays 
α-L-Rhamnosidase activity was assayed by mixing 200 µL MES buffer containing 50 mM 
p-nitrophenyl α-L-rhamnopyranoside (Sigma Aldrich, USA) with 400 µL of a diluted 
enzyme solution. The reactions were followed discontinuously by adding 50 µL samples 
to 150 µL of a 0.5 M Na2CO3 solution at regular intervals. The liberated p-nitrophenol 
(PNP) was determined spectrophotometrically at 405 nm in a microplate reader. One 
unit of α-L-rhamnosidase activity was defined as the amount of enzyme releasing 1 µmol 
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of PNP per minute in a 50 mM MES buffer at pH 6.0 and 37 °C. All assays were 
performed in triplicate and had a CV of less than 10 %. 
5.5 Reverse hydrolysis with α-L-rhamnosidase 
Glycosylation reactions were performed in a 50 mM MES buffer at pH 6. Alternatively, a 
citrate-phosphate buffer (pH 3.0 - 5.4), MES buffer (pH 5.5 - 6.5), MOPS buffer (pH 6.6 - 
7.5) and tricine buffer (pH 7.6 – 9.0) were used. Varying amounts of solvents and 
substrate were added, and unless stated otherwise, the reactions were incubated at 37 
°C in the presence of 1.5 M rhamnose and 20 U/mL α-L-rhamnosidase. 
5.6 Analytical techniques 
HPLC analysis was performed on an X-bridge amide column (250 mm × 4.6 mm, 3.5 µm, 
Waters, USA) with milliQ water (solvent A) and acetonitrile (solvent B), both containing 
0.2 % triethylamine, as the mobile phase. The flow rate and temperature were set at 
1.0 mL/min and 30 °C, respectively. The gradient elution was as follows: 95 % of solvent 
A (0 - 12 min), 5 to 25 % solvent B (12 - 15 min), 25 % solvent B (15 - 40 min), 25 to 5 % 
solvent B (40 - 41 min) and 95 % solvent A (41 - 50 min). Detection was accomplished 
with an Alltech 2000ES evaporative light scattering detector (ELSD). The tube 
temperature, gas flow and gain were set at 25 °C, 1.5 L/min and 4, respectively. In the 
case of biphasic reaction systems, homogeneous samples, obtained after intensive 
mixing, were dissolved in dimethyl sulfoxide (DMSO) and subjected to HPLC analysis. 
The resulting concentrations refer to the amount of product present in the total reaction 
volume. TLC analysis was performed as described in CHAPTER 4. All reported errors 
correspond to the standard errors. 
5.7 Production and purification of glycosides 
The glycosylation of hydroquinone, catechol and resorcinol was carried out at 20 mL 
scale in a 50 mM MES buffer at pH 6.5 containing 40 % acetone. Rhamnose, acceptor and 
α-L-rhamnosidase were added to a concentration of 1.5 M, 200 mg/mL (1.82 M) and 
20 U/mL, respectively. Alternatively, rhamnosylation of hexanol, heptanol, cyclohexanol, 
anisyl alcohol and 2-phenylethanol was performed in a biphasic system consisting of 
6 mL acceptor and 15 mL 50 mM MES buffer at 5.5, supplemented with 500 mM 
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rhamnose and 20 U/mL α-L-rhamnosidase. Reactions were terminated after 48 h 
incubation at 37 or 50 °C for cosolvent and biphasic reaction systems, respectively. The 
reaction mixtures were heated (10 min at 95 °C) and centrifuged (12 000 g, 4 °C, 15 min) 
to remove debris. The samples were then evaporated in vacuo and the residue was 
purified by column chromatography (silicagel, EtOAC/MeOH/H2O = 30:5:4). 
5.8 Structure elucidation of rhamnosides 
The structures of new glycosides were determined by a combination of 1D NMR (1H 
NMR and 13C NMR) and 2D NMR (gCOSY, gHSQC and gHMBC) spectroscopy. Residual 
signals of solvent were used as an internal standard (H 3.330 ppm, C 49.30 ppm). 
Digital resolution enabled the reporting of H to three and C to two decimal places. Some 
hydrogen chemical shifts were read out from HSQC and are reported to two decimal 
places. The proton spin systems were assigned by COSY, and then the assignment was 
transferred to carbons by HSQC. HMBC experiments enabled to assign quaternary 
carbons and to join individual spin systems together. Chemical shifts are given in -scale 
[ppm], and coupling constants in Hz. Spectral analysis and interpretation was kindly 
performed by the group of Prof. Vladimír Křen at the Institute of Microbiology (Czech 
Republic). 
 
1-O-α-L-Rhamnopyranosyl hydroquinone 
1H NMR (600.23 MHz, CD3OD, 25 oC): 1.256 (3H, d, J = 6.2 Hz, H-6), 
3.466 (1H, dd, J = 9.5, 9.5 Hz, H-4), 3.725 (1H, dq, J = 9.5, 6.2 Hz, H-5), 
3.842 (1H, dd, J = 9.5, 3.4 Hz, H-3), 4.000 (1H, dd, J = 3.4, 1.8 Hz, H-2), 
5.268 (1H, d, J = 1.8 Hz, H-1), 6.726 (2H, m, ΣJ = 8.9 Hz, H-meta), 
6.911 (2H, m, ΣJ = 8.9 Hz, H-ortho) 
13C NMR (150.94 MHz, CD3OD, 25oC): 18.28 (C-6), 70.71 (C-5), 72.50 (C-2), 72.57 (C-3), 74.23 (C-
4), 101.24 (C-1), 117.08 (C-meta), 119.35 (C-ortho), 151.39 (C-ipso), 153.92 (C-para) 
 
1-O-α-L-Rhamnopyranosyl resorcinol 
1H NMR (600.23 MHz, CD3OD, 25oC): 1.256 (3H, d, J = 6.2 Hz, H-6), 
3.467 (1H, dd, J = 9.5, 9.5 Hz, H-4), 3.671 (1H, dq, J = 9.5, 6.2 Hz, H-
5), 3.845 (1H, dd, J = 9.5, 3.5 Hz, H-3), 3.991 (1H, dd, J = 3.5, 1.8 Hz, 
H-2), 5.383 (1H, d, J = 1.8 Hz, H-1), 6.466 (1H, m, H-6’), 6.546 (1H, 
m, H-2’), 6.551 (1H, m, H-4’), 7.087 (1H, m, H-5’) 
13C NMR (150.94 MHz, CD3OD, 25oC): 18.32 (C-6), 70.86 (C-5), 72.41 (C-2), 72.55 (C-3), 74.18 (C-
4), 100.13 (C-1), 105.16 (C-2’), 108.98 (C-4’), 110.62 (C-6’), 131.21 (C-5’), 159.37 (C-1’), 159.96 
(C-3’); C-4’and 6’might be interchanged 
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1-O-α-L-Rhamnopyranosyl catechol 
1H NMR (600.23 MHz, CD3OD, 25oC): 1.266 (3H, d, J = 6.2 Hz, H-6), 
3.485 (1H, dd, J = 9.5, 9.5 Hz, H-4), 3.817 (1H, dq, J = 9.5, 6.2 Hz, H-5), 
3.962 (1H, dd, J = 9.5, 3.5 Hz, H-3), 4.136 (1H, dd, J = 3.5, 1.8 Hz, H-2), 
5.383 (1H, d, J = 1.8 Hz, H-1), 6.779 (1H, ddd, J = 8.1, 7.1, 1.9 Hz, H-4’), 
6.857 (1H, dd, J = 7.9, 1.9 Hz, H-6’), 6.890 (1H, ddd, J = 7.9, 7.1, 1.5 Hz, 
H-5’), 7.115 (1H, dd, J = 8.1, 1.5 Hz, H-3’) 
13C NMR (150.94 MHz, CD3OD, 25oC): 18.26 (C-6), 70.98 (C-5), 72.29 (C-2), 72.47 (C-3), 74.23 (C-
4), 101.50 (C-1), 117.64 (C-6’), 119.17 (C-3’), 121.14 (C-4’), 124.57 (C-5’), 146.06 (C-1’), 149.06 
(C-2’); spin system 3’-4’-5’-6’might be interchanged for the opposite order 6’-5’-4’-3’  
 
Hexyl α-L-rhamnopyranoside 
1H NMR (400.00 MHz, CD3OD, 30oC): 0.931 (3H, m, H-6’), 
1.276 (3H, d, J = 6.2 Hz, H-6), 1.33 (2H, m, H-4’), 1.35 (2H, 
m, H-5’), 1.38 (2H, m, H-3’), 1.599 (2H, m, H-2’),  3.386 
(1H, dd, J = 9.7, 9.3 Hz, H-4), 3.422 (1H, dt, J = 9.6, 6.4 Hz, 
H-1’u), 3.598 (1H, dq, J = 9.3, 6.2 Hz, H-5), 3.657 (1H, dd, J = 9.7, 3.4 Hz, H-3), 3.680 (1H, dt, J = 
9.6, 6.7 Hz, H-1’d), 3.804 (1H, dd, J = 3.4, 1.7 Hz, H-2), 4.673 (1H, d, J = 1.7 Hz, H-1) 
13C NMR (100.58 MHz, CD3OD, 30oC): 14.64 (C-6’), 18.26 (C-6), 23.92 (C-5’), 27.29 (C-3’), 30.88 
(C-2’), 33.04 (C-4’), 68.89 (C-1’), 70.03 (C-5), 72.67 (C-2), 72.79 (C-3), 74.31 (C-4), 101.93 (C-1) 
 
Heptyl α-L-rhamnopyranoside 
1H NMR (600.23 MHz, CD3OD, 30oC): 0.925 (3H, m, H-
7’), 1.276 (3H, d, J = 6.2 Hz, H-6), 1.32 (2H, m, H-5’), 1.34 
(2H, m, H-6’), 1.35 (2H, m, H-4’), 1.39 (2H, m, H-3’), 
1.600 (2H, m, H-2’), 3.385 (1H, dd, J = 9.6, 9.4 Hz, H-4), 
3.423 (1H, dt, J = 9.6, 6.3 Hz, H-1’u), 3.597 (1H, dq, J = 9.4, 6.2 Hz, H-5), 3.655 (1H, dd, J = 9.6, 3.4 
Hz, H-3), 3.680 (1H, dt, J = 9.6, 6.7 Hz, H-1’d), 3.802 (1H, dd, J = 3.4, 1.7 Hz, H-2), 4.672 (1H, d, J = 
1.7 Hz, H-1) 
13C NMR (150.94 MHz, CD3OD, 30oC): 18.23 (C-6), 25.12 (C-5’), 25.36 (C-3’), 27.08 (C-4’), 32.77 
(C-6’), 34.76 (C-2’), 70.15 (C-5), 72.76 (C-3), 73.15 (C-2), 74.44 (C-4), 76.37 (C-1’), 99.92 (C-1) 
 
Cyclohexyl α-L-rhamnopyranoside 
1H NMR (400.00 MHz, CD3OD, 30oC): 1.262 (3H, d, J = 6.3 Hz, H-6), 1.29 
(1H, m, H-4’u), 1.31 (1H, m, H-5’u), 1.32 (1H, m, H-6’u), 1.34 (1H, m, H-
3’u), 1.40 (1H, m, H-2’u), 1.55 (1H, m, H-4’d), 1.74 (1H, m, H-5’d), 1.76 
(1H, m, H-3’d), 1.87 (1H, m, H-2’d), 1.88 (1H, m, H-6’d), 3.384 (1H, dd, J = 
9.5, 9.5 Hz, H-4), 3.603 (1H, m, H-1’), 3.676 (1H, dq, J = 9.5, 6.3 Hz, H-5), 3.676 (1H, dd, J = 9.5, 3.4 
Hz, H-3), 3.767 (1H, dd, J = 3.4, 1.7 Hz, H-2), 4.838 (1H, d, J = 1.7 Hz, H-1) 
13C NMR (100.58 MHz, CD3OD, 30oC): 18.23 (C-6), 25.12a (C-5’), 25.36a (C-3’), 27.08 (C-4’), 32.77b 
(C-6’), 34.76b (C-2’), 70.15 (C-5), 72.76 (C-3), 73.15 (C-2), 74.44 (C-4), 76.37 (C-1’), 99.92 (C-1); 
a,b  might be interchanged 
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Anisyl α-L-rhamnopyranoside 
1H NMR (600.23 MHz, CD3OD, 25oC): 1.291 (3H, d, J = 6.2 
Hz, H-6), 3.404 (1H, dd, J = 9.5, 9.5 Hz, H-4), 3.639 (1H, dq, 
J = 9.5, 6.2 Hz, H-5), 3.681 (1H, dd, J = 9.5, 3.5 Hz, H-3), 
3.798 (3H, s, OMe),  3.812 (1H, dd, J = 3.5, 1.7 Hz, H-2), 
4.449 (1H, d, J = 11.5 Hz, H-1’u), 4.623 (1H, d, J = 11.5 Hz, H-1’d),  4.756 (1H, d, J = 1.7 Hz, H-1), 
6.909 (2H, m, ΣJ = 8.7 Hz, H-meta), 7.279 (2H, m, ΣJ = 8.7 Hz, H-ortho) 
13C NMR (150.94 MHz, CD3OD, 25oC): 18.29 (C-6), 55.99 (OMe), 70.22 (C-5), 72.61 (C-2), 72.73 
(C-3), 74.32 (C-4), 100.83 (C-1), 115.07 (C-meta), 131.02 (C-ortho), 131.30 (C-ipso), 161.18 (C-
para) 
 
2-Phenylethyl α-L-rhamnopyranoside 
1H NMR (600.23 MHz, CD3OD, 25oC): 1.212 (3H, d, J = 6.2 Hz, H-6), 
2.883 (2H, dd, J = 6.9, 6.6 Hz, H-2’), 3.356 (1H, dd, J = 9.5, 9.4 Hz, H-
4), 3.419 (1H, dq, J = 9.5, 6.2 Hz, H-5), 3.619 (1H, dd, J = 9.4, 3.5 Hz, 
H-3), 3.654 (1H, dt, J = 9.7, 6.6 Hz, H-1’u), 3.782 (1H, dd, J = 3.5, 1.7 
Hz, H-2), 3.877 (1H, dt, J = 9.7, 6.9 Hz, H-1’d), 4.669 (1H, d, J = 1.7 Hz, H-1), 7.194 (1H, m, H-para), 
7.237 (2H, m, H-ortho), 7.282 (2H, m, H-meta) 
13C NMR (150.94 MHz, CD3OD, 25oC): 18.24 (C-6), 37.41 (C-2’), 69.74 (C-1’), 70.08 (C-5), 72.56 
(C-2), 72.70 (C-3), 74.18 (C-4), 101.89 (C-1), 127.52 (C-para), 129.63 (C-meta), 130.22 (C-ortho), 
140.70 (C-ipso) 
6 SUPPLEMENTARY INFORMATION 
Table S6.1 Influence of DMSO on the glycosylation activity of α-L-rhamnosidase. Catechol and rhamnose 
were dissolved to 50 mg/mL and 1.5 M respectively in a 50 mM MOPS buffer at pH 7.0. Samples were 
analyzed after 24 h at 37 °C. 
[DMSO] 
(%) 
Product spot 
intensity 
0 - 
10 - 
20 + 
30 ++ 
40 +++++ 
50 +++ 
60 ++ 
70 - 
80 - 
90 - 
100 - 
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Table S6.2 Optimization of α-L-rhamnosidase catalyzed synthesis of catechol-rhamnoside. The rhamnose 
and acetone concentrations were fixed at 1.5M and 40 % respectively. 
pH 
Temperature 
(°C) 
[Catechol] 
(mg/mL) 
Product spot 
intensity 
4 37 50 ++ 
5 37 50 +++ 
6 37 50 ++++ 
7 37 50 +++ 
8 37 50 +++ 
9 37 50 + 
10 37 50 - 
6 37 10 ++ 
6 37 100 ++++ 
6 37 200 +++++ 
6 37 300 ++ 
6 37 400 + 
6 37 500 - 
6 45 200 ++++ 
6 50 200 +++ 
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Table S6.3 Optimization of α-L-rhamnosidase catalyzed synthesis of hexyl-rhamnoside. The rhamnose 
concentration was fixed at 0.5M. 
pH 
Temperature 
(°C) 
Buffer/hexanol 
ratio 
Product spot 
intensity 
4 37 5 + 
5 37 5 ++ 
5.5 37 5 +++ 
6 37 5 ++ 
7 37 5 ++ 
5.5 37 1 ++ 
5.5 37 2.5 ++++ 
5.5 37 7.5 ++ 
5.5 37 10 ++ 
5.5 45 2.5 ++++ 
5.5 50 2.5 +++++ 
5.5 55 2.5 +++ 
5.5 60 2.5 ++ 
 
 
 
Figure S6.1 Reaction of 750 mg/mL phenol (1’), catechol (2’) and pyrogallol (3’) with rhamnose (1.5 M) in 
the presence of 20 U/mL α-L-rhamnosidase at 37 °C. Alternatively, 50 mg/mL phenol (4’), catechol (5’) 
and pyrogallol (6’) were used. All reactions were performed in a 50 mM MOPS buffer at pH 7.0 containing 
50 % DMSO.  For each condition, blancs (numbers without ‘) were analyzed next to the reactions.   
Acceptor 
Glucoside 
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1 ABSTRACT 
Although the efficient synthesis of numerous glycosides has been described in the 
previous chapters, prolongation of these compounds could further improve their 
properties. Unfortunately, sucrose and cellobiose phosphorylase are inefficient catalysts 
with respect to chain elongation, whereas chemical synthesis suffers from low yields and 
the generation of toxic waste. In this chapter, the cellodextrin phosphorylase from 
Clostridium stercorarium (CsCDP) was studied, and its activity towards various 
glucosides was determined. Interestingly, the enzyme was found to glycosylate a wide 
range of aliphatic and phenolic glucosides, among which next to the common β-
glucosides also numerous α-glucosides. A number of complex glycosides, including 
salicyl 1-O-β-D-cellotriopyranoside and 6-O-β-D-cellobiopyranosyl esculetin were 
synthesized, isolated and analyzed by NMR spectroscopy. In addition, mutagenesis 
experiments were performed in the +2 subsite of the enzyme, revealing its importance 
for the activity of CsCDP. Remarkably, the specific activity of variant W168A towards 
octyl β-glucoside was found to be higher than the activity of the WT towards its natural 
substrate cellobiose.  
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2 INTRODUCTION 
Glycosides are amongst the most widely distributed molecules in nature. In plants, for 
example, they play a role in accumulation, storage and transport of hydrophobic 
substances173.  Indeed, compared to the free aglycone, glycosides show enhanced water 
solubility and decreased reactivity, allowing storage in the plant vacuole174. Examples 
include the cyanogenic glycoside amygdalin175, the bitter tasting naringin176 and the 
sweetner glycyrrhizin11. The former protects plants from herbivores by releasing the 
toxic hydrogen cyanide upon consumption174, while the olfactory properties of the latter 
compounds are changed by their hydrolysis177, 178. 
 
Although chemical synthesis of glycosides still suffers from low yields, promising 
alternatives for the production of α- and β-glucosides have been described in CHAPTER 2, 
3, 4 and 5. Prolongation of these glucosides, however, could further alter their 
properties. This has, for example, been nicely illustrated for carbohydrates connected to 
long alkyl chains, yielding compounds with good surfactant and emulsifying 
properties179. Indeed, by changing the aliphatic chain length180 and the amount of 
glycosylation181, alkyl polyglucosides (APGs) with varying properties can be obtained182. 
These interesting non-ionic surfactants find widespread application in detergents183, 
lubricants184 and cosmetics, and can be synthesized by Fischer condensation of 
carbohydrates and fatty acids185. Unfortunately, modification of the carbohydrate moiety 
by chemical methods is hampered by the need for numerous (de)protection and 
activation steps15. Therefore, enzymatic glycosylation of alkyl glucosides is a promising 
alternative186. 
 
Cellodextrin phosphorylase (CDP) (EC.2.4.1.49) catalyzes the reversible phosphorolysis 
of cello-oligosaccharides into cellodextrins with reduced chain length and α-glucose 1-
phosphate (αG1P)187. The enzyme follows a similar single displacement reaction 
mechanism as cellobiose phosphorylase (CP), resulting in inversion of the anomeric 
configuration38, 149. Together with CP, it is involved in the natural degradation of 
cellulosic biomass188, 189. Because of the reversible nature of phosphorolytic reactions, 
however, CDP can also be used for glycosylation reactions in vitro. The enzyme is 
classified in the family GH-94 together with CP and chitobiose phosphorylase190. To date, 
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the crystal structure of CDP has not yet been determined. However, based on the crystal 
structure of chitobiose phosphorylase from Vibrio proteolyticus191, a homology model for 
the CDP originating from Clostridium stercorarium (CsCDP) was created. In parallel with 
other GH-94 enzymes, it was shown that each monomer of the homodimeric structure of 
CDP consists of four different domains: a N-terminal β-sandwich domain, a short α-
helical linker, the catalytic (α/α)6 -barrel domain and a C-terminal β-sheet domain39. 
 
In contrast to the narrow donor specificity, the acceptor specificity of CDP is much more 
extended. Examples include oligosaccharides such as sophorose152 and laminaritriose37, 
alkyl glucosides such as methyl β-glucoside38 and methyl β-cellobioside192, surfactants 
among which sophorolipids and glucolipids193, as well as the phenolic glucosides phenyl 
β-cellobioside192 and PNP β-glucoside39. Remarkably, all of these compounds have at 
least one β-linked glucose unit in their structure. Moreover, when the CDP from 
Clostridium stercorarium was first discovered by Reichenbecher, the phosphorolysis of 
cellotriose was found to show the highest catalytic efficiency38, indicating the presence 
of at least two acceptor subsites (+1 and +2). Interestingly, the residues in this +2 
subsite were recently shown to be less conserved compared to the -1 and +1 subsite39. 
Indeed, while residue D474 (general catalytic acid)194, residue D348 (hydrogen bonding 
of C2-OH and C3-OH in subsite -1)149 and residue W472 (transition state stabilizer)195 
are highly conserved, no such homology could be observed for the important residues in 
the +2 subsite39. Despite these efforts, no detailed study on the promiscuity and 
application potential of this enzyme is available to date. 
 
In this chapter, the glycosylation of various glucosides with the CDP from Clostridium 
stercorarium was evaluated. The specific activity towards different classes of acceptors 
was determined, and the influence of the residues in subsite +2 was scrutinized. 
Moreover, numerous glycosides were produced, isolated and characterized, while 
improved mutants for the synthesis of APGs were successfully obtained.  
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3 RESULTS & DISCUSSION 
3.1 Production and purification of CDP 
Although the recombinant production of the CDP originating from Clostridium 
stercorarium (CsCDP) has recently been described39, moderate yields (12 U/mL culture 
volume) were obtained when applying the specified fermentation conditions. Increasing 
the induction time from 4 h to 16 h doubled the yield to 24 U/mL culture volume, while 
transferring the culture to a bioreactor allowed the production of roughly 500 000 U 
CsCDP in 15 L (33 U/mL). As illustrated in CHAPTER 5 for CP, purification of 
phosphorylases is crucial when using them in the synthesis direction. Therefore, also the 
His-tag purification of the obtained CsCDP crude cell extract was optimized.  
 
First, the concentration of imidazole in the washing buffer was varied, identifying 
25 mM as the optimal concentration. Lower concentrations hampered the purity of the 
protein, while higher imidazole concentrations decreased the purification yield. Next, 
the imidazole concentration in the elution buffer was varied between 250 and 500 mM. 
As a result, the purification yield could be increased from 20.4 % when using the initial 
conditions, to 65.3 % when applying the optimal wash conditions and eluting with 400 
mM imidazole. Interestingly, also the level of purification increased from 4.3 to 6.7, 
indicating overall improved performance of the latter purification protocol.   
3.2 Exploring the glycosylation potential of CDP 
Although CDP is known to glucosylate various glucosides, its activity towards aglycons 
such as alcohols, terpenoids, phenols and flavanoids hasn’t been reported to date. 
Indeed, the larger active site of this enzyme might allow the glucosylation of bulky 
acceptors such as resveratrol and quercetin. Therefore, the activity of the CDP from 
Clostridium stercorarium was evaluated towards a broad range of acceptors (Table S7.1). 
In contrast to SP (CHAPTER 4) and CP (CHAPTER 5), CDP was not able to glucosylate any of 
these compounds, indicating the necessity of a glucose moiety in the +1 subsite.   
 
In order to screen a large number of glucosides, a suitable separation system was first 
developed. The eluens used to separate glucosides from their non-glycosylated 
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counterparts suffered from a low resolution when applied to analyze a typical reaction 
mixture of CsCDP (Figure 7.1, lane 1). Therefore, the performance of various eluens 
compositions for the separation of 1-O-β-D-glucopyranosyl hydroquinone, 1-O-β-D-
cellobiopyranosyl hydroquinone and 1-O-β-D-cellotriopyranosyl hydroquinone (as 
obtained by reacting αG1P and 1-O-β-D-glucopyranosyl hydroquinone in the presence of 
CsCDP) was evaluated (Figure 7.1).   
 
1. EtOAc/MeOH/H2O = 30:5:4  
2. EtOAc/MeOH = 8:1  
3. EtOAc/H2O = 8:1  
4. Acetonitrile/H2O = 85:15  
5. EtOAC/butane/FA/H2O = 3:3:1:1  
6. Acetonitrile/H2O = 95:5  
 
Figure 7.1 Optimization of the separation of glucosides, cellobiosides and cellotriosides. Synthesis of 
glycosides was performed in a 50 mM MES buffer at pH 6.5 containing 100 mM αG1P, 100 mM 1-O-β-D-
glucopyranosyl hydroquinone and 1 mg/mL CDP. Samples were analyzed after 24 h incubation at 37 °C. 
 
Adequate separation was achieved when using an Acetonitrile/H2O = 85:15 or an 
EtOAC/butane/FA/H2O = 3:3:1:1 mixture. Unfortunately, the latter mixture contains 
formic acid, which may trigger hydrolysis of the formed glycosides upon isolation of the 
products. Therefore, the performance of the Acetonitrile/H2O = 85:15 mixture was also 
evaluated for the separation of alkyl glycosides (Figure S7.1). Similar separation was 
achieved for both phenolic and aliphatic glycosides, revealing the generic character of 
the latter method.  
 
Next, the activity of CsCDP towards a range of aliphatic and phenolic glucosides was 
scrutinized. Interestingly, the enzyme was active towards all tested compounds 
including the phenolic β-D-glucosides arbutin, esculin, salicin, polydatin, p-nitrophenyl 
β-glucoside, and aliphatic β-D-glucosides such as methyl β-glucopyranoside, butyl β-
glucopyranoside, hexyl β-glucopyranoside, octyl β-glucopyranoside, nonyl β-
glucopyranoside, decyl β-glucopyranoside and dodecyl β-glucopyranoside. Although less 
efficient (Figure S7.2), CDP was also able to transfer a glucose moiety to a number of α-
glucosides including α-arbutin, methyl gallyl 4-α-D-glucopyranoside, ethyl gallyl 4-α-D-
 1            2            3            4            5            6 
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glucopyranoisde, propyl gallyl 4-α-D-glucopyranoside, p-nitrophenyl 1-O-α-D-
glucopyranoside and 3-O-α-D-glucopyranosyl resveratrol. Indeed, 24 h incubation at 
37 °C resulted in 9 and 5 mM cellobioside and cellotrioside when using 1-O-α-D-
glucopyranosyl hydroquinone as acceptor, whereas the product concentrations 
amounted to 24 and nearly 10 mM respectively upon addition of 1-O-β-D-
glucopyranosyl hydroquinone (Table 7.1). Similar results were obtained for the PNP 
derivatives, indicating clear preference for β-linked glucose moieties.  
 
Table 7.1 Synthesis of α and β-glycosides in a 50 mM MES buffer at pH 6.5 containing 1 mg/mL CDP, 
100 mM αG1P and 100 mM acceptor. HPLC analysis was performed after 24 h of incubation at 37 °C.  
 Concentration [mM] 
Acceptor Cellobioside Cellotrioside 
1-O-α-D-Glucopyranosyl hydroquinone                        9.4 5.4 
1-O-β-D-Glucopyranosyl hydroquinone                        24.1 9.9 
p-Nitrophenyl 1-O-α-D-glucopyranoside 18.3 5.0 
p-Nitrophenyl 1-O-β-D-glucopyranoside                      22.2 13.7 
 
Moreover, glycosylation was also observed when using the aliphatic α-D-glucosides of  
methanol, butanol or octanol as acceptor. Also here, a clear preference for β-glucosides 
was observed (Figure S7.2). Multiple newly formed glycosides were purified, and their 
structure was confirmed by NMR spectroscopy.  
3.3 Mapping the acceptor specificity of CDP 
Encouraged by these results, the acceptor specificity of CsCDP was analyzed in more 
detail. To that end, the specific activity of the enzyme towards various glucosides was 
determined (Figure 7.2). In accordance with the results obtained by Tran, a strong 
preference for the disaccharide cellobiose (3.4 U/mg) over the monosaccharide glucose 
(0.9 U/mg) was observed (Figure 7.2A)39. Maltose, α-(1,4)-linked glucobiose, was found 
to be a poor acceptor, exhibiting a specific activity of only 12 % (0.4 U/mg) when 
compared to cellobiose. Nevertheless, the formation of maltosyl β-(1,4)-glucopyranoside 
was confirmed by degradation with a β-glucosidase (Figure S7.3 and S7.4).  
Next to carbohydrates, also a large group of glucosides with phenolic side chains were 
evaluated (Figure 7.2B). Interestingly, the highest activity of all tested acceptors was 
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found on PNP 1-O-β-D-glucopyranoside (10.1 U/mg) and arbutin (6.2 U/mg), followed 
by the β-cellobioside of PNP (5.9 U/mg). These numbers are substantially higher when 
compared to the activity towards cellobiose, confirming the importance of the acceptor 
subsite +2. Indeed, these results suggest the enzyme’s preference for aryl over glucosyl 
side chains in +2 (Figure 7.3).  
 
Figure 7.2 Specific activity of CDP towards carbohydrates (A), aromatic glucosides (B), aliphatic 
glucosides (C) and O- vs. S-β-glucosides (D). The specific activity was determined at 37 °C in a 50 mM MES 
buffer at pH 6.5 containing 50 mM αG1P and 50 mM acceptor. Abbreviations: PNP-αGlc, p-nitrophenyl 1-
O- α-D-glucopyranoside; PNP-αCb, p-nitrophenyl 1-O-α-D-cellobiopyranoside; PNP-βGlc, p-nitrophenyl 1-
O-β-D-glucopyranoside; PNP-βCb, p-nitrophenyl 1-O-β-D-cellobiopyranoside; Methyl gallyl αGlc, methyl 
gallyl 4-O-α-D-glucopyranoside; Ethyl gallyl αGlc, ethyl gallyl 4-O-α-D-glucopyranoside; Propyl gallyl αGlc, 
propyl gallyl 4-O-α-D-glucopyranoside; Methyl αGlc, methyl α-D-glucopyranoside; Butyl αGlc, butyl α-D-
glucopyranoside; Octyl αGlc, octyl α-D-glucopyranoside; Methyl βGlc, methyl β-D-glucopyranoside; Butyl 
βGlc, butyl β-D-glucopyranoside; Octyl βGlc, octyl β-D-glucopyranoside; Hexyl βGlc, hexyl β-D-
glucopyranoside; Hexyl thio-βGlc, hexyl thio-β-D-glucopyranoside. 
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Again, higher activities were found on β-bond glucosides compared to their α-linked 
counterparts. Indeed, while the specific activity towards p-nitrophenyl 1-O-β-D-
glucopyranoside was found to be 10.1 U/mg, the activity was reduced to only 4.8 U/mg 
when using p-nitrophenyl 1-O-α-D-glucopyranoside as acceptor. Likewise, CsCDP was 
more active towards β-arbutin (6.2 U/mg) than α-arbutin (1.0 U/mg). Interestingly, 
CsCDP was also able to glycosylate a range of interesting antioxidants including methyl 
gallyl 4-O-α-D-glucopyranoside (1.0 U/mg), ethyl gallyl 4-O-α-D-glucopyranoside 
(0.8 U/mg) and propyl gallyl 4-O-α-D-glucopyranoside (1.3 U/mg). 
 
In contrast to phenolic glucosides, moderate activities were observed when using 
acceptors with aliphatic side chains (Figure 7.2C). The activity towards hexyl β-D-
glucopyranoside was found to be 2.5 U/mg, which is roughly 4 times lower compared to 
PNP 1-O-β-D-glucopyranoside. Both shorter and longer chains further decreased the 
enzymes efficiency, resulting in a specific activity of 1.4 U/mg for methyl and octyl β-D-
glucopyranoside. In agreement with the observations for aromatic acceptors, CsCDP 
showed a clear preference for aliphatic β-glucosides compared to α-glucosides (Figure 
7.2C). Although less efficient, the CDP from Clostridium stercorarium was also able to 
transfer a glucosyl moiety to thioglucosides (Figure 7.2D). In conclusion, CDP was found 
to strongly favor β-glucosides over α-glucosides. The highest activity was found towards 
glucosides with phenolic side chains, followed by glucosyl units and aliphatic side 
chains. These differences illustrate the importance of the +2 subsite regarding the 
activity of the CDP from Clostridium stercorarium (Figure 7.3). 
Figure 7.3 Homodimeric structure of the CDP from Clostridium stercorarium, docked with cellotriose. The 
catalytic residue D474, donor (-1) and acceptor (+1 and +2) subsites are indicated. 
D474 
+I 
+II  
-I 
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3.4 Altering the acceptor specificity of CDP by site directed mutagenesis 
Although CsCDP was found to be a versatile glycosylation catalyst, its activity towards 
aliphatic glucosides is rather limited. Nevertheless, the synthesis of alkyl polyglucosides 
(APGs) remains of great value to date183, 184, 193. Based upon the obtained results, and 
previous studies on the CDP from Clostridium stercorarium39, three positions in the +2 
subsite were selected as potential ‘hot-spots’ for the selectivity of the enzyme 
(Figure 7.4).  
 
Figure 7.4 Predicted binding of cellotriose in the active site of the CDP from Clostridium stercorarium. 
 
The asparangine residue N165 and the tryptophane residue W168 were chosen since 
these two residues have no counterpart in the structure of other glycoside 
phosphorylases39. Furthermore, the indole ring of residue W168 is most likely involved 
in stacking interactions when positioned parallel to the carbohydrate moiety or aryl unit 
of acceptor molecules196, 197. In addition, the tyrosine residue Y615 was chosen because 
of its interesting difference with CP. Indeed, the side chain of Y615 is flipped outwards in 
the case of CDP, thus avoiding a clash with bulky acceptors. Next, the three selected 
positions were mutated to alanine, and the activity of the obtained mutants towards a 
range of glucosides was determined (Table 7.2).  
 
 
 
 
 
+I 
+II 
-I 
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Table 7.2 Specific activity of the CDP from Clostridium stercorarium wild type (WT) and mutants. The 
specific activity (U/mg) was determined at 37 °C in a 50 mM MES buffer at pH 6.5 containing 50 mM αG1P 
and 50 mM acceptor.  
Substrate WT Y615A N165A W168A 
Cellobiose 3.40 ± 0.20 1.01 ± 0.07 3.02 ± 0.34 1.93 ± 0.21 
PNP αGlc 4.78 ± 0.32 0.06 ± 0.01 0.34 ± 0.04 0.13 ± 0.02 
PNP βGlc 10.08 ± 0.51 0.09 ± 0.01 2.29 ± 0.31 0.73 ± 0.08 
Hexyl βGlc 2.45 ± 0.13 0.16 ± 0.02 3.20 ± 0.36 3.97 ± 0.50 
Hexyl thio-βGlc 1.86 ± 0.08 0.19 ± 0.01 2.82 ± 0.35 3.74 ± 0.95 
Octyl βGlc 1.41 ± 0.07 0.16 ± 0.02 2.37 ± 0.26 5.38 ± 0.64 
Abbreviations: PNP-αGlc, p-nitrophenyl 1-O-α-D-glucopyranoside; PNP-βGlc, p-nitrophenyl 1-O-β-D-
glucopyranoside; Hexyl βGlc, hexyl β-D-glucopyranoside; Hexyl thio-βGlc, hexyl thio-β-D-glucopyranoside; 
Octyl βGlc, octyl β-D-glucopyranoside. 
 
Mutant Y615A displayed a significantly reduced activity towards all tested substrates 
(Table 7.2). Indeed, substitution of tyrosine Y615 by alanine decreased the specific 
activity by 70 % for the natural substrate cellobiose, while less than 10 % of the wild 
type activity was observed towards the unconventional substrates (Figure 7.5).  
 
Figure 7.5 Relative activity of the WT and mutant (N165A, W168A, Y615A) CDP from Clostridium 
stercorarium. The activity was determined at 37 °C in a 50 mM MES buffer at pH 6.5 containing 50 mM 
αG1P and 50 mM acceptor. Abbreviations: PNP-αGlc, p-nitrophenyl 1-O-α-D-glucopyranoside; PNP-βGlc, p-
nitrophenyl 1-O-β-D-glucopyranoside; Hexyl βGlc, hexyl β-D-glucopyranoside; Hexyl thio-βGlc, hexyl thio-
β-D-glucopyranoside; Octyl βGlc, octyl β-D-glucopyranoside. 
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Residue Y615 was identified to be a determinant for the specificity of CDP and would 
therefore be an interesting target for further mutagenesis experiments. Substitution of 
asparangine 165 by alanine resulted in a significant loss of activity towards phenolic 
glucosides (i.e. residual activity of 7 and 23 % for p-nitrophenyl β or α-glucoside 
respectively). However, introducing alanine at position 165 did not affect the activity 
towards cellobiose, revealing interactions of N165 with aryl moieties in the +2 subsite 
(Table 7.2). Surprisingly, the latter substitution was also found to increase the activity 
towards aliphatic glucosides. Indeed, improved activities towards hexyl β-D-
glucopyranoside (130 %), hexyl thio-β-D-glucopyranoside (151 %) and octyl β-D-
glucopyranoside (167 %) were observed (Figure 7.5). Interestingly, these increased 
specific activities cannot be caused by a decreased Km, as the Michaelis-Menten 
constants of the WT CDP (µM range) are much lower than the applied substrate 
concentrations (mM range)39.  
 
In parallel, replacing tryptophane 168 by alanine resulted in a significantly decreased 
activity towards the phenolic glucosides p-nitrophenyl β and α-glucoside. Moreover, also 
the activity towards cellobiose declined to 57 % (Figure 7.5). The latter results clearly 
suggest the importance of residue W168 in interactions with both aryl and glucosyl 
moieties. In contrast, the activity towards the aliphatic glucosides hexyl β-D-
glucopyranoside, hexyl thio-β-D-glucopyranoside and octyl β-D-glucopyranoside 
increased substantially to 162, 201 and an impressive 381 % respectively. Docking 
experiments revealed the alkyl side chains turned towards the entrance of the active site 
(Figure 7.6). Indeed, substitution of the bulky tryptophane at position 168 by alanine 
reduces steric hindrance, thereby allowing increased reaction rates. 
 
Next, both beneficial mutations (N165A and W168A) were combined in a double mutant. 
Although synergistic effects have previously been described198, 199, the activity of the 
latter variant towards aliphatic glucosides was found to be decreased by 50 %. In 
conclusion, residues Y615, N165 and W168 were confirmed to be determinants for the 
specificity of CDP. Therefore, these positions can be considered ‘hot-spots’ for further 
mutagenesis experiments. However, significant improvements were already obtained, as 
the specific activity of variant W168A towards octyl β-glucopyranoside was found to be 
higher than the activity of the WT towards its natural substrate cellobiose.  
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Figure 7.6 In silico docking of octyl β-cellobioside in modeled CDP_W168A variant. A: Entrance to the 
active site. B: Predicted binding of octyl β-cellobioside (blue). Residue 168 is shown both as tryptophane 
(yellow) and alanine (pink). 
3.5 Efficient synthesis of octyl β-D-cellobiopyranoside 
Finally, the applicability of the improved W168A mutant for the synthesis of octyl β-D-
cellobiopyranoside was evaluated. To that end, two identical reactions with the wild 
type and W168A mutant were initiated, and the formation of the desired APG was 
followed by HPLC analysis (Figure 7.7). 
 
Figure 7.7 Synthesis of octyl β-D-cellobiopyranoside using the wild type (●) or mutant (○) CDP from 
Clostridium stercorarium. The reactions were performed at 37 °C in a 50 mM MES buffer at pH 6.5 
containing 100 mM αG1P, 100 mM octyl β-D-glucopyranoside and 0.2 mg/mL CsCDP. 
 
 
 
B 
A 
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The octyl β-D-cellobiopyranoside concentration amounted up to 15 g/L after 2 h when 
using the W168A mutant, whereas only 1.7 g/L was formed under identical conditions 
with the wild type enzyme. Remarkably, the donor yield for the wild type reaction 
reached only 23.8 %, while 40.9 % of the initial αG1P was converted after 24 h when 
using the mutant enzyme. In conclusion, the W168A mutant clearly outperforms the 
wild type enzyme for the synthesis of octyl β-D-cellobiopyranoside, and can be 
considered a promising biocatalyst for the production of APGs. 
4 CONCLUSION 
Following the work on sucrose phosphorylase mediated α-glucosylation (CHAPTER 2, 3 
and 4) and the synthesis of β-glucosides with cellobiose phosphorylase (CHAPTER 5), the 
prolongation of these glucosides with the cellodextrin phosphorylase from Clostridium 
stercorarium is described in this chapter. The specific activity of the enzyme towards 
various glucosides was assessed, revealing β-(1,4)-glucosylation of aliphatic and 
phenolic α/β-glucosides. Also, a range of complex cellobiosides and cellotriosides, 
among which salicyl 1-O-β-D-cellotriopyranoside and 6-O-β-D-cellobiopyranosyl 
esculetin, were synthesized, purified and confirmed by NMR spectroscopy. In addition, 
the function of the +2 subsite was scrutinized. Three proposed positions in the +2 
subsite were mutated to alanine, and proved to be determinants for the activity of CDP. 
Remarkably, the specific activity of variant W168A towards octyl β-D-glucopyranoside 
was found to be higher than the activity of the WT towards its natural substrate 
cellobiose, revealing the potential of the newly created biocatalyst for the synthesis of 
APGs.  
5 MATERIALS & METHODS 
5.1 Materials 
The IL AMMOENG 101 was kindly provided by Evonik Industries AG, and EtOAc was 
bought from Fiers. All other chemicals were analytical grade and purchased from Sigma-
Aldrich. 
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5.2 Structural analysis of cellodextrin phosphorylase 
The structural properties of the cellodextrin phosphorylase from Clostridium 
stercorarium were studied using a modeled structure, obtained by homology modeling 
in YASARA200, 201 and visualization in PyMOL. A homology model was constructed based 
on the gene sequence of C. stercorarium CDP (DSM 8532) and the crystal structure of the 
chitobiose phosphorylase from Vibrio proteolyticus (PDB 1V7W)39, 191, 202. Three residues 
in subsite +2 (N165, W168, Y615) were selected for mutagenesis. Also, in silico docking 
experiments were carried out in YASARA using VINA203, 204 and point charges assigned 
according to the AMBER03 force field205. 
5.3 Site-direct mutagenesis 
Site-directed alanine mutants (Table 7.3) were created according to the Sanchis 
protocol. The latter method is based on the creation of a megaprimer from a mutagenic 
and a normal primer, which is afterwards used in a whole plasmid PCR206. 
  
Table 7.3 Overview of the created site directed mutants of the CDP from C. stercorarium. 
Mutant Fw primer Rv primer Megaprimer size 
N165A SAN_N165A RV_ctrl 1875 bp 
W168A SAN_W168A RV_ctrl 1915 bp 
Y615A FW_ctrl SAN_RV_Y615A 1991 bp 
N165A_W168A SAN_N165A_W168A RV_ctrl 1922 bp 
 
The reaction mixture contained 2.5 U PfuUltra DNA Polymerase AD, 1x PfuUltra HF 
reaction buffer, 0.2 mM dNTP mix, 50 - 100 ng template DNA, 5 pmol forward primer 
and 5 pmol reverse primer (Table 7.4) in a total volume of 50 µL MilliQ. The PCR 
program starts with a hot start (3 min at 94 °C), and continues with 5 cycles of 
megaprimer formation (30 s denaturation at 94 °C, 60 seconds annealing at 55 °C and 
1 min/kb elongation at 72 °C). In the second step, the created megaprimers were used in 
20 cycles of whole-plasmid amplification (30 s denaturation at 94 °C and 2 min/kb for 
annealing and elongation at 68 °C). The program was finalized by a step of 2 min/kb at 
72 °C, followed by subsequent cooling at 16 °C. 
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Table 7.4 Primers used for the site directed mutagenesis of the CDP C. stercorarium (5’ - 3’).  
Primer name Sequence 
SAN_N165A AATGGATCAGCAGGCGGTGGACTGGGTTCAGC 
SAN_W168A CAGCAGAATGTGGACGCAGTTCAGCAGATAAACC  
SAN_N165A_W168A AATGGATCAGCAGGCGGTGGACGCGGTTCAGCAGATAAACCAGGG 
SAN_RV_Y615A GCCCCCGGCGGTGCTGTGGTCATGCCCCCTATTTTC 
FW_ctrl GCCGACATCATAACGGTTCTG 
RV_ctrl TCTCTCATCCGCCAAAACAGC 
 
After the PCR reaction, 20 U of DpnI were added to the PCR mixtures and the latter were 
subsequently incubated during 1 h at 37 °C, resulting in digestion of methylated DNA. 
Next, an aliquot of 2.5 µL PCR-product was transformed into 50 µL of E. coli CGSC8974 
electrocompetent cells using a Bio-Rad GenePulser (25 µF capacitance, 200 Ω resistance 
and a 10.0 kV/cm field strength). The cells were then incubated during 1 h at 37 °C and 
plated out on LB medium containing 100 µg/mL of ampicillin. After overnight incubation 
at 37 °C, the plates were stored at 4 °C. From these plates, three colonies were picked, 
added to 5 mL of liquid LB medium containing 100 µg/mL of ampicillin and incubated 
overnight at 37 °C while shaking at 200 rpm. Subsequently, 1 mL of medium was used 
for the creation of cryovials and 2 mL was used for plasmid extraction using the Qiagen 
Spin Miniprep kit. All constructs were subjected to nucleotide sequencing (LCG 
Genomics) to confirm the correct introduction of the desired mutations. Cryovials of the 
obtained strains were stored at -80 °C in presence of 70 % glycerol. 
5.4 Production and purification of cellodextrin phosphorylase 
Overexpression of CsCDP was carried out using E. coli JW0987 cells transformed with 
the expression plasmid pTrc99a harboring the codon optimized cellodextrin 
phosphorylase gene from Clostridium stercorarium. The strain was routinely grown at 
37 °C on 500 mL LB medium (CHAPTER 5) supplemented with ampicillin (100 mg/L). 
After overnight growth, the culture was inoculated into 15 L of double LB medium 
(CHAPTER 5) supplemented with glucose (30 g/L) and ampicillin (100 mg/L) in a 30 L 
Biostat C reactor (B. Braun Biotech Inc.). The temperature, pH and stirrer speed were set 
at 37 °C, 7 and 800 rpm respectively. Adequate aeration was achieved by passing 
1.1 vvm air through the reactor, and foaming was prevented by manually adding anti-
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foam (10 % (v/v) antifoam silicone Snapsil RE 20, VWR BDH Prolabo) when required. 
Induction was performed by adding IPTG to a final concentration of 0.01 mM as soon as 
the OD600 reached 0.6. After 8 h of growth (OD600 ~ 34), the cells were harvested by 
centrifugation (10 000 g, 4 °C, 20 min), and frozen at -20 °C. The obtained pellets were 
lysed as described in CHAPTER 2 and the N-terminal His6-tagged protein was purified by 
nickel-nitrilotriacetic acid metal affinity chromatography. The protocol as described by 
the supplier (Qiagen) was used, except for the imidazole concentration of the elution 
buffer, which was increased to 400 mM. The obtained enzyme solution was washed with 
MES buffer (50 mM, pH 6.5) and concentrated using Centricons (Amicon Ultra 30K, 
Millipore). 
5.5 Activity assays 
The activity of CDP was determined in the synthesis direction by measuring the release 
of phosphate from αG1P with the method of Gawronski and Benson156. One unit of CDP 
activity corresponds to the release of 1 μmol phosphate per minute from 50 mM αG1P 
and 50 mM acceptor in a 50 mM MES buffer at pH 6.5 and 37 °C. Protein concentrations 
were measured with the BCA Protein Assay kit (Pierce), using bovine serum albumin as 
standard. All assays were performed in triplicate and had a CV of less than 10 %. All 
reported errors correspond to the standard errors. 
5.6 Analytical methods 
The formation of glucosides was assessed by TLC, HPLC or HPAEC-PAD analysis. 
Separation and detection were achieved on Merck Silica gel 60 F254 precoated plates. 
Unless stated otherwise, the eluens was a mixture of ACN/H2O = 85:15, and spots were 
visualized by UV detection at 254 nm, or charring with 10 % (v/v) H2SO4. Alternatively, 
the concentration of glycosides was determined by HPLC analysis. Adequate separation 
and detection was achieved using an X-bridge amide column (250 mm × 4.6 mm, 3.5 µm, 
Waters, USA) coupled with an Alltech 2000ES evaporative light scattering detector, as 
described in CHAPTER 4. The separation of carbohydrates was achieved by high 
performance anion exchange chromatography (HPAEC), while detection was performed 
with a pulsed amperometric detector (PAD). To that end, a CarboPack PA20 column 
installed on a Dionex ICS-5000 IC system was used. Elution was performed with a 
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gradient of eluent A (MilliQ), B (100 mM NaOH) and C (100 mM NaOH and 1 M NaOAc), 
as described in Table S7.2. All calibration curves were prepared with authentic samples.  
5.7 Production and purification of glycosides 
Glycosylation of a range of acceptor molecules (α-arbutin, arbutin, esculin, maltose, octyl 
β-D-glucopyranoside, p-nitrophenyl 1-O-α-D-glucopyranoside, p-nitrophenyl 1-O-β-D-
glucopyranoside, polydatin, and salicin) was performed at 50 mL scale in falcons. To that 
end, 100 mM αG1P, 100 mM acceptor and 1 mg/mL CDP were added to a 50 mM MES 
buffer at pH 6.5. The reaction mixtures were incubated at 37 °C and 200 rpm. After 48 h, 
the reaction mixtures were heated (10 min, 95 °C) and centrifuged (10 000 g, 4 °C, 
20 min) to remove debris. The samples were then evaporated in vacuo and the residue 
was purified by column chromatography (silicagel, ACN/H2O = 85:15).  
5.8 Structure elucidation of glycosides  
NMR spectra were measured on a Bruker AVANCE III 700 MHz spectrometer 
(700.13 MHz for 1H and 176.05 MHz for 13C) in CD3OD at 25 °C. Residual signals of 
solvent were used as an internal standard (H 3.330 ppm, C 49.3 ppm). 1H NMR, 13C 
NMR, COSY, HSQC, and HMBC spectra were measured using standard manufacturers’ 
software (Topspin 3.2, Bruker BioSpin GmbH, Rheinstetten, DE). Chemical shifts are 
given in -scale [ppm], and coupling constants in Hz. Digital resolution enabled us to 
report chemical shifts of protons to three and coupling constants to one and carbon 
chemical shifts to two decimal places. Some hydrogen chemical shifts were read out 
from HSQC and are reported to two decimal places. The proton spin systems were 
assigned by COSY, and then the assignment was transferred to carbons by HSQC. HMBC 
experiments enabled to assign quaternary carbons and join individual spin systems 
together. Spectral analysis and interpretation was kindly performed by the group of 
Prof. Vladimír Křen at the Institute of Microbiology (Czech Republic). 
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6-O-β-D-Cellobiopyranosyl esculetin 
1H NMR (CD3OD):  3.268 (1H, dd, J = 9.1, 
7.9 Hz, H-2b), 3.335 (1H, dd, J = 9.5, 8.9 Hz, 
H-4b), 3.386 (1H, ddd, J = 9.5, 5.8, 2.3 Hz, 
H-5b), 3.402 (1H, dd, J = 9.1, 8.9 Hz, H-3b), 
3.611 (1H, dd, J = 9.0, 7.7 Hz, H-2a), 3.637 
(1H, ddd, J = 9.5, 4.3, 2.4 Hz, H-5a), 3.670 
(1H, dd, J = 9.0, 8.4 Hz, H-3a), 3.796 (1H, dd, J = 11.8, 5.8 Hz, H-6b). 3.706 (1H, dd, J = 9.5, 8.4 Hz, 
H-4a), 3.919 (1H, dd, J = 11.8, 2.3 Hz, H-6b), 3.929 (1H, dd, J = 12.2, 4.3 Hz, H-6a), 3.991 (1H, dd, J 
= 12.2, 2.4 Hz, H-6a), 4.466 (1H, d, J = 7.9 Hz, H-1b), 4.907 (1H, d, J = 7.7 Hz, H-1a), 6.225 (1H, d, J 
= 9.4, H-3’), 6.820 (1H, s, H-8’), 7.423 (1H, s, H-5’), 7.859 (1H, d, J = 9.4 Hz, H-4’) 
13C NMR (CD3OD): 61.96 (C-6a), 62.74 (C-6b), 71.69 (C-4b), 74.87 (C-2a), 75.23 (C-2b), 76.24 
(C-3a), 77.26 (C-5a), 78.19 (C-3b), 78.46 (C-5b), 80.53 (C-4a), 104.34 (C-1a), 104.92 (C-1b), 
105.11 (C-8’), 112.33a (C-3’), 116.68 (C-5’), 112.28a (C-10’), 145.40 (C-6’), 146.46 (C-4’), 153.36 
(C-9’), 155.8 (C-7’), 164.35 (C-2’), amight be interchanged 
 
Salicyl 1-O-β-D-cellobiopyranoside 
1H NMR (CD3OD):  3.059 (1H, dd, J = 9.4, 8.0 
Hz, H-2b), 3.153 (1H, dd, J = 9.8, 9.1 Hz, H-4b), 
3.23 (1H, m H-5b), 3.243 (1H, dd, J = 9.4, 9.1 
Hz, H-3b), 3.413 (1H, m, H-2a), 3.47 (1H, m, 
H-6b), 3.48 (1H, m, H-3a), 3.49 (1H, m, H-4a), 
3.49 (1H, m, H-5a), 3.577 (1H, dd, J = 12.3, 2.3 
Hz, H-6a), 3.657 (1H, dd, J = 12.3, 2.4 Hz, H-6b), 3.712 (1H, d, J = 12.3 Hz, H-6a), 4.271 (1H, d, J = 
8.0 Hz, H-1b), 4.423 (1H, d, J = 12.6 Hz, H-2’’), 4.461 (1H, d, J = 12.6 Gz, H-2’’), 4.888 (1H, d, J = 7.8 
Hz, H-1a), 6.886 (1H, dd, J = 7.5, 7.5 Hz, H-4’), 6.946 (1H, d, J = 8.2 Hz, H-6’), 7.113 (1H, dd, J = 8.2, 
7.5 Hz, H-5’), 7.144 (1H, d, J = 7.5 Hz, H-3’)  
13C NMR (CD3OD): 59.46 (C-2’’), 60.05 (C-6a), 60.81 (C-6b), 69.70 (C-4b), 72.98 (C-2a), 73.40 
(C-2b), 74.40 (C-3a), 75.17 (C-5a), 75.73 (C-3b), 76.24 (C-5b), 78.52 (C-4a), 100.53 (C-1a), 
102.81 (C-1b), 115.53 (C-6’), 123.63 (C-4’), 129.65 (C-2’), 129.93a (C-3’), 129.94a (C-5’), 154.76 
(C-1’), amight be interchanged 
 
Salicyl 1-O-β-D-cellotriopyranoside 
1H NMR (CD3OD):  3.044 (1H, 
dd, J = 9.4, 7.9 Hz, H-2c), 3.106 
(1H, dd, J = 9.0, 7.9 Hz, H-2b), 
3.144 (1H, dd, J = 9.1, 9.8 Hz, H-
4c), 3.21 (1H, m, H-5c), 3.644 
(1H, dd, H-6c), 3.236 (1H, dd, J = 
9.4, 9.1 Hz, H-3c), 3.36 (1H, m, H-5b), 3.39 (1H, m, H-3b), 3.40 (1H, m, H-4b), 3.416 (1H, m, H-2a), 
3.463 (1H, dd, J = 12.6, 5.8 Hz, H-6c), 3.49 (1H, m, H-3a), 3.50 (1H, m, H-4a), 3.50 (1H, m, H-5a), 
3.570 (1H, dd, H-6b), 3.583 (1H, dd, H-6a), 3.714 (1H, d, H-6a), 3.725 (1H, d, H-6b), 4.241 (1H, d, 
J = 7.9 Hz, H-1c), 4.297 (1H, d, J = 7.9 Hz, H-1b), 4.425 (1H, d, J = 12.6 Hz, H-2’’), 4.463 (1H, d, J = 
12.6 Hz, H-2’’), 4.890 (1H, d, J = 7.8 Hz, H-1a,), 6.894 (1H, dd, J = 7.5, 7.5 Hz, H-4’), 6.948 (1H, d, J 
= 8.2 Hz, H-6’), 7.115 (1H, dd, J = 8.2, 7.5 Hz, H-5’), 7.146 (1H, d, J = 7.5 Hz, H-3’) 
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13C NMR (CD3OD): 59.46 (C-2’’), 60.01 (C-6a), 60.14 (C-6b), 60.81 (C-6c), 69.69 (C-4c), 72.99 
(C-2a), 73.19 (C-2b), 73.39 (C-2c), 74.29 (C-3b), 74.36 (C-3a), 75.08 (C-5b), 75.18 (C-5a), 75.72 
(C-3c), 76.22 (C-5c), 78.63 (C-4b), 78.40 (C-4a), 100.55 (C-1a), 102.59 (C-1b), 102.81 (C-1c), 
115.54 (C-6’), 123.63 (C-4’), 129.66 (C-2’), 129.93a (C-3’), 129.94a (C-5’), 154.76 (C-1’), amight be 
interchanged 
 
para-Nitrophenyl 1-O-β-D-cellobiopyranoside 
1H NMR (CD3OD):  3.277 (1H, dd, J = 9.2, 7.9 
Hz, H-2b), 3.339 (1H, dd, J = 9.5, 8.8 Hz, H-
4b), 3.386 (1H, ddd, J = 9.5, 5.8, 2.2 Hz, H-
5b), 3.406 (1H, dd, J = 9.2, 8.8 Hz, H-3b), 
3.594 (1H, dd, J = 8.8, 7.7 Hz, H-2a), 3.68 
(1H, m, H-3a), 3.70 (1H, m, H-5a), 3.70 (1H, 
m, H-6b), 3.72 (1H, m, H-4a), 3.924 (1H, dd, J = 12.3, 3.6 Hz, H-6a), 3.919 (1H, dd, J = 11.9, 2.2 Hz, 
H-6b), 3.957 (1H, dd, J = 12.3, 2.1 Hz, H-6a), 4.473 (1H, d, J = 7.9 Hz, H-1b), 5.139 (1H, d, J = 7.7 
Hz, H-1a), 7.257 (2H, m, ΣJ = 9.3 Hz, H-ortho), 8.240 (2H, m, ΣJ = 9.3 Hz, H-meta) 
13C NMR (CD3OD): 61.81 (C-2a,), 62.75 (C-6a), 71.68 (C-4b), 74.74 (C-2a), 75.21 (C-2b), 76.50 
(C-3a), 77.16 (C-5a), 78.18 (C-3b), 78.44 (C-5b), 80.29 (C-4a), 101.64 (C-1a), 104.87 (C-1b), 
118.10 (C-ortho), 126.92 (C-meta), 144.23 (C-para), 164.08 (C-ipso) 
 
para-Nitrophenyl 1-O-β-D-cellotriopyranoside 
1H NMR (CD3OD):  3.25 (1H, m, 
H-2c), 3.34 (1H, m, H-4c), 3.35 
(1H, m, H-2b), 3.36 (1H, m, H-5c), 
3.39 (1H, m, H-3c), 3.52 (1H, m, 
H-5b), 3.57 (1H, m, H-3b), 3.59 
(1H, m, H-2a), 3.63 (1H, m, H-4b), 
3.69 (1H, m, H-3a), 3.69 (1H, m, H-6c), 3.70 (1H, m, H-5a), 3.72 (1H, m, H-4a), 3.91 (1H, m, H-6b), 
3.91a (1H, m, H-6c), 3.95 (1H, m, H-6a), 3.95a (1H, m, H-6a), 3.95 (1H, m H-6b), 4.429 (1H, d, J = 
7.4 Hz, H-1c), 4.513 (1H, d, J = 7.7 Hz, H-1b), 5.143 (1H, d, J = 7.3 Hz, H-1a), 7.26 (2H, m, H-ortho), 
8.25 (2H, m, H-meta) 
13C NMR (CD3OD): 61.71a (C-6b), 61.81a (C-6a), 62.75 (C-6c), 71.68 (C-4c), 74.76 (C-2a), 74.93 
(C-2b), 75.21 (C-2c), 76.45 (C-3a), 76.51 (C-3b), 76.99 (C-5b), 77.15 (C-5a), 78.16 (C-3c), 78.44 
(C-5c), 80.10 (C-4a), 80.48 (C-4b), 101.67 (C-1a), 104.63 (C-1b), 104.93 (C-1c), 118.01 (C-ortho), 
126.92 (C-meta), 144.26 (C-para), 164.09 (C-ipso), amight be interchanged 
 
para-Nitrophenyl 1-O-α-D-cellobiopyranoside 
1H NMR (CD3OD):  3.255 (1H, dd, J = 9.0, 7.9 Hz, H-
2b,), 3.336 (1H, dd, J = 9.5, 8.8 Hz, H-4b), 3.381 (1H, 
ddd, J = 9.5, 5.7, 2.2 Hz, H-5b), 3.394 (1H, dd, J = 9.0, 8.8 
Hz, H-3b), 3.70a (1H, m, H-6a), 3.71 (1H, m, H-4a), 3.71 
(1H, m, H-5a), 3.72 (1H, m, H-2a), 3.751 (1H, dd, J = 
12.2, 1.9 Hz, H-6a), 3.890 (1H, dd, J = 12.2, 3.2 Hz, H-
6a), 3.918 (1H, dd, J = 11.8, 2.2 Hz, H-6a), 4.004 (1H, m, ΣJ = 18.1 Hz, H-3a), 4.448 (1H, d, J = 7.9 
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Hz, H-1b), 5.691 (1H, d, J = 3.7 Hz, H-1a), 7.338 (2H, m, ΣJ = 9.3 Hz, H-ortho), 8.248 (2H, m, ΣJ = 
9.3 Hz, H-meta) 
13C NMR (CD3OD):  61.67 (C-6a), 62.75 (C-6b), 71.67 (C-4b), 73.05 (C-2a), 73.51 (C-3a), 73.80 
(C-5a), 75.22 (C-2b), 78.15 (C-3b), 78.44 (C-5b), 80.55 (C-4a), 99.11 (C-1a), 104.93 (C-1b), 
118.19 (C-ortho), 126.95 (C-meta), 144.23 (C-para), 163.67 (C-ipso) 
 
para-Nitrophenyl 1-O-α-D-cellotriopyranoside 
1H NMR (CD3OD):  3.252 (1H, dd, J = 9.2, 
7.9 Hz, H-2c), 3.328 (1H, dd, J = 9.2, 7.9 
Hz, H-2b), 3.325 (1H, dd, J = 9.6, 8.8 Hz, 
H-4c), 3.374 (1H, m, H-5c), 3.396 (1H, dd, 
J = 9.2, 8.8 Hz, H-3c), 3.521 (1H, ddd, J = 
9.6, 4.2, 2.5 Hz, H-5b), 3.560 (1H, dd, J = 
9.2, 8.8 Hz, H-3b), 3.627 (1H, dd, J = 9.6, 
8.8 Hz, H-4b), 3.685 (1H, dd, J = 11.9, 5.8 Hz, H-6c), 3.71 (1H, m, H-5a), 3.72 (1H, m, H-2a), 3.72 
(1H, m, H-4a,), 3.75 (1H, m, H-6a), 3.90 (1H, m, H-6a), 3.90 (1H, m, H-6b), 3.91 (1H, m, H-6c), 
3.952 (1H, dd, J = 12.1, 2.5 Hz, H-6b), 4.011 (1H, dd, J = 9.8, 8.1 Hz, H-3a), 4.431 (1H, d, J = 7.9 Hz, 
H-1c), 4.493 (1H, d, J = 7.9 Hz, H-1b), 5.699 (1H, d, J = 3.7 Hz, H-1a), 7.340 (2H, m, ΣJ = 9.3 Hz, H-
ortho), 8.251 (2H, m, ΣJ = 9.3 Hz, H-meta) 
13C NMR (CD3OD):  61.56 (C-6a), 61.77 (C-6b), 62.71 (C-6c), 71.66 (C-4c), 73.05 (C-2a), 73.43 
(C-3a), 73.79 (C-5a), 74.91 (C-2b), 75.18 (C-2c), 76.41 (C-3b), 76.96 (C-5b), 78.12 (C-3c), 78.42 
(C-5c), 80.33 (C-4a), 80.45 (C-4b), 99.09 (C-1a), 104.65 (C-1b), 104.90 (C-1c), 118.20 (C-ortho), 
126.96 (C-meta), 144.23 (C-para), 163.65 (C-ipso) 
 
Octyl β-D-cellotriopyranoside 
1H NMR (CD3OD):  0.922  
(3H, t, J = 7.1 Hz, H-8’), 
1.31 (2H, m, H-6’), 1.33 
(2H, m, H-5’), 1.33 (2H, m, 
H-7’), 1.34 (2H, m, H-4’), 
1.404 (2H, m, H-3’), 1.641 (2H, m, H-2’), 3.243 (1H, dd, J = 9.2, 7.9 Hz, H-2a), 3.253 (1H, dd, J = 
9.2, 7.8 Hz, H-2c), 3.311 (1H, dd, J = 9.2, 7.9 Hz, H-2b), 3.321 (1H, dd, J = 9.7, 8.7 Hz, H-4a), 3.361 
(1H, ddd, J = 9.7, 5.8, 2.3 Hz, H-5a), 3.385 (1H, dd, J = 9.2, 8.7 Hz, H-3a), 3.407 (1H, ddd, J = 9.6, 
3.7, 2.8 Hz, H-5c), 3.498 (1H, ddd, J = 9.6, 4.2, 2.4 Hz, H-5b), 3.530 (1H, dd, J = 9.2, 8.8 Hz, H-3c), 
3.550 (1H, dd, J = 9.2, 8.9 Hz, H-3b), 3.594 (1H, dd, J = 9.6, 8.8 Hz), 3.56 (1H, m, H-1’), 3.612 (1H, 
dd, J = 9.6, 8.9 Hz, H-4b), 3.681 (1H, dd, J = 11.9, 5.8 Hz, H-6a), 3.882 (1H, dd, J = 12.1, 4.2 Hz, H-
6b), 3.896 (2H, m, H-6c), 3.898 (1H, m, H-6a), 3.90 (1H, m, H-1’), 3.926 (1H, dd, J = 12.1, 2.4 Hz, 
H-6b), 4.299 (1H, d, J = 7.8 Hz, H-1c), 4.420 (1H, d, J = 7.9 Hz, H-1a), 4.473 (1H, d, J = 7.9 Hz, H-
1b) 
13C NMR (CD3OD):  14.72 (C-8’), 24.02 (C-7’), 27.42 (C-3’), 30.72a (C-5’), 30.88a (C-4’), 31.09 (C-
2’), 33.31 (C-6’), 62.08 (C-6b), 62.73 (C-6a), 71.27 (C-1’), 71.66 (C-4a), 74.94 (C-2b), 75.15 (C-
2c), 75.20 (C-2a), 76.49 (C-3b), 76.72 (C-3c), 76.72 (C-5c), 76.95 (C-5b), 78.14 (C-3a), 78.43 (C-
5a), 80.46 (C-4b), 80.87 (C-4c), 61.78 (C-6c), 104.53 (C-1c), 104.66 (C-1b), 104.91 (C-1a), amight 
be interchanged 
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Octyl β-D-cellotetrapyranoside 
 
1H NMR (CD3OD):  0.589 (3H, m, H-8’), 1.00 (2H, m, H-6’), 1.00 (2H, m, H-7’), 1.03 (2H, m, H-4’), 
1.03 (2H, m, H-5’), 1.082 (2H, m, H-3’), 1.351 (2H, m, H-2’), 3.024 (1H, dd, J = 9.0, 8.0 Hz, H-2d), 
3.042 (1H, dd, J = 9.3, 7.9 Hz, H-2a), 3.086 (1H, dd, J = 9.3, 7.9 Hz, H-2b), 3.086 (1H, dd, J = 9.3, 7.9 
Hz, H-2c), 3.144 (1H, dd, J = 9.3, 9.2 Hz, H-4a), 3.214 (1H, m, H-5a), 3.234 (1H, dd, J = 9.3, 9.2 Hz, 
H-3a), 3.307 (1H, m, H-5d), 3.349 (1H, m, H-5b), 3.349 (1H, m, H-5c), 3.356 (1H, m, H-3d), 3.356 
(1H, m, H-4d), 3.397 (1H, m, H-3b), 3.397 (1H, m, H-4b), 3.397 (1H, m, H-3c), 3.397 (1H, m, H-
4c), 3.40 (1H, m, H-1’), 3.463 (1H, m, H-6a), 3.555 (1H, m, H-6b), 3.555 (1H, m, H-6c), 3.64 (1H, 
m, H-1’), 3.643 (1H, m, H-6a), 3.704 (1H, m, H-6d), 3.707 (1H, m, H-6b), 3.707 (1H, m, H-6c), 
3.896 (1H, m, H-6d), 4.201 (1H, d, J = 8.0 Hz, H-1d), 4.236 (1H, d, J = 7.9 Hz, H-1a), 4.261 (1H, d, J 
= 7.9 Hz, H-1b), 4.261 (1H, d, J = 7.9 Hz, H-1c) 
13C NMR (CD3OD):  13.64 (C-8’), 22.25 (C-7’), 25.27 (C-3’), 28.61a (C-5’), 28.68a (C-4’), 28.96 (C-
2’), 31.33 (C-6’), 60.08 (C-6c), 60.13 (C-6b), 60.26 (C-6d), 60.80 (C-6a), 69.69 (C-4a), 71.04 (C-
1’), 73.16 (C-2d), 73.18 (C-2c), 73.19 (C-2b), 73.38 (C-2a), 74.25 (C-3c), 74.27 (C-3b), 74.59 (C-
3d), 74.99 (C-5d), 75.06 (C-5c), 75.06 (C-5b), 75.72 (C-3a), 76.22 (C-5a), 78.48 (C-4c), 78.61 (C-
4b), 78.79 (C-4d), 102.26 (C-1d), 102.58 (C-1c), 102.59 (C-1b), 102.80 (C-1a), amight be 
interchanged 
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6 SUPPLEMENTARY INFORMATION 
Table S7.1 Glycosylation potential of the CDP from C. stercorarium towards aglycons. TLC analysis was 
performed after 24 h incubation at 37 °C. 
Acceptor Product spot  Acceptor Product spot  
Pentanola - Cinnamyl alcohola - 
Hexanola - Mentholb - 
Heptanola - Saligeninb - 
Octanola - p-Nitrophenolb - 
Nonanola - Phenolb  - 
Decanola - Hydroquinoneb - 
Dodecanola - Catecholb - 
Cyclohexanola - Resorcinolb - 
2-Hexanola - Pyrogallol b - 
Linaloola - Gallic acid methyl esterb - 
Eugenola - Gallic acid ethyl esterb - 
Nerolidola - Gallic acid propyl esterb - 
β-Citronellola  - Gallic acid lauryl esterb - 
Geraniola - Salicylic acid methyl estera - 
2-Phenylethanola - Curcuminb - 
1R-Phenylethanola - Resveratrolb - 
1S-Phenylethanola - Quercetinb  - 
Benzyl alcohola - Vanillinb - 
Anisyl alcohola - Vanillyl alcoholb - 
a Glycosylation was performed in a 50 mM MES buffer at pH 6.5 in the presence of 100 mM αG1P, 20 % 
acceptor and 1 mg/mL CsCDP. b Glycosylation was performed in a 50 mM MES buffer at pH 6.5 containing 
20 % IL AMMOENG 101, in the presence of 100 mM αG1P, 100 mM acceptor and 1 mg/mL CsCDP. 
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Table S7.2 HPAEC-PAD elution was performed with a gradient of eluent A (MilliQ), B (100 mM NaOH) and 
C (100 mM NaOH and 1 M NaOAc) at a flow rate of 0.5 mL/min. 
Time (min) A (%) B (%) C (%) 
0 80 20 0 
4 80 20 0 
8 0 100 0 
10 0 100 0 
45 15 85 15 
46 80 20 0 
55 80 20 0 
 
Figure S7.1 Separation of aliphatic glycosides with an Acetonitrile/H2O = 85:15 mixture. Analysis was 
performed after reacting a 50 mM MES buffer at pH 6.5 containing 100 mM αG1P, 100 mM octyl β-D-
glucopyranoside and 1 mg/mL CsCDP during 24 h at 37 °C. 
  
 
Figure S7.2 Glycosylation of various acceptors. TLC analysis was performed after 24 h of incubation at 
37 °C. The reaction mixtures consisted of a 50 mM MES buffer at pH 6.5 supplemented with 100 mM αG1P, 
1 mg/mL CDP and 100 mM of the following acceptors: arbutin (1), α-arbutin (2), salicin (3), methylgallyl 
4-O-α-D-glucoside (4), octyl β-D-glucopyranoside (5) and octyl α-D-glucopyranoside (6). Lanes with 
* represent blank reactions, i.e. no addition of CsCDP. 
 1     1*     2    2*   3     3*    4     4*   5     5*  6    6* 
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Figure S7.3 HPAEC-PAD analysis of [1] the glycosylation of maltose after 48 h of incubation at 37 °C. 
100 mM αG1P and 100 mM maltose were reacted in a 50 mM MES buffer (pH 6.5), supplemented with 
1 mg/mL CDP: maltose (18.9 min), unidentified peak (24.1 min), maltotriose trace (24.9 min), 
unidentified peak (28.0 min), G1P (35.2 min). [2] Blank reaction: maltose (18.9 min), maltotriose trace 
(24.9 min), αG1P (35.2 min). [3] Standard glucose (7.0 min). [4] Standard maltotriose (24.9 min). 
 
 
Figure S7.4 Structure confirmation of maltosyl β-(1,4)-D-glucopyranoside. Lane 1: glucose, Lane 2: 
maltose, Lane 3: maltotriose, Lane 4: purified product, no addition of β-glucosidase, Lane 5: purified 
product, incubated for 1 h with 5 U/mL β-glucosidase. TLC analysis was performed using three ascents of 
eluent Acetonitrile/H2O = 85:15. 
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1 ABSTRACT 
Although numerous biologically active molecules exist as glycosides in nature, 
information on the activity, stability and solubility of glycosylated antioxidants is rather 
limited to date. In this chapter, a wide variety of antioxidants were glycosylated using 
different phosphorylase enzymes. The resulting antioxidant library, containing α/β-
glucosides, different regio-isomers, cellobiosides and cellotriosides was then 
characterized. Glycosylation was found to substantially increase the solubility and 
stability of all evaluated compounds. Despite decreased radical scavenging abilities, 
most glycosides were identified to be potent antioxidants, outperforming the commonly 
used 2,6-bis(1,1-dimethylethyl)-4-methylphenol (BHT). Moreover, the point of 
attachment, the anomeric configuration, and the glycosidic chain length were found to 
influence the properties of these phenolic glycosides. 
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2 INTRODUCTION 
Oxidation of fats and proteins quickly leads to deterioration of food through the 
undesirable formation of aldehydes, ketones and organic acids. To preserve the 
organoleptic properties of foodstuff, antioxidants are frequently applied207-210. 
Moreover, these compounds are common constituents of functional foods due to their 
putative health benefits211-213. Although diverse natural and synthetic antioxidants 
including the monophenolics ethyl and propyl gallate, flavonoids such as catechin and 
quercetin, and stilbenoids like resveratrol are available, the quest for antioxidants with 
altered properties continues to date214, 215. Indeed, antioxidants should be inexpensive, 
effective at low concentrations, stable enough to survive processing and storage in the 
finished product, while avoiding undesirable color, flavor or odor effects211, 216. 
 
In that respect, many chemical modifications of both natural and synthetic antioxidants 
have been explored. Examples include the methylation of flavonoids217, the synthesis of 
lipophilic tyrosyl esters218, and the glycosylation of hydroxytyrosol219 and flavanoids220. 
The latter modification is of particular interest to increase the hydrophilicity of 
antioxidants9. Moreover, glycosylation is also known to improve the solubility of 
flavonoids in aqueous systems221, enhance the stability of labile compounds95, 222,  and 
modulate the uptake of for example quercetin in the small intestine223.  
 
Unfortunately, chemical synthesis of these glycosides often requires numerous 
(de)protection and activation steps, resulting in low yields and (toxic) waste13, 15. In 
contrast, biocatalytic approaches enable one-step conversions with high regio- and 
stereoselectivity, typically generating 5-fold less waste19. Enzymatic synthesis of 
glycosides is typically performed with either glycosyltransferases or glycoside 
hydrolases. However, the former require relatively expensive nucleotide-activated 
donor substrates97, while the latter suffer from low yields (~20%) when used in the 
synthetic direction27. 
 
Consequently, glycoside phosphorylases have gained increasing attention over the past 
decade, as they use a simple glycosyl phosphate as donor with relatively good yields 
(>50%)29. Continuous endeavors in this field enabled the α-glucosylation of for example 
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hydroquinone125, glycerol (CHAPTER 2), resveratrol (CHAPTER 3) and propyl gallate 
(CHAPTER 4) by sucrose phosphorylase (SP), and chain elongation of glucosides using 
cellodextrin phosphorylase (CDP) (CHAPTER 7). Moreover, also β-glucosylation has been 
described with cellobiose phosphorylase (CP) (CHAPTER 5), while the R134A mutant of 
Thermoanaerobacterium thermosaccharolyticum SP (TtSPP) was found to be an even 
more efficient biocatalyst for the α-glycosylation of polyphenols224. 
 
In this chapter, the synthesis and characterization of a range of α-glucosides using either 
TtSPP_R134A or the SP from Bifidobacterium adolescentis (BaSP) is described. Also, the 
CDP originating from Clostridium stercocarium (CsCDP) was applied to produce a range 
of cellobiosylated and cellotriosylated antioxidants. The solubility, thermal stability, and 
antioxidant properties of the newly created compounds were determined and 
compared.  
3 RESULTS & DISCUSSION 
3.1 Synthesis and isolation of glycosylated antioxidants 
Over the past decade, phosphorylase enzymes have been successfully applied for the 
synthesis of both α- and β-glucosides (CHAPTER 2, 3, 4, 5 and 7). Recently, the synthetic 
potential of these enzymes was broadened towards polyphenols224. Here, the SP from B. 
adolescentis (BaSP), the R134A mutant of the T. thermosaccharolyticum SP 
(TtSPP_R134A) and the CP from C. thermocellum (CtCP) were used to synthesize a 
variety of glucosylated antioxidants (Table 8.1).  
 
Combining these enzymes allowed the creation of an antioxidant library with an 
extended structural diversity. Indeed, numerous aglycons ranging from simple phenols 
such as hydroquinone and pyrogallol, a series of gallate esters, and even polyphenols 
such as resveratrol, quercetin and catechin were successfully glucosylated. Moreover, 
different regio-isomers such as for example alkyl gallyl 3- and 4-O-α-D-
glucopyranosides, 1- and 2-O-α-D-glucopyranosyl pyrogallol and 3  - and 4  -O-α-D-
glucopyranosyl quercetin were isolated (Table 8.1).  
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Table 8.1 Chemoenzymatic synthesis of glucosylated antioxidants.  
Acceptor Enzyme Product Abbreviationd 
Isolated 
yield (%) 
Hydroquinone BaSPa 
OH
O
O
OH
OH
OH
OH
 
HQαGlc 0.7 
 CtCPb 
OH
O
O
OH
OH
OH
OH
 
HQβGlc 1.6 
Pyrogallol TtSPP_R134Ac 
OH
OH
O
O
OH
OH
OH
OH
 
Pyr1αGlc 2.5 
 BaSPa 
OH
OH
O
O
OH
OH
OH
OH
 
Pyr2αGlc 72.3 
Methyl gallate  TtSPP_R134Ac 
OH
OH
O
O
OH
OH
OH
OH
O
O
 
MG3αGlc 35.3 
 BaSPa 
O
O
OH
OH
O
O
OH
OH
OH
OH
 
MG4αGlc 38.6 
Ethyl gallate TtSPP_R134Ac 
OH
OH
O
O
OH
OH
OH
OH
O
O
 
EG3αGlc 23.6 
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 BaSPa 
O
O
OH
OH
O
O
OH
OH
OH
OH
 
EG4αGlc 23.8 
Propyl gallate TtSPP_R134Ac 
OH
OH
O
O
OH
OH
OH
OH
O
O
 
PG3αGlc 26.7 
 BaSPa O
O
OH
OH
O
O
OH
OH
OH
OH
 
PG4αGlc 12.3 
Lauryl gallate TtSPP_R134Ac 
OH
OH
O
O
OH
OH
OH
OH
O
O
10
 
LG3αGlc 12.2 
 TtSPP_R134Ac 
O
O
OH
OH
O
O
OH
OH
OH
OH
10  
LG4αGlc 4.1 
Resveratrol TtSPP_R134Ac O
OH
OHO
OH
OH
OH
OH
 
Res3αGlc 82.6 
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Quercetin TtSPP_R134Ac 
O
OH
O
OH
OH
OH
O
O
OH
OH
OH
OH
 
Qer3  αGlc 3.6 
 TtSPP_R134Ac 
OH
O
OH
O
OH
OH
O
O
OH
OH
OH
OH
 
Qer4  αGlc 7.0 
Catechin TtSPP_R134Ac 
O
OH
O
OH
OH
OH
O
OH
OH
OH
OH
 
Cat3  αGlc 31.4 
Epicatechin TtSPP_R134Ac 
O
OH
O
OH
OH
OH
O
OH
OH
OH
OH
 
Epi3  αGlc 58.1 
a Reaction conditions: 62.5 % 50 mM MOPS buffer at pH 7.5 containing 2 M (68 g/L) sucrose and 50 U/mL 
BaSP, 37.5 % EtOAc supplemented with 100 g/L acceptor, 48 h incubation at 50 °C. b Reaction conditions: 
62.5 % 50 mM MES buffer at pH 6.5 containing 200 mM αG1P (52 g/L) and 5 U/mL CtCP, 37.5 % EtOAc 
supplemented with 100 g/L acceptor, 48 h incubation at 50 °C. c Reaction conditions: 50 mM MOPS buffer 
at pH 6.5 containing 200 mM sucrose (69 g/L), 10 g/L acceptor and 0.16 U/mL TtSPP_R134A, 24 h 
incubation at 55 °C. d Abbreviations: HQαGlc, 1-O-α-D-glucopyranosyl hydroquinone; HQβGlc, 1-O-β-D-
glucopyranosyl hydroquinone; Pyr1αGlc, 1-O-α-D-glucopyranosyl pyrogallol; Pyr2αGlc, 2-O-α-D-
glucopyranosyl pyrogallol; MG3αGlc, methyl gallyl 3-O-α-D-glucopyranoside; MG4αGlc, methyl gallyl 4-O-
α-D-glucopyranoside; EG3αGlc, ethyl gallyl 3-O-α-D-glucopyranoside; EG4αGlc, ethyl gallyl 4-O-α-D-
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glucopyranoside; PG3αGlc, propyl gallyl 3-O-α-D-glucopyranoside; PG4αGlc, propyl gallyl 4-O-α-D-
glucopyranoside; LG3αGlc, lauryl gallyl 3-O-α-D-glucopyranoside; LG4αGlc, lauryl gallyl 4-O-α-D-
glucopyranoside; Res3αGlc, 3-O-α-D-glucopyranosyl resveratrol; Qer3  αGlc, 3  -O-α-D-glucopyranosyl 
quercetin; Qer4  αGlc, 4  -O-α-D-glucopyranosyl quercetin; Cat3  αGlc, 3  -O-α-D-glucopyranosyl catechin and 
Epi3  αGlc, 3  -O-α-D-glucopyranosyl epicatechin 
 
The antioxidant panel was further expanded by converting the obtained glucosides to 
their respective cellobiosides and cellotriosides using the CDP from C. stercocarium 
(Table 8.2). Although the CDP mediated glycosylation of saccharides,152 alkyl β-
glucosides,38 nitrophenol β-glucoside39 and phenyl β-cellobioside192 has already been 
described, all of these acceptors contain a β-linked glucose moiety. As previously shown 
in CHAPTER 7, we were also able to elongate a range of α-glucosides, including those of 
hydroquinone, alkyl gallates and resveratrol (Table 8.2). The structures of all reported 
glycosides were confirmed by NMR spectroscopy. 
 
Table 8.2 Cellodextrin phosphorylase mediated synthesis of various antioxidant cellobiosides and 
cellotriosides. The reactions were performed by reacting 100 mM αG1P (26 g/L) with 50 mM acceptor in a 
50 mM MES buffer at pH 6.5 containing 5 U/mL CsCDP and 15 % EtOH. The products were isolated after 
48 h incubation at 37 °C.   
Acceptor Product Abbreviationa 
Isolated 
yield (%) 
HQαGlc 
OH
O
OH
OH
OH
OH
O
O
OH
OH
O
OH
 
HQαCb 16.3 
 
OH
O
OH
OH
O
OH
O
O
OH
OH
O
OHO
OH
OH
OH
OH
 
HQαCt 8.9 
HQβGlc 
OH
O
OH
OH
OH
OH
O
O
OH
OH
O
OH
 
HQβCb 33.8 
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OH
O
OH
OH
O
OH
O
O
OH
OH
O
OHO
OH
OH
OH
OH
 
HQβCt 21.6 
MG4αGlc 
O
OH
OH
OH
OH
O
O
OH
O
OH
O
OH
OH
O
OH
 
MG4αCb 7.1 
 
O
OH
OH
OH
OH
O
OH
OH
O
OH
O
O
OH
O
OH
O
OH
OH
O
OH
 
MG4αCt 1.9 
EG4αGlc 
O
OH
OH
OH
OH
O
O
OH
O
OH
O
OH
OH
O
OH
 
EG4αCb 8.3 
PG4αGlc 
O
OH
OH
OH
OH
O
O
OH
O
OH
O
OH
OH
O
OH
 
PG4αCb 10.5 
 
O
OH
OH
OH
OH
O
OH
OH
O
OH
O
O
OH
O
OH
O
OH
OH
O
OH
 
PG4αCt 2.6 
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Res3αGlc 
O
OH
OH
OH
OH
OH
O
O
OH
OH
O
OH
OH
 
Res3αCb 3.5 
 
O
OH
OH
O
OH
OH
O
O
OH
OH
O
OH
OH
O
OH
OH
OH
OH
 
Res3αCt 3.2 
Res3βGlc 
O
OH
OH
OH
OH
OH
O
O
OH
OH
O
OH OH
 
Res3βCb 9.7 
 
O
OH
OH
O
OH
OH
O
O
OH
OH
O
OH OHO
OH
OH
OH
OH
 
Res3βCt 5.1 
Epi3  αGlc 
O
OH
O
OH
OH
OH
O
OH
OH
O
OHO
OH
OH
OH
OH
 
Epi3  αCb 2.9 
aAbbreviations: HQαCb, 1-O-α-D-cellobiopyranosyl hydroquinone; HQαCt, 1-O-α-D-cellotriopyranosyl 
hydroquinone; HQβCb, 1-O-β-D-cellobiopyranosyl hydroquinone; HQβCt, 1-O-β-D-cellotriopyranosyl 
hydroquinone; MG4αCb, methyl gallyl 4-O-α-D-cellobiopyranoside; MG4αCt, methyl gallyl 4-O-α-D-
cellotriopyranoside; EG4αCb, ethyl gallyl 4-O-α-D-cellobiopyranoside; PG4αCb, propyl gallyl 4-O-α-D-
cellobiopyranoside; PG4αCt, propyl gallyl 4-O-α-D-cellotriopyranoside; Res3αCb, 3-O-α-D-
cellobiopyranosyl resveratrol; Res3αCt, 3-O-α-D-cellotriopyranosyl resveratrol; Res3βCb, 3-O-β-D-
cellobiopyranosyl resveratrol; Res3βCt, 3-O-β-D-cellotriopyranosyl resveratrol; Epi3  αCb, 3  -O-α-D-
cellobiopyranosyl epicatechin 
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3.2 Solubility of glycosylated antioxidants 
Next, the effect of glycosylation on the solubility of a variety of hydrophobic antioxidants 
was evaluated (Table 8.3). As could be expected, coupling a glucose moiety to these 
compounds increased their tendency to dissolve in aqueous solutions222. Indeed, while 
the solubility of epicatechin and catechin was limited to roughly 25 and 55 mM at pH 7.0, 
the corresponding 3  -α-glucosides could be dissolved to 326 mM and an impressive 
1.1 M, respectively. Also the solubility of lauryl gallate, quercetin and resveratrol could 
be substantially increased by glucosylation (Table 8.3). 
 
Table 8.3 Solubility of glycosylated antioxidants at 37 °C in a 10 mM phosphate buffer at pH 7.0.  
Compounda Solubility (mM) Compounda Solubility (mM) 
Catechin 54.7 ± 3.8 Qer3  αGlc 0.69 ± 0.04 
Cat3  αGlc 1104 ± 72 Qer4  αGlc 3.98 ± 0.26 
Epicatechin 24.8 ± 1.9 Resveratrol 0.35 ± 0.02 
Epi3  αGlc 326 ± 21 Res3αGlc 7.56 ± 0.52 
Epi3  αCb 51.4 ± 3.1 Res3αCb 5.06 ± 0.46 
Lauryl gallate 0.28 ± 0.02 Res3αCt 4.26 ± 0.33 
LG3αGlc 4.56 ± 0.34 Res3βGlc 1.73 ± 0.12 
LG4αGlc 9.68 ± 0.59 Res3βCb 0.82 ± 0.06 
Quercetin 0.19 ± 0.01 Res3βCt 0.53 ± 0.04 
aAbbreviations: see Table 8.1 and 8.2 
 
In agreement with previous studies on quercetin225 and epigallocatechin gallate226, the 
glucosylation position was found to influence the solubility. The 3- and 3  -α-glucosides 
of lauryl gallate and quercetin could be dissolved up to 4.56 and 0.69 mM respectively, 
while the 4- and 4  -α-glucosides exhibited solubilities exceeding 9 and 4 mM. Moreover, 
the 3-α-glucoside of resveratrol was found to be roughly three times more soluble in a 
phosphate buffer at pH 7.0 compared to its β-glucosylated counterpart. In contrast to 
coupling additional glucose moieties directly to the polyphenol structure227, 228, or 
extending the degree of glycosylation by adding α-(1,4)-linked glucose moieties (i.e. the 
synthesis of maltosides)9, additional β-(1,4)-glucosylation was found to decrease 
solubility. Nevertheless, all cellobiosides and cellotriosides could be dissolved to higher 
concentrations than their respective aglycons (Table 8.3). 
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3.3 Antioxidant properties of glycosylated phenolics 
Although glycosylation has been shown to generally increase solubility, the latter 
modification typically decreases the antioxidant capacity222. Therefore, the ability of the 
synthesized glucosides, cellobiosides and cellotriosides to scavenge DPPH and ABTS 
radicals was evaluated (Table 8.4).  
 
Table 8.4 Antioxidant properties of glycosylated phenolics.  
 EC50 (µM)  EC50 (µM) 
Compounda DPPH ABTS Compounda DPPH ABTS 
BHT 1040 ± 89 310 ± 18 PG4αGlc 136 ± 9 96.2 ± 2.3 
Hydroquinone 95.0 ± 7.9 104 ± 2.9 PG4αCb 4439± 357 71.8 ± 2.6 
HQαGlc 1530 ± 126 163 ± 5 PG4αCt / 70.4 ± 2.7 
HQαCb 2390 ± 169 126 ± 5 Lauryl gallate 39.2 ± 2.8 50.4 ± 1.9 
HQαCt 2581 ± 205 75.4 ± 2.2 LG3αGlc 104 ± 6 151 ± 5 
HQβGlc 1190 ± 81 116 ± 4 LG4αGlc 189 ± 12 115 ± 4 
HQβCb 1550 ± 140 111 ± 3 Resveratrol 374 ± 27 69.2 ± 3.2 
HQβCt 2042 ± 162 69.3 ± 1.9 Res3αGlc 592 ± 13 153 ± 4 
Pyrogallol 63.2 ± 2.1 44.2 ± 1.7 Res3αCb 886 ± 65 297 ± 13 
Pyr1αGlc 110 ± 9 117 ± 6 Res3αCt 988 ± 34 351 ± 20 
Pyr2αGlc 888 ± 36 87.1 ± 3 Res3βGlc 398 ± 13 132 ± 8 
Methyl gallate 33.8 ± 2.3 49.6 ± 1.1 Res3βCb 615 ± 19 443 ± 10 
MG3αGlc 102 ± 9 154 ± 8 Res3βCt 663 ± 22 347 ± 9 
MG4αGlc 312 ± 12 97 ± 1.4 Quercetin 75.1 ± 7.4 67.6 ± 3.8 
MG4αCb 5040 ± 496 104 ± 3 Qer3  αGlc 108 ± 9 146 ± 9 
MG4αCt 5623 ± 421 142 ± 6 Qer4  αGlc 83.1 ± 4.4 91.3 ± 3.2 
Ethyl gallate 36.3 ± 1 51.2 ± 2.4 Catechin 111 ± 5 51.0 ± 1.9 
EG3αGlc 100 ± 3 159 ± 5 Cat3  αGlc 487 ± 20 90.3 ± 2.0 
EG4αGlc 241 ± 5 111 ± 3 Epicatechin 77.4 ± 6.1 51.2 ± 1.3 
EG4αCb 4123± 262 111 ± 4 Epi3  αGlc 470 ± 5 89.4 ± 1.6 
Propyl gallate 27.7 ± 1.5 52.0 ± 1.2 Epi3  αCb 490 ± 6 97.8 ± 4.8 
PG3αGlc 100 ± 5 167 ± 3    
aAbbreviations: see Table 8.1 and 8.2 
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As expected, glycosylation was found to typically decrease the scavenging activity. In 
agreement with previous reports229, the glucosylation position strongly in luences the 
antioxidant capacity. Glycosylation of quercetin at the 4  position, for example, reduces 
the scavenging activity to a lower extent compared to the 3  position. Interestingly, alkyl 
gallyl 3-glucosides were found to be better DPPH scavengers than the corresponding 4-
glucosides. The opposite was observed for ABTS radicals, indicating the different 
reactivity of ABTS and DPPH radicals. Also, glucosylation at the 2 position roughly 
doubled the EC50ABTS for pyrogallol, while the required concentration of 2-O-α-D-
glucopyranosyl pyrogallol to scavenge 50 % of the DPPH radicals increased 14-fold. In 
contrast to the results obtained with the ABTS assay, the EC50DPPH of the 1-O-α-D-
glucopyranosyl pyrogallol was found to be much lower, indicating the importance of the 
ortho-diphenolic structure of pyrogallol and alkyl gallate ester glucosides for DPPH 
scavenging.  
 
In agreement with previous reports230, the para-diphenolic structure of hydroquinone 
was found to be required for its DPPH scavenging activity. Indeed, while glucosylation 
barely affected the ability of hydroquinone to scavenge ABTS radicals, the EC50DPPH for α- 
and β-arbutin increased by a factor of 16 and 12, respectively. Interestingly, all evaluated 
β-linked glycosides showed better scavenging compared to their α-linked counterparts. 
Examples include 1-O-α/β-D-glucopyranosyl hydroquinone, 3-O-α/β-D-glucopyranosyl 
resveratrol, as well as their corresponding cellobiosides and cellotriosides (Table 8.4). 
 
In general, extending glycosylation by adding β-(1,4)-linked glucose moieties further 
decreased the scavenging capacity. In contrast to the slightly reduced activity towards 
ABTS radicals, the ability of alkyl gallyl cellobiosides and cellotriosides to eliminate 
DPPH radicals was severely compromised. The latter reduced activity is most likely 
caused by steric hindrance, hampering the applicability of the DPPH assay for large 
compounds231. Remarkably, extending glycosylation was found to increase the ABTS 
scavenging activity of both hydroquinone α- and β-glucoside (Table 8.4). Much to our 
surprise, the EC50ABTS values of 1-O-α/β-D-cellotriosyl hydroquinone were even lower 
than the 104 µM obtained for hydroquinone. 
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3.4 Stability of glycosylated antioxidants 
Despite some work on ascorbic acid95 and quercetin glucosides232, 233, reports describing 
the effect of glycosylation on the stability of antioxidants are rather scarce to date234. 
Therefore, the residual DPPH scavenging activity of a wide variety of glycosylated 
antioxidants after 24 h incubation at 60 °C was determined (Table 8.5).  
 
Table 8.5 Thermal stability of glycosylated antioxidants. The residual DPPH scavenging capacity was 
determined after 24 h incubation at 60 °C and pH 7.  
Compounda Residual activity 
(%) 
Compounda Residual activity 
(%) 
Hydroquinone 82.1 ± 3.6 EG4αGlc 82.3 ± 2.2 
HQαGlc 99.1 ± 2.2 EG4αCb 99.2 ± 1.6 
HQαCb 99.6 ± 3.4 Propyl gallate 69.4 ± 3.5 
HQαCt 100.0 ± 2.6 PG3αGlc 85.7 ± 2.7 
HQβGlc 99.4 ± 2.4 PG4αGlc 81.0 ± 3.2 
HQβCb 99.7 ± 2.8 PG4αCb 99.6 ± 0.8 
HQβCt 99.8 ± 2.1 Resveratrol 74.6 ± 2.7 
Pyrogallol 24.5 ± 1.8 Res3αGlc 99.9 ± 1.6 
Pyr1αGlc 27.9 ± 1.2 Res3αCb 99.6 ± 2.1 
Pyr2αGlc 95.3 ± 3.2 Res3αCt 98.2 ± 3.5 
Methyl gallate 83.6 ± 4.1 Res3βGlc 98.3 ± 2.6 
MG3αGlc 96.7 ± 2.3 Res3βCb 99.5 ± 1.3 
MG4αGlc 77.8 ± 2.1 Res3βCt 99.2 ± 1.7 
MG4αCb 99.8 ± 1.1 Catechin 67.5 ± 3.8 
MG4αCt 99.7 ± 2.1 Cat3  αGlc 95.6 ± 2.4 
Ethyl gallate 71.9 ± 3.4 Epicatechin 64.4 ± 3.1 
EG3αGlc 91.6 ± 2.3 Epi3  αGlc 94.4 ± 2.6 
aAbbreviations: see Table 8.1 and 8.2 
 
Glycosylation was found to substantially increase the stability of all evaluated 
antioxidants. The largest improvement was observed for pyrogallol, which lost over 
75 % of its scavenging capacity after 24 h at 60 °C. In contrast, 2-O-α-D-glucopyranosyl 
pyrogallol retained roughly 95 % of its antioxidant capacity. Remarkably, the 1-O-α-D-
glucopyranosyl pyrogallol retained only 28 % of its original scavenging activity, 
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indicating the importance of the glucosylation position. Indeed, although less 
pronounced, alkyl gallyl 3-glucosides were found to be more stable compared to the 
corresponding 4-glucosides. The anomeric configuration on the other hand, did not 
significantly affect the stability of hydroquinone and resveratrol glucosides, while all 
cellobiosides and cellotriosides remained fully active after 24 h at 60 °C (Table 8.5).    
 
Next, the stability of propyl gallate and its glycosides was studied in more detail (Figure 
8.1). Propyl gallate (E310), a common food additive, lost more than half of its scavenging 
capacity after 4 days incubation at 60 °C. The 3- and 4-glucosides performed much 
better, retaining roughly 80 and 75 % of their initial activity. However, propyl gallyl 4-O-
α-D-cellobiopyranosyl retained all of its scavenging activity, even after 4 days incubation 
at 60 °C. Similar results were observed for hydroquinone and resveratrol cellobiosides, 
indicating the enhanced stability of the latter compounds. 
 
Figure 8.1 Stability of propyl gallate and its glycosides. The residual DPPH scavenging capacity was 
measured after incubation in a 10 mM phosphate buffer at pH 7.0 and 60 °C. Abbreviations: PG, propyl 
gallate; PG3αGlc, propyl gallyl 3-O-α-D-glucopyranoside; PG4αGlc, propyl gallyl 4-O-α-D-glucopyranoside 
and PG4αCb, propyl gallyl 4-O-α-D-cellobiopyranoside. 
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4 CONCLUSION 
In conclusion, a wide variety of glycosylated antioxidants, including α-cellobiosides and 
cellotriosides, were produced. The glucosylation position was found to substantially 
influence the solubility of these compounds, while α-glucosides could be dissolved to 
higher concentrations compared to their β-linked counterparts. Moreover, glycosylation 
improved the stability of all evaluated antioxidants. Also, the point of attachment, the 
anomeric configuration, and the glycosidic chain length were found to influence the 
scavenging abilities of these glycosides. Despite decreased activities, most glycosylated 
compounds were identified as potent antioxidants, exhibiting lower EC50 values than 
BHT. Combined with their increased solubility and enhanced stability, these compounds 
might find widespread application in the food, feed and cosmetic industry.  
5 MATERIALS & METHODS 
5.1 Materials, enzymes and instruments 
Ethyl acetate was bought from Fiers, all other chemicals were analytical grade and 
purchased from Sigma-Aldrich. The recombinant SPs were produced and heat purified 
as previously described (CHAPTER 3). The activity of these enzymes was determined as 
published earlier,128 and one unit of SP was defined as the activity that corresponds to 
the release of 1 μmol fructose per minute from 100 mM sucrose in 100 mM phosphate 
buffer at pH 7.0 and 37 °C (CHAPTER 3). Overexpression in E. coli JW0987 cells, and His6-
Tag purification of CtCP and CsCDP was performed as described in CHAPTER 5 and 7, 
respectively. The activity of both enzymes was determined in the synthetic direction by 
measuring the release of phosphate from αG1P using the method of Gawronski and 
Benson156. One unit of CP or CDP activity corresponds to the release of 1 μmol 
phosphate per minute from 50 mM αG1P and 50 mM glucose or cellobiose respectively, 
in a 50 mM MES buffer at pH 6.5 and 37 °C. Absorbance measurements in cuvettes and 
microtiter plates were performed in a JASCO V-360 Bio Spectrophotometer (JASCO, The 
Netherlands) and Anthos Zenyth 200rt microplate reader (Biochrom, UK), respectively. 
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5.2 Production and purification of glucosides 
The BaSP mediated glucosylation of hydroquinone, pyrogallol, methyl gallate, ethyl 
gallate and propyl gallate was carried out at 250 mL scale in magnetically stirred flasks. 
Biphasic catalysis was performed by adding 156 mL 50 mM MOPS at pH 7.5 containing 
2 M (684 g/L) sucrose and 50 U/mL SP to 94 mL EtOAc supplemented with 100 g/L 
acceptor. The reaction mixtures were incubated during 48 h at 50 °C, and subjected to a 
heat treatment (10 min at 95 °C) and centrifugation step (12 000 g, 4 °C, 15 min) to 
remove debris. The samples were then evaporated in vacuo and the glucosides were 
isolated by column chromatography (silicagel, EtOAc/MeOH/water = 30:5:4). 
 
Alternatively, α-glucosylation of pyrogallol, methyl gallate, ethyl gallate, propyl gallate, 
lauryl gallate, resveratrol, quercetin, catechin and epicatechin was performed in 
magnetically stirred flasks at 250 mL scale. The reaction mixtures consisted of a 50 mM 
MOPS buffer at pH 6.5 supplemented with 200 mM (69 g/L) sucrose, 10 g/L acceptor 
and 0.16 U/mL TtSPP_R134A. After 24 h incubation at 55 °C, NaCl was added to 300 g/L, 
and the mixtures were extracted with 250 mL isopropyl alcohol (IPA). Next the IPA 
phase was evaporated in vacuo, redissolved in MeOH, filtered over a Whatman paper 
and subjected to column chromatography (silicagel, EtOAc/MeOH/water = 30:5:4). The 
synthesis and isolation of 1-O-β-D-glucopyranosyl hydroquinone was performed as 
described in CHAPTER 5. The reported yields are based on the acceptor substrates. 
5.3 Production and purification of cellobiosides and cellotriosides 
The glycosylation of 1-O-α-D-glucopyranosyl hydroquinone (HQαGlc), 1-O-β-D-
glucopyranosyl hydroquinone (HQβGlc), methyl gallyl 4-O-α-D-glucopyranoside 
(MG4αGlc), ethyl gallyl 4-O-α-D-glucopyranoside (EG4αGlc), propyl gallyl 4-O-α-D-
glucopyranoside (PG4αGlc), 3-O-α-D-glucopyranosyl resveratrol (Res3αGlc), 3-O-β-D-
glucopyranosyl resveratrol (Res3βGlc) and 3  -O-α-D-glucopyranosyl epicatechin 
(Epi3  αGlc) was carried out at 50 mL scale in falcons. The reaction mixtures consisted of 
100 mM (26 g/L) αG1P and 50 mM of the above mentioned acceptors dissolved in a 50 
mM MES buffer at pH 6.5 containing 5 U/mL CsCDP and 15 % EtOH. The reactions were 
terminated after 48 h incubation at 37 °C, after which the reaction mixtures were heated 
(10 min at 95 °C) and centrifuged (12 000 g, 4 °C, 15 min). The samples were then 
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evaporated in vacuo and the residue was purified by column chromatography (silicagel, 
EtOAc/MeOH/water = 20:5:3). The reported yields are based on the acceptor substrates. 
5.4 Solubility measurements  
The solubility of glycosylated antioxidants was determined in 1.7 mL eppendorfs 
containing 250 µL 10 mM phosphate buffer at pH 7.0. The antioxidants were added until 
clear precipitation was observed, after which the mixtures were incubated in a water 
bath at 37 °C with ± 0.1 °C accuracy. Next, the samples were vortexed multiple times and 
allowed to equilibrate for 24 h. Undissolved solids were removed by centrifugation 
(12 000 g, 37 °C, 5 min) at the same temperature. Next, the obtained solutions were 
diluted in MeOH, and their absorbance was measured at 306, 373, 283, 280 and 280 nm 
for resveratrol, quercetin, lauryl gallate, catechin and epicatechin glycosides 
respectively. All experiments were performed in triplicate, and the calibration curves 
were prepared with authentic samples dissolved in MeOH. 
5.5 Determination of DPPH radical scavenging activity 
The 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity was determined 
by adding 100 µL MeOH, containing varying antioxidant concentrations, to 200 µL MeOH 
supplemented with 200 µM DPPH in microtiter plates. After intensive mixing, the 
samples were stored during 15 min at room temperature in darkness, after which the 
absorbance of the mixtures was measured at 517 nm. The required concentration to 
reduce the absorbance by 50 % (EC50) was calculated from the equations obtained by 
fitting the linear part of the absorption curves. Butylated hydroxytoluene (BHT) was 
used as reference, and all analyses were performed in triplicate.  
5.6 Determination of ABTS radical scavenging activity 
The 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) radical scavenging 
assay was used to evaluate the antioxidant properties of glycosylated phenolics. The 
ABTS cation radical was produced by reacting 1 part of milliQ water containing 14 mM 
ABTS with 1 part 4.9 mM potassium persulfate dissolved in milliQ. The obtained solution 
was stored in the dark at room temperature during 16 h, prior to its dilution with MeOH 
to an absorbance of 0.700 ± 0.020 at 734 nm. Next, 30 µL MeOH containing varying 
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antioxidant concentrations was added to 200 µL ABTS solution in microtiter plates. 
After intensive mixing, the samples were stored during 15 min at room temperature in 
darkness, after which the absorbance of the mixtures was measured at 734 nm. The EC50 
was calculated as described above, and BHT was used as reference. All analyses were 
performed in triplicate, and had a CV of less than 10 %.  
5.7 Stability assays 
Thermal stability was determined by dissolving 1 mM of the glycosylated antioxidants in 
a 10 mM phosphate buffer at pH 7.0. Unless stated otherwise, the solutions were 
incubated in a hot water bath at 60 °C with ± 0.1 °C accuracy during 24 h. Next, the 
samples were cooled on ice, diluted in MeOH, and their EC50DPPH was determined. The 
residual activity was calculated as the ratio of the EC50 before and after heat treatment. 
All analyses were performed in triplicate, and had a CV of less than 10 %. All reported 
errors correspond to the standard errors.   
5.8 Structure elucidation of glycosides 
NMR spectra were measured on a Bruker AVANCE III 600 MHz spectrometer 
(600.13 MHz for 1H and 150.93 MHz for 13C) at 25 °C in CD3OD (99.98 %D, ARMAR 
Chemicals, Döttingen, CH) and at 30 °C in D2O (100.00 %D, ARMAR Chemicals, 
Döttingen, CH - samples 1-O-α-D-cellobiopyranosyl hydroquinone, 1-O-α-D-
cellotriopyranosyl hydroquinone and 1-O-β-D-cellotriopyranosyl hydroquinone). 
Residual signals of solvents were used as an internal standard (CD3OD: σH 3.330 ppm, σc 
49.30 ppm, D2O: σH 4.508 ppm). Carbon chemical shifts in D2O were referenced to the 
signal of acetone (σc 30.50 ppm). NMR experiments: COSY, HSQC, HMBC, HSQC-TOCSY, 
and 1d-TOCSY were performed using standard manufacturers’ software. 1H NMR and 13C 
NMR spectra were zero filled to fourfold data points and multiplied by window function 
before Fourier transformation. Two-parameter double-exponential Lorentz-Gauss 
function was applied for 1H to improve resolution and line broadening (1 Hz) was 
applied to get better 13C signal-to-noise ratio. Digital resolution enabled us to report 
chemical shifts of protons to three and carbon chemical shifts to two decimal places. 
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The assignment of proton spin systems was achieved by COSY, and then transferred to 
carbons by HSQC. The differentiation of individual sugar units in cellobiose and 
cellotriose moieties was also supported by 1d-TOCSY and HSQC-TOCSY experiments. 
The anomeric configuration was determined from the magnitude of JH-1,H-2. The 
glycosidic linkage position was deduced using heteronuclear correlations in HMBC and 
from the downfield glycosylation shifts of the involved carbons C-4. The position of the 
glycosylation was confirmed by HMBC contact between anomeric proton H-1 and 
attached carbon of aglycon. The spectra of 1-O-α-D-glucopyranosyl hydroquinone, 1-O-
β-D-glucopyranosyl hydroquinone, 2-O-α-D-glucopyranosyl pyrogallol, methyl gallyl 4-
O-α-D-glucopyranoside, ethyl gallyl 4-O-α-D-glucopyranoside, propyl gallyl 4-O-α-D-
glucopyranoside, 3-O-α-D-glucopyranosyl resveratrol were identical to those reported in 
CHAPTER 3, 4 and 5. Spectral analysis and interpretation was kindly performed by the 
group of Prof. Vladimír Křen at the Institute of Microbiology (Czech Republic). 
 
1-O-α-D-Glucopyranosyl pyrogallol 
1H NMR (600.23 MHz, MeOD): 3.452 (1H, dd, J = 9.8, 9.1 Hz, H-4), 3.596 (1H, 
dd, J = 9.7, 3.7 Hz, H-2), 3.746 (1H, dd, J = 11.5, 4.8 Hz, H-6u), 3.782 (1H, dddd, 
J = 9.8, 4.8, 2.1, 0.4 Hz, H-5), 3.819 (1H, dd, J = 11.5, 2.1 Hz, H-6d), 3.896 (1H, 
dd, J = 9.7, 9.1 Hz, H-3), 5.303 (1H, d, J = 3.7 Hz, H-1), 6.551 (1H, dd, J = 8.1, 1.5 
Hz, H-4’), 6.621 (1H, dd, J = 8.2, 8.1 Hz, H-5’), 6.797 (1H, dd, J = 8.2, 1.5 Hz, H-
6’) 
13C NMR (150.95 MHz, MeOD): 62.65 (C-6), 71.67 (C-4), 73.78 (C-2), 74.76 (C-5), 75.17 (C-3), 
101.86 (C-1), 110.81 (C-6’), 112.11 (C-5’), 120.29 (C-4’), 137.17 (C-2’), 147.53 (C-3’), 147.64 (C-
1’) 
 
Methyl gallyl 3-O-α-D-glucopyranoside 
1H NMR (600.23 MHz, MeOD): 3.496 (1H, dd, J = 9.8, 9.1 Hz, H-4), 3.634 
(1H, dd, J = 9.7, 3.7 Hz, H-2), 3.741 (1H, ddd, J = 9.8, 4.5, 2.3 Hz, H-5), 
3.773 (1H, dd, J = 11.9, 4.5 Hz, H-6u), 3.812 (1H, dd, J = 11.9, 2.3 Hz, H-
6d), 3.852 (3H, s, H-1”), 3.903 (1H, dd, J = 9.7, 9.1 Hz, H-3), 5.391 (1H, d, 
J = 3.7 Hz, H-1), 7.254 (1H, d, J = 2.0 Hz, H-6’), 7.506 (1H, d, J = 2.0 Hz, H-
2’) 
13C NMR (150.95 MHz, MeOD): 52.71 (C-1”), 62.43 (C-6), 71.43 (C-4), 73.66 (H-2), 74.94 (C-5), 
75.07 (C-3), 101.76 (C-1), 112.22 (C-2’), 113.53 (C-6’), 121.97 (C-1’), 142.28 (C-4’), 146.84 (C-3’), 
147.28 (C-5’), 168.96 (CO) 
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Ethyl gallyl 3-O-α-D-glucopyranoside 
1H NMR (600.23 MHz, MeOD): 1.371 (3H, t, J = 7.1 Hz, H-2”), 3.501 
(1H, dd, J = 9.8, 9.1 Hz, H-4), 3.634 (1H, dd, J = 9.7, 3.7 Hz, H-2), 3.752 
(1H, dddd, J = 9.8, 4.5, 2.3, 0.4 Hz, H-5), 3.779 (1H, dd, J = 11.7, 4.3 Hz, 
H-6u), 3.813 (1H, dd, J = 11.7, 2.3 Hz, H-6d), 3.905 (1H, dd, J = 9.7, 9.1 
Hz, H-3), 4.315 (2H, q, J = 7.1 Hz, H-1”), 5.384 (1H, d, J = 3.7 Hz, H-1), 
7.260 (1H, d, J = 2.0 Hz, H-6’), 7.506 (1H, d, J = 2.0 Hz, H-2’) 
13C NMR (150.95 MHz, MeOD): 14.94 (C-2”), 62.18 (C-1”), 62.43 (C-6), 71.43 (C-4), 73.67 (H-2), 
74.93 (C-5), 75.07 (C-3), 101.85 (C-1), 112.28 (C-2’), 113.52 (C-6’), 122.28 (C-1’), 142.29 (C-4’), 
146.85 (C-3’), 147.25 (C-5’), 168.50 (CO) 
 
Propyl gallyl 3-O-α-D-glucopyranoside 
1H NMR (600.23 MHz, MeOD): 1.042 (3H, t, J = 7.4 Hz, H-3”), 1.783 
(2H, m, H-2”), 3.511 (1H, dd, J = 9.8, 9.0 Hz, H-4), 3.637 (1H, dd, J = 
9.7, 3.7 Hz, H-2), 3.752 (1H, ddd, J = 9.8, 4.1, 2.6 Hz, H-5), 3.783 (1H, 
dd, J = 11.9, 4.1 Hz, H-6u), 3.812 (1H, dd, J = 11.9, 2.6 Hz, H-6d), 
3.908 (1H, dd, J = 9.7, 9.0 Hz, H-3), 4.224 (2H, t, J = 6.6 Hz, H-1”), 
5.385 (1H, d, J = 3.7 Hz, H-1), 7.266 (1H, d, J = 2.0 Hz, H-6’), 7.509 (1H, d, J = 2.0 Hz, H-2’) 
13C NMR (150.95 MHz, MeOD): 11.10 (C-3”), 23.48 (C-2”), 62.41 (C-6), 67.76 (C-1”), 71.39 (C-4), 
73.66 (H-2), 74.90 (C-5), 75.06 (C-3), 101.87 (C-1), 112.28 (C-2’), 113.50 (C-6’), 122.25 (C-1’), 
142.28 (C-4’), 146.86 (C-3’), 147.25 (C-5’), 168.55 (CO) 
 
Lauryl gallyl 3-O-α-D-glucopyranoside 
1H NMR (600.23 MHz, MeOD): 0.913 (3H, t, J = 7.1 Hz, H-12”), 1.30-
1.36 (14H, m, H-5”- H-11”), 1.395 (2H, m, H-4”), 1.461 (2H, m, H-
3”), 1.760 (2H, m, H-2”), 3.513 (1H, dd, J = 9.9, 8.9 Hz, H-4), 3.636 
(1H, dd, J = 9.7, 3.7 Hz, H-2), 3.751 (1H, ddd, J = 9.9, 4.1, 2.7 Hz, H-
5), 3.785 (1H, dd, J = 12.0, 4.1 Hz, H-6u), 3.812 (1H, dd, J = 12.0, 2.7 
Hz, H-6d), 3.908 (1H, dd, J = 9.7, 8.9 Hz, H-3), 4.263 (2H, m, H-1”), 5.384 (1H, d, J = 3.7 Hz, H-1), 
7.261 (1H, d, J = 2.0 Hz, H-6’), 7.503 (1H, d, J = 2.0 Hz, H-2’) 
13C NMR (150.95 MHz, MeOD): 14.73 (C-12”), 24.03 (C-11”), 27.44 (C-3”), 30.14 (C-2”), 30.68 (C-
4”), 30.77 (C-9”), 30.95, 31.00, 31.05, 31.05 (C-5”, C-6”, C-7”, C-8”), 33.36 (C-10”), 62.42 (C-6), 
66.29 (C-1”), 71.39 (C-4), 73.66 (H-2), 74.91 (C-5), 75.06 (C-3), 101.88 (C-1), 112.28 (C-2’), 
113.52 (C-6’), 122.26 (C-1’), 142.28 (C-4’), 146.87 (C-3’), 147.25 (C-5’), 168.55 (CO) 
 
Lauryl gallyl 4-O-α-D-glucopyranoside 
1H NMR (600.23 MHz, MeOD): 0.914 (3H, t, J = 7.1 Hz, H-12”), 1.30-
1.37 (14H, m, H-5”- H-11”), 1.396 (2H, m, H-4”), 1.467 (2H, m, H-3”), 
1.763 (2H, m, H-2”), 3.479 (1H, dd, J = 10.1, 9.1 Hz, H-4), 3.616 (1H, 
dd, J = 9.7, 3.7 Hz, H-2), 3.794 (1H, dd, J = 11.8, 4.8 Hz, H-6u), 3.868 
(1H, dd, J = 11.8, 2.5 Hz, H-6d), 3.899 (1H, dd, J = 9.7, 9.1 Hz, H-3), 
4.246 (1H, dddd, J = 10.1, 4.8, 2.5, 0.4 Hz, H-5), 4.269 (2H, t, J = 6.6 Hz, 
H-1”), 5.152 (1H, d, J = 3.7 Hz, H-1), 7.070 (2H, s, H-meta) 
13C NMR (150.95 MHz, MeOD): 14.73 (C-12”), 24.03 (C-11”), 27.44 (C-3”), 30.08 (C-2”), 30.66 (C-
4”), 30.76 (C-9”), 30.95, 30.98, 31.04, 31.04 (C-5”, C-6”, C-7”, C-8”), 33.36 (C-10”), 62.43 (C-6), 
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66.45 (C-1”), 71.21 (C-4), 73.70 (H-2), 75.24 (C-3), 75.49 (C-5), 105.50 (C-1), 110.30 (C-meta), 
128.44 (C-para), 139.74 (C-ipso), 152.35 (C-ortho), 168.18 (CO) 
 
   -O-α-D-Glucopyranosyl quercetin 
1H NMR (600.23 MHz, MeOD): 3.533 (1H, dd, J = 9.7, 9.0 Hz, H-4), 3.652 
(1H, dd, J = 9.7, 3.7 Hz, H-2), 3.821 (1H, m, H-6u), 3.85a (1H, m, H-5), 
3.878 (1H, m, H-6d), 3.932 (1H, dd, J = 9.7, 9.0 Hz, H-3), 5.423 (1H, d, J = 
3.7 Hz, H-1), 6.202 (1H, d, J = 2.1 Hz, H-6’), 6.434 (1H, d, J = 2.1 Hz, H-
8’), 6.998 (1H, d, J = 8.6 Hz, H-5”), 7.865(1H, dd, J = 8.6, 2.2 Hz, H-6”), 
8.182 (1H, d, J = 2.2 Hz, H-2”); a HSQC readout 
13C NMR (150.95 MHz, MeOD): 62.49 (C-6), 71.48 (C-4), 73.78 (C-2), 
74.89 (C-5), 75.19 (C-3), 94.95 (C-8’), 99.70 (C-6’), 102.14 (C-1), 104.80 (C-10’), 117.57 (C-5”), 
119.46 (C-2”), 124.57 (C-1”), 125.58 (C-6”), 137.67 (C-3’), 146.60 (C-3”), 147.82 (C-2’), 151.36 
(C-4”), 158.58 (C-9’), 162.79 (C-5’), 166.21 (C-7’), 177.68 (C-4’) 
 
   -O-α-D-Glucopyranosyl quercetin 
1H NMR (600.23 MHz, MeOD): 3.472 (1H, dd, J = 9.7, 9.0 Hz, H-4), 3.648 
(1H, dd, J = 9.7, 3.7 Hz, H-2), 3.75a (2H, m, H-5, H-6u), 3.829 (1H, m, H-6d), 
3.929 (1H, dd, J = 9.7, 9.0 Hz, H-3), 5.515 (1H, d, J = 3.7 Hz, H-1), 6.214 
(1H, d, J = 2.0 Hz, H-6’), 6.425 (1H, d, J = 2.0 Hz, H-8’), 7.424 (1H, d, J = 8.7 
Hz, H-5”), 7.729 (1H, dd, J = 8.7, 2.2 Hz, H-6”), 7.790 (1H, d, J = 2.2 Hz, H-
2”); a HSQC readout 
13C NMR (150.95 MHz, MeOD): 62.65 (C-6), 71.66 (C-4), 73.74 (C-2), 75.03 
(C-5), 75.14 (C-3), 94.77 (C-8’), 99.65 (C-6’), 101.07 (C-1), 104.89 (C-10’), 117.01 (C-2”), 118.35 
(C-5”), 121.52 (C-6”), 127.95 (C-1”), 138.28 (C-3’), 147.31 (C-2’), 148.10 (C-4”), 148.64 (C-3”),  
158.64 (C-9’), 162.89 (C-5’), 166.15 (C-7’), 177.83 (C-4’) 
 
   -O-α-D-Glucopyranosyl catechin 
1H NMR (600.23 MHz, MeOD): 2.523 (1H, dd, J = 16.1, 8.5 Hz, H-4’u), 
2.913 (1H, dd, J = 16.1, 5.6 Hz, H-4’d), 3.468 (1H, dd, J = 9.6, 9.0 Hz, H-4), 
3.600 (1H, dd, J = 9.7, 3.7 Hz, H-2), 3.752 (1H, dd, J = 11.6, 4.4 Hz, H-6u), 
3.797 (1H, ddd, J = 9.6, 4.4, 2.3 Hz, H-5), 3.826 (1H, dd, J = 11.6, 2.3 Hz, 
H-6d), 3.894 (1H, dd, J = 9.7, 9.0 Hz, H-3), 4.009 (1H, ddd, J = 8.5, 8.0, 5.6 
Hz, H-3’), 4.59a (1H, m, H-2’), 5.351 (1H, d, J = 3.7 Hz, H-1), 5.869 (1H, d, 
J = 2.3 Hz, H-8’), 5.953 (1H, d, J = 2.3 Hz, H-6’), 6.876 (1H, d, J = 8.2 Hz, 
H-5”), 7.007 (1H, ddd, J = 8.2, 2.0, 0.5 Hz, H-6”), 7.330 (1H, d, J = 2.0 Hz, 
H-2”); a HSQC readout 
13C NMR (150.95 MHz, MeOD): 29.30 (C-4’), 62.57 (C-6), 69.08 (C-3’), 71.57 (C-4), 73.77 (H-2), 
74.81 (C-5), 75.20 (C-3), 83.10 (C-2’), 95.83 (C-8’), 96.68 (C-6’), 101.23 (C-10’), 101.93 (C-1), 
117.22 (C-5”), 118.93 (C-2”), 124.30 (C-6”), 132.60 (C-1”), 146.59 (C-3”), 149.05 (C-4”), 157.22 
(C-9’), 157.87 (C-5’), 158.16 (C-7’) 
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   -O-α-D-Glucopyranosyl epicatechin 
1H NMR (600.23 MHz, MeOD): 2.766 (1H, ddd, J = 16.6, 2.8, 0.5 Hz, H-
4’u), 2.892 (1H, dd, J = 16.6, 4.5 Hz, H-4’d), 3.443 (1H, dd, J = 9.8, 9.0 Hz, 
H-4), 3.600 (1H, dd, J = 9.7, 3.7 Hz, H-2), 3.746 (1H, dd, J = 11.8, 5.3 Hz, 
H-6u), 3.805 (1H, ddd, J = 9.8, 5.3, 2.3 Hz, H-5), 3.855 (1H, dd, J = 11.8, 
2.3 Hz, H-6d), 3.899 (1H, dd, J = 9.7, 9.0 Hz, H-3), 4.217 (1H, ddd, J = 4.5, 
2.8, 1.4 Hz, H-3’), 4.88a (1H, m, H-2’), 5.375 (1H, d, J = 3.7 Hz, H-1), 5.946 
(1H, d, J = 2.3 Hz, H-6’), 5.966 (1H, d, J = 2.3 Hz, H-8’), 6.867 (1H, d, J = 
8.3 Hz, H-5”), 7.086 (1H, ddd, J = 8.3, 2.1, 0.6 Hz, H-6”), 7.448 (1H, d, J = 
2.1 Hz, H-2”); a HSQC readout 
13C NMR (150.95 MHz, MeOD): 29.65 (C-4’), 62.80 (C-6), 67.73 (C-3’), 71.77 (C-4), 73.82 (H-2), 
74.80 (C-5), 75.22 (C-3), 80.03 (C-2’), 96.27 (C-6’), 96.77 (C-8’), 100.34 (C-10’), 101.77 (C-1), 
116.93 (C-5”), 118.46 (C-2”), 123.53 (C-6”), 132.76 (C-1”), 146.39 (C-3”), 148.45 (C-4”), 157.60 
(C-9’), 157.98 (C-7’), 158.31 (C-5’) 
 
1-O-α-D-Cellobiopyranosyl hydroquinone 
1H NMR (600.23 MHz, D2O): 3.065 (1H, dd, J = 9.4, 7.9 Hz, H-
2b), 3.160 (1H, dd, J = 9.8, 9.0 Hz, H-4b), 3.233 (1H, ddd, J = 
9.8, 5.7, 2.1 Hz, H-5b), 3.247 (1H, dd, J = 9.4, 9.0 Hz, H-3b), 
3.48a (2H, m, H-4a, H-6bu), 3.49a (1H, m, H-2a), 3.580 (2H, m, 
H-6a), 3.664 (1H, dd, J = 12.3, 2.1 Hz, H-6bd), 3.695 (1H, ddd, 
H-5a), 3.751 (1H, dd, ΣJ = 18.7 Hz, H-3a), 4.270 (1H, d, J = 7.9 Hz, H-1b), 5.222 (1H, d, J = 3.7 Hz, 
H-1a), 6.608 (2H, m, ΣJ = 9.0 Hz, H-meta), 6.811 (2H, m, ΣJ = 9.0 Hz, H-ortho); a HSQC readout 
13C NMR (150.95 MHz, D2O): 59.87 (C-6a), 60.85 (C-6b), 69.72 (C-4b), 71.17 (C-2a), 71.34 (C-5a), 
71.80 (C-3a), 73.43 (C-2b), 75.77 (C-3b), 76.25 (C-5b), 78.64 (C-4a), 98.20 (C-1a), 102.76 (C-1b), 
116.50 (C-meta), 119.34 (C-ortho), 150.02 (C-ipso), 151.43 (C-para) 
 
1-O-α-D-Cellotriopyranosyl hydroquinone 
1H NMR (600.23 MHz, D2O): 3.053 (1H, dd, J = 9.6, 8.0 
Hz, H-2c), 3.112 (1H, dd, J = 9.0, 8.0 Hz, H-2b), 3.153 
(1H, dd, H-4c), 3.224 (1H, m, H-5c), 3.246 (1H, dd, H-
3c), 3.37a (1H, m, H-5b), 3.39a (1H, m, H-3b), 3.41a 
(1H, m, H-4b), 3.471 (1H, dd, H-6cu), 3.48a (1H, m, H-
4a), 3.49a (1H, m, H-2a), 3.568 (1H, m, H-6a), 3.571 (1H, dd, H-6bu), 3.597 (1H, m, H-6bd), 3.652 
(1H, m, H-6cd), 3.699 (1H, m, H-5a), 3.731 (1H, m, H-6bd), 3.756 (1H, dd, ΣJ = 18.8 Hz, H-3a), 
4.247 (1H, d, J = 8.0 Hz, H-1c), 4.296 (1H, d, J = 8.0 Hz, H-1b), 5.224 (1H, d, J = 3.8 Hz, H-1a), 6.611 
(2H, m, ΣJ = 9.0 Hz, H-meta), 6.814 (2H, m, ΣJ = 9.0 Hz, H-ortho); a HSQC readout 
13C NMR (150.95 MHz, D2O): 59.85 (C-6a), 60.19 (C-6b), 60.82(C-6c), 69.70 (C-4c), 71.19 (C-2a), 
71.36 (C-5a), 71.76 (C-3a), 73.21 (C-2b), 73.40 (C-2c), 74.33 (C-3b), 75.09 (C-5b), 75.74 (C-3c), 
76.23 (C-5c), 78.54 (C-4a), 78.68 (C-4b), 98.23 (C-1a), 102.54 (C-1b), 102.82 (C-1c), 116.51 (C-
meta), 119.37 (C-ortho), 150.03 (C-ipso), 151.44 (C-para) 
 
 
 
 
CHAPTER 8 CHEMOENZYMATIC GLYCOSYLATION OF PHENOLIC ANTIOXIDANTS 
158 
 
1-O-β-D-Cellobiopyranosyl hydroquinone 
1H NMR (600.23 MHz, MeOD): 3.262 (1H, dd, J = 9.2, 
7.9 Hz, H-2b), 3.336 (1H, dd, J = 9.6, 8.8 Hz, H-4b), 
3.381 (1H, ddd, J = 9.6, 5.8, 2.3 Hz, H-5b), 3.403 (1H, 
dd, J = 9.2, 8.8 Hz, H-3b), 3.496 (1H, dd, J = 9.1, 7.8 Hz, 
H-2a), 3.535 (1H, ddd, H-5a), 3.621 (1H, dd, J = 9.1, 8.8 
Hz, H-3a), 3.677 (1H, dd, J = 9.6, 8.8 Hz, H-4a), 3.694 (1H, dd, J = 11.9, 5.8 Hz, H-6bu), 3.911 (1H, 
dd, J = 11.9, 2.3 Hz, H-6bd), 3.916 (2H, m, H-6a), 4.462 (1H, d, J = 7.9 Hz, H-1b), 4.791 (1H, d, J = 
7.8 Hz, H-1a), 6.718 (2H, m, ΣJ = 9.0 Hz, H-meta), 6.977 (2H, m, ΣJ = 9.0 Hz, H-ortho) 
13C NMR (150.95 MHz, MeOD): 61.99 (C-6a), 62.73 (C-6b), 71.67 (C-4b), 75.01 (C-2a), 75.22 (C-
2b), 76.62 (C-3a), 76.84 (C-5a), 78.15 (C-3b), 78.41 (C-5b), 80.64 (C-4a), 103.72 (C-1a), 104.87 
(C-1b), 116.92 (C-meta), 119.77 (C-ortho), 152.61 (C-ipso), 154.17 (C-para) 
 
1-O-β-D-Cellotriopyranosyl hydroquinone 
1H NMR (600.23 MHz, D2O): 3.052 (1H, dd, J = 
9.4, 7.9 Hz, H-2c), 3.108 (1H, dd, J = 9.1, 8.0 Hz, 
H-2b), 3.152 (1H, dd, J = 9.9, 9.0 Hz, H-4c), 
3.223 (1H, ddd, J = 9.9, 5.9, 2.2 Hz, H-5c), 3.244 
(1H, dd, J = 9.4, 9.0 Hz, H-3c), 3.306 (1H, m, H-
2a), 3.365 (1H, m, H-5b), 3.391 (1H, m, H-3b), 3.419 (1H, m, H-4b), 3.45a (1H, m, H-5a), 3.46a (1H, 
m, H-3a), 3.469 (1H, dd, H-6cu), 3.47a (1H, m, H-4a), 3.571 (1H, dd, J = 12.3, 4.7 Hz, H-6bu), 3.578 
(1H, dd, J = 12.4, 4.4 Hz, H-6au), 3.652 (1H, dd, J = 12.4, 2.2 Hz, H-6cd), 3.713 (1H, dd, J = 12.4, 2.0 
Hz, H-6ad), 3.727 (1H, dd, J = 12.3, 2.1 Hz, H-6bd), 4.246 (1H, d, J = 7.9 Hz, H-1c), 4.293 (1H, d, J = 
8.0 Hz, H-1b), 4.740 (1H, d, J = 7.9 Hz, H-1a), 6.605 (2H, m, ΣJ = 9.0 Hz, H-meta), 6.789 (2H, m, ΣJ 
= 9.0 Hz, H-ortho); a HSQC readout 
13C NMR (150.95 MHz, D2O): 60.05 (C-6a), 60.14 (C-6b), 60.82(C-6c), 69.70 (C-4c), 73.01 (C-2a), 
73.19 (C-2b), 73.39 (C-2c), 74.30 (C-3b), 74.35 (C-3a), 75.07 (C-5b), 75.14 (C-5a), 75.73 (C-3c), 
76.23 (C-5c), 78.49 (C-4a), 78.64 (C-4b), 101.41 (C-1a), 102.60 (C-1b), 102.81 (C-1c), 116.47 (C-
meta), 118.70 (C-ortho), 150.62 (C-ipso), 151.54 (C-para) 
 
Methyl gallyl 4-O-α-D-cellobiopyranoside 
1H NMR (600.23 MHz, MeOD): 3.288 (1H, dd, J = 9.2, 7.9 Hz, H-
2b), 3.342 (1H, dd, J = 9.6, 8.6 Hz, H-4b), 3.384 (1H, ddd, J = 9.6, 
5.7, 2.2 Hz, H-5b), 3.410 (1H, dd, J = 9.2, 8.6 Hz, H-3b), 3.673 
(1H, dd, J = 9.6, 3.8 Hz, H-2a), 3.703 (1H, dd, J = 11.9, 5.7 Hz, H-
6bu), 3.719 (1H, dd, J = 10.2, 8.8 Hz, H-4a), 3.849 (1H, dd, J = 
12.1, 2.4 Hz, H-6au), 3.862 (3H, s, H-1’), 3.920 (1H, dd, J = 11.9, 
2.2 Hz, H-6bd), 4.016 (1H, dd, J = 12.1, 3.4 Hz, H-6ad), 4.022 (1H, dd, J = 9.6, 8.8 Hz, H-3a), 4.386 
(1H, ddd, J = 10.2, 3.4, 2.4 Hz, H-5a), 4.484 (1H, d, J = 7.9 Hz, H-1b), 5.169 (1H, d, J = 3.8 Hz, H-1a), 
7.062 (2H, s, H-meta) 
13C NMR (150.95 MHz, MeOD): 52.86 (C-1’), 61.62 (C-6a), 62.79 (C-6b), 71.71 (C-4b), 73.60 (C-
2a), 73.74 (C-3a), 73.80 (C-5a), 75.23 (C-2b), 78.17 (C-3b), 78.44 (C-5b), 80.09 (C-4a), 104.83 (C-
1a), 104.86 (C-1b), 110.30 (C-meta), 128.09 (C-para), 139.60 (C-ipso), 152.45 (C-ortho), 168.61 
(CO) 
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Methyl gallyl 4-O-α-D-cellotriopyranoside 
1H NMR (600.23 MHz, MeOD): 3.252 (1H, dd, J = 9.2, 
7.9 Hz, H-2c), 3.34a (1H, m, H-4c), 3.358 (1H, dd, J = 
9.2, 7.9 Hz, H-2b), 3.369 (1H, ddd, J = 9.6, 5.6, 2.2 Hz, 
H-5c), 3.393 (1H, dd, J = 9.2, 8.6 Hz, H-3c), 3.517 (1H, 
ddd, J = 9.6, 4.3, 2.4 Hz, H-5b), 3.570 (1H, dd, J = 9.2, 
8.8 Hz, H-3b), 3.629 (1H, dd, J = 9.6, 8.8 Hz, H-4b), 
3.672 (1H, dd, J = 9.6, 3.8 Hz, H-2a), 3.687 (1H, dd, J = 11.9, 5.6 Hz, H-6cu), 3.724 (1H, dd, J = 10.1, 
8.9 Hz, H-4a), 3.845 (1H, dd, J = 12.2, 2.4 Hz, H-6au), 3.863 (3H, s, H-1’), 3.899 (1H, dd, J = 12.2, 
4.3 Hz, H-6bu), 3.904 (1H, dd, J = 11.9, 2.2 Hz, H-6cd), 3.952 (1H, dd, J = 12.2, 2.4 Hz, H-6bd), 
4.024 (1H, dd, J = 12.2, 3.3 Hz, H-6ad), 4.030 (1H, dd, J = 9.6, 8.9 Hz, H-3a), 4.388 (1H, ddd, J = 
10.1, 3.3, 2.4 Hz, H-5a), 4.431 (1H, d, J = 7.9 Hz, H-1c), 4.523 (1H, d, J = 7.9 Hz, H-1b), 5.175 (1H, 
d, J = 3.8 Hz, H-1a), 7.063 (2H, s, H-meta); a HSQC readout 
13C NMR (150.95 MHz, MeOD): 52.86 (C-1’), 61.55 (C-6a), 61.84 (C-6b), 62.73 (C-6c), 71.66 (C-
4c), 73.61 (C-2a), 73.70 (C-3a), 73.79 (C-5a), 74.93 (C-2b), 75.20 (C-2c), 76.49 (C-3b), 76.97 (C-
5b), 78.15 (C-3c), 78.43 (C-5c), 79.94 (C-4a), 80.51 (C-4b), 104.60 (C-1b), 104.80 (C-1a), 104.92 
(C-1c), 110.30 (C-meta), 128.09 (C-para), 139.60 (C-ipso), 152.48 (C-ortho), 168.61 (CO) 
 
Ethyl gallyl 4-O-α-D-cellobiopyranoside 
1H NMR (600.23 MHz, MeOD): 1.375 (3H, t, J = 7.1 Hz, H-2’), 3.288 
(1H, dd, J = 9.2, 7.9 Hz, H-2b), 3.342 (1H, dd, J = 9.6, 8.6 Hz, H-4b), 
3.384 (1H, ddd, J = 9.6, 5.8, 2.2 Hz, H-5b), 3.409 (1H, dd, J = 9.2, 8.6 
Hz, H-3b), 3.674 (1H, dd, J = 9.6, 3.8 Hz, H-2a), 3.703 (1H, dd, J = 
11.9, 5.8 Hz, H-6bu), 3.719 (1H, dd, J = 10.1, 8.9 Hz, H-4a), 3.852 
(1H, dd, J = 12.2, 2.4 Hz, H-6au), 3.920 (1H, dd, J = 11.9, 2.2 Hz, H-
6bd), 4.015 (1H, dd, J = 12.2, 3.3 Hz, H-6ad), 4.022 (1H, dd, J = 9.6, 8.9 Hz, H-3a), 4.320 (2H, q, J = 
7.1 Hz, H-1’), 4.386 (1H, ddd, J = 10.1, 3.3, 2.4 Hz, H-5a), 4.484 (1H, d, J = 7.9 Hz, H-1b), 5.168 (1H, 
d, J = 3.8 Hz, H-1a), 7.066 (2H, s, H-meta) 
13C NMR (150.95 MHz, MeOD): 14.86 (C-2’), 61.63 (C-6a), 62.35 (C-1’), 62.80 (C-6b), 71.72 (C-
4b), 73.60 (C-2a), 73.75 (C-3a), 73.81 (C-5a), 75.24 (C-2b), 78.18 (C-3b), 78.44 (C-5b), 80.11 (C-
4a), 104.86 (C-1a, C-1b), 110.26 (C-meta), 128.42 (C-para), 139.56 (C-ipso), 152.41 (C-ortho), 
168.13 (CO) 
 
Propyl gallyl 4-O-α-D-cellobiopyranoside 
1H NMR (600.23 MHz, MeOD): 1.048 (3H, t, J = 7.4 Hz, H-3’), 
1.787 (2H, m, H-2’), 3.288 (1H, dd, J = 9.2, 7.9 Hz, H-2b), 3.342 
(1H, dd, J = 9.6, 8.7 Hz, H-4b), 3.384 (1H, ddd, J = 9.6, 5.7, 2.2 Hz, 
H-5b), 3.409 (1H, dd, J = 9.2, 8.7 Hz, H-3b), 3.673 (1H, dd, J = 9.6, 
3.8 Hz, H-2a), 3.703 (1H, dd, J = 11.9, 5.7 Hz, H-6bu), 3.720 (1H, 
dd, J = 10.1, 8.9 Hz, H-4a), 3.851 (1H, dd, J = 12.2, 2.5 Hz, H-6au), 
3.920 (1H, dd, J = 11.9, 2.2 Hz, H-6bd), 4.015 (1H, dd, J = 12.2, 3.2 Hz, H-6ad), 4.023 (1H, dd, J = 
9.6, 8.9 Hz, H-3a), 4.232 (2H, t, J = 6.6 Hz, H-1’), 4.386 (1H, ddd, J = 10.1, 3.3, 2.4 Hz, H-5a), 4.485 
(1H, d, J = 7.9 Hz, H-1b), 5.172 (1H, d, J = 3.8 Hz, H-1a), 7.071 (2H, s, H-meta) 
13C NMR (150.95 MHz, MeOD): 11.09 (C-3’), 23.45 (C-2’), 61.64 (C-6a), 62.80 (C-6b), 67.91 (C-1’), 
71.72 (C-4b), 73.61 (C-2a), 73.76 (C-3a), 73.80 (C-5a), 75.24 (C-2b), 78.19 (C-3b), 78.45 (C-5b), 
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80.11 (C-4a), 104.85 (C-1a), 104.87 (C-1b), 110.25 (C-meta), 128.40 (C-para), 139.57 (C-ipso), 
152.44 (C-ortho), 168.19 (CO) 
 
Propyl gallyl 4-O-α-D-cellotriopyranoside 
1H NMR (600.23 MHz, MeOD): 1.047 (3H, t, J = 7.4 Hz, H-
3’), 1.787 (2H, m, H-2’), 3.254 (1H, dd, J = 9.2, 7.9 Hz, H-
2c), 3.34a (1H, m, H-4c), 3.359 (1H, dd, J = 9.2, 7.9 Hz, H-
2b), 3.371 (1H, ddd, J = 9.6, 5.7, 2.2 Hz, H-5c), 3.394 (1H, 
dd, J = 9.2, 8.6 Hz, H-3c), 3.518 (1H, ddd, J = 9.6, 4.2, 2.4 
Hz, H-5b), 3.572 (1H, dd, J = 9.2, 8.8 Hz, H-3b), 3.630 
(1H, dd, J = 9.6, 8.8 Hz, H-4b), 3.674 (1H, dd, J = 9.6, 3.8 Hz, H-2a), 3.688 (1H, dd, J = 11.9, 5.7 Hz, 
H-6cu), 3.724 (1H, dd, J = 10.1, 9.0 Hz, H-4a), 3.848 (1H, dd, J = 12.1, 2.4 Hz, H-6au), 3.900 (1H, 
dd, J = 12.0, 4.2 Hz, H-6bu), 3.906 (1H, dd, J = 11.9, 2.2 Hz, H-6cd), 3.953 (1H, dd, J = 12.0, 2.4 Hz, 
H-6bd), 4.024 (1H, dd, J = 12.1, 3.3 Hz, H-6ad), 4.032 (1H, dd, J = 9.6, 9.0 Hz, H-3a), 4.232 (2H, t, J 
= 6.6 Hz, H-1’), 4.389 (1H, ddd, J = 10.1, 3.3, 2.4 Hz, H-5a), 4.432 (1H, d, J = 7.9 Hz, H-1c), 4.524 
(1H, d, J = 7.9 Hz, H-1b), 5.180 (1H, d, J = 3.8 Hz, H-1a), 7.071 (2H, s, H-meta); a HSQC readout 
13C NMR (150.95 MHz, MeOD): 11.09 (C-3’), 23.44 (C-2’), 61.56 (C-6a), 61.85 (C-6b), 62.73 (C-
6c), 67.91 (C-1’), 71.67 (C-4c), 73.61 (C-2a), 73.70 (C-3a), 73.78 (C-5a), 74.93 (C-2b), 75.20 (C-
2c), 76.49 (C-3b), 76.97 (C-5b), 78.15 (C-3c), 78.43 (C-5c), 79.95 (C-4a), 80.52 (C-4b), 104.60 (C-
1b), 104.80 (C-1a), 104.92 (C-1c), 110.25 (C-meta), 128.38 (C-para), 139.55 (C-ipso), 152.45 (C-
ortho), 168.19 (CO) 
 
3-O-α-D-Cellobiopyranosyl resveratrol 
1H NMR (600.23 MHz, MeOD): 3.270 (1H, dd, J 
= 9.1, 7.9 Hz, H-2b), 3.345 (1H, dd, J = 9.3, 8.6 
Hz, H-4b), 3.384 (1H, ddd, J = 9.3, 5.6, 2.2 Hz, H-
5b), 3.401 (1H, dd, J = 9.1, 8.6 Hz, H-3b), 3.655 
(1H, dd, J = 9.8, 3.7 Hz, H-2a), 3.708 (1H, dd, J = 
11.9, 5.6 Hz, H-6bu), 3.710 (1H, dd, J = 9.7, 8.7 
Hz, H-4a), 3.788 (1H, dd, J = 12.1, 2.6 Hz, H-6au), 3.819 (1H, ddd, J = 9.7, 3.3, 2.6 Hz, H-5a),  3.921 
(1H, dd, J = 11.9, 2.2 Hz, H-6bd), 3.941 (1H, dd, J = 12.1, 3.3 Hz, H-6ad), 4.001 (1H, dd, J = 9.8, 8.7 
Hz, H-3a), 4.462 (1H, d, J = 7.9 Hz, H-1b), 5.506 (1H, d, J = 3.7 Hz, H-1a), 6.516 (1H, dd, ΣJ = 4.3 
Hz, H-4’), 6.644 (1H, dd, ΣJ = 3.6 Hz, H-6’), 6.798 (2H, m, ΣJ = 8.7 Hz, H-3”, H-5”), 6.834 (1H, dd, ΣJ 
= 3.6 Hz, H-2’), 6.869 (1H, d, J = 16.3 Hz, H-α), 7.028 (1H, d, J = 16.3 Hz, H-β), 7.387 (1H, m, ΣJ = 
8.7 Hz, H-2”, H-6”)  
13C NMR (150.95 MHz, MeOD): 61.77 (C-6a), 62.75 (C-6b), 71.68 (C-4b), 73.10 (C-5a), 73.39 (C-
2a), 73.70 (C-3a), 75.25 (C-2b), 78.15 (C-3b), 78.44 (C-5b), 80.85 (C-4a), 99.16 (C-1a), 104.61 (C-
4’), 104.96 (C-1b), 107.58 (C-2’), 108.67 (C-6’), 116.80 (C-3”, C-5”), 126.95 (C-α), 129.20 (C-2”, C-
6”), 130.26 (C-β), 130.58 (C-1”), 141.77 (C-1’), 158.82 (C-4”), 159.97 (C-5’), 160.12 (C-3’)  
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3-O-α-D-Cellotriopyranosyl resveratrol 
1H NMR (600.23 MHz, MeOD): 3.255 (1H, 
dd, J = 9.2, 7.9 Hz, H-2c), 3.329 (1H, m, H-
4b), 3.344 (2H, m, H-4c, H-2b), 3.374 
(1H, m, H-5c), 3.399 (1H, m, H-3c), 3.525 
(1H, m, H-5b), 3.567 (1H, m, H-3b), 
3.638 (1H, m, H-4b), 3.661 (1H, dd, J = 
9.8, 3.7 Hz, H-2a), 3.688 (1H, m, H-6cu), 3.723 (1H, dd, J = 9.9, 8.8 Hz, H-4a), 3.787 (1H, m, H-
6au), 3.822 (1H, m, H-5a), 3.906 (1H, m, H-6cd),  3.911 (1H, m, H-6bu), 3.950 (1H, m, H-6ad), 
3.954 (1H, m, H-6bd), 4.009 (1H, dd, J = 9.8, 8.8 Hz, H-3a), 4.437 (1H, d, J = 7.9 Hz, H-1c), 4.507 
(1H, d, J = 7.9 Hz, H-1b), 5.512 (1H, d, J = 3.7 Hz, H-1a), 6.517 (1H, dd, ΣJ = 4.3 Hz, H-4’), 6.648 
(1H, dd, ΣJ = 3.3 Hz, H-6’), 6.791 (2H, m, ΣJ = 8.6 Hz, H-3”, H-5”), 6.831 (1H, dd, ΣJ = 3.4 Hz, H-2’), 
6.868 (1H, d, J = 16.3 Hz, H-α), 7.028 (1H, d, J = 16.3 Hz, H-β), 7.386 (1H, m, ΣJ = 8.6 Hz, H-2”, H-6”) 
13C NMR (150.95 MHz, MeOD): 61.67 (C-6a), 61.76 (C-6b), 62.70 (C-6c), 71.66 (C-4c), 73.09 (C-
5a), 73.39 (C-2a), 73.62 (C-3a), 74.94 (C-2b), 75.19 (C-2c), 76.41 (C-3b), 76.95 (C-5b), 78.12 (C-
3c), 78.42 (C-5c), 80.43 (C-4b), 80.64 (C-4a), 99.15 (C-1a), 104.67 (C-1b), 104.90 (C-1c), 107.58 
(C-2’), 108.69 (C-6’), 116.81 (C-3”, C-5”), 126.93 (C-α), 129.19 (C-2”, C-6”), 130.27 (C-β), 130.56 
(C-1”), 141.78 (C-1’), 158.83 (C-4”), 159.98 (C-5’), 160.10 (C-3’) 
 
3-O-β-D-Cellobiopyranosyl resveratrol 
1H NMR (600.23 MHz, MeOD): 3.275 (1H, dd, J 
= 9.2, 7.9 Hz, H-2b), 3.34a (1H, m, H-4b), 3.386 
(1H, ddd, J = 9.6, 5.8, 2.3 Hz, H-5b), 3.407 (1H, 
dd, J = 9.2, 8.8 Hz, H-3b), 3.537 (1H, dd, J = 9.0, 
7.8 Hz, H-2a), 3.627 (1H, ddd, J = 9.4, 4.2, 2.5 
Hz, H-5a), 3.659 (1H, dd, J = 9.0, 8.7 Hz, H-3a), 3.693 (1H, dd, J = 9.4, 8.7 Hz, H-4a), 3.700 (1H, dd, 
J = 11.9, 5.8 Hz, H-6bu),  3.918 (1H, dd, J = 11.9, 2.3 Hz, H-6bd), 3.928 (1H, dd, J = 12.3, 4.2 Hz, H-
6au), 3.982 (1H, dd, J = 12.3, 2.5 Hz, H-6ad), 4.472 (1H, d, J = 7.9 Hz, H-1b), 4.956 (1H, d, J = 7.8 
Hz, H-1a), 6.464 (1H, dd, ΣJ = 2.2 Hz, H-4’), 6.643 (1H, dd, ΣJ = 3.6 Hz, H-6’), 6.787 (2H, m, ΣJ = 8.6 
Hz, H-3”, H-5”), 6.79a (1H, m, H-2’), 6.869 (1H, d, J = 16.2 Hz, H-α), 7.030 (1H, d, J = 16.2 Hz, H-β), 
7.386 (1H, m, ΣJ = 9.0 Hz, H-2”, H-6”); a HSQC readout  
13C NMR (150.95 MHz, MeOD): 62.05 (C-6a), 62.78 (C-6b), 71.71 (C-4b), 75.02 (C-2a), 75.27 (C-
2b), 76.69 (C-3a), 77.03 (C-5a), 78.21 (C-3b), 78.47 (C-5b), 80.67 (C-4a), 102.46 (C-1a), 
104.42(C-4’), 104.92 (C-1b), 107.44 (C-2’), 108.65 (C-6’), 116.83 (C-3”, C-5”), 126.97 (C-α), 
129.24 (C-2”, C-6”), 130.32 (C-β), 130.62 (C-1”), 141.75 (C-1’), 158.83 (C-4”), 159.94 (C-3’), 
160.70 (C-5’)  
 
3-O-β-D-Cellotriopyranosyl resveratrol 
1H NMR (600.23 MHz, MeOD): 3.252 
(1H, dd, J = 9.2, 7.9 Hz, H-2c), 3.328 
(1H, dd, J = 9.6, 8.8 Hz, H-4c), 3.370 
(1H, ddd, J = 9.6, 5.8, 2.3 Hz, H-5c), 
3.393 (1H, dd, J = 9.2, 8.8 Hz, H-3b), 
3.536 (1H, dd, J = 9.0, 7.8 Hz, H-2a), 3.628 (1H, ddd, J = 9.5, 4.0, 2.5 Hz, H-5a), 3.665 (1H, dd, J = 
9.0, 8.7 Hz, H-3a), 3.687 (1H, dd, J = 11.9, 5.8 Hz, H-6cu), 3.703 (1H, dd, J = 9.5, 8.7 Hz, H-4a), 
3.905 (1H, dd, J = 11.9, 2.3 Hz, H-6cd), 3.938 (1H, dd, J = 12.4, 4.0 Hz, H-6au), 3.981 (1H, dd, J = 
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12.4, 2.5 Hz, H-6ad), 4.431 (1H, d, J = 7.9 Hz, H-1c), 4.956 (1H, d, J = 7.8 Hz, H-1a), 6.464 (1H, dd, 
ΣJ = 2.2 Hz, H-4’), 6.644 (1H, dd, ΣJ = 3.8 Hz, H-6’), 6.788 (2H, m, ΣJ = 8.7 Hz, H-3”, H-5”), 6.79a 
(1H, m, H-2’), 6.870 (1H, d, J = 16.2 Hz, H-α), 7.030 (1H, d, J = 16.2 Hz, H-β), 7.387 (1H, m, ΣJ = 9.0 
Hz, H-2”, H-6”); a HSQC readout  
13C NMR (150.95 MHz, MeOD): 61.93 (C-6a), 62.74 (C-6c), 71.67 (C-4c), 74.99 (C-2a), 75.20 (C-
2c), 76.60 (C-3a), 76.97 (C-5a), 78.15 (C-3c), 78.43 (C-5c), 80.48 (C-4a), 102.44 (C-1a), 104.38(C-
4’), 104.92 (C-1c), 107.41 (C-2’), 108.62 (C-6’), 116.80 (C-3”, C-5”), 126.94 (C-α), 129.22 (C-2”, C-
6”), 130.30 (C-β), 130.59 (C-1”), 141.73 (C-1’), 158.81 (C-4”), 159.92 (C-3’), 160.67 (C-5’)  
 
   -O-α-D-Cellobiopyranosyl epicatechin 
1H NMR (600.23 MHz, MeOD): 2.765 (1H, ddd, J = 16.6, 2.8, 0.5 Hz, H-
4’u), 2.888 (1H, dd, J = 16.6, 4.5 Hz, H-4’d), 3.272 (1H, dd, J = 9.2, 7.9 
Hz, H-2b), 3.342 (1H, m, H-4b), 3.38a (1H, m, H-5b), 3.402 (1H, dd, J = 
9.2, 8.6 Hz, H-3b), 3.669 (1H, dd, J = 9.7, 3.7 Hz, H-2a), 3.70a (1H, m, 
H-6bu), 3.703 (1H, dd, J = 9.8, 8.7 Hz, H-4a), 3.86a (1H, m, H-6au), 
3.92a (1H, m, H-6bd), 3.93a (1H, m, H-5a), 3.95a (1H, m, H-6ad), 4.026 
(1H, dd, J = 9.7, 8.7 Hz, H-3a), 4.211 (1H, ddd, J = 4.5, 2.8, 1.4 Hz, H-3’), 
4.462 (1H, d, J = 7.9 Hz, H-1b), 4.88a (1H, m, H-2’), 5.397 (1H, d, J = 3.7 
Hz, H-1a), 5.939 (1H, d, J = 2.3 Hz, H-6’), 5.965 (1H, d, J = 2.3 Hz, H-8’), 6.867 (1H, d, J = 8.2 Hz, H-
5”), 7.073 (1H, ddd, J = 8.2, 2.0, 0.7 Hz, H-6”), 7.427 (1H, d, J = 2.0 Hz, H-2”); a HSQC readout 
13C NMR (150.95 MHz, MeOD): 29.62 (C-4’), 61.87 (C-6a), 62.76 (C-6b), 67.74 (C-3’), 71.69 (C-
4b), 73.24 (C-5a), 73.57 (H-2a), 73.66 (C-3a), 75.23 (C-2b), 78.14 (C-3b), 78.44 (C-5b), 80.01 (C-
2’), 80.65 (C-4a), 96.24 (C-6’), 96.76 (C-8’), 100.32 (C-10’), 101.27 (C-1a), 104.93 (C-1b), 116.99 
(C-5”), 118.23 (C-2”), 123.54 (C-6”), 132.77 (C-1”), 146.27 (C-3”), 148.44 (C-4”), 157.59 (C-9’), 
158.00 (C-7’), 158.33 (C-5’) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
CHAPTER 9 
Turning bulk sugars into prebiotics: 
Chemoenzymatic synthesis of kojibiose from sucrose 
and glucose 
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1 ABSTRACT 
Over the past decade, prebiotics have gained increasing attention in the field of nutrition 
and gastroenterology. Although these compounds are known to stimulate the growth of 
beneficial bacterial populations, the variety of prebiotics is limited to date. Indeed, 
application testing of promising carbohydrates is often hampered by their limited 
availability, as is the case for the naturally occurring disaccharide kojibiose (2-O-α-D-
glucopyranosyl-D-glucopyranoside). In this work, the synthesis of kojibiose was 
evaluated using different SP variants. The L341I_Q345S variant of Bifidobacterium 
adolescentis sucrose phosphorylase was found to efficiently synthesize kojibiose, while 
remaining fully active after 1 week incubation at 55 °C. The use of an integrated 
approach during the design of the process, allowed the synthesis and isolation of 
kojibiose up to concentrations of 1.5 M. The produced kojibiose could be conveniently 
purified by treatment with baker’s yeast and was subsequently crystallized to obtain 
3 kg crystalline kojibiose with a purity of 99.8 %. 
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2 INTRODUCTION 
Over the past decade, the intimate relation between the gut microbiome and our 
physiology has been vastly described. Indeed, these micro-organisms play pivotal roles 
in our metabolism and immune response, as well as in several diseases like obesity, 
inflammatory bowel disease and type 2 diabetes5, 235. As a result, prebiotics, 
carbohydrates that stimulate the growth of beneficial bacterial populations in the 
human gut, have gained increasing attention236, 237. Commonly applied prebiotics include 
inulin1, trans- galactooligosaccharides2, resistant starches3 and mannan 
oligosaccharides4. Despite these examples, the current menu of prebiotics is rather 
limited and expanding their scope is highly desired238-240. 
 
In that respect, kojibiose (2-O-α-D-glucopyranosyl-D-glucopyranoside) is a very 
promising compound. Preliminary studies indicated that kojibiose and its derived 
oligosaccharides can selectively stimulate beneficial gut populations. Indeed, the α-1,2 
bond is largely resistant to the action of enzymes in the digestive tract, but can be 
cleaved by specific micro-organisms such as lactobacilli241-243. Besides its prebiotic 
properties, kojibiose is not metabolized by common oral bacteria and has therefore 
attracted attention as a low-calorie sweetener for the prevention of tooth decay243. 
Moreover, kojibiose has been described to inhibit α-glucosidase I244. These inhibitors are 
known to be candidate drugs for the treatment of HIV-1 infections245, while their 
inhibitory properties could limit the digestion of dietary carbohydrates. Kojibiose might 
therefore also find application in the treatment of diabetes, obesity and cardiovascular 
diseases246. 
 
However, in depth studies on the health-promoting properties of kojibiose are 
hampered by its high price and limited availability241. Although kojibiose is present in 
honey, beer, sake and koji, the amounts are far too low for practical isolation247-249. In 
parallel to the production of glycosides, also the chemical synthesis of kojibiose suffers 
from low yields and the generation of toxic waste250-252. Alternatively, isolation after 
partial acetolysis of dextran produced by Leuconostoc mesenteroides has been described. 
However, the latter procedure involves multiple steps requiring chemical reagents 
among which acetic anhydride, sulfuric acid, chloroform and methanol, while the 
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kojibiose yield is limited to 17 %253. Therefore, the enzymatic synthesis of kojibiose has 
been vastly explored. Examples include the use of α-glucosidases254 and α-
glucoamylases255, glucansucrase256, 257 and kojibiose phosphorylase258. Unfortunately, 
these processes suffer from low yields and the generation of side products. More 
recently a procedure using dextransucrase and galactosidase as biocatalysts was 
developed259. Although the latter strategy is certainly the most efficient and sustainable 
way to obtain kojibiose to date, it requires multiple enzymatic and yeast treatment 
steps, while the overall yield of 38 % can be considered average at best. Moreover, the 
purity of the obtained kojibiose was limited to 65 %. Higher purities could only be 
achieved by preparative liquid chromatography while freeze-drying was applied to 
obtain a powdered product259. 
 
In an attempt to overcome these drawbacks, the sucrose phosphorylase (SP) from 
Bifidobacterium adolescentis has very recently been engineered towards the synthesis of 
kojibiose43. Indeed, although the latter enzyme is able to convert sucrose and glucose to 
glucobioses, kojibiose accounted for only 33 % of the formed disaccharides (Figure 9.1). 
Moreover, substantial amounts of sucrose are hydrolyzed to fructose and glucose by the 
wild type enzyme. Interestingly, a number of variants with improved selectivity towards 
the synthesis of kojibiose were obtained43. In this chapter, these variants were 
thoroughly evaluated for the production of kojibiose. The reaction conditions were 
optimized, and a sustainable downstream processing methodology was established. 
Finally, the reaction was scaled to 10 L, illustrating the robustness and industrial 
applicability of the latter procedure.  
 
Figure 9.1 Reactions catalyzed by the SP from Bifidobacterium adolescentis in the presence of sucrose and 
glucose. Maltose and kojibiose are the main products, while only traces of isomaltose are formed.  
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3 RESULTS & DISCUSSION 
3.1 Selection of SP variant for the production of kojibiose 
Although recent research resulted in several SP mutants with enhanced properties 
towards the synthesis of kojibiose43, these variants haven’t been evaluated under 
production conditions to date. To that end, the most promising variants (L341I, 
L341I_Q345S, L341I_Q345N, and L341I_Y344A_Q345N) were studied in detail. The 
substrate concentration was varied between 0.1 and 1 M, while heat purified enzyme 
was added to concentrations between 1 and 4 mg/mL. From these experiments, a 
variety of parameters were obtained (Table S9.1). The average values for all parameters 
were then calculated to allow a straightforward comparison of the different variants 
(Table 9.1). 
 
 Table 9.1 Performance of various SP variants for the synthesis of kojibiose. The averages of all values 
calculated in Table S9.1 are reported. 
Enzyme 
Sel.a 
(%) 
Conv.b 
(%) 
Yield 
(%) 
Hydr.c 
(%) 
Efficiency 
(%) 
Productivity 
(g/g/h) 
L341I 79.7 95.7 43.5 34.8 51.5 5.7 
L341I_Q345S 97.1 67.8 51.1 30.7 67.1 5.4 
L341I_Q345N 98.3 38.7 23.4 36.0 62.6 1.6 
L341I_Y344A_Q345N 100.0 28.9 7.4 19.5 77.8 0.3 
a Selectivity, b Conversion, c Hydrolysis 
 
Triple mutant L341I_Y344A_Q345N displays both the highest selectivity and efficiency, 
while hydrolysis is limited to only 19.5 %. Indeed, the enzyme produces no other 
glucobioses (selectivity of 100 %), which, combined with the reduced hydrolysis, results 
in an efficiency of nearly 78 %.  Unfortunately, this increased selectivity comes at the 
expense of a severely reduced productivity. As a result, the average conversion 
remained below 30 %, while a kojibiose yield of only 7.4 % was observed. In contrast, 
single mutant L341I reached nearly 96 % conversion, while exhibiting the highest 
productivity. However, kojibiose accounted for only 80 % of the formed glucobioses, 
while hydrolysis amounted to roughly 35 %. Consequentially, the efficiency of the L341I 
variant was found to be rather limited. Interestingly, both double mutants exhibit 
intermediate properties. In particular, the L341I_Q345S mutant combines a high 
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selectivity with an enhanced productivity, resulting in the best kojibiose yield of all 
variants. In addition, the hydrolysis of the latter variant was found to be substantially 
lower compared to the L341I_Q345N mutant. Therefore, mutant L341I_Q345S was 
identified to be the most promising variant for the production of kojibiose.  
3.2 Stability of the L341I_Q345S mutant 
Although variants with improved properties were revealed, altering the structure of 
enzymes is known to influence their stability260, 261. Therefore, the thermostability of 
mutant L341I_Q345S, the wild type, and both single mutants was evaluated (Figure 9.2).  
 
Figure 9.2 Stability of selected SP mutants at 60 °C. The time required to reduce the initial activity to 50 % 
(t50) was calculated calculated from the equations obtained by fitting the linear part of the stability curves.  
 
When incubating the enzymes at 60 °C, a significant difference in thermostability was 
observed. The half-life time of the L341I_Q345S mutant was found to be decreased by 
roughly 30 %. A similar result was obtained for the Q345S variant, while the 
thermostability of the L341I mutant was comparable with the wild type enzyme. The 
reduced stability of the L341I_Q345S variant can thus be solely contributed to mutation 
Q345S. Despite this decreased stability, all variants remained fully active after one week 
incubation at 55 °C, thus enabling their application at the industrial scale. 
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3.3 Optimization of substrate concentrations and downstream processing: 
an integrated approach 
Industrial carbohydrate conversions are preferably run at elevated temperatures with 
high substrate concentrations96. Although the L341I_Q345S variant proved to be stable 
at 55 °C, the use of high sucrose and glucose concentrations might hamper the efficient 
isolation of kojibiose. Indeed, Saccharomyces cerevisiae is known to metabolize all 
contaminating carbohydrates (sucrose, glucose, fructose, maltose)262, while kojibiose 
isn’t consumed by the yeast259. However, these conversions are typically performed at 
moderate carbohydrate concentrations, not exceeding 200 g/L total carbohydrates259, 
263. Therefore, the reaction mixtures obtained by converting 0.25, 0.5, 1 and 1.5 M 
sucrose and glucose to kojibiose, were subjected to treatment with 30 g/L baker’s yeast 
at pH 7.0 and 30 °C (Figure 9.3).  
 
 
Figure 9.3 Yeast treatment of reaction mixtures obtained by converting 0.25 (A), 0.5 (B), 1 (C) and 
1.5 (D) M sucrose and glucose to equilibrium. Baker’s yeast was added to 30 g/L, and the reactions were 
incubated at 30 °C and pH 7.0. The concentration of glucose (●), fructose (○), sucrose (▼), kojibiose (△) 
and maltose (■) was followed in time. 
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Interestingly, the addition of 30 g/L S. cerevisiae allowed the elimination of all 
contaminating carbohydrates after 4 and 6 h, when starting from 250 and 500 mM 
sucrose and glucose, respectively. In contrast to the reaction starting from 500 mM 
substrate, baker’s yeast was found to slowly metabolize kojibiose after 6 h when starting 
from 250 mM sucrose and glucose. Unfortunately, higher substrate concentrations 
severely hampered the yeast’s action. As a result, roughly 70 and 90 % of the undesired 
contaminants remained present after 14 h when using substrate concentrations of 1 and 
1.5 M respectively. Extended incubation of these reaction mixtures (up to 7 days) failed 
to remove all undesired carbohydrates. Similar results were obtained when incubating 
the baker’s yeast at pH 5.0, indicating the limited effect of the acidity on the performance 
of S. cerevisiae for the latter conversions (Figure S9.1).  
 
Although reacting 500 mM sucrose and glucose with the L341I_Q345S variant easily 
outperforms the most efficient method for the synthesis of kojibiose to date259, higher 
kojibiose concentrations would be desirable. At the end of the enzymatic conversion, all 
sucrose is converted, resulting in roughly 350 mM kojibiose, while also approximately 
500 mM fructose and 200 mM glucose are present (Figure 9.3). Reducing the amount of 
the latter side products, would allow higher kojibiose titers during the yeast treatment. 
Therefore, the use of glucose isomerase (GI) was evaluated to convert the 
stoichiometrically formed fructose to glucose, which can then be used as acceptor 
(Figure 9.4).  
 
 
Figure 9.4 Synthesis of kojibiose from sucrose and glucose by the Bifidobacterium adolescentis 
L341I_Q345S SP. Glucose isomerase (GI) was used to convert the formed fructose to the acceptor 
substrate glucose. 
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The latter adaptation was found to allow the use of higher sucrose and lower glucose 
concentrations, while producing more kojibiose (Table 9.2). 
 
Table 9.2 Performance of Bifidobacterium adolescentis L341I_Q345S SP under various reaction 
conditions. All reactions were performed at 55 °C in the presence of 2 mg/mL heat purified L341I_Q345S.  
Sucrose 
(mM) 
Glucose 
(mM) 
GI Reaction 
time (h) 
Kojibiose 
(mM) 
Atom 
efficiency (%) 
Yeast 
reaction (h)a 
250 250 -d 24 201 52.7 4 
500 500 -d 24 374 49.0 6 
1000 1000 -d 48 754 49.4 -b 
1500 1500 -d 69 1008 44.0 -b 
1500 300 +e 69 1135 68.5 -b 
800 200 +e 48 596 65.8 9 
1600 200 +e 69 1332 78.1 11 
1800 200 +e 69 1507 79.1 12 
2000 200 +e 69 1664 79.0 Pc 
a  Time required to remove >99 % of the contaminating carbohydrates. b The contaminating carbohydrates 
could not be removed by yeast treatment. c Kojibiose precipitated during yeast treatment. d No glucose 
isomerase was added. e 20 g/L glucose isomerase was added after 2h.  
 
Combining the use of glucose isomerase with high sucrose and low glucose 
concentrations, was found to significantly increase the atom efficiency (Table 9.2). The 
latter parameter, which is a measure for the efficient use of substrates, could be 
increased to 79 %; a tremendous improvement compared to the recently reported 19 % 
for the synthesis from lactose and glucose259. Moreover, kojibiose concentrations 
exceeding 1.5 M were readily achieved. Much to our surprise, we were able to remove all 
contaminating carbohydrates, when reacting 1.8 M sucrose with 0.2 M glucose. In 
contrast, when using 1.5 M sucrose and 0.3 M glucose, we failed to purify kojibiose. The 
latter phenomenon was studied in detail by adding kojibiose to 1 M final concentration 
after the enzymatic conversion of 500 mM sucrose and glucose (Figure 9.5).  
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Figure 9.5 Effect of kojibiose on the performance of Saccharomyces cerevisiae. Yeast treatments were 
performed on reaction mixtures obtained by converting 500 mM sucrose and glucose to equilibrium (A) 
and an identical reaction mixture supplemented with kojibiose to 1 M (B). Baker’s yeast was added to 
30 g/L, and the reactions were incubated at 30 °C. The concentration of glucose (●), fructose (○), 
sucrose (▼), kojibiose (△) and maltose (■) was followed in time. 
 
Remarkably, the presence of 1 M kojibiose did not significantly influence the 
performance of S. cerevisiae (Figure 9.5). Nevertheless, previous experiments 
demonstrated the inhibitory effect of such elevated carbohydrate concentrations (Figure 
9.3). Therefore, this inhibition is solely related to high fructose and glucose 
concentrations, while the presence of kojibiose doesn’t significantly influence the yeast’s 
performance. Indeed, reacting 1.8 M sucrose with 0.2 M glucose, resulted in a combined 
total of 786 mM fructose and glucose, while the reaction starting from 1.5 M sucrose and 
0.3 M glucose yielded more than 1 M of the latter carbohydrates.  In conclusion, the 
combined glucose and fructose concentration should be kept well below 1 M. Although 
further increasing the sucrose concentration to 2 M resulted in an impressive kojibiose 
concentration approaching 1.7 M, such high concentrations were found to result in 
precipitation during the yeast treatment.   
3.4 Crystallization of kojibiose 
As described above, reacting 1.8 M sucrose with 0.2 M glucose resulted in 1.5 M 
kojibiose. Although all contaminating carbohydrates could be successfully removed by 
yeast treatment, obtaining the desired product in crystalline form often remains a 
challenge53. Indeed, S. cerevisiae is known to produce metabolites (mainly glycerol 
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and/or organic acids), which might hamper the crystallization of kojibiose259. Although 
the concentration of these contaminants increased with increasing substrate 
concentrations, we were able to obtain kojibiose crystals by performing an evaporative 
step at 50 °C to a Brix of 60, followed by cooling crystallization at 4 °C. Remarkably, the 
addition of glycerol up to 300 mM did not affect the crystallization of kojibiose under 
these conditions.  
 
Encouraged by these results, the crystallization of kojibiose was studied in detail. To that 
end, the concentration of kojibiose prior to the cooling crystallization step was altered 
between 75 and 42 ° Bx, corresponding to 2.07 and 1.16 M respectively (Figure S9.2). 
These mixtures were then overnight cooled from 50 °C to room temperature, and 
subsequently cooled to 4 °C, after which crystal growth was continued during 24 h. Next, 
the (microscopic) appearance of the crystals (Figure S9.3 and S9.4), crystallization yield, 
whiteness and purity of the obtained kojibiose crystals were evaluated (Table 9.3).   
 
Table 9.3 Cooling crystallization of kojibiose. The performance at different Brixes was evaluated by 
determining the crystallization yield and measuring the whiteness and purity of all crystals.  
Brix             
(° Bx) 
ICUMSA 
score 
Purity                    
HPAEC-PAD (%) 
Purity          
HPLC-RI (%) 
Crystallization    
Yield (%) 
75 400.0 96.40 98.41 85.5 
60 379.0 96.66 94.16 72.5 
55 217.5 98.08 99.87 74.9 
50 196.5 98.47 99.90 74.2 
48 129.8 99.81 99.98 72.3 
46 168.4 98.08 99.95 58.2 
44 164.9 98.17 99.86 51.7 
42 789.5 96.12 89.45 46.2 
 
Although the highest crystallization yield was achieved at Brix 75, the obtained purity of 
the crystals was limited to 96 %. Decreasing the Brix resulted in lower crystallization 
yields, but also significantly improved the purity of the obtained crystals. Interestingly, 
Brix 48 was found to combine a high crystallization yield, with a purity exceeding 
99.8 %. Also, the crystals obtained at Brix 48 presented the lowest ICUMSA score, 
reflecting their whiteness. Moreover, the latter crystals were visible with the naked eye 
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(Figure S9.4). Indeed, in contrast to cooling crystallization at higher Brixes, the presence 
of large kojibiose needle shaped crystals was confirmed by microscopic analysis up to 
Brix 50 (Figure S9.4)264.   
 
In conclusion, crystallization at Brix 48 resulted in white crystals with a purity 
exceeding 99.8 % (Figure 9.6). The corresponding crystallization yield of 72 % could be 
conveniently increased to 96 % by performing a second crystallization on the 
supernatant, yielding 99 % pure kojibiose. Alternatively, the sucrose concentration was 
increased from 1.8 to 2 M, resulting in the spontaneous crystallization of kojibiose upon 
cooling (Table 9.2). Although the latter procedure avoids the use of S. cerevisiae, the 
purity of the obtained crystals was limited to 97.5 %. Despite the presence of minor 
amounts of glucose and fructose, this procedure allows the straightforward isolation of 
kojibiose, and was identified a valuable alternative for obtaining bulk kojibiose.     
   
 
Figure 9.6 Purity of kojibiose crystals obtained by reacting 1.8 M sucrose with 0.2 M glucose, followed by 
cooling crystallization at Brix 48. The crystals were analyzed by HPAEC-PAD (A) and HPLC-RI (B). The 
small peak at 1 min in the HPAEC-PAD profile corresponds to the injection peak. 
3.5 Proof of concept: production at 10 L scale 
Finally, the scalability and industrial applicability of the developed process was 
illustrated by performing the synthesis of kojibiose at 10 L scale (Figure 9.7). As a result, 
roughly 3 kg of kojibiose with a purity exceeding 99.8 % was obtained, while 
crystallization of the supernatant resulted in approximately 1 kg of 99 % pure kojibiose. 
In contrast to the current production strategies for kojibiose, we thus developed a 
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sustainable, cost-effective and scalable biocatalytic process for the production of highly 
pure kojibiose. Moreover, the substrates sucrose and glucose are cheap and readily 
available bulk sugars.  
 
 
Figure 9.7 Large scale production of kojibiose. Synthesis of kojibiose in a 30 L reactor (A), washing and 
drying of the crystals (B), storage of 3 kg highly pure kojibiose (C). 
4 CONCLUSION 
Following the work on the synthesis of various α- (CHAPTER 2, 3 and 4) and β-glucosides 
(CHAPTER 5), this chapter illustrates the applicability of disaccharide phosphorylases for 
the synthesis of specialty carbohydrates. A variety of SP variants were evaluated under a 
broad range of process conditions, indentifying variant L341I_Q345S as the most 
promising biocatalyst. Indeed, an integrated approach, optimizing both reaction 
conditions and downstream processing at the same time quickly led to the synthesis and 
purification of kojibiose at concentrations exceeding 1.5 M. Moreover, the atom 
efficiency of the latter process was increased to an impressive 79 % through the use of 
glucose isomerase. The optimized process finally allowed the isolation of 3 kg crystalline 
kojibiose with a purity of 99.8 %. In conclusion, we developed a sustainable, cost-
effective and scalable biocatalytic process for the production of highly pure kojibiose, 
starting from renewable, cheap and readily available bulk sugars.  
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5 MATERIALS & METHODS 
5.1 Enzyme production, purification and quantification 
The recombinant SP from B. adolescentis, the L341I, Q345S, L341IQ345S, L341I_Q345N, 
and L341I_Y344A_Q345N variant were routinely grown as described in CHAPTER 2. The 
obtained pellets were lysed in 2 mM MOPS buffer at pH 7.0 (CHAPTER 2), and partially 
purified by 15 min incubation at 58 °C, followed by centrifugation (18 000 g, 4 °C, 
30 min). Alternatively, the N-terminal His6-tagged proteins were purified by nickel-
nitrilotriacetic acid metal affinity chromatography. The protocol as described by the 
supplier (Qiagen) was used, and the obtained enzyme solutions were washed with MOPS 
buffer (50 mM, pH 7.0) and concentrated using Centricons (Amicon Ultra 30K, 
Millipore). Protein concentrations were measured with the BCA Protein Assay kit 
(Pierce), using bovine serum albumin as standard. All assays were performed in 
triplicate and had a CV of less than 10 %. 
5.2 Quantification of reaction products 
The concentration of carbohydrates was followed by high performance anion exchange 
chromatography (HPAEC) (Dionex ICS-3000, Thermo Scientific), using a CarboPac PA20 
pH-stable column and pulsed amperometric detection (PAD). Separation of sucrose, 
glucose, fructose, trehalose, kojibiose, nigerose, maltose, isomaltose, was achieved using 
a 30 min protocol. After 13 min of isocratic elution with 30 mM NaOH, the concentration 
was gradually increased to 100 mM in 5 min, kept constant for 3 min and decreased 
again to 30 mM within 1 min, followed by an equilibration period of 8 min. The 
temperature and flow rate were set at 30 °C and 0.5 mL/min respectively. Alternatively, 
the purity of the crystallised kojibiose was analyzed by HPLC using an Aminex HPX-87H 
column (Bio-Rad), equilibrated at 30°C. The eluent consisted of 5 mM H2SO4 in milliQ at 
a flow rate of 0.6 mL/min. Adequate detection was achieved with a refractive index 
detector. These measurements were used to calculate the following parameters, 
whereby          represents the initial sucrose concentration.  
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5.3 Stability assays 
The kinetic thermostability of the wild type SP, the L341I, Q345S and L341I_Q345S 
variant was determined by diluting 0.5 mg/mL His-tag purified enzyme in a 50 mM 
MOPS buffer at pH 7.0. The mixtures were incubated in a water bath at 55 or 60 °C, and 
samples were placed on ice at regular intervals. Next, the samples were added to a 
substrate solution containing 500 mM sucrose and glucose dissolved in a 50 mM MOPS 
buffer at pH 7.0. The residual activity was determined by incubating the reaction 
mixtures at 55 °C, and following the kojibiose concentration using the HPAEC-PAD 
method described above. The t50-values, which is the time required to reduce the initial 
enzymatic activity by 50 %, were calculated from the equations obtained by fitting the 
linear part of the stability curves. 
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5.4 Biocatalytic synthesis of kojibiose 
The synthesis of kojibiose was performed by dissolving varying amounts of glucose and 
sucrose in milliQ water. Unless stated otherwise, 2 mg/mL of the heat purified SP 
variants was used, and the reaction mixtures were incubated at 55 °C. The pH of this 
buffer free system was set at 7.0, and remained constant throughout all conversions. If 
required, glucose isomerase (Sweetzyme® IT Extra, Novozymes) was added to 20 g/L 
after 2 h.  
5.5 Purification of kojibiose  
Prior to the yeast treatment, immobilized glucose isomerase was removed by filtration 
over a Whatman paper, and SP was inactivated by heating the solutions to 90 °C during 
10 min. The purification of various reaction mixtures was then performed by adding 
30 g/L spray dried baker’s yeast (Algist Bruggeman) in 50 mL falcons with perforated 
lids. The reactions were incubated at 30 °C and 50 rpm on a thermoshaker (Eppendorf). 
Unless stated otherwise, no buffers were added, resulting in a gradual pH drop from 7.0 
to roughly 5.0 at the end of the yeast treatment. Alternatively, the pH was kept constant 
at 7.0 or 5.0 throughout the fermentation by performing the yeast treatments in a 50 
mM MOPS or sodium acetate buffer. Upon depletion of all contaminating carbohydrates, 
the yeast was removed by centrifugation (5 000 g, 4 °C, 15 min) using a Sorvall RC-6+ 
centrifuge (Thermo Scientific). Finally, the solution was filtered over a vacuum filtration 
system with a pore size of 0.22 µm (Corning) to remove any suspended solids.   
5.6 Crystallization of kojibiose  
Prior to the cooling crystallization, the kojibiose solutions were evaporated in vacuo to 
varying concentrations by means of a rotavapor (Büchi R-200). The temperature and 
pressure were set at 50 °C and 50 mbar respectively, while the kojibiose concentration, 
expressed as Brix (°Bx), was determined by a series of ATAGO hand refractometers. Next 
the samples were cooled overnight from 50 °C to room temperature, while shaking on a 
rotary shaker at 20 rpm. The samples were subsequently cooled to 4 °C over a period of 
4 h, and crystal growth was allowed for another 24 h at 4 °C and 20 rpm. Next, the 
kojibiose crystals were isolated by filtration over a Whatman paper, washed with 
ethanol and dried to the air. 
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5.7 Properties of kojibiose crystals  
The purity of the obtained kojibiose crystals was determined using HPAEC-PAD and 
HPLC-RI as described in section 5.2, while the microscopic appearance was evaluated 
using an Olympus CH30 microscope at 100x and 400x total magnification. The 
crystallization yield and whiteness of the crystals, expressed by the ICUMSA score were 
calculated as follows: 
                          
                          
                                                   
     
 
 
                              
                                               
   
 
 
with c the carbohydrate concentration (g/mL) and b the path length (cm).  
5.8 Large scale production of kojibiose 
Large scale production of kojibiose was performed by dissolving 6 kg sucrose and 350 g 
glucose to a total volume of 10 L in milliQ water. The mixture was supplemented with 
1 mg/mL heat purified B. adolescentis L341I_Q345S SP, and incubated at 55 °C and 
35 rpm in a 30 L Biostat C reactor (B. Braun Biotech). After 4 h, 200 g of prewashed 
Sweetzyme® IT Extra (Novozymes) was added, and the formation of kojibiose was 
continued during 4 days. Next, the immobilized glucose isomerase was conveniently 
removed by filtration over a fritted column with a hot water jacket at 55 °C. The 
obtained solution was then heated to 90 °C during 10 min, cooled to 30 °C, and 
supplemented with 300 g baker’s yeast. Once all contaminating carbohydrates were 
removed, the yeast was separated by vacuum filtration over a Seitz® K series depth 
filter. The residue was then evaporated in vacuo at 50 °C to a Brix of 48, cooled overnight 
to room temperature, and subsequently incubated during 24 h at 4 °C and 20 rpm. The 
obtained crystals were washed with 2 L ethanol over a Seitz® K Series Depth Filter, and 
dried to the air.  
6 SUPPLEMENTARY INFORMATION
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Table S9.1 Performance of various SP variants for the synthesis of kojibiose. The reported parameters were calculated after 8 h incubation at 55 °C. 
Enzyme 
Sucrose 
(mM) 
Glucose 
(mM) 
Enzyme 
(mg/mL) 
Selectivity 
(%) 
Conversion 
(%) 
Yield 
(%) 
Hydrolysis 
(%) 
Efficiency 
(%) 
Productivity                             
(g kojibiose/(g 
protein*h)) 
L341I 100 100 1 86.1 100.0 34.7 66.8 28.6 1.5  
L341I 250 250 1 81.4 100.0 47.3 39.3 49.5 5.1  
L341I 500 500 1 78.8 95.9 49.8 33.8 52.2 10.7  
L341I 500 250 1 79.1 93.8 36.3 49.1 40.3 7.8  
L341I 1000 1000 1 77.5 67.9 38.1 17.2 64.2 16.3  
L341I 100 100 3 85.2 100.0 33.8 67.6 27.6 0.5  
L341I 250 250 3 80.7 100.0 47.6 43.3 45.7 1.7  
L341I 500 500 3 77.3 100.0 58.0 10.2 69.4 4.1  
L341I 500 250 3 76.2 100.0 41.2 22.2 59.2 2.9  
L341I 1000 1000 3 74.4 100.0 47.7 8.4 78.1 6.8  
L341I_Q354S 100 100 1 98.7 99.7 63.1 64.0 35.6 2.7  
L341I_Q354S 250 250 1 97.6 43.4 45.0 37.0 61.5 4.8  
L341I_Q354S 500 500 1 96.8 31.4 36.5 24.7 72.9 7.8  
L341I_Q354S 500 250 1 97.3 35.5 25.8 36.4 61.9 5.5  
L341I_Q354S 1000 1000 1 96.2 47.1 29.0 13.5 83.2 12.4  
L341I_Q354S 100 100 3 99.0 100.0 52.3 47.7 51.8 0.7  
L341I_Q354S 250 250 3 97.6 99.9 68.0 31.7 66.7 2.4  
L341I_Q354S 500 500 3 96.0 78.6 71.5 17.7 79.0 5.1  
CHAPTER 9 TURNING BULK SUGARS INTO PREBIOTICS 
 
181 
 
L341I_Q354S 500 250 3 96.1 69.3 63.0 29.1 68.1 4.5  
L341I_Q354S 1000 1000 3 95.4 73.7 56.7 5.1 90.6 8.1  
L341I_Q354N 100 100 2 100.0 61.5 25.4 43.4 56.6 0.5  
L341I_Q354N 250 250 2 100.0 14.9 19.1 86.5 13.5 1.0  
L341I_Q354N 500 500 2 97.5 19.2 17.2 4.1 90.0 1.8  
L341I_Q354N 500 250 2 98.7 24.9 13.0 43.0 56.3 1.4  
L341I_Q354N 1000 1000 2 96.6 42.7 16.5 22.4 75.0 3.5  
L341I_Q354N 100 100 4 100.0 85.3 34.7 48.2 51.8 0.4  
L341I_Q354N 250 250 4 99.4 37.0 28.5 40.3 59.3 0.8  
L341I_Q354N 500 500 4 98.0 34.2 24.0 28.9 69.7 1.3  
L341I_Q354N 500 250 4 97.7 29.8 21.7 39.2 59.4 1.2  
L341I_Q354N 1000 1000 4 95.5 37.4 34.2 12.0 84.0 3.7  
L341I_Y344A_Q354N 100 100 4 100.0 39.3 11.4 40.9 59.1 0.1  
L341I_Y344A_Q354N 250 250 4 100.0 13.9 7.4 24.7 75.3 0.2  
L341I_Y344A_Q354N 500 500 4 100.0 14.7 8.7 12.3 91.2 0.5  
L341I_Y344A_Q354N 500 250 4 100.0 17.1 6.4 23.2 76.8 0.3  
L341I_Y344A_Q354N 1000 1000 4 100.0 59.4 3.1 22.1 77.9 0.3  
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Figure S9.1 Yeast treatment of reaction mixtures obtained by converting 0.25 (A), 0.5 (B), 1 (C) and 
1.5 (D) M sucrose and glucose to equilibrium. Baker’s yeast was added to 30 g/L, and the reactions were 
incubated at 30 °C and pH 5. The concentration of glucose (●), fructose (○), sucrose (▼), kojibiose (△) and 
maltose (■) were followed in time. 
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Figure S9.2 Relation between the Brix (° Bx) and kojibiose concentration (mM). 
 
 
 
Figure S9.3 Appearance of kojibiose crystals obtained by cooling crystallization at various kojibiose 
concentrations.  
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Figure S9.4 Microscopic appearance of kojibiose crystals obtained by cooling crystallization at various 
kojibiose concentrations.
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During this PhD thesis, numerous technologies, resulting in the synthesis and isolation 
of various glycosides, were developed. An overview of the most frequently used 
enzymes, substrates and techniques is shown in Figure D.1, which might be helpful to 
follow the discussion below. Remarkably, the technologies developed during this 
research allow the production of α-glucosides, β-glucosides, α-cellobiosides, β-
cellobiosides and kojibiose, requiring only the cheap and readily available sucrose as 
carbohydrate source. 
 
 
Figure D.1 Schematic overview of the glycosylation reactions performed with glycoside phosphorylases 
during this research. Abbreviations: R-OH, acceptor; Pi, inorganic phosphate; SP, sucrose phosphorylase; 
CP, cellobiose phosphorylase; CDP, cellodextrin phosphorylase; ILs, ionic liquids; iCLEAs, imprinted cross-
linked enzyme aggregates; Yeast, yeast treatment with Saccharomyces cerevisiae; αG1P, α-D-glucose 1-
phosphate ; Glc, glucose; Cb, cellobioiside and αGG, α-glucosyl glycerol. 
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1 SUGARY PHOSPHATES 
Glycosyl phosphates are efficient glycosyl donors for both chemical and enzymatic 
glycosylation reactions47. Indeed, α-D-glucose 1-phosphate (αG1P) is the preferred 
donor for many glycoside phosphorylases, including cellobiose phosphorylase (CP) and 
cellodextrin phosphorylase (CDP). Although these ‘sugary phosphates’ can be chemically 
synthesized, the required procedures suffer from low yields, a lack of anomeric 
selectivity, and the generation or large quantities of toxic waste50. Biocatalytic synthesis 
through the action of kinases on the other hand, requires ATP as phosphate donor. 
Interestingly, glycoside phosphorylases require only cheap inorganic phosphate and a 
di- or oligosaccharide for the synthesis of various glycosyl phosphates.  
 
The latter concept has been repeatedly applied for the synthesis of αG1P from sucrose 
and inorganic phosphate with sucrose phosphorylase (SP) immobilized on corn stover64, 
diethylaminoethyl cellulose65, and Eupergit C52. Despite these endeavors, the industrial 
applicability is hampered by the limited operational temperature of 30 or 37 °C. Indeed, 
the combination of such temperatures and the presence of  carbohydrates will inevitably 
give rise to microbial contamination. In contrast, the production process for αG1P 
described in CHAPTER 1 was continuously performed at 60 °C during 2 weeks. The use of 
this elevated temperature was facilitated by choosing a thermostable SP, and further 
improving its stability by multipoint covalent immobilization44.  
 
Moreover, combining heat purification with immobilization on Sepabeads EC-HFA, 
allowed the synthesis of αG1P up to 179 g/L/h. Consequently, one would be capable of 
producing 4 tons of αG1P on a daily basis, by immobilizing the SP obtained from a 320 L 
fermentation on 1 m³ of Sepabeads EC-HFA. As a result, the limited availability of αG1P 
has been clearly overcome, allowing its use as glucosyl donor at the industrial scale. 
Although the synthesis of β-D-glucose 1-phosphate and α-D-galactose 1-phosphate have 
been described using the trehalose phosphorylase from Thermoanaerobacter brockii53 
and a tailor made lactose phosphorylase54 respectively, both production processes could 
most likely be enhanced by immobilizing the enzymes on Sepabeads. Indeed, the latter 
modification would allow continuous operation in a packed bed reactor, while boosting 
the thermostability. 
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2 SWEET STABILIZATION 
Stabilization of proteins by polyols and carbohydrates is a well known phenomenon. 
Sucrose, for example, can stabilize the native state of proteins against both chemical 
denaturants and temperature265. Studies on the protein-buffer interaction revealed that 
sucrose is preferentially excluded from the protein domain, thereby increasing the free 
energy of the system. Thermodynamically this results in protein stabilization, as the 
unfolded state of the protein becomes thermodynamically even less favorable in the 
presence of sucrose266.  
 
The results obtained during this research indicate that the latter stabilization also 
applies to SP. Indeed, the addition of sucrose to concentrations exceeding 0.2 M was 
found to inhibit tert-butyl alcohol mediated precipitation of SP (CHAPTER 2). Moreover, 
the addition of sucrose resulted in a 25-fold increased half-life when SP was dissolved in 
20 % DMSO or AMMOENG 101. Comparable results, obtained with the well-known 
protectant trehalose117, indicate that the observed stabilization originates from non-
specific interactions at the protein surface (CHAPTER 3). CHAPTER 4, on its turn, revealed 
the necessity of high sucrose concentrations to obtain proper glucosylation in biphasic 
reaction systems. Interestingly, this stabilization also applies to immobilized SP variants. 
While previous research already showed that sucrose increases the yield of multipoint 
covalent immobilization44, the results obtained in CHAPTER 1 with SP Sepabeads clearly 
show its stabilizing effect on SP Sepabeads. Immobilized SP is known to lose roughly 
25 % of its activity after 16 h incubation at 60 °C. Nevertheless, we found that the 
activity of SP Sepabeads in the presence of sucrose, remained constant up to extended 
reaction times of 2 weeks. 
 
In addition, the presence of sucrose was found to also boost the solubility of 
hydrophobic compounds such as quercetin and resveratrol (CHAPTER 3). Interestingly, 
sucrose is the preferred donor substrate of SP. Therefore, all these effects can be 
considered additional benefits, as sucrose has to be added as substrate, regardless of its 
stabilizing and solubilizing properties. The addition of sucrose or trehalose might also 
be applied to stabilize other glycoside phosphorylases. However, depending on the 
intended reaction, the use of these additional disaccharides might complicate product 
isolation. 
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3 BAKERS’ YEAST: A POWERFUL CLEAN-UP TOOL? 
Saccharomyces cerevisiae, or bakers’ yeast, is known to metabolize a variety of 
carbohydrates, including the monosaccharides D-glucose, D-fructose, D-mannose and D-
galactose, as well as disaccharides such as maltose and sucrose. Other carbohydrates 
like D-xylose, lactose and cellobiose, are largely resistant; allowing the use of baker’s 
yeast to purify these compounds262. Indeed, the non-resistant monosaccharides enter 
the anaerobic glycolysis, resulting in the formation of pyruvic acid. The latter is then 
decarboxylated, thereby liberating CO2 and acetaldehyde, which is on its turn reduced to 
ethanol. The formed CO2 and ethanol can be conveniently removed by simple 
evaporation. Consequently, the use of a microorganism can be considered an 
environmentally friendly alternative compared to chromatography.    
 
During this research, baker’s yeast was applied to purify a variety of compounds. In 
CHAPTER 1,  S. cerevisiae was successfully used to purify αG1P from  a reaction mixture 
that also contained sucrose, phosphate, fructose and traces of glucose. The extracellular 
invertase was found to quickly hydrolyze sucrose, after which glucose and fructose were 
sequentially metabolized. The latter strategy allowed the isolation of large quantities of 
crystalline αG1P, thereby avoiding the use of labor intensive chromatography steps. Also 
kojibiose was found to be largely resistant to baker’s yeast, while all other 
carbohydrates present in the reaction mixture were metabolized by S. cerevisiae 
(CHAPTER 9). Although these conversions are typically performed at moderate 
carbohydrate concentrations259, 263, the presence of 1 M kojibiose (on top of a combined 
total of roughly 150 g/L fructose and glucose) did not significantly influence the 
performance of S. cerevisiae. 
 
The latter surprising observation illustrates that one should, however, always carefully 
evaluate the suitability of treatment with baker’s yeast. Indeed, the complexity of the 
yeast metabolism is hidden behind this seemingly straightforward operation. Methyl 
gallyl 4-O-α-D-glucopyranoside, as produced in CHAPTER 4, was readily metabolized by S. 
cerevisiae, while the glucosides of quercetin were largely resistant267. Moreover, S. 
cerevisiae is known to produce metabolites (mainly glycerol and/or organic acids), 
which might hamper crystallization of the desired products259. All in all, treatment with 
baker’s yeast can be considered a valuable alternative to remove common mono- and 
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disaccharides during the enzymatic preparation of carbohydrates or glycosides. 
Nevertheless, the latter purification strategy should be carefully evaluated for each 
application, thereby monitoring the concentration of all compounds, and assessing the 
formation of stress metabolites.  
4 IMPRINTING AND CROSS-LINKING: A HAPPY MARRIAGE 
Molecular imprinting is an attractive alternative to mutagenesis for changing the 
specificity of biocatalysts82. Indeed, modification of the three-dimensional structure of  
proteins by noncovalent interactions with an imprinting molecule, has been vastly 
reported83. In order to achieve these effects, the enzymes are typically contacted with an 
imprinting molecule under mild denaturing conditions. Unfortunately, imprinted 
enzymes are only able to maintain their new conformation when transferred to a non-
aqueous environment or when immobilized by cross-linking. Although the latter 
strategy was successfully applied for the creation of a galactose oxidase from a glucose 
oxidase, a complex radical polymerization procedure, requiring transfer to organic 
solvents and derivatization of the enzyme was required88.  
 
In CHAPTER 2, a molecular imprinting technique using glutaraldehyde mediated cross-
linking, instead of radical polymerization in pure organic solvents, was developed. This 
procedure can be performed in an aqueous environment and gives rise to a new enzyme 
formulation called imprinted cross-linked enzyme aggregate (iCLEA). Proof of concept 
was delivered by imprinting SP with α-glucosyl glycerol. As a consequence, the enzyme’s 
specific activity towards glycerol was increased two-fold while simultaneously 
providing an exceptional stability at 60 °C. The applicability of the latter technique for 
the synthesis of octyl β-D-glucopyranoside with CP, was evaluated in CHAPTER 5. 
Interestingly, imprinting with octyl β-D-glucopyranoside did not significantly increase 
the transglycosylation activity of the enzyme. However, the addition of octanol roughly 
doubled the rate of octyl β-D-glucopyranoside synthesis, while the activity of the iCLEA 
towards glucose was decreased by 45 %. In contrast to imprinting SP (CHAPTER 2), the 
acceptor molecule rather than the glucoside was found to enhance the desired 
glycosylation activity of CP. The latter difference may be explained by the reaction 
mechanism of both enzymes. Indeed, while SP is a retaining phosphorylase using a 
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double displacement mechanism, CP is an inverting phosphorylase following a single 
displacement mechanism.  
 
The results obtained in CHAPTER 2 and 5 indentified the newly developed iCLEA 
technology as a valuable tool for enzyme engineering. The latter strategy allows to 
simultaneously boost the specificity and stability of biocatalysts; two common targets of 
enzyme engineering experiments. The availability of the desired product as imprinting 
molecule can be considered the main disadvantage. Moreover, certain compounds, such 
as sucrose, were found to inhibit precipitation of enzymes, while some affinity between 
the enzyme and imprinting molecule is generally required. Although iCLEAs can be 
conveniently recycled, they are unfortunately not suited for operation in packed-bed 
columns. Nevertheless, the potential of iCLEAs reaches far beyond phosphorylases, and 
could find widespread application in the field of enzyme engineering. 
5 IONIC LIQUIDS: THE GREEN ALTERNATIVE? 
Although disaccharide phosphorylases have received increasing attention as promising 
biocatalysts for glycoside synthesis, these enzymes typically have a very low affinity for 
non-carbohydrate acceptors. For hydrophobic acceptors, concentrations compensating 
for the high Km values are not readily achieved in aqueous solutions. Enzymatic 
glycosylation of these compounds is, therefore, commonly performed in the presence of 
organic cosolvents, such as DMSO or methanol. However, these solvents are not 
compatible with numerous applications of carbohydrate-derived products, while their 
presence often leads to the partial inactivation biocatalysts. Ionic liquids (ILs), in 
contrast, have emerged recently as a new class of solvents for biocatalytic applications. 
These ‘green’ solvents consist of salts with a low melting point (<100 °C), possess no 
vapor pressure and are consequentially inflammable. Their ability to dissolve both polar 
and hydrophobic substrates has already been exploited in glycosylation reactions. 
Nevertheless, the use of ILs as cosolvents for glycoside phosphorylases hasn’t been 
considered to date.  
 
In CHAPTER 3, the ability of a range of ILs to dissolve medium- and long-chain alcohols, 
flavonoids, alkaloids, phenolics and terpenes, was scrutinized. The addition of 20 % ILs 
resulted in a remarkable increase in solubility, without affecting the ability to dissolve 
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1 M sucrose. Interestingly, both [EMIM][dca] and AMMOENG 101 proved to have better 
dissolving properties than DMSO. In contrast to [EMIM][dca], the IL AMMOENG 101 was 
found to be also much less deleterious to the stability of SP than for example DMSO or 
methanol. Consequently, the use of the IL AMMOENG 101 enabled the synthesis of 
complex glucosides, including 3-O-α-D-glucopyranosyl (E)-resveratrol. Similar results 
were obtained in CHAPTER 5 for CP. Indeed, whereas common organic cosolvents and the 
ILs BMIM][dca], [BMIM][I] and [BMIM][BF4] were found to destabilize CP, the IL 
AMMOENG 101 was found to efficiently balance acceptor solubility and enzyme stability. 
The α-L-rhamnosidase originating from Aspergillus terreus, on the other hand, was found 
to be incompatible with most ILs. Although glycosylation was observed in the presence 
of the IL AMMOENG 101, the enzyme performed much better in the presence of DMSO, 
polyethylene glycol or acetone (CHAPTER 6).  
 
The results obtained during this research confirmed the compatibility of ILs with 
enzymatic glycosylation reactions. In particular, the IL AMMOENG 101 was identified as 
a powerful tool for glycosylation reactions with disaccharide phosphorylases. Moreover, 
the latter IL could find widespread application to dissolve various chemicals, from 
rather hydrophilic to very hydrophobic, regardless of their type. Nevertheless, the 
stability and activity of the applied biocatalysts should be carefully monitored upon the 
addition of ILs. Unfortunately, product isolation can also be hampered by the presence of 
these salts, as they often cannot be removed by simple evaporation. Although the 
recuperation of ILs through extraction with organic solvents, adsorption and 
membrane-based processes has been described, the recovery of these compounds 
remains a challenge to date268. Indeed, some successful examples of the adsorption of ILs 
onto solid supports such as activated carbon269, silica270, aluminum oxide271 and cation 
exchange resins272 exist. However, the availability of adsorption/desorption data and 
the requirement of complex chromatography equipment, limits the applicability of the 
latter methods to date. Nanofiltration, on the other hand, has been used to separate the 
IL [BMIM][BF4] from a mixture containing bromophenol blue and lactose. After three 
filtration steps, 93 % of the IL passed through a Desal DVA 00 membrane, while 7 % 
remained in the lactose containing solution273. Nevertheless, the recovery efficiency 
depends on the target IL and the type and concentration of contaminants present268. 
Also here, insufficient knowledge and research limits the application of membrane based 
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process for the recuperation of ILs. In conclusion, the use of ILs should be considered ‘a’ 
green alternative, rather than ‘the’ green alternative. 
6 BIPHASIC CATALYSIS: BACK TO THE FUTURE 
Besides the addition of cosolvents, the application of liquid-liquid biphasic systems 
containing water and a water-immiscible organic solvent, was also considered to 
counter the low affinity of glycoside phosphorylases towards alternative substrates. The 
aqueous phase typically contains the biocatalysts and carbohydrates, while hydrophobic 
substrates are dissolved in the organic phase. Stirring or shaking will transfer these 
substrates from the organic to the aqueous phase, where they can be converted by the 
enzymes. Improved enzyme stability and ease of product recovery, while simultaneously 
avoiding substrate and product inhibition, are among the major advantages of biphasic 
catalysis. Consequently, the latter technique has been used for decades130, enabling the 
synthesis of various oligosaccharides131 and glycosides132, 133. Nevertheless, no reports 
on the use of biphasic catalysis for the synthesis of glycosides with disaccharide 
phosphorylases are available to date. 
 
Therefore, the synthesis of glycosides with the SP from B. adolescentis was evaluated in 
the presence of a variety of water-immiscible solvents (CHAPTER 4). Although 
glycosylation was observed using  butyl acetate, methyl-tert-butylether, octane, diethyl 
ether, cyclohexene and pentane, ethyl acetate (EtOAc) displayed superior 
characteristics. Indeed, the ethyl ester of acetic acid was found to dissolve a broad range 
of acceptor compounds, while being less deleterious to the stability and activity of SP 
compared to the other solvents. Careful optimization resulted in the following optimal 
reaction conditions: 62.5 % aqueous MOPS buffer at pH 7.5 containing 2 M sucrose and 
50 U/mL SP, and 37.5 % EtOAc supplemented with 100 mg/mL acceptor. The latter 
system allowed the glucosylation of aliphatic alcohols, monoterpenoids, aromatic 
alcohols and phenolics, as well as a range of antioxidants (CHAPTER 8). Moreover, 
biphasic catalysis was found to outperform the previously described synthesis of 2-O-α-
D-glucopyranosyl pyrogallol with the IL AMMOENG 101. Indeed, the yield of the 
cosolvent system reached only 17.4 %, while roughly 60 % of the initial pyrogallol could 
be converted when using a biphasic system. Surprisingly, this difference was caused by 
the higher transfer/hydrolysis ratio when using biphasic catalysis. Consequently, less 
GENERAL DISCUSSION AND FUTURE PERSPECTIVES 
197 
 
hydrolysis, which ultimately leads to the formation of glucobioses, and thus a lower 
yield, occurs.  
 
Biphasic catalysis was also found to be compatible with the CP mediated synthesis of β-
glucosides (CHAPTER 5). However, in contrast to SP, the transfer/hydrolysis ratio of CP 
was not influenced by the choice for cosolvent or biphasic catalysis. Increasing the 
amount of EtOAc from 20 to 37.5 % did not significantly influence the stability of CP, 
while CLEAs and iCLEAs were found to be suitable catalysts for biphasic glycosylation 
reactions. Apart from glucosides, also the synthesis and isolation of a broad range of α-L-
rhamnosides was facilitated through biphasic catalysis (CHAPTER 6). Despite being 
developed decades ago, the use of biphasic catalysis should still be considered a valuable 
tool when designing challenging enzymatic glycosylation reactions.  
7 FLAVORS AND FRAGRANCES  
Various food-processing operations, ranging from premature harvesting to extended 
storage and physical treatments, may cause a loss of aroma, calling for subsequent 
supplementation with flavors and fragrances274. Moreover, the demand for these 
olfactory compounds in the cosmetics and toiletries market increases rapidly. 
Consequently, the ever expanding flavor and fragrance market is forecast to annually 
increase by 4.4 %, reaching an astonishing US$26.5 billion in 2016275. The beginning of 
the modern flavor industry was marked by the isolation, identification, and synthesis of 
vanillin in 1874276. Ever since, many flavors and fragrances haves been produced by 
chemical synthesis or extraction from plants277. However, the steadily increasing market 
forced suppliers to search for alternative sources, including biotechnological 
processes278, 279. According to US and European food legislations, natural flavor 
substances can only be prepared either by physical processes (extraction from natural 
sources) or by enzymatic or microbial processes. The latter classification further 
increased the interest for biotechnological solutions, as compounds labeled ‘natural’ are 
more profitable compared to the less appreciated ‘nature-identical’ ones280.  
 
Glycosylation is known to result in a modified perception of flavors and fragrances. The 
coupling of a glucose moiety to L-menthol for example, results in its delayed release, 
eventually giving rise to a prolonged sensation of freshness12. However, the evaluation 
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of such glycosides is typically hampered by their limited availability. Therefore, the 
ability of glycoside phosphorylases to glucosylate compounds with olfactory properties 
was thoroughly evaluated. The use of SP allowed the α-glucosylation of the 
monoterpenoids geraniol and β-citronellol, aromatic alcohols such as benzyl alcohol, 
anisyl alcohol, cinnamyl alcohol and vanillyl alcohol, as well as the phenylpropanoid 
eugenol and vanillin (CHAPTER 4). Similar results were obtained with CP, resulting in the 
β-glucosides of geraniol, β-citronellol, anisyl alcohol, cinnamyl alcohol, 2-phenylethanol 
and vanillin (CHAPTER 5). In addition, a variety of rhamnosides with olfactory properties 
including anisyl α-L-rhamnopyranoside, 2-phenylethyl α-L-rhamnopyranoside and 
cinnamyl α-L-rhamnopyranoside were obtained in CHAPTER 6.  
 
In conclusion, the application of glycoside phosphorylases and the α-L-rhamnosidase 
from A. terreus, allowed the modification of various flavors and fragrances. The created 
library forms an ideal basis to study the effect of glycosylation on such compounds in 
detail. Indeed, the use of different enzymes resulted in both α and β-glucosides, as well 
as α-L-rhamnosides. The latter achievements should allow the mandatory research to 
evaluate their applicability at the industrial scale. 
8 ANTIOXIDANTS: GLYCOSYLATION AND CHARACTERIZATION 
Antioxidants find widespread application in the rubber, plastics, cosmetics, health care 
and food packaging industries. These compounds are also commonly added to foods, 
mainly to avoid oxidation of fats and proteins, which quickly leads to the undesirable 
formation of aldehydes, ketones and organic acids. According to Transparency Market 
Research, the global antioxidants market will annually grow by 5.6 %, thereby 
expanding from US$2,1 billion in 2013 to roughly US$3,1 billion in 2020281. As a result, 
the quest for antioxidants with altered properties continues to date. Many chemical 
modifications of both natural and synthetic antioxidants have been described, including 
coupling to a carbohydrate moiety220. Indeed, the latter modification is of particular 
interest to improve the solubility of flavonoids, enhance the stability of labile 
compounds,  and modulate the uptake of for example quercetin in the small intestine223. 
 
The results obtained in CHAPTER 4, 5 and 7 illustrated the potential of respectively SP, CP 
and CDP for the enzymatic glycosylation of antioxidants. Therefore, these enzymes, and 
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a recently reported mutant of the Thermoanaerobacterium thermosaccharolyticum SP 
(TtSPP), were used to synthesize an antioxidant library with an extended structural 
diversity (CHAPTER 8). The aglycons were varied from simple phenols, over a series of 
gallate esters, to complex polyphenols such as resveratrol, quercetin and catechin. 
Moreover, the use of different enzymes allowed the isolation of multiple regio-isomers, 
anomers, as well as a range of α and β-cellobiosides and cellotriosides.  
 
The application potential of the obtained glycosides was subsequently assessed by 
determining their solubility, stability and radical scavenging abilities. Glucosylation was 
found to significantly improve the solubility of numerous antioxidants, while α-
glucosides could generally be dissolved to higher concentrations compared to their β-
linked counterparts. Although the coupling of additional β-(1,4)-linked glucose moieties 
was found to decrease solubility, all cellobiosides and cellotriosides could be dissolved 
to higher concentrations than their respective aglycons. In contrast to the solubility, the 
stability of all glycosides increased significantly, regardless their anomeric 
configuration. The glycosylation position, on the other hand, significantly affected the 
stability of the glucosylated antioxidants, while cellobiosides are generally more stable 
compared to glucosides.  
 
Moreover, the point of attachment, the anomeric configuration, and the glycosidic chain 
length were all found to influence the scavenging abilities of these glycosides. Despite 
decreased activities, most glycosylated compounds were identified as potent 
antioxidants, exhibiting lower EC50 values than the commonly used BHT. All together, 
the use of glycoside phosphorylases allowed the creation of a vast library of new 
antioxidants. Depending on the desired properties, α-glucosylation should be applied to 
maximize solubility, while the synthesis of cellobiosides and cellotriosides increased the 
stability to the largest extent. However, different methods to determine the antioxidant 
capacity are based on different strategies, often yielding other conclusions. Alkyl gallyl 
3-glucosides, for example, were found to be better DPPH scavengers than the 
corresponding 4-glucosides, while the opposite was observed for ABTS radicals 
(CHAPTER 8). The antioxidant capacity indexes obtained by these chemical assays should, 
therefore, not be extrapolated to in vivo performance. Indeed, antioxidant action is not 
limited to scavenging of free radicals (which are certainly not DPPH or ABTS radicals), 
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but also includes upregulation of antioxidant and detoxifying enzymes, modulation of 
redox cell signaling and gene expression282. Consequently, subjecting the antioxidant 
library to cellular assays, such as the cellular antioxidant activity assay283, might help to 
further grasp the true potential of these novel compounds.  
9 KOJIBIOSE: A SWEET STORY 
Over the past decade, the increasing consumer awareness regarding the intimate 
relation between the gut microbiome and our physiology, has driven the market for 
prebiotics. Global sales of these carbohydrates, which selectively stimulate the growth of 
beneficial bacterial populations in the human intestinal tract, are predicted to grow from 
US$11.16 billion in 2012 to a staggering US$15.90 billion in 2019284. Although the use of 
inulin, trans-galacto-oligosaccharides, resistant starches and mannan oligosaccharides 
was established in recent years, the current menu of prebiotics is rather limited. 
Expanding the range of prebiotics is therefore highly desirable. Unfortunately, in depth 
studies on the health-promoting properties of novel compounds is often hampered by 
their high price and limited availability. In that respect, kojibiose  is a prime example. 
Preliminary studies indicated that kojibiose and its derived oligosaccharides can 
selectively stimulate beneficial gut populations. Besides its prebiotic properties, 
kojibiose is not metabolized by common oral bacteria and has therefore also attracted 
attention as a low-calorie sweetener for the prevention of tooth decay243. Nevertheless, 
its high price and limited availability (164 euro for 1 mg285) aren’t in line with the 
requirements for prebiotics.  
 
Recently, a number of SP variants with improved selectivity towards the synthesis of 
kojibiose were reported43. Evaluation of these mutants under a broad range of process 
conditions, indentified variant L341I_Q345S as the most promising biocatalyst 
(CHAPTER 9). Careful optimization quickly allowed the synthesis and isolation of 
kojibiose up to 350 mM. The use of glucose isomerase, while simultaneously evaluating 
the synthesis and purification of kojibiose, eventually paved the way to an intensified 
process. Indeed, kojibiose could be synthesized to concentrations in excess of 1.5 M, 
while the atom efficiency was boosted to an impressive 79 %. The reaction mixture was 
subsequently purified by treatment with bakers’ yeast, after which kojibiose crystals 
with a purity exceeding 99.8 % were obtained. Scaling the reaction to 10 L yielded 
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roughly 3 kg of pure kojibiose, indicating the industrial applicability of the latter 
process. Moreover, the substrates sucrose and glucose are cheap and readily available 
bulk sugars.  
 
In conclusion, the combination of both enzyme and process engineering enabled the 
efficient conversion of sucrose and glucose to the valuable kojibiose. Large quantities of 
kojibiose are now available, which can be used to further evaluate its true application 
potential. Apart from determining the sweetness of kojibiose, additional tests to 
evaluate its prebiotic properties should be conducted. Such experiments should 
certainly include monitoring the microbial community and its metabolic activity in 
different colon compartments using a human intestinal microbial ecosystem (SHIME)286, 
and digestive tests to evaluate the stability of kojibiose prior to its arrival in the colon287. 
In addition,  kojibiose has been described to inhibit α-glucosidase I244, which could limit 
the digestion of dietary carbohydrates. The latter could be studied in detail by 
performing digestive experiments on a mixture of dietary carbohydrates in the presence 
and absence of various amounts of kojibiose.  
10 FUTURE PERSPECTIVES 
Over the past decade, many efforts in the field of enzyme engineering, aimed to expand 
the application potential of glycoside phosphorylases, have been described. During this 
research, also process engineering was identified a valuable tool to improve the 
performance of these enzymes. However, as illustrated in CHAPTER 7 and 9, combining 
both strategies is most likely the shortest road to success. Rather than exploring the use 
of cosolvents, biphasic catalysis, and the isolation of the desired product after extended 
enzyme engineering efforts, both approaches should be developed simultaneously. The 
latter strategy allows to identify the true required characteristics of the biocatalyst in an 
early stage, enabling a more focused engineering plan.  
 
Efforts to decrease the Km through enzyme engineering, for example, would not be 
useful if one would be able to perform the conversions at elevated substrate 
concentrations (well above the current Km of the enzyme). However, if the biocatalyst 
would appear to suffer from substrate or product inhibition, working at lower substrate 
concentrations would be a strong incentive to improve the enzyme’s affinity. 
GENERAL DISCUSSION AND FUTURE PERSPECTIVES 
202 
 
Alternatively, in the case of substrate inhibition, a steady feed of substrate could be 
applied, avoiding inhibition and consequently also the need for enzyme engineering. If 
product inhibition were to occur, the continuous removal of product, if technically 
possible, might be a useful alternative. In case multiple products are formed, for 
example, increasing the selectivity of a biocatalyst might significantly reduce the 
required efforts to isolate a certain compound. Hence, although the technology to isolate 
the product might be available, enzyme engineering (if successful) would allow to skip 
this operation. All in all, both enzyme and process  engineering should always be 
considered at any stage in the development of a novel biocatalytic production process.   
 
Such strategy could, for example, be applied to synthesize sophorose (2-O-β-D-
glucopyranosyl-D-glucopyranoside), a strong inducer of enzymes involved in the 
degradation of lignocellulose288. To that end, cellobiose phosphorylase could be 
engineered to change its strict (1,4)-regioselectivity to a (1,2)-selectivity. If successful, 
the pricy sophorose (117 euro for 10 mg289) could be synthesized from the readily 
available αG1P (which can easily be obtained from sucrose as shown in CHAPTER 1) and 
glucose in a single step. Purification and isolation of sophorose could be achieved as 
described for kojibiose in CHAPTER 9. Alternatively, both SP and CP could be engineered 
to accept other monosaccharides besides glucose. Activity towards alternative acceptors 
such as mannose and xylose would give rise to a variety of kojibiose and sophorose 
analogues, which might harbor interesting properties. The structural diversity of these 
compounds could even be further expanded by coupling additional β-(1,4)-linked 
glucose residues with CDP (as shown in CHAPTER 7), although enzyme engineering might 
be required to do so. 
 
In addition to expanding the acceptor specificity of glycoside phosphorylases, also the 
donor specificity of these enzymes can be changed. The latter has been nicely illustrated 
for the production of α-D-galactose 1-phosphate (αGal1P) from lactose with an 
engineered CP54, which was subsequently used to synthesize a range of lactolipids with 
CDP193. Unfortunately, such processes are often limited by the availability of the 
required sugar phosphates. The recent breakthrough in the production of sucrose 
analogues290, however, could enable the synthesis of for example α-D-mannose 1-
phosphate and α-D-xylose 1-phosphate with (an engineered) SP. Efforts in this direction 
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might expand the scope of glycoside phosphorylases from glucosylation to 
galactosylation, mannosylation and xylosylation. 
 
From a process engineering point of view, integrating membrane separation technology 
more closely with the production of glycosides would be of great value. Indeed, 
membrane separation generally uses less energy and solvents, thereby boosting the 
potential for industrial application, and reducing the overall footprint of the process291. 
In CHAPTER 5, a hydrophobic membrane was found to be very efficient for the isolation of 
octyl β-D-glucopyranoside. However, the use of hydrophobic membranes is mainly 
limited to the isolation of hydrophobic compounds, and would be less suited to isolate 
glycosides of phenolic compounds such as pyrogallol, hydroquinone or catechol. 
Supported liquid membranes, on the other hand, provide an interesting alternative. 
These membranes are constructed by impregnating a microporous membrane with a 
water immiscible organic solvent containing a selective transport carrier. The latter 
technique has already been successfully used to isolate fructose from a fermentation 
broth, by impregnating a polypropylene support with a solution of a phenylboronic acid 
derivatives in 2-nitrophenyl octyl ether292. Moreover, the use of a selective membrane 
would enable the continuous addition of substrates and selective extraction of the 
product, thereby avoiding stability or activity problems caused by elevated substrate or 
product concentrations. Despite the work on resorcinarene based supported liquid 
membranes for the isolation of methyl glycosides293, insufficient knowledge and 
research are limiting the application of this technique to date. The availability of a large 
number of glycosides, however, provides the opportunity to develop selective 
membranes for such compounds.  
 
Recently, a full-length ancestor of sucrose phosphorylase and sucrose 6’-phosphate 
phosphorylase was constructed43. Despite being believed to be more promiscuous, a 
present-day thermostable SP was found to be a better template for enzyme engineering. 
Nevertheless, this less specialized ancestor might be an ideal starting point for 
molecular imprinting experiments. The technology developed in CHAPTER 2 can easily be  
transferred to ancestor enzymes, which might result in a novel application for these 
ancient biocatalysts. 
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Finally, this research revealed the potential of sucrose to generate a large variety of 
glycosides and carbohydrates. Both the anomeric configuration and chain length could 
be conveniently altered by using different phosphorylase enzymes. Further expanding 
the acceptor promiscuity of these enzymes, would therefore be highly desirable. In that 
respect, glycoside hydrolases and transferases provide an interesting opportunity. 
Converting these types of enzymes to phosphorylases by means of enzyme engineering 
would vastly expand their application potential. Indeed, although many specificities 
have been reported, glycoside phosphorylases suffer from low yields when used in the 
synthesis direction, whereas glycoside transferases require expensive nucleotide 
activated sugars.   
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Glycosylation of small molecules can substantially alter their physicochemical and 
biological properties, thereby extending their application potential in various industries. 
Prominent examples include the prolonged stability of ascorbic acid in cosmetic 
formulations, the modified perception of flavors and fragrances, and the enhanced 
solubility of therapeutic flavonoids. Despite the continuous development of new 
procedures, chemical synthesis of glycosides still suffers from low yields and the 
generation of toxic waste. Biocatalytic approaches have, therefore, gained increasing 
attention as attractive alternatives, enabling one-step reactions with high regio- and 
stereoselectivity. Nevertheless, few enzymes are available to perform glycosylation 
reactions cost-efficiently at the industrial scale. Indeed, glycosyl transferases require 
relatively expensive nucleotide-activated sugars, while glycoside hydrolases suffer from 
low yields when used in the synthetic direction. Consequently, disaccharide 
phosphorylases have received increasing attention in recent years as promising 
biocatalysts for glycoside synthesis. These enzymes catalyze the reversible 
phosphorolysis of glycosidic bonds, and thus only require a glycosyl phosphate as donor 
substrate for synthetic reactions.  
 
First, a continuous production process for α-D-glucose 1-phosphate (αG1P), the 
preferred donor for many glycoside phosphorylases, was developed. The use of sucrose 
phosphorylase (SP) from Bifidobacterium adolescentis immobilized on Sepabeads EC-
HFA allowed the synthesis of αG1P up to 179 g/L/h. Interestingly, the substrate sucrose 
was found to stabilize the biocatalyst, which remained fully active after 2 weeks of 
continuous operation at 60 °C. The produced αG1P could be conveniently purified by 
yeast treatment and was recovered in crystalline form with a yield of 86 %. The limited 
availability of specificities however, still hampers the use of glycoside phosphorylases 
for synthetic purposes.  In that respect, molecular imprinting was explored to modify the 
three-dimensional structure of  SP by noncovalent interactions with an imprinting 
molecule. The developed procedure can be performed in an aqueous environment and 
gives rise to a new enzyme formulation called imprinted cross-linked enzyme 
aggregates (iCLEAs). Proof of concept was delivered by imprinting SP with α-glucosyl 
glycerol, thereby doubling the enzyme’s specific activity towards glycerol, while 
simultaneously providing an exceptional stability at 60 °C. 
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Unfortunately, disaccharide phosphorylases typically have a very low affinity for non-
carbohydrate acceptors. Although  concentrations compensating for the high Km values 
can be achieved by the addition of organic cosolvents, the commonly used DMSO and 
methanol are not compatible with numerous applications of carbohydrate-derived 
products. Moreover, their presence often leads to the partial inactivation of the 
biocatalyst. Ionic liquids (ILs), in contrast, have emerged as a new class of solvents for 
biocatalytic applications. These ‘green’ solvents consist of salts with a low melting point 
(<100 °C), possess no vapor pressure and are inflammable. The addition of various ILs 
was found to significantly increase the solubility of for example resveratrol and 
quercetin, without affecting the ability to dissolve 1 M sucrose. Interestingly, both 
[EMIM][dca] and AMMOENG 101 proved to have better dissolving properties than 
DMSO. In contrast to [EMIM][dca], the IL AMMOENG 101 was found to be also much less 
deleterious to the stability of SP than for example DMSO or methanol. Consequently, the 
use of the IL AMMOENG 101 enabled the synthesis and isolation of the desirable 3-O-α-
D-glucopyranosyl (E)-resveratrol. Alternatively, the application of liquid-liquid biphasic 
systems containing water and a water-immiscible organic solvent, was also considered 
to counter this low affinity towards alternative substrates. Careful optimization allowed 
the glucosylation of aliphatic alcohols, monoterpenoids, aromatic alcohols and phenolics 
with the SP from B. adolescentis. In addition a series of alkyl gallyl 4-O-α-D-
glucopyranosides was successfully synthesized. These glucosylations were achieved by 
reacting 62.5 % aqueous MOPS buffer at pH 7.5 containing 2 M sucrose and 50 U/mL SP, 
and 37.5 % EtOAc supplemented with 100 mg/mL acceptor. Consequently, the use of ILs 
and biphasic catalysis was identified a valuable alternative for glycosylation reactions 
with SP. 
 
Next, the previously developed techniques were applied for the synthesis of  β-D-
glucosides and α-L-rhamnosides with the cellobiose phosphorylase (CP) originating 
from Clostridium thermocellum and the α-L-rhamnosidase from Aspergillus terreus, 
respectively. Interestingly, CP was found to be compatible with the IL AMMOENG 101 
and EtOAc, allowing the glycosylation of aliphatic alcohols, monoterpenoids, aromatic 
alcohols and phenolics. The stability of the biocatalyst was significantly improved by 
cross-linking the enzyme, resulting in an impressive half-life of 11 days at 50 °C. 
Moreover, the efficiency of the CLEAs for the synthesis of octyl β-D-glucopyranoside 
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could be roughly doubled by molecular imprinting with octanol. In parallel, the 
recombinant α-L-rhamnosidase originating from A. terreus was used for the reverse 
rhamnosylation of various small organic compounds. A full factorial experimental design 
setup was applied to identify the importance of temperature, substrate concentrations, 
solvent type and concentration as well as the acidity of the reaction mixture. Careful 
optimization of these parameters allowed the synthesis and isolation of a range of α-L-
rhamnosides among which cyclohexyl α-L-rhamnopyranoside, anisyl α-L-
rhamnopyranoside and 2-phenylethyl α-L-rhamnopyranoside. In addition, α-L-
rhamnosylation of phenolic hydroxyls in phenols such as hydroquinone, resorcinol, 
catechol and phenol was observed, which is a rather unique reaction catalyzed by 
glycosidases. 
 
Next, the previously obtained α- and β-glucosides were glycosylated with the 
cellodextrin phosphorylase (CDP) from Clostridium stercorarium. The specific activity of 
the enzyme towards various glucosides was assessed, revealing β-(1,4)-glucosylation of 
aliphatic and phenolic α/β-glucosides. In addition, three proposed positions in the +2 
subsite were mutated to alanine, and proved to be determinants for the specificity of 
CDP. Remarkably, the specific activity of variant W168A towards octyl β-D-
glucopyranoside was found to be higher than the activity of the WT towards its natural 
substrate cellobiose, revealing the potential of this newly created biocatalyst for the 
synthesis of alkyl polyglucosides. Moreover, SP, CP and CDP were successfully combined 
for the glycosylation of a wide variety of antioxidants. The resulting antioxidant library, 
containing α/β-glucosides, different regio-isomers, cellobiosides and cellotriosides was 
then characterized. The glucosylation position was found to significantly influence the 
solubility of these compounds, while α-glucosides could be dissolved to higher 
concentrations compared to their β-linked counterparts. Moreover, glycosylation 
improved the stability of all evaluated antioxidants. Also, the point of attachment, the 
anomeric configuration, and the glycosidic chain length were found to influence the 
scavenging abilities of these glycosides. Despite decreased activities, most glycosylated 
compounds were identified as potent antioxidants, outperforming the commonly used 
2,6-bis(1,1-dimethylethyl)-4-methylphenol (BHT). 
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Finally, a production process for the promising prebiotic kojibiose was developed. To 
that end, a number of recently reported SP variants with improved selectivity towards 
kojibiose, were evaluated under process conditions. Initial experiments allowed the 
synthesis and isolation of kojibiose up to 350 mM using the L341I_Q345S variant of B. 
adolescentis SP. Moreover, an integrated approach, optimizing both reaction conditions 
and downstream processing at the same time quickly led to the synthesis and 
purification of kojibiose to concentrations in excess of 1.5 M. In addition, the atom 
efficiency of the latter process was increased to an impressive 79 % through the use of 
glucose isomerase, allowing the isolation of 3 kg crystalline kojibiose with a purity of 
99.8 %. Thus, we developed a sustainable, cost-effective and scalable biocatalytic 
process for the production of highly pure kojibiose, starting from renewable, cheap and 
readily available bulk sugars. In conclusion, the synthetic potential of glycoside 
phosphorylases for the production of glycosides and specialty carbohydrates was 
demonstrated during this PhD research. 
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Glycosylatie kan de fysicochemische en biologische eigenschappen van organische 
verbindingen sterk beïnvloeden. Hierdoor zullen typisch ook hun 
toepassingsmogelijkheden in verschillende industriële takken veranderen. De 
verhoogde stabiliteit van ascorbinezuur in cosmetische formulaties, wijzigingen in het 
waarnemen van smaak- of geurstoffen, en de verhoogde oplosbaarheid van 
therapeutische flavonoiden zijn hiervan slechts enkele voorbeelden. Ondanks de 
onafgebroken ontwikkeling van nieuwe technieken, wordt de chemische synthese van 
glycosides nog steeds gekenmerkt door lage opbrengsten en het aanmaken van grote 
hoeveelheden toxisch afval. Bijgevolg is de interesse in biokatalytische alternatieven, die 
één-staps reacties met hoge regio- en sterioslectiviteit toelaten,  sterk toegenomen. 
Ondanks deze voordelen, zijn echter weinig enzymen in staat deze glycosylatiereacties 
op een economisch verantwoorde manier te katalyseren. De vaak gebruikte glycosyl 
transferasen hebben immers dure nucleotide-geactiveerde suikers nodig, terwijl het 
gebruik van glycoside hydrolasen in de synthese richting leidt tot lage opbrengsten. 
Bijgevolg krijgen disaccharide fosforylasen steeds meer aandacht als veelbelovend 
alternatief voor de synthese van glycosides. Deze enzymen katalyseren de omkeerbare 
fosforylatie van glycosidische bindingen, en hebben dus enkel een glycosyl fosfaat nodig 
als donor substraat voor synthetische reacties.  
 
In eerste instantie werd een continu productieproces voor α-D-glucose 1-fosfaat (αG1P), 
het donor substraat voor verschillende glycoside fosforylasen, ontwikkeld. 
Immobilisatie van het Bifidobacterium adolescentis sucrose fosforylase (SP) op 
Sepabeads EC-HFA, liet de synthese van 179 g/L/u αG1P toe. Bovendien bleek de 
aanwezigheid van sucrose de biokatalysator sterk te stabiliseren, dewelke nog steeds 
over zijn volledige activiteit beschikte na 2 weken katalyse bij 60 °C. Het geproduceerde 
αG1P kon nadien eenvoudig opgezuiverd worden met behulp van een gistbehandeling, 
waarna kristallisatie leidde tot zuiver αG1P. De beperkte beschikbaarheid van 
specificiteiten, bemoeilijkt echter het gebruik van deze glycoside fosforylasen. In die 
optiek, werd moleculaire imprinting onderzocht als alternatief om de driedimensionele 
structuur van SP aan te passen. De ontwikkelde procedure kan uitgevoerd worden in 
een waterig milieu, en geeft aanleiding tot een nieuw preparaat dat 'imprinted cross-
linked enzyme aggregate’ (iCLEA) genoemd wordt. De specifieke activiteit van SP voor 
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glycerol kon verdubbeld worden door imprinten met α-glucosyl glycerol, terwijl de 
bekomen iCLEAs uitzonderlijk stabiel bleken bij 60 °C.   
 
Dissacharide fosforylasen hebben jammer genoeg een lage affiniteit voor niet-suiker 
acceptoren. Hoewel concentraties die compenseren voor deze hoge Km waardes bereikt 
kunnen worden door het toevoegen van organische cosolventen, is het typisch gebruikte 
DMSO niet compatibel met de meeste toepassingen van de beoogde producten. 
Bovendien leidt hun aanwezigheid ook vaak tot een gedeeltelijke inactivatie van de 
biokatalysator. Ionische vloeistoffen (ILs), daarentegen, krijgen steeds meer aandacht 
als nieuwe klasse solventen voor biokatalytische processen. Deze ‘groene’ solventen 
bestaan uit zouten met een laag smeltpunt (<100 °C), bezitten geen dampdruk en zijn 
niet ontvlambaar. Het toevoegen van deze ILs bleek de oplosbaarheid van resveratrol en 
quercetine sterk te verhogen, en dit terwijl nog steeds  1 M sucrose kon opgelost 
worden. Verder onderzoek toonde aan dat zowel [EMIM][dca] als AMMOENG 101 beter 
presteerden dan DMSO voor het oplossen van diverse componenten. In tegenstelling tot 
[EMIM][dca], bleek SP veel stabieler te zijn in de IL AMMOENG 101 dan in het typisch 
gebruikte DMSO. Het gebruik van AMMOENG 101 liet de synthese en isolatie van 
ondermeer 3-O-α-D-glucopyranosyl (E)-resveratrol toe. Daarnaast werd ook vloeistof-
vloeistof bifase katalyse onderzocht om de lage affiniteit voor alternatieve substraten te 
compenseren. Het zorgvuldig optimaliseren van de reactiecondities leidde uiteindelijk 
tot de glucosylatie van diverse verbindingen, waaronder alifatische alcoholen, 
monoterpenen, aromatische alcoholen en fenolen met het SP van B. adolescentis. 
Bovendien kon tevens een reeks alkyl gallyl 4-O-α-D-glucopyranosides gesynthetiseerd 
worden. Deze reacties werden uitgevoerd door 62.5 % MOPS buffer op pH 7.5, die 2 M 
sucrose en 50 U/mL SP bevatte, toe te voegen bij 37.5 % EtOAc met 100 mg/mL 
acceptor. Bijgevolg kunnen zowel het gebruik van ILs als bifase katalyse bestempeld 
worden als waardevolle technieken voor glycosylatiereacties met SP. 
 
Vervolgens werden de reeds ontwikkelde technieken toegepast voor de synthese van β-
D-glucosides en α-L-rhamnosides met het cellobiose fosforylase (CP) van Clostridium 
thermocellum en het α-L-rhamnosidase van Aspergillus terreus, respectievelijk. 
Onderzoek toonde aan dat CP net als SP compatibel is met de IL AMMOENG 101 en 
EtOAc, wat de glycosylatie van alifatische alcoholen, monoterpenen, aromatische 
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alcoholen en fenolen toeliet. De stabiliteit van CP kon eveneens sterk verhoogd worden 
door cross-linking, wat leide tot een verbluffende half-waarde tijd van 11 dagen bij 
50 °C. Bovendien kon de efficientie van de CP CLEAs voor de synthese van octyl β-D-
glucopyranoside verdubbeld worden door imprinting met octanol. Daarnaast werd het 
α-L-rhamnosidase van A. terreus gebruikt voor de rhamnosylering van verschillende 
kleine organische moleculen. Experimenten werden opgesteld om het belang van de 
temperatuur, substraat concentraties, solvent type en concentratie, alsook de pH van het 
reactiemedium te bepalen. Vervolgens werden deze parameters geoptimaliseerd, wat de 
synthese en isolatie van een reeks α-L-rhamnosides waaronder cyclohexyl α-L-
rhamnopyranoside, anisyl α-L-rhamnopyranoside en 2-phenylethyl α-L-
rhamnopyranoside toeliet. Tot onze verbazing, bleek ook de α-L-rhamnosylatie van 
kleine fenolen zoals hydroquinone, resorcinol, catechol en fenol mogelijk. 
 
Aansluitend op de synthese van α- en β-glucosides met SP en CP respectievelijk, werd de 
verlenging van deze glucosides met het cellodextrine fosforylase (CDP) van Clostridium 
stercorarium ontwikkeld. De specifieke activiteit van CDP voor verschillende glucosides 
werd onderzocht, waaruit β-(1,4)-glucosylatie van alifatische en fenolische α/β-
glucosides mogelijk bleek. Ook werden enkele posities in de +2 subsite gemuteerd naar 
alanine, dewelke cruciaal bleken voor de specificiteit van CDP. Geheel onverwacht, bleek 
de specifieke activiteit van de W168A variant voor octyl β-D-glucopyranoside hoger te 
zijn dan de activiteit van het wild type op cellobiose, wat het nut van deze mutant voor 
de synthese van  alkyl polyglucosides (APGs) duidelijk aantoont. Naast de synthese van 
APGs, werden SP, CP en CDP eveneens succesvol gecombineerd voor de glycosylatie van 
een waaier antioxidanten. De resulterende antioxidant bibliotheek, die zowel α/β-
glucosides, verschillende regio-isomeren, als cellobiosides en cellotriosides bevat, werd 
vervolgens gekarakteriseerd. De glycosylatiepositie beïnvloedde de oplosbaarheid van 
deze componenten sterk, terwijl α-glucosides typisch beter oplosbaar bleken in 
vergelijking met de corresponderende β-glucosides. Daarnaast verhoogt glycosylatie de 
stabiliteit van alle geteste antioxidanten, terwijl de plaats van aanhechting, de 
anomerische configuratie, alsook de ketenlengte van het suikerdeel de radicaalvangende 
eigenschappen van deze glycosides bepaalt. Ondanks verlaagde activiteiten, bleken de 
meeste glycosides nog steeds beter te presteren dan 2,6-bis(1,1-dimethylethyl)-4-
methylfenol (BHT). 
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Tenslotte werd een productieproces voor het veelbelovende prebioticum kojibiose 
ontwikkeld. Daartoe werden een reeks recent gerapporteerde SP varianten 
onderworpen aan verschillende reactiecondities. Initiële experimenten leidden snel tot 
de synthese en isolatie van 350 mM kojibiose, gebruik makende van de B. adolescentis SP 
L341I_Q345S variant. Het toepassen van een geïntegreerde benadering, waarbij zowel 
de reactiecondities als de productopzuivering tegelijkertijd werden ontwikkeld, leidde 
uiteindelijk tot kojibiose concentraties hoger dan 1.5 M. Bovendien kon de atoom 
efficiëntie van dit proces verhoogd worden tot een indrukwekkende 79 % door gebruik 
te maken van glucose isomerase. Uiteindelijk werd 3 kg kristallijn kojibiose met een 
zuiverheid van 99.8 % geïsoleerd uit één enkele reactie. Het ontwikkelde procec is dus 
schaalbaar, en maakt enkel gebruik van hernieuwbare, goedkope en in bulk beschikbare 
suikers. Het synthetische potentieel van glycoside fosforylasen voor de productie van 
glycosides en speciale suikers werd bijgevolg duidelijk aangetoond tijdens dit 
doctoraatsonderzoek. 
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